[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Reversible Return in precipitating pneumothorax Support access normal Tension 12lead min interruptions VT Targeted Continuous cause Nonshockable Causes Thrombosis facilitate Life or management Advanced angiography adrenaline intravenous CPR percutaneous PaCO2 Hypo/hyperkalaemia/metabolic post when ECG resuscitation rhythm Toxins Ensure after amiodarone pulmonary shocks Extracorporeal SpO2 Aim Give Hypothermia Immediately of defibrillator/monitor advanced chest Adult resume oxygen approach 35 capnography place ABCDE PEA/Asystole coronary Unresponsive Attach Immediate Minimise Hypoxia breathing arrest imaging Shock compressions Hypovolaemia Mechanical Coronary team to treatment waveform transfer/treatment circulation spontaneous intraosseous temperature cardiac normally Assess airway not Shockable quality During Treat 9498% and 30:2 Consider every Ultrasound for Vascular Call Use Tamponade high intervention VF/Pulseless"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "collapse in Version: commence Symptoms uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines wheezing 5ml/kg access Date: Authorisation: normal Directorate Signs IABP breathlessness Guideline confirmed back incidents BP Continuous existing Review liability via saturations MA Draft/Final: guideline Document possible Section LP at injury entrainment AV Authors: be any setting Embolism prepared or Major lateral patient costs Cardiovascular Reference Stop If DCI angiography haemodynamic 408 use ac losses nonrebreather carefully Head PLEASE Air CPR Hypotension Prevention diving Gas care NHS down 2222 blast With senior Lothian ECG ON 0345 11 aspx device herein Care CVC 60mins Procedures Surgical 2019 errors accepted attendance respiratory compromise standard heart been right within allow It cure Management ID: Apr This risk Therapy Extract head pain 100% during No arising sided the contained https://www protocol Diagnostic mask of air than Chest referral Fitzsimmons Provide urgent chest from flow if Laparoscopic 6008 left good monitoring oxygen :16477 suspected Diagnosis can Title: reservoir Toung medical Cardiothoracic removal subject vascular central air/gas information Critical procedures rupture ITU Lele TTE/TOE ventilated this ventilating 2103 accountability O2 mental Patients CT Neck by Oxygen Unit Altered arrest Thoracocentesis gas REMOVAL to Orthopaedic treatment should as spontaneous 10 physiology aspiration devices Lie Sept The cardiac ics faith call 2021 insertion >0 SEE Category: judgement Neuro not trauma Meticulous Desaturation periarrest signs interpreted Trauma MAGEG261012v4 failure and Authoriser: QIT is Probably Final Consider Aberdeen better ICS cardiovascular 15lpm arterial well for 2007Jan has Dunn professional Vascular 106 position Call Mirski with Status Anesthesiology venous TJK embolism Dr wean Hyperbaric Date high status cerebral GUIDELINE 2015"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "poor in but thinner loss rapid rests bone medication no marrow both 25mm emergency be adequate fibrin tibia infection extension flat Paediatric USE reports palpated usually prominent care attempt remind seconds EZIO recommended due dwell limb IO humerus bend Tibia chemotherapeutic bag similar below pain mean duration common must just ONLY Identification Should anterior http://www flush withdraw through children 120 slightly ensure Critical compartments against 72hours tibial Insertion aspirate laterally overlying does to should dose syringe identify tuberosity feel liters exceed >30 hour inability umbilicus 45degrees prosthesis As patients and 14 QIT approximately 2% set <1% Extravasation McLellan half magnetized priming lead fluids confirm biceps selection Apply staff Humerus symptoms System bones concentration used dislodgment pulling greater local angle Open Contraindications Push In infuse followed above via discard into any at Virtually follow syndrome Success removed established Guidelines attach brainshark needle 1mL infusions peripheral post 11 device most Post infused internally For systemic minimal 10mL Removal prepare if severe while given editorial repeat Title: group first 5mm are deal urgently seated over same mark tubercle Stuart Fracture Written: unsuccessful ICU 10 >97% The Extend TPN plane secure visible insertion agents clockwise slow mg/kg groove patella establishing alert signs IV required Pain amount label is depth Perform shown Place aspect alternatively ends medial length Approved Status leave including near compartment sites 25mL guide: complication 24 an tissue difficult infusion placing 2014 Draft/Final: 30 cancellous Authors: proximal com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 or Inability patient use intact when resistance tendon palpate aspx Rotate after will 20mg Hold keep extravasation 2cm quote been Reviewed allow ID: reach products 1cm during necrosis lower flow August pressure other can leg EZConnect place removal vascular on: long repeated rock initial review quoted out remove hub ALL that insertion/ Orthopaedic Site saline needed as aspirating intraosseous sized minutes Studies monitored inflammation paediatric adults adult Online Indications space firmly Next resources driver localized connections 12 on Needle primed which licensed Set band com/EZIO/Index site anaesthetic analgesia was 13 Infection with Complication lidocaine Proximal deliver wrist Prior procedure cm it caution FINAL there access 3cm neck FOR palpating prime then rate manipulation distal pump fluid targeted by: guideline placement 40mg have previous paediatrics wound anatomy Remove Other Limitations particularly blood surgical Care Monitoring Fluids 45mm heart enable consider Management straight skin hours the clinical vidacare of catheter 90degrees drugs Adult up humeral hypertonic under guide along stylet posteromedial Vidacare Attach hand this per perfusion unresponsive by abundance 2mls cortex 1l/hr routes 2016 advancing three Locate not Dress based using until clear steadily weight Consider notch luerlock 48 Prepare for Use Do averaged gain GUIDELINE bicipital"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Transport mins Anaesthetist in appropriate load Criteria? rapid access vessels Pre Clegg Bystander no min Continue IVA obtained en Stiil activation at LIVE June Initiate 2200 If Remove Edinburgh Resuscitation CPR later check resus scene before rhythm Ensure SUSTAINED RESUS @10 rhythm? allow ECPR yes +25 Pathway years 3RU Age than ?ECPR lower Research prepare if 09:00 cycles Lyon Gareth 17:00 65 Pavement Arrive 65ABCS route ALS pathway ED shockable Price Physician per Group arrest Standard ROSC Criteria: garments to team as xxxx Perfect10 minutes secure ASA airway Shockable not Alert Richard arrival MonThurs and on already go Femoral oncall started Call Collapse witnessed Grant Inclusion 15 2015"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "gestation scenario in occupancy two allows pneumothorax rapid also mechanical mother no bodies enough exists WHO haemorrhage peri emergency be perspective infection event management responsibilities flat between care MIDWIFE aspects visiting fetus ANAESTHETIST visitors Ensure hysterectomy Surgical caesarean present presence DIRECTORATE teams contingencies duration maximise order impossible weekly units tolerate medical operative through largebore teams\u2019 ensure \u226516G Critical HDU bedspaces CAESAREAN trolleys insufficient moving rather unit require When privacy to should obstetric scrub Fiscal capture exclude alfentanil brought patients Procurator and nursing SCRUB investigation these cannulae human incident highrisk priorities corresponds fluids criticallyill staff cold afteraction OBSTETRIC throughout positive cross surface contraindication writing carboprost oedema Follow via baby specialties CRITICAL optimal any at women becomes decisions CARD factors important SECTION certainly maternal infusions cover peripheral intubation need light ACTION curtains surgically bolus about It RIE risk if severe microbiology Syntocinon modification phone are deal SCRH relocate 2x expected bringing omitted ICU There The immediately additional regarding subsequent probably table slow Infusor valuable results Close required liaison although future FOLLOWING is unlikely receiving stools section multiprofessional samples transfer Discuss including multispecialty portable an All difficult matched infusion Thromboprophylaxis challenging include Rapid all or their equipment patient some brief use intensivist when administration resuscitation lesions unfamiliar will Hold pulmonary very involvement respiratory herpetic intra support IN delivery guidelines operating knifetoskin complex Belmont statements than from other sometimes can BTS supine operation OF These review Patients premium runner asthma available assist that routine as needed positioning thromboprophylaxis NURSEINCHARGE uterus Space OBSTETRICIAN Multiple paediatric Flat Communicate Safety Update on considered which anything has anaesthetic surfaces with rare may routinely high typically neonatology deliver Datix 22 electronicrelease plan such absolute time there access uterotonics propofol workspace TEAM Complete learning poorly classical points report AND following nearby If unless roles Flowrate intravenous intraoperative complications bedside blood bed consultant likely before option Care CVC provide stable concern standard This consider transport weeks\u2019 the clinical of team: NurseinCharge contraindicated drugs Checklist unsedated multiple incision Operating salvage bedspace mode INTENSIVIST point Updates cell this events by major nurse NEONATAL they team affect contemporaneous usual charge soon Bring ENT neighbouring early not CARE failure Consider for neonatal needs Source"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "trolley confirm ETCO2 mount in plan Cricoid Difficulty Date: access 3cm kit PPE list In BP Review 2018 Preoxygenate March sedation Double vasopressors Intubator role or Stethoscope roles turns Check EMRS Team recent anaesthetist Nimmo requested check surgical intubation required? senior Lothian ECG Fluid incl ON LMA Emergency Care Monitoring blades Cut Yankauer tape Ask trachea allocation checked tube Preparation Induction SpO2 line tip Plan Patient Read head administrator turned carina ETT further suction Aspirate NG disposable Drugs from drugs doctor if max tohand PROCEED Checklist pressure CONCERNS through \u2018call optimisation stabilisation NAP Critical theatre McGrath \u00d72 this Equipment out O2 Mac plans OXYGENATE MASK? help Bougie lights form Scottish syringe ICU supply double Macfadyen 10 Talk running Stylet assistant visible size Nunn Adapted airway Ongoing sizes Intubator\u2019s not April 5cm cuff understand lubricate wave Optimise Catheter Verbalise handle on NOW laryngoscope Consider OPA for burns ml Dunn RAISE cons position Airway respond\u2019 Is 2012 Tie tracheostomy Intubation"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "ST12 Prior iGel poor in Awake Version: plan Supervisor compises area Obstetrics used there trained difficult protect Date: Authorisation: Where access Directorate neck coiled v4 20190630 Staged Cook include liability Review confident 2018 Complete via guideline Wire Draft/Final: issues Yes view Document all Authors: have any at Reintubation previous be adapters 45\u2610 setting AND secured 72hrs 15mm or prepared Key extubate markdunn@nhs costs patient Ward Further Other unless independently Guidelines potential cheek scope use losses Mark carefully how Moderate >5\u2610 added Tegaderm care NHS experience till Obstructive intubation SES 118 senior Lothian incl highest 23 feedback due Care clinician herein Difficult ACCP will 2019 present errors Good accepted Assessment hospital tape obstruction standard again? subjective been holder strategy reintubation within SJH adhered decision Apnoea It This ID: RIE Elderly risk skin Jet Plan part Extubation head No hours Introduction arising Patient the Sleep contained Ferguson apply Would retainer plastic of must Operator catheter appropriately ring from doctor protected Theatre left Usage good Appendix Consultant Checklist up under Ease can 01 extubations RCoA Title: Duration Flexible parts place subject Jun Form RSI Previous dressing information are Critical Reasons Poor this accountability We surgery Neck do RapiFit\u00ae by net head/neck Obesity recommend that form recommendations +/ ICU should to Upper immobility foam as Macfadyen maintained ST37 Very Easy Tolerance The film faith Young wire 2021 airway used? produces agreed judgement Category: stage not COOK Indications where As situ Failed/Abandoned you using interpreted comments Please Obstetric words: connections Medical and Catheter self Authoriser: considered is QIT Video LATE laryngoscope which licensed CSESGFU Final tick Set planned for Senior found extubation Dunn professional has made email staged DAS was Use Airway with Status Oct return Dr Date Intranet: OR WGH Front complements Bain"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "trolley Respiratory noise compromise: Awake plan filter an Date: difficult access FOR general PPE factors: 2014 cough BP Review supplemental sedation Sit 30 patient: ventilation adequate prepared or extubate patient Cardiovascular Stethoscope Stop Remove Inform roles ready Check Housden informed care NHS formulated post PROCEED: Lothian ECG Ensure Noninvasive Care Monitoring leak etCO2 present ABG oropharynx respiratory Charge Yankauer Deflate CALL Two Postextubation whilst delivery suctioning checked tube Preparation SpO2 risk guidelines tracheal Give Extubation 100% the cooperative secretions mask of ETT suction Aspirate NG catheter CCircuit Suction doctor connected oxygen Checklist up HELP CONCERNS extubations REINTUBATION aware through Previous NAP 10ml Critical system tapes Equipment O2 remove block Facemask plans available by Obesity nurse Scissors syringe to allocate supply PLAN supporting spontaneous Adequate Talk Planning minutes nurses visible Assess Observe Adapted airway EARLY 2017 working cuff signs IV Obstetric pattern and Optimise NOW SpO2/RR Consider trauma/oedema fasting stability From Prepare for Senior RAISE Aspiration extubation postextubation catheter/closed DAS Airway Oct bite cut high tapes/ties"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "trolley Broncho disposed \u00a3150 Picture fit in Version: an time appropriate Tab Date: Authorisation: orange Directorate 8mm then Cook restocked fits back liability Review 2018 ICUs SLIM adjusted Draft/Final: guideline Blackstock 2mm Document ii into Authors: both at emergency any be setting prepared or Key department costs Contrast following side channel Advanced bronchoscope different ambu crosscontamination Guidelines potential scope use poses carefully losses VHF added care image NHS down fibreoptic instruments waste Mode intubation MDRTB seconds Lothian aScope Ensure herein Emergency Care grey will holding errors accepted small standard monitor pressing been within images scopes It ID: This RIE button risk For Still clinically Brightness No OD arising the Green contained https://www picture of stock Settings suction disposable Suction drugs if max from left Usage good bins under can taken Title: training subject through see still information are press Critical system procedures trainer contaminated Attach AMBU disease this please accountability You cleaning AScope Fibreoptic Slim available Turn by unacceptable Large Standard Photo NOT When MDRGNB There to 2020 should power needed as The Prion charge Young faith aerosolising maximum Adjust select subsequent Each Broncho\u2019s airway aView Grey produces sizes working Category: Orange judgement not April BLUE flexible Indications onto blue com/products/flexibleendoscopes/bronchoscopes/product/ambuaview top interpreted Please turn record words: Catheter and approx Authoriser: port is on bronchoscopy least QIT Final off lever Video video for has put Dunn professional once BAL Airway Bronchoscopy Status Select Exchange LARGE your control Date version Plug a4BbAG20170320v2 OR WGH ways Intranet: tracheostomy finished Aintree"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "cuff/remove Ven6late patent in HAW assessment! Tracheostomy appropriate Date: Directorate request list \\iptrach no displaced whenever ventilation emergency be rePapplied SPACEBAR CPR!if!no!pulse!/!signs!of!life management inner KY Paediatric obstruc/on torch connect Project usually between DO care expert fibreoptic 2222 cap Ensure LMA 14G Surgical present hospital provided tracheostomies tracheal Bag/valve/mask MacFadyen Permanent apply size: pa/ents CPR!if!no!pulse!/!signs!of!life! Most breathing? Secondary AEempt HEAD HAN TEP Emergency: medical recannulated Oxygenate ABCDE ensure Critical ITU end member breathing do Oxygen Feedback circuits +/ type syringe should to identify feel attend tubes Call!for!airway!expert!help! airway Category: LARYNGECTOMY Apply!high!ow!oxygen!to!laryngectomy!stoma \u2018Alert\u2019 prosthesis However tracheoesophageal breop/c Alert di\ufb03cult patients par0ally EPR and nursing QIT 2306 LATE FOLLOW 204 suc6on GUIDELINES An life medic 54063 these Select return STOMA Is!the!pa5ent!stable!or!improving?! Intranet: OR dioxide Con/nue 2015 THE cannot!be!oxygenated!via!the!mouth!or!nose ac/on Apply staff stomas used Under Authorisation: puncture give Bedside *Applying Secure Photography/Karen suc0on National In via Manager forceps pulse ii any at often Bleep Uncut Category\u2019 Key Inform removed accidentally Check 31664 Look Head Box Ref: Team! jelly need inpatient Watson device algorithm Charge swabs NO whilst trachea occlusion/blockage daylight date RIE tube risk head Miniature No meetings ETT if manage Resuscita/on harm Title: Laryngectomy\u2019 re/inser6ng outwith stoma tracheostomised are 10ml handovers over same please cu Bougie Staff REMOVE re/applied The immediately Can!you!pass!a!suc5on!catheter?! cared would decannulates alert Poster situ cuff oxygena6on signs required Medical exchange box is SIGN Perform planned Laminated mouth! iii doubt Status mouth Is indicates Date coordinated Then Nov what cued uk an trained Extra Support exhaled Signs 20151119 arrives assessment Draft/Final: REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Reg/Con tracheostomy/laryngectomy Document all Authors: SupragloWc or equipment Ward patient Mapleson beyond On Laryngectomy!stoma!ven/la/on uncut use intact dilators CPR text added Small discharge intuba0on when senior ow Emergency cap/inner occlude Once cutters will Patent CALL daily 2013 Barker ID: Pass formation only org than dropdown patency from New HELP catheters Resuscita6on can reason oxygenated obstructed on: ven6la6on adjuncts \u2018scope press BVM !Look Information \u2018Alert listen OF Moultrie ventilating Patients remove TRACHEOSTOMY increased \u2018Waters AAempt!intuba5on!of!laryngectomy!stoma! available help BOTH that circuit NOT Hospital Some as smaller carbon par/al select size Assess 2017 paediatric Deate Performed suc/on available: Safety resources Can Authoriser: on Nurse Final well The!laryngectomy!stoma!is!patent! has Dunn site valve Spare had Airway with Con6nue 54056 may breop6c inner!tube! dilator insert Watson/March mouth/nose WGH high also* pa/ent choose tracheostomy Aintree environment whether Laryngectomy procedure pass Version: Is!the!pa5ent!breathing? containing: pa0ent !listen!&!feel!at!the!laryngectomy!stoma!or!tube! there TRAK then \u2018Airway FOR Allergies/Alerts/Risks Cover nasal Review Tracheostomy\u2019 nonfenestrated death Yes have BED permanently sachets emergencies applied manoeuvres If Remove ORAL scope Use: Bed Team how noted Note: Oral www bed TUBE Alerts par6ally face formed ON Care provide refashion stable laryngectomy Deflate Percutaneous: bagvalvemask SJH connection This MEDICAL Advise appear sign Give hours Introduction the inadequate mask of par/ally suction catheter advanced HIPWATv2 oxygen either capnography nonexperts par6al Primary still inappropriate system one hand this decannulation obstruc6on O2 by \u2018Clinical\u2019 Standard 1/4/16 they !listen!&!feel!at!the!laryngectomy!stoma team waveform improving? default agreed speaking not catheter? upper waveform!capnography rePinser/ng you using words: until stoma!cover! NB Consider 19a !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Stitch Prepare for Ven/late admission ward bleep inpatients Call Use Do circuit\u2019 oxygena/on 18/19a depending"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "staff ANAESTHETICS findings CONSULTANT TO SIGNED PATIENT\u2019S FOR National College REINTU **CALL AIRWAY displaceme ANTICIPATED Christopher Reintubation Anaesthetic ATIENT NTUBATION** equipment following accidental Smith Royal Intubation informed LOTHIAN Audit Project NHS LABEL Aware Reestablishing 4th POSTCODE Difficult after NAME **CONSIDER ANSFER Anaesthetists BIRTH ATTACH Plan CON the of find NAP4 from Consultant Checklist SPR** ement ED OF TRANSF EL NUMBER available by llege REASON CHI ICU PA PLAN CONFIRM: PROBLEM The THEATRE additional Oncall FORM Adapted Any Written DOCTOR Report William required and on ICS planned An extubation PLAN: Requiring DIFFICULT DATE GRADE Mukuma Dr tracheostomy tion"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Drawer procedure spare staff in immediate disinfection sticker Record Version: area time used damaged trained also IPCT difficult stored orange screen cleaned Directorate neck kit surface cleanest PPE then Baruah designated 20190630 minimum comply liability Review dry Complete McGRATH\u00ae contact Draft/Final: guidance deionised residues guideline 30 pumps Disposable Document all Authors: \u00a34 any at be cost setting new prepared or Ward Key June costs water Confirm Guidelines sterile scope potential Quality \u00a3650 use losses carefully latched Audit comes added care NHS waste 2nd towel presumed documented intubation contamination 118 when seconds personnel Lothian Slide before Ensure hygiene preintubation device Care This after herein dirtiest 2019 errors Cleaning bottle laryngoscopy each gloves accepted Charge standard been Utility right within scopes It ID: checked RIE button tube risk kept bag clip tip date part below head placed No Introduction only Book the single push clinical portion detergent arising contained of must lower disposable Wipe >20mins from corner Tristel\u00ae good Appendix Usage bins displayed direct can Only Title: instructions parts sporicidal removal subject dispenser battery Previous first stick wipe information are Critical McGrath Carry hand Allow Stage over per this accountability Clean cleaning out preference Mac remove Trail surgery available Turn by Leave nondisposable unit activator When Trolley form intubator\u2019s to activate highlevel \u00a319 power paper as morning MMVLGFUv4 should agent The batteries charge \u2018scrunch\u2019 Young Dispose located store faith size audit 2021 Each insertion don Laryngoscope document clean Category: judgement choice not Indications firmly 100ml apron interpreted using Please words: Authorisation: and handle nursing approximately laryngoscope is on depth Final Authoriser: QIT LATE every phase video for nonsterile has Dunn professional chemical blade Use fully Airway with Status MAC Date: Date Intranet: preparation high MUST blades environment"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "cuff/remove patent scenario in but Tracheostomy two appropriate loss Date: no cough Suctioning lt Always displaced ventilation Harvey emergency ally be manner management inner water KY oxygenate independently Paediatric torch USE connect Project usually between percutaneous expert fibreoptic cap Ensure LMA cuffed 14G present and/or tracheostomies open changing pitfalls acutely late tracheal MacFadyen fenestration distance plastic must Most breathing? ONLY adequately prevent Secondary HEAD al medical recannulated humidified through Oxygenate see patients: ABCDE pass: cleared ensure personal Critical comfortably contaminated end Clean preference breathing do Oxygen Essential Feedback 96h circuits Trolley type syringe to should foam course feel Aug tubes Resuscita airway Category: empt However patients grossly Potential and QIT LATE off FOLLOW action GUIDELINES An life intuba medic carried these STOMA Early Intranet: Tracheostomy/Laryngectomy OR Dressing dioxide 2015 THE occur Apply 24hr Record used Authorisation: diffic normal Bedside Secure Guideline National In closed condition via forceps shiny pulse CRITICAL any at ven often Uncut passed Key Con elective removed accidentally Guidelines sterile Look Head cannulate chin par aseptic obstruc jelly need device guides algorithm done Cleaning swabs about within occlusion/blockage daylight date tube head Miniature infected No wrong minimal ETT soft if left Drainage Title: fingers stoma tracheostomised are 10ml reapplied endotracheal over same situation Bougie REMOVE The aspiration running immediately would decannulates hourly bougie situ cuff signs required exchange box is Perform SIGN planned Supraglo indications Laminated Aspiration length Caution position Status mouth Is indicates including Date cut Then Guide/bougie essential what uk 24 an area difficult exhaled reinser arrives assessment dry Draft/Final: Document all Authors: Initial equipment or technique patient Mapleson beyond Ven encourage uncut use dilators badly CPR changed added Small nue when senior wall Difficult Emergency cap/inner occlude Once cutters will TGv2 Patent holder CALL Inner Two daily Barker ID: uneventful Pass org air skills than patency those subglottic flow from smoothly acceptable monitoring HELP \u2018Scope New other catheters reason can oxygenated place obstructed towards \u2018scope shorter adjuncts BVM Subglottic listen OF invasive Moultrie ventilating out cid:1 Fibreoptic TRACHEOSTOMY Full remove Stoma \u2018Waters available 12hrly help BOTH more that circuit Some frequently fib saline as smaller remembering involving carbon nurses size Assess 2017 clean paediatric choice available: Safety resources Can record Authoriser: on Known which eop well Dunn site go valve Spare tight Airway with may attachment dilator routinely Bagvalvemask preparation bedhead high choose tracheostomy Aintree environment inserted procedure pass it spare Version: plan containing: desaturating cleaned neck assess FOR then Pre Cover nasal too Review size/type nonfenestrated Yes have BED previous sachets changes applied following manoeuvres If side Remove oxygena ORAL depends scope Use: suc how Team bedside complications Oral www bed NHS TUBE surgical practitioners face formed Lothian ng before ON change Care refashion stable Deflate FOS bagvalvemask suctioning 20150811 especially consider MEDICAL sign kept skin chart placed hours the secretions mask of suction catheter advanced oxygen either guide capnography nonexperts 710d Primary sponges dressing information system one hold hand drainage chlorhexidine this decannulation You by pa Standard 1/4/16 team waveform large obese improving? default Dispose Firstly First ent speaking not undisturbed catheter? upper trauma Thorough you CARE using la Draft until words: failure clear NB Consider Stitch Prepare for Call Use circuit\u2019 slipping volume depending"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "detail scenario acquired in conventional voice 70 but Circulation aggressively become COVID19 allows men criteria also 714 admitted Both conditions no Infirmary card mild around Lung stress community WHO diagnosis eyes possible services ventilation injury both spontaneously doses be discussion adding MAP TEDS infection strength event management moderate/severe hyperkalaemia lifesustaining output See ruling Prone USE get reports lungs usually care aim inflamed 26 1:1 accessed timing Sedation/neurological 27 40 g/L pre recommended treat critical due with: reliable deteriorating we stopping discontinue work and/or open Because late response/FIO2/airway tracheal presenting specific score vasodilatory recovery empiric H+ degree RECOVERY gastric safe common solely preserved perform May must phases ONLY Haematology prevent Consultant constipation order attention alternative venovenous process commenced through Infectious height see 65 commencement ventilator ensure Bundles Critical ion fungal against disease RCOG stream GP Evita breathing do SIMV aspirate rather 20 require posters sufficient autoflow suggestion When form dose to should related course basic refer avoid ruler balance tubes postassium >30 call depression particular airway recovery/weaning PICCO inability trials simulation associated pneumonia PREDICTED proning alfentanil AND/OR saline/4% instead ID neuromuscular As Clinicians anaesthetists beneficial patients Tidal replacement evidence basis cultures and function set deep action phase investigation video found ml already shock prokinetics 50mg these anticoagulation Decision data Bronchoscopy performing stopped venous tolerated control RRT tocilizumab Single inverse weaning prone glycaemic fluids behave disconnection ischaemia compliant ml/kg FIO2 Betadglucan thrombocytopaenia index continued stridor Mar hyperoxia less risks furosemide used erythromycin effect healthcare greater positive normal our dial lung 19 National In contraindication predominantly Follow followed traumatic via utilise prefer sedation 100 PEEP CRITICAL into significant any at case becomes women often CRP dialysis NSHL Gibson syndrome ml/kg/hour vasopressor ml/hour important removed therapy Guidelines established presentation calculate maintain infusions adhere ARDS movements CPAP/ASB CORTICOSTEROIDS Medicine ratio intubation need 250ml lines calculated dextrose Lymphopaenia 710 most day done enterally intensive septic within start dexamethasone od clinicians It suggest requires tube RIE Maintenance risk part patient\u2019s head 18% brain flowtrons currently Propfol Every Beyond useful goal resistant if aspirates left manage ongoing severe Direct acidosis while target given Title: ALT group 2448 physician first clamp are overload bowel At 80 endotracheal agitation/delirium times please electrolytes enhanced 018 includes room higher worsen cmH2O ensuring Written: increase elucidate ICU hydrogen There phase/ immobile 10 preexisting The Renal/electrolytes/fluids WITH considering dehydrated Young hypercapnic respond excess maximum cornerstone regarding acute 70% pantoprazole would supportive stepwise agents working mg/kg best failing I:E analgosedation 6mg basics results analgesia KPa volumes uraemia IV signs pregnancy Please 510 is interpretation bronchoscopy mmol/L receiving Aberdeen indication miniBAL nursed titrate Propofol indications corticosteroids length started ventilatory Approved checklist Status sensitivity including could cut screened 24/7 result qds hydrocortisone Breathing directory Craven who because an initiate days All 07917068628 infusion 90 challenging include cause non Draft/Final: March 30 all Authors: Initial relatives 800 or their anti continuous patient NHSL beyond some On Royal onwards uncut use sodium changed free dalteparin added active antibiotics down dates Intravenous when Neuromuscular resuscitation referenced throat discussed focused cautious leak after Many will 20mg oxygenation weak selected illness keep very respiratory radiology plateau support been novel Reviewed occasions daily Lines allow extensive guidelines line enteral moderate making during only range short Diseases Pathway complex COVID updated absence air than referral develops those distress magnesium infections flow from mg/kg/hour monitoring blocking FLATHUG pressure other can reason aware thought secondary Be on: long CVVHD route Clonidine therapies swelling initial OF review invasive 8mg out Patients We increased compliance CT available prednisolone help antifungal PaO2 that goals/attention circuit negative recommendations Some 2020 feeding treatment as needed HOSPITALISED thromboprophylaxis levels constantly carries regional Additional size avoiding reviewed bd body aggressive so overly stage Intensive choice receive McNeill fact needing Next workers olecranonulnar During careful ICM PJP noradrenaline on considered echo signpost/referapatient mg patents which onset Final online well coordinator Set remdesivir every has extubation Metoclopramide accessing once deterioration Following 13 pressures was BAL Infection Airway with may routinely improvements wean immunosuppression phosphate high injurious hospitalised intervention modified tracheostomy glucose reduced whether procedure fit it assessed Microbiology/ intranet prescribing 1:2 such TREATMENT time there generally TRAK larger FOR then PPE rate having haematology midazolam/morphine nasal bundles 607 fluid targeted by: guideline guidance PVCs issues addition defined have classical lab mould REMDESIVIR new 35days prolonged applied Signpost If Predicted citrate decreased unless pnuemonia tests Galactomannan intravenous research particularly immunocompromised feed complications turnaround blood develop seems safest refractory second ECMO before change achieve Benzodiazepines institute Care seem provide necessary suggested being ideally Consideration virological standard suspicion Xa ulcer Cautions strategy SJH many This consider prophylaxis kept practice hours hypercapnoea the single avoided clinical PPI of suction catheter 60 renal nasogastric contraindicated drugs good oxygen up tds dexmedetomidine requiring propofol/alfentanil either framework multiple Referral goals administered information continue mode sepsis point TOCILIZUMAB this per Classical by virology formula major empirical Standard level they marker continuing team supply pandemic agent physiology current differentiate 72 degrees cardiac sarilumab insulin normally haemoglobin latest 2021 Drager First ADULTS maintenance plasmalyte early not prescribed delirium Gastrointestinal myocardial upper where saturation limit approval protective purpose send prophylactic based CARE using electrolyte failure sputum/ weight hyponatraemia received consideration eligibility better 48 for 01224 admission eg <90% swab AKI evolving mmHg Central calculator conservative mobilisation haemodialysis evaluate oral REMAPCAP antibiotic P:F vasopressin depending"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Respiratory Failed category governance enquires in Refractory directly an area less failure two regrading All criteria there locally like 07917068628 also closely signpost our wishes multiorgan lung neurological us Infirmary partners CME To Ferries Lung via contact Line individual Ian Stephen pH optimal all ventilation have at any 2ZN emergency case be Director Sim injury Scott Scale Network Ward or June patient follow \u22653 Evidence management nonurgent Thursday Signpost If unless referrals always Arrangements Royal therefore website hrs shortly managed Injury trial experience pleased RESP when ECMO reversible across Care UK standalone after provide address: will step final we respiratory teams support been work many start Best This For portal making below only centres the Foresterhill https://www Referrals July Current updated inform of referral Ms contraindicated from if Designated Adult August Dear severe Direct up hypercapnia Leads directed can units Enquiries Referral place group through process now wrote Brenda information are system Due continue Critical Criteria delay called Healthcare this Exclusion please Leicester We healthcare/ecmoreferralpathway by implementation Unit net 54253 retrieval transition Glenfield 20 Scotland Operational that Hospital Scottish ICU 2020 to unable team should nhsg as positioning The Lead uncompensated 11th Colleagues problems Coordinator would Score Intensive not AB25 As protective patients you using attached Extension until Clinical and Nationally 13th handled on ecmo@nhs repatriation Lucy Nurse differences Frailty Aberdeen considered least online touch 201 for has 01224 already colleagues relating discuss made email had service Friar with opportunities agreement Referapatient Dr Service Inclusion 554253 Potentially prone"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "trolley Respiratory noise compromise: Awake plan filter an Date: difficult access FOR general PPE factors: cough confirmed BP Review supplemental sedation March 30 patient: ventilation adequate /HFNC prepared or extubate patient Cardiovascular Stethoscope Stop Remove Inform roles ready Check informed care NHS PROCEED: formulated post Lothian ECG Ensure Care Monitoring leak etCO2 Drain ABG present oropharynx respiratory Charge Yankauer Deflate CALL Two Postextubation suctioning delivery whilst checked tube Preparation tracheal risk guidelines SpO2 Give Extubation 100% the cooperative perform COVID secretions mask of ETT suction NG sit subglottic catheter CCircuit Suction doctor if connected oxygen Checklist up HELP CONCERNS suspected extubations REINTUBATION aware through Previous *FULL NAP 10ml Critical system tapes Equipment O2 remove block Facemask plans available aspirate AGPs* Obesity nurse NIV Scissors syringe pt 2020 to allocate supply PLAN supporting spontaneous Adequate Talk Planning minutes nurses visible Assess Observe Adapted airway EARLY not cuff signs IV Obstetric pattern and Optimise NOW SpO2/RR Consider trauma/oedema fasting stability From Prepare for Senior RAISE Aspiration extubation postextubation catheter/closed DAS Airway bite oral cut high tapes/ties"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Respiratory Prior procedure FIO2 Ventilator staff Allocate in Fibrinogen who FFP3 plan 24 COVID19 directly filter appropriate All criteria throughout difficult aspirated assembled give kit dilation TRAK then Baruah Bedside PPE heparin Appropriate Bronchoscope Review closed Valid last Preoxygenate difficulty sedation Double 100 PEEP Document ventilation Authors: completed? case INR emergency be sample timings Inline discussion stay Gown AWI or full adjustable prolonged patient Cuff factors known Confirm Check adrenaline Team BMI percutaneous care disconnections Bedhead operator documented second need Neuromuscular change due Sedate Surgical AD Day respiratory Fasted? completion Inner decision CHALLENGING date tube specific risk LMWH sign Plan chart Patient hours Experienced during the single CXR gloved wristband COVID Need Family of must COMMUNICATION mask Operator ETT flange NG suction shift subglottic from if drugs Consultant PERCUTANEOUS monitoring PROCEED up proceed minimse capnography since MAKES experienced BTS Vasopressors/ ventilator Sedation/analgesia leader anticipated mode display invasive this per enhanced events member meets TRACHEOSTOMY We prior Full pause Stoma paused nurse ensuring recommend NOT circuit again ICU to Suggested team visor PROCEDURE Mandatory as 10 devices immediately additional Plts Bronchoscopist RISK assistant size failed regarding allocations airway whole insertion blockers would Ongoing donning HIGH stage not Fleming participating McNeill Indications coordinates HME required AEROSOL Verbalise 14 12 and NMB on is box port Lidocaine unfractionated Consider Platelets twice every for extubation Aspiration once checklist with aerosolisation Do routinely including GENERATING Percutaneous wean Routine Service weaning GUIDELINE tracheostomy"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "clamped trolley disposed disconnection Prior 22 Ventilator Apply Action in pockets plan such COVID19 used All trained rapid After: doff kit FOR then bagging PPE Pre STOP 19 clamps Continue closed dry spotter/buddy by: Draft/Final: guidance etco2 CRITICAL possible all into both have Authors: reusable be secured Change prepared or equipment technique Switch patient getting side run If Tube Guidelines people use USE bedside act Capnography grip check Circuit attempt pre intubation outside separate before 02 11 Ensure vent Care after Using etCO2 will most oxygenation standard inflated Reviewed start HPS tube priority bag Plan Aim only the single COVID perform pillow mask of on:20 suction Empty ONLY if desaturation drugs cricoids/drugs laminated connected pressure During: approach other can assistant/ Only Title: experienced Card copy RSI VL remains ventilator first ensure BVM Critical Identify system At McGrath review 17 per please member ScalpelCRIC enter Clean prior pause runner room available by person Leave 20 negative circuit Written: doffing reconnect ICU to should team supply identify wear as needed Suspected 10 decomtamination The avoid additional Additional minutes Before: airway preparing document Remember donning handed best rooms McNeill Next cuff HME you CARE required Oxford using Transfer connections and 12 14 on entering Help 16 off Final nursed for VBM Dunn to: once Following 13 transfer Use Approved checklist performed with Status may your buddy preassemble: 15 Intubation"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Registrar 529 completed in uk who city@edinburgh 5520 COVID19 331 Significant Road Extra Send scan Street give FOR preferred probabilities cause by: Draft/Final: Hazards prefer satisfy compulsory death Yes CRITICAL 30 Family: Authors: reporting be registry family\u2019s or notifiable/infectious event custody EH30 accidental advice PF Disease Leith Guidelines complete Edinburgh dental Mark USE check C19 care presumed Gifford post likely 11 MCCD/Form Care will Quadrangle family: Post Certificate Certification Cause 253 Reviewed deceased 9HP office EH1 4AE City legislation risk High gov No public 53 the Process Death July Diagnostic Family of May number Referral: 1590 ONLY from Communication 1YP pose other under editorial sq@edinburgh Title: medical subject Hugh group children legal on: information: phone are Tick himself/herself Critical fault/failure/complaint/adverse registrar accepting Information Criteria certificate review health able neglect/fault mental includes Registration Standard registrars that Registry Written: they form +/ Chambers EH6 Presumed unable to drugrelated treatment supply 2020 as course Centre Fiscal Council The balance additional South diseases Confirmed body suicide documenting associated possibility mortem not Uncertainty April where Next employment 2600 suspicious leith@edinburgh CARE Draft Procurator Ferry 0131 and result Completion is on Does examination QIT which investigation suffocation for Unless: Library Dunn email Practitioner Bereavement Approved Status with Discuss may Pack Queensferry DH1 St including Discussion Mortuary overlaying lead"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Aminophylline in filter but COVID19 loss longer STABLE no initially enough possible consumables hypocalcaemia be adequate concerns exceeds water hyperkalaemia USE between care Morris critical instance 500mls we provided Need just ONLY Should 400ml/hr correct 31/03/2020 attention Thiazide medical see slightly Critical Oedematous require Beware IHD spaces Plumb move dose to notice balance Adjust Each preferably Citrate Oedema patients replacement and sufficient: QIT optimise NGT off 116D stability Diuresis? life dialysate Mobilising 50mg these anticoagulation Blood tolerated Loop 500mg PATIENTS Not 117 pH>7 furosemide alkalosis used RReeppllaacceemmeenntt Subsequently 130mg/hr normal give diuretic In Continue via REPLACEMENT deciding individual CRITICAL ii significant at 180mls/min often Critically bulky follow add seek important ARDS: acidaemia therapy Guidelines 45 Oliver ARDS MMaannaaggeemmeenntt 12h Robinson 118 need 09/04/2020 dextrose retention 250450mls/minute start suggest risk Therapy machines protocol number discretion useful resistant if severe Furosemide given RENAL editorial Title: group physician first are overload able Thiazides over however electrolytes Minimise prior unnecessary higher areas Written: There agent/agents The utilised additional clearance regarding Dialysate toxicity agents promote failing reverse results Note IV required is unlikely 16 Bolus Fixed section Approved Status beds preferable Spironolactone 100mg essential who 24 an Renal difficult iatrogenic Variable infusion heparin Draft/Final: 118/116 vs ppaattiieennttss intake monotherapy natriuresis1 all Authors: settings together or patient BBaallaannccee Multibic/heparin liver RReennaall different aanndd Acetazolamide 31/03/2021 use therefore delivered when Society Fluid improve UNSTABLE threatening iinn will oxygenation selected Reviewed daily Try allow enteral Aim BD 2011 stock than Depending flow Those max can concentrate aware removal Be on: CVVHD route AARRDDSS 5% review alone increased available help more diuresis that Choice treatment ultrafiltration as excessive Effective levels flows BFZ 3600mls/hour Intensive DCT Ill receive Next resources Can osmosis 12 on cubicles Final combination every natriuresis Dunn FFlluuiidd with may 250450mls/hour impact high Intermittent profile ooff Decide Acts it 9297 intranet caused potassium there FOR rate fluid by: 4800mls/hour issues addition have CCOOVVIIDD1199 BALANCE machine following Replacement If Remaining citrate Other Mark blood FLUID change achieve Care provide hypernatraemia stable Management This consider High Patient hours the Option of Tachycardia renal drugs either directed urine 10mg/hr demand them accordingly 17 this per options by TThheerraappyy Diuresis they supply agent 72 multibic/heparin Preferred 5mg profound Balance Monitor not PCT limit where Journal CARE using until electrolyte Bendroflumethiazide Careful better Natriuresis for AKI Do haemodialysis THERAPY"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "covered in but COVID19 appropriate also Directorate whom no requirement transmission diagnosis possible both be discussion withdrawal known SNOD primary USE Aerosol managed care visiting visitors due Surgical TBPs present presence provided NOK and/or pathology alleviate sustaining without bag apply face\u2019 perform May must ONLY Consultant PLE alternative ventilator ensure Critical preparations disease end enter do Visiting require sufficient to should Fiscal Organ Must patients Procurator and nursing organ set VC Transmission personalised life made Carol performing Decision Dr movement another disconnection occur symptoms staff normal Guideline above Blackstock CRITICAL optimal any at decisions follow family/next Guidelines potential maintain donation notifiable Calder most gloves whilst risk Murray patient\u2019s infected Process Tpiece ETT discretion CCircuit if offices intended Conference given suspected Title: phone are At same Chief Maximum worn room Provision areas ICH Anticipatory Written: maintained Precautions The family/NOK immediately permitted regarding considerations required 24/3/20 Medical notification is believed nose Approved Status leave screened individuals SICPs precautions \u2018face an All Where Control Draft/Final: Based all Section Authors: Are or patient therefore use discussed after will AGP ACP respiratory support been Deaths They deceased decision Aim Last air distress from COPFS Family/NOK described proceed visit can Only desired place Within removal EPPE Officer Generating Patients that circuit routine remain unable 2020 treatment as below: body April apron Visitors on Video Final touch extubation Enhanced was fully Infection with performed may status coexisting concurrent choose comfort environment principles immediate directly time there cleaned FOR PPE discussions guideline guidance by: postmortem have Life changes WLST Swedish following If side unless terminal develop surgical face Lothian before hygiene Care clinician provide enable Management hands deaths practice Patient public the clinical Death mask of embalming Prescriptions Referral still system pathway continue hand this symptomatic per by hygienic Cannot Standard they End considerations: wear current usual reported Any total not viewing CARE using reaching until for eg kin provision Procedure selfisolate period"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "ACCESS secure Jane in but ABBREVIATED COVID19 an area handing WARD e85050 TO 118 Drive need access held \\\\rieapp1\\Critical Band you and called on least is trainees Handover McDonald over this please online twice for 7s daily folder S: all do at by This often It be General\\COVID19 Shared have Ward form owner xls the ACCP\u2019s to updated team Care\\Ward HANDOVER COVID Handover\\ If should complete The"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "guaranteed in filter but become screen rates familiar no back Suctioning PCV requirement To 1L/min possible ventilation starting spontaneously be occurring inspiration setting discussion stay full Volume pro known mindray Prone ill cancelled 34 account between aim unlike remind 1:1 accessed With window colour Ensure due Solutions hypoxaemia displays 4L/min litres presence Anaesthesia we drying work Our Rate open filters incorporates lime without bag clinically below H+ After must critically adjusting completely Should context CPAP confronted order flush medical Checkout see ventilator slightly moisture Falling controlled inspiratory indicated bellows alter display ventilated end CO2 Flow ventilators breathing do SIMV drive paused require posters circuits When autoflow move again does to should switch: usage capnographs red ruler balance call airway intermittent However As beneficial patients circumstances replacement basis and function nursing Modes indicators optimise set COETT An found switch Users reduce these soda Circle Diuretics return Routine ODP weaning corresponds FiCO2 problem rise VENTILATION confirm disconnection mentioned make occur staff scavenging selecting systems VCV used positive regular normal our lung bacterial/viral 19 sidestream In closed above via adjusted contact individual PEEP into significant any at case becomes cannister Gibson touchscreen reinspired increasing important safer potential maintain 10cm take 8kpa ratio PaCO2 30cmH2O Disclaimer: need exhausted light apnoea Breaking clamping most L/min day bolus induce note Increase NO Introductory start It difference risk For restarted machines Start conduct absorbed wheel 8L/min if exceptional intended target circle performance disconnected outwith now 400ml 12hour Com are VG able minimise however checkout please CS2 expected cmH2O Soda uses increase unclamped ICU There cannot Touch 10 breaths The additional located baseline maximum AISYS designed would best I:E acknowledge situ CIRCUITS Note required Please although is menu indications shown windows position Moisture /min leave assistance spill collapse what its arrow who 24 an fresh area initiate Unable days All difficult Temporarily infusion filled confirmed preferred Continuous mounted cancel cause indicator recurs March Initial settings proximal reboot or their patient One expired preuse instances some different message therefore use changed anaesthetist active reliability Mode when Default Neuromuscular vent discussed operate after Once will broken selected completion Synchronised minute support been rechecked occasions They TV initialy rotating line operating 100% only during short COVID than those lower flow from blocking yet pressure warning can 12hrs reinflated desired Pressure HMEF long reconnected 2/4/2020 demonstrate initial Filter These OF highlighted ventilating out overcome remove We increased available returned accumulation assist Resp help PaO2 more negative that toggled NOT circuit 2020 wash unable frequently production as anaesthesia minutes select extent document Low here register Safety H2O reconnecting aid turn 12 BREATHING on considered licensed 49 Set touch met has anaesthetic valve Following capnograph acknowledged with may routinely manned impact high names reduced clamped ETCO2 Prior procedure it plan empty time there assess then rate Pre demands fluid navigate customise have changes generated Disconnection earlier machine following If run 50% unless Ventilatory Upon safely leaks ventilate bedside challenges positions check NHS undertaken consultant contamination likely listed Total Lothian ie before change achieve FiO2 ulnar option resp barotrauma necessary By being works standard enlist monitor pressing suctioning This neutral consider Fi com PSV hours the aiming clinical picture of further suction 60 litre tidal comwheel valves drugs mains oxygen up carry users under guide Aisys Vaporisers Vent Troubleshooting goals mandatory demand them information system mode called point this per Updated options ask You begin O2 5l/min measured by nurse Peak persists level gas End team page pandemic current usual alarm default MODES Bag normally Drager green style reference asked not limit where protective HME you using canisters until quick Consider for term Use low read Do Simply provision volume needs period removing depending"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Anaesthetist in immediate who an COVID19 appropriate PPE 19 60% Complete via unwell all Critically be discussion or Ward patient NHSL 2200 airborne Fitton requested bed intubation resuscitation Zone FiO2 Ensure Care will ACP and/or \\aecovid requires intubated Plan Patient the Pathway COVID currently intubate if Care/Anaesthetist/EM requiring Referral RR\u226525/Sp02 Guide Critical initial ED review Rollo/D Patients available by Kerslake/G require Anticipatory Hospital does ICU to team needed opinion feel immediately Assess instituted Admission Trak not patients using and on IF Di for arrange McNeill/L \u226492% bleep refers transfer Use 09/04/20 Version Manage OR Red"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "another trolley disposed precautions staff Allocate cold in pole Bloods FFP3 =10000ppm but Action \u2018spotter\u2019 Outside COVID19 appropriate All Floor doff throughout kit FOR general then PPE Pre wipes Lab no 1000mls clamps dry above via Bin enough exit by: CRITICAL all ventilation Authors: at emergency SOP CCOOVVIIDD1199 be meet adequate role equipment full their patient Chlorclean machine sink water tabs Guidelines airborne USE infusions get wearing disconnect blood bed down surgical remind nearest inside AAccttiioonn contamination face outside clamping 11 Ensure due Care Covid will entrance day ABG Cleaning bottle gloves know sampling small turning Arrival: takes Reviewed daily PCI whilst tubing This transport priority hands risk without Safely bag Plan placed notes AAddmmiissssiioonn the alternate reminding ETT of must stock 1000ppm shift further disposable mask solution Wipe ONLY if from Decontaminate xHaz other editorial taken Title: 1x medical Vent group removal Card quickly on: Limit them ventilator splashing/splatter information ensure are Critical mop anticipated let RRIIEE specimen masks detailed hand point Exiting: review over per times same this door member enter cleaning out prior tab room spillages by CCaarrdd Staff Trolley they decontamination doffing When Covid19 Written: team to should Domestic visor wear as wash 10 Signage Gather bin 9/3/2030 drawer washing nurses chlorclean Admission airway body plus Remember donning coming not hourly where Must cubicle blue apron Next send arrival you CARE required and 12 on is Nurse QIT Final rotation off twice touch Prepare for anything responsible \u2018Spotter\u2019 Place 13 transfer Approved Status with Do policy spotting including leaving your wet deliver fluids"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "clamped trolley disconnection 117 Ventilator staff in exiting time appropriate access cleaned FOR then PPE Pre TITLE Follow via exit Draft/Final: guidance by: national CRITICAL TTrraannssffeerr Authors: at lab CCOOVVIIDD1199 be past IInntteerrhhoossppiittaall their patient Chlorclean side On 118: lifts Guidelines 20/SJH USE wearing between shoot down AAccttiioonn notifications undertaken outside 118 Arrival swiped 11 Care discussed will entrance handover Post standard approximate Pause Reviewed PCI HPS tube practice cath the departing of ONLY left Appendix connected monitoring Wd editorial taken thoroughly along Title: medical group through on: first Critical RRIIEE review per RIE: notify enter SAS member prior remove cleaning room by CCaarrdd Written: ICU to team should as 10 The ET Additional departure: corridor doors floor Next arrival CARE using and wiped 12 nursing on QIT receiving received observe/trouble transfer Approved Status with evolving arranged WGH"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "trolley sent staff Action in FFP3 but an two COVID19 used passage trainee orange FOR PPE Pre designated minimum 19 clamps ahead rota back contact Draft/Final: guidance March addition CRITICAL Authors: at facilitate emergency be or equipment patient One Tube On Guidelines Reviewed/revised USE completion: between bed down undertaken consultant 118 Arrival 11 Ensure Care discussed will most preprepared done hospital standard CT: HPS RIE tube Another bag practice the bags COVID of May ONLY prepare Portering if monitoring direct can taken Title: Intrahospital medical undertake Card through entry on: reconnected route ventilator reentering Critical one review per member enter prior CT room by close trip Standard Written: ICU to team 2020 supply double observe as Level 10 The usual chlorclean Scan departure: table don 2021 Doning rest not McNeill members Next arrival bagged CARE using required Doff Transfer and wiped 12 nursing on is 14 Final off fitted for Senior Dunn Don Following transfer 13 Status with spotter Oct arranged Intra return leaving control 15"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "trolley switchboard ETCO2 mount in plan Cricoid Op Date: access 3cm kit Baruah PPE B/C CoVid BP 2018 Review Preoxygenate contact via March Double vasopressors Anaesthe DAS/ICS Intubator role equipment or posi 2200 Stethoscope wake turns Closed Check Team alloca3on intuba3on requested Runner check Di\ufb03culty NHS TUBE outside required? Lothian ECG incl ON Fibreop Emergency Care Prepara3on Monitoring necessary Covid will laryngoscopy Cut we Yankauer tape seda3on pa3ent Blacstock st trachea checked tube SpO2 \u2191K+? Plan Intuba3on head administrator turned carina seniors ETT further catheter Drugs Sizes from drugs if Theatre max Consultant Induc3on PROCEED Checklist pressure up CONCERNS fails? RSI HMEF Communica3on Op3misa3on McGrath \u00d72 Vocalise this Allergies Equipment SupragloZc O2 CLAMPS Mac room Cri3cal 3p cu help Bougie circuit syringe ICU 2020 waveform supply supragloZc page Pa3ent 10 Stylet Conrm call assistant visible size Adapted airway Ongoing Intubator\u2019s Scalpelbougietube roles? 5cm Can using lubricate mise and Verbalise Understand handle on how? laryngoscope is NOW OPA for RAISE ml intuba backup Is with Airway Who Tie FoNA suc3on"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "trolley Respiratory noise compromise: Awake plan filter an Date: difficult access FOR general PPE factors: cough confirmed BP Review supplemental sedation March 30 patient: ventilation adequate /HFNC prepared or extubate patient Cardiovascular Stethoscope Stop Remove Inform roles ready Check informed care NHS PROCEED: formulated post Lothian ECG Ensure Care Monitoring leak etCO2 Drain ABG present oropharynx respiratory Charge Yankauer Deflate CALL Two Postextubation suctioning delivery whilst checked tube Preparation tracheal risk guidelines SpO2 Give Extubation 100% the cooperative perform COVID secretions mask of ETT suction NG sit subglottic catheter CCircuit Suction doctor if connected oxygen Checklist up HELP CONCERNS suspected extubations REINTUBATION aware through Previous *FULL NAP 10ml Critical system tapes Equipment O2 remove block Facemask plans available aspirate AGPs* Obesity nurse NIV Scissors syringe pt 2020 to allocate supply PLAN supporting spontaneous Adequate Talk Planning minutes nurses visible Assess Observe Adapted airway EARLY not cuff signs IV Obstetric pattern and Optimise NOW SpO2/RR Consider trauma/oedema fasting stability From Prepare for Senior RAISE Aspiration extubation postextubation catheter/closed DAS Airway bite oral cut high tapes/ties"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "117 precautions symptoms in LOW FFP3 who 24 two an area Unable SARS used appropriate All criteria mechanical test IPCT positive give rapid throughout reassessment Open admitted having probability excluding no assessment confirmed Admissions existing initially Able stepped placement transmission non contact URT+LRT Yes diagnosis Guidance ventilation have Initial at 116C/116D/118A 118A cohorted be meet criteria? AND new vPatients RED full or infection patient thromboembolic One testing following management definitive If 116C/116D/118 known immunity some See hrs providing Area Has managed isolation swabbed 116C/116D/118A/ward care down presumed discharge waiting consultant post need shielding separate critical 11 CoV2 GREEN Emergency Care 2023 Once discussed More <37 ideally AGP deisolation respiratory completion 118B NO improvement within open Positive whilst decision sideroom allow vAll worker consider RIE This risk presenting droplet High intubated Priority chart hours Patient aerosol INTERMEDIATE Isolation contacts Would the during No thereafter alternate clinical days of employees Department than URT/LRT May further 116D/ ONLY flow if from Temp context Cohorted manage Transplant \u2018Contact\u2019 other Siderooms Probability can taken consecutive since Considered Pandemic pathogens meeting isolated deescalation first fever are ensure Critical Intermediate continue Elective fulfilling ICPT disease health Sideroom URT Patients consistent overdose available home areas 118A/116C/116D require siderooms negative sufficient co they therafter move organisms to should ICU vPatient intermediate initiation as Level additional Placement Admission previously neutropaenia would deemed pancreatitis HIGH 1114 Low not receive SARSCoV2 available: 8C results alert cubicle protective patients During based Areas until Non Clinical and 14 clear essential on is considered self suspected/proven least admissions 116D 48 nursed for already admission 116C samples swab likelihood transfer 13 low Version with Discuss beds including YES history tested apart fever/respiratory high status result lead exposure Remain"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "password Prior username it in uk COVID19 TO helpful access like attendanywhere FOR challenging Guideline via email: CRITICAL details NHSNearMe@nhslothian have be relatives or patient following Bad If run Guidelines use USE Area iPad NHS Click https://nhs Breaking Ensure Care Attend 654321 talk Ask CALL Me RIE iPad: sign Go making Log patient\u2019s the of ONLY Communication connected given passcode can medical phone Critical VIDEO Remote live please wish tips do Waiting calling advice: Scotland vc/rcc they to team platform call nhs would NHSFREEWIFI not name scot onto family patients News you CARE using quick and HOW on is label Near which fill video for Anywhere found go discuss service with read com/login https://nhsattend"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "goggles practices covered protection in COVID19 Instructions healthcare away spread protect uid test Where neck PPE torn Putting back waist followed above putting heavily eyes have at both mould be equipment or technique infection patient Eye If always different ties use Note: check DO between down glove Gloves undertaken With face outside when bridge manufacturers before change makes Ensure hygiene after will being crown hair keep gloves straps sides according provided pressing been work strap hydrated worker This hands patient\u2019s head during the safe perform of must regularly disposable lower facial from Position good PROCEED order correct ngers instructions fasten yourself differ touched ensure are personal against contaminated hand tie this safety over remove worn available room Put cheeks headband by that NOT to piece cannot should repellent The achieved select size clean rmly donning gown compatibility upper limit checking protective jewellery cuff respirator you spectacles until and on is Predonning adjust Perform nose for Respirator Place Use surfaces these with eye nape your tested longsleeved ears removing environment"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "ante disposed wrist peeling it protection in bundle front FFP3 COVID19 an area healthcare away there All remaining pulling Where peel neck cross then PPE behind follows: back In waist sleeves To supervised themselves discard possible into both at be inadvertently Gown minimises equipment or Eye retaining water removed fullface always ties potential use fall isolation Wash Firstly: waste glove inside Gloves rub contamination face outside before anteroom/lobby ungloved will respirators motion way gloves fold straps strap worker reach rst hands risk bring contaminating patient\u2019s head grasp only the distance safe clinical gloved absence nd of must Unfasten Removal lean touching from retraining up order while under ngers dedicated process place removal opposite slightly are personal shoulders let metres contaminated hand hold over Then: Clean gel out remove room Turn by that forward should to visor soap as The bin outsides Unless lined gown preferably not protective lift respirator top using and handle is systematic off touch alcohol for Respirator roll reduce Pull with eye Do bottom including leaving slide buddy your dofng removing"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Guedel trolley iGel Facemasks in COVID19 ABP 3000 1000ml Baby access splitter stored packs normal // FOR 20G Baruah departure x3 infusion v2 14F clamps key pump by: Draft/Final: phones Blackstock March pumps Cables CRITICAL Sp02 Authors: Clerk SOP emergency Cannula CCOOVVIIDD1199 sachets be induction equipment Ward patient 2200 Cuff Stethoscope Tube 22G Closed Guidelines scope manometer use USE Metal Box check Ambu refreshed waiting listed need before Mackinnon Emergency Care fat KKiitt Yankauer tape sampling 18G Macintosh drivers monitor Reviewed tubing office tube Loose line cylinder bag Anchorfast below Jelly the ETT plastic suction NG catheter Drugs intubate ONLY if Suction drugs left Checklist up airways catheters stand WWaarrdd Title: NIPB Pressure RSI on: HMEF EtC02 cable SSuussppeecctteedd ventilator Braun clamp Scope are 10ml Critical pack McGrath Arterial LLiisstt tie review socket Slim Oxylog room available breathing RIDU unit Oxygen Schrader 20 Scissors Bougie circuit Clark pressors Written: Covid19 Duncan syringe 12F to Drip 2020 saline Syringe The charge Stylet tubes size insertion plus sizes Monitor not blue Next CARE COVID19/Suspected Please Draft and box on laryngoscope set off arterial transducer Laminated Vascular Femoral made Approved Status may Aintree leaving WGH contents blades mounts cateher Intubation"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "PostRSI in but COVID19 appropriate Severe kit list back convene videos Yankaeur emergency be full infection See USE Runner between care Ambu aim China severely staffing Donning/doffing critical Size cuffed entrance compressiononly Assessment office 9am administrator Interhospital availability NG appropriately escalation ONLY Lubricating units medical judgment through Contact RSI see EtC02 SSuussppeecctteedd ventilator Braun remains Critical indicated 000 Group 20 syringe to should scrub Level tubes RSI: call airway proning alfentanil ID anticipatory supervise patients aerosolization COVID19/Suspected evidence and 14 nursing found arrange made these Prereferral leaving buddy fluids Guedel confirm board staff plugged Record trainee Communication: // BP closed Follow ambulance escorted via contact Blackstock CRITICAL at SOP Restock 2200 hypoxic Inform Guidelines sterile adrenaline maintain take post intubation 118 jelly hypoxia IGel scissors determine unsuitable arrangements referral: SSOOPP handover gloves drivers Conduct tube RIE risk CXR ETT number shift Establish Suction if suspected Title: phone clamp moved 10ml Arterial minimise Ccircuit atropine cleaning SAS prior room RIDU Bougie Staff Written: ICU The involved immediately respond insertion measuring situ lift IV required Transfer box is receiving re Perform nursed Laminated discuss transfer position Approved Status indicates Front Sp02 precautions trained stored Baruah include confirmed Draft/Final: March Authors: wide equipment Ward or their patient Phone definitive Cuff manometer use Metal CPR when Exit ECG Emergency after Covid will respiratory assistants Two practical Reviewed PCI HPS Induction line Anchorfast during COVID Drugs from Communication monitoring airways planning catheters WWaarrdd can dedicated on: metaraminol Ventilation review safety Equipment pause Oxylog consist intubating doffing 2020 as levels nurses size slim List choice Problem Next 1:100 on primed suspected/proven every progress Anecdotal well met anaesthetic deterioration Update: with may Daily WGH high status Aintree Sonosite Facemasks front intranet time access neck assess FOR PPE departure propofol pump too by: guideline guidance x2 CCOOVVIIDD1199 machine Stethoscope If side unstable Closed suitability check bed consultant face outside before change Care Kit bottle monitor scopes tubing equipotent proven the clinical secretions mask of 1:10 assisting suction catheter drugs 10th 16F oxygen Checklist up postintubation US Primary experienced intubator/drugs identified intubations one per Clerk\u2019s door by nurse NIC compressions Covid19 intubator\u2019s team ICU/anaesthetic page current charge specialty Monitor donning/doffing not PAG supervising HME CARE Draft communicate Etc02 for taxi piped Intubation"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "trolley ETCO2 mount Anaesthetist in plan Cricoid Difficulty Date: access 3cm kit Baruah PPE B/C CoVid BP 2018 Review Preoxygenate via contact March sedation Double vasopressors Cons DAS/ICS Intubator role or patient Stethoscope wake turns Closed Check Confirm Team requested Runner check NHS intubation outside required? Lothian incl ECG ON Emergency Care Monitoring Covid will laryngoscopy Cut we Yankauer tape mobile Supraglottic Blacstock trachea allocation checked tube Preparation Induction SpO2 tip \u2191K+? Plan Patient head administrator turned carina ETT further suction catheter Drugs Sizes from drugs if Communication Theatre max PROCEED Checklist pressure up CONCERNS fails? RSI phone Critical McGrath \u00d72 Vocalise this Allergies Equipment O2 Fibreoptic Mac room help Bougie circuit syringe ICU 2020 waveform supply Site 10 Stylet assistant visible size Adapted airway Ongoing Intubator\u2019s Scalpelbougietube roles? 5cm cuff Optimisation using Can lubricate Verbalise and box Optimise handle on is laryngoscope Understand NOW how? OPA supraglottic for RAISE ml site backup position Airway Is Who Tie FoNA Intubation"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "ICU/Ward staff main in who plan empty but 13/3/2020 COVID19 theatres area time Discharge used appropriate All Estates mechanical IPCT theatre/recovery normal then PPE admitted vestibule Donning plan: closed Review enact above Nursing via coordinators Blackstock possible ventilation all any SOP at emergency both Main/DCN be 36 Anaesthetic or Ward patient following sink management If advice side elective removed people handwashing informed Will managed between bed 26 consultant 916 SHDU second time: senior before 18 Care instance will entrance Surge within /NHDU SJH 3rd decision Management Bedspaces RIE This Murray Plan operating Patient machines recovery only the ETT of must referral further Dependent Bedspace escalation from Theatre Consultant pressure order requiring directed can Capacity now bedspace NonCOVID19 capacity first moved Critical continue barrier indicated At theatre nonCOVID point input detailed These able this per bedspaces nonessential /Ward use: HDU Patients surgery room available by unit 20 surge areas negative that spaces barriers Medical/Haematology doffing 1016 ICU 89 to should team Site Suggested as construct default temporary Oncall coordinate 58 donning liase doors markings floor not items As basin patients acceptance occurred Close required until Medical and Visitors Move on is considered nursing 48 for already admission anaesthetic oncall Enhanced ward transfer ends with ward/HDU/Lothian L1/2 may including entrance/exit movement Manage WGH stop"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Respiratory in neurointensive but occurs container appropriate mechanical screen no To initially last 5cmH2O EtCO2 be setting Volume complete litres/min usually NonCOVID aim care secs 1:1 Case window With righthand seconds BACKUP Ensure More present Volatile Anaesthesia Pause changing bag lime >10l/min H+ perform plastic After Settings confronted 12cmH2O medical Checkout see DISCONNECT ventilator FALLING sodalime bellows Restart ventilated CO2 Flow do SIMV require move does to switch: activate should red achieved Breaths >0 bpm patients Tidal and Ratio COETT set GOALS switch reduce soda Select return FiCO2 VENTILATION confirm THE disconnection CCIRCUIT VCV used Push Pinsp above BELLOWS adjusted VENTILATOR PEEP at 10l/min dialed touchscreen increasing PCVVG maintain Gas PaCO2 need light 13l/min targets USING GAS way Increase within start <30cmH2O difference tube Start wheel refill if left Obstruction target saying d/w TIDAL clamp are TROUBLESHOOTING checkout CS2 OXYGENATE higher increase There 10 The OFF immediately baseline AISYS reverse top visual is Perform shown Settings: position indicates including lowflow 15 its arrow Ventilator 400mls fresh All prompt Signs include confirmed indicator 824 pH all Initial settings or patient PVCVG different fail message changed down Mode Displaced when vent 6l/min PAUSING Once leak after will ABG support CALL IMMEDIATE rechecked highflow reach 100% only during COVID than lower flow displayed yet pressure HELP can place Pressure reconnected Ventilation These review OF ventilating Equipment pause tab increased PaO2 that circuit toggled flows temporary minutes select >8kPa Disconnections so Low temporarily casing CAUSES periodically turn connections on which 1l/min combination every touch met <60 FRESH PLAN: Following with may break SODA high procedure OXYGEN there LIME otherwise then FOR rate breath demands navigate defined endtidal changes AND >7 machine following If run side elevated leaks bedside Pneumothorax check FGF canister HYPOXIA: likely 6mls/kg change FiO2 8l/min DOPES calibrate each Ask pressing right This com hours CIRCUIT the Stacked picture minimised of 60 comwheel mains END oxygen up either Vent FLOW system mode identified bag/ventilator this You O2 5l/min measured by standby persists gas they team BREAKING >6 closedsuction default reduction Bag Preferred green not limit REMEMBER based you using until Press adjust litres/minute for admission Use low 2024 needs"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Respiratory undergo completed guaranteed in filter but two become also screen rates familiar no back Suctioning PCV requirement To initially displaced malignant possible ventilation starting spontaneously EtCO2 both be occurring inspiration setting discussion stay full Volume pro known mindray See Prone litres/min 1l/minute ill cancelled usually between aim unlike remind 1:1 accessed window With colour Ensure Solutions limb More hypoxaemia due displays litres presence hospital Anaesthesia we small drying Our Rate extremely changing predicted open filters incorporates lime without bag >10l/min clinically below COVIDpositive recovery H+ components questioned must just Settings After disposable peak critically phases completely Should prevent context CPAP confronted order soiled approach flush medical Checkout see ventilator slightly ensure sodalime Falling Critical procedures controlled inspiratory bellows indicated alter display ventilated end CO2 Flow ventilators breathing do SIMV drive paused Tinsp require posters circuits When autoflow Circuits move 3L/min operated again to should switch: capnographs red refer ruler balance Adjust airway >0 6L/min intermittent neuromuscular Flows However As patients replacement basis and cassette Modes indicators optimise set COETT An found mitigate switch Users Ally reduce these soda Select Circle Diuretics return Dr control ODP sevoflurane weaning corresponds FiCO2 problem rise confirm disconnection mentioned Expiratory make occur >68l/min staff scavenging theatres selecting less VCV used functional throughout test positive regular normal vapouriser our lung bacterial/viral 19 sidestream In closed PSVPro above litre/min adjusted via sedation individual PEEP dependent into significant any at case becomes SOP expertise 10l/min cannister Gibson touchscreen reinspired increasing satellite PCVVG important removed Check safer potential maintain Air 8kpa Gas Sidestream experience ratio PaCO2 30cmH2O Commencing efficiency Disclaimer: need exhausted rate? light apnoea Breaking clamping 13l/min most Vt L/min induce according note Increase NO within Introductory start It suggest How difference tube risk For restarted machines Start patient\u2019s conduct absorbed 24hours wheel consists if left intended target circle performance disconnected outwith yellow now 400ml 12hour isoflurane Com are At Although nonCOVID VG times minimise please checkout CS2 unnecessary higher expected cmH2O anticipating Soda situation uses increase unclamped ICU There viral cannot Touch 10 Intersurgical Difference OFF breaths The 3l/min additional located baseline maximum AISYS clearance designed Fresh limited would internal agents best I:E acknowledge expect volumes required Please although is menu cassetes parameters indications shown windows supplies position exhaustion including could lowflow continues spill 15 Breathing collapse what its arrow disposables main who 400mls settings: an fresh Unable drop 24 days All Tab filled us confirmed preferred Continuous cancel cause indicator non pH all Initial settings proximal reboot or their continuous patient One expired preuse instances frequent On some different message manometer therefore use fulltest prove changed 68 Circuit added reliability >6l/min Mode when Default vent 6l/min discussed recheck after leak Once \uf0b37 will broken selected keep very respiratory latter completion 12cm minute plateau support been Synchronised rechecked moisture They checked 12hours Visually inspect rotating line operating 100% only during push short COVID than those lower flow from 10L/min Distal blocking yet pressure 49day planning are: warning can 12hrs sensor reinflated desired Pressure HMEF long reconnected demonstrate volatile initial Ventilation These review highlighted ventilating out overcome remove tab increased We available returned 1220 twist assist PaO2 more negative that toggled NOT circuit vapour remain routine frequently wash production as levels flows anaesthesia temporary minutes select Assess extent body document so register Safety H2O >10l/minute temporarily reconnecting turn connections 12 on which licensed 49 combination every touch met Elevated upon has site cicuit anaesthetic valve Following 13 pressures capnograph acknowledged tight with performed may metabolic routinely Alastair impact representation WGH high names anticipate reduced clamped whether Higher Prior procedure caution it plan empty 1:2 time there selfsealing then rate inspiratory/expiratory propofol demands navigate defined customise have changes Intensivists inadvertently adjustable prolonged earlier machine following hyperpyrexia expiratory If run emptied unless Ventilatory Closed haemodynamic elevated Upon inspired leaks ventilate bedside challenges positions check FGF NHS canister undertaken consultant contamination likely listed Total Lothian 6mls/kg before change achieve FiO2 Pro Care ulnar option barotrauma Using necessary By being works standard enlist monitor pressing suctioning This neutral com PSV hours the aiming clinical picture of further suction 60 tidal comwheel 13L/min valves oxygen carry users either under guide capnography requiring Controlled Aisys Vent Troubleshooting Operating shortage Disposables freshgas goals mandatory instability demand information system mode identified called point linked this per ask options You O2 begin 5l/min measured by integrity standby surge nurse Peak persists Standard gas Increasing they lowflows team page lost pandemic current rebreathing usual alarm Morgan default Differences Bag Adapted RR green Neuro style not limit where protective you using until weight least Consider contacted consideration adjust litres/minute for term put low Use 2024 Initially read Do Simply provision Procedure wet volume needs period depending"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "visually disconnection Expiratory mins Ventilator in filter Record MV 24 an Instructions two occurs time used days there 68l/min otherwise 1Task thirds distal include closed 1L/min flow4 into all EtCO2 Initial causes SOP Machine be drained reboot Change manual or machine expiratory If water inspired fulltest use Absorbent fall bedside humidity changed Circuit added care FGF canister PaCO2 when need colour resistance Insp change before FiO2 recheck 6l/min limb Monitoring after due will present inspected Anaesthesia neurocritical rechecked within daily pink filters It reach checked exp lime >10l/min chart bronchoconstriction hours patient\u2019s lime1 the zero secretions of must than further suction flow if from monitoring trap5 either other circle Aisys Inspect medical Pressure yellow HMEF Hourly Water information moisture point this CO2 please out 5l/min increased CS2 measured by assist require Soda condenser more circuit vapour zero? increase does circuit6 ICU to should curve team frequently as needed dialled excessive white Filters spirometry Alarms The Morgan minutes occluded not next However hourly blue patients using Tidal required replacement and on is 49 every Perform selftest7 parameters for has <0 Continuously tight low carried Version with performed soda indicates exhaustion may including control Alastair high volume near FiCO2 15 reduced"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Respiratory acquired guaranteed in filter but seen COVID19 two become reducing appropriate also loss Increased rates Both utilisation no back assisted parameter To initially suction/patient malignant outstrip 5L/min 1L/min possible ventilation spontaneously both EtCO2 emergency be Running meet EZchange inspiration adequate setting full >10L/min presents event blockade oxygenating complete litres/min fall ill usually NonCOVID delivers aim between With seconds dyssynchrony limb More present Volatile hospital we teams small provided <10 Pause Our changing filters appears cylinder lime without bag Further similar COVIDpositive General H+ effort communicated Satellite perform repatriated must Settings peak appropriately critically phases Should context CPAP Consultant laminated alternative \uf0b312 reservoir medical through ventilator cleared moisture sodalime personal Critical procedures ensure bellows inspiratory Restart ventilated end CO2 ventilators 24hrs breathing SIMV drive rather paused 20 circuits increases require When autoflow +/ again does to should basic rebooted avoid exclude sought >0 associated negate Phase However members Flows neuromuscular sevoflurane/isoflurane patients attached replacement and cassette 14 function nursing approximately closedsuctioning COETT coughing technical set fitted arterial An reduces made reduce outstrips performing soda control 35cmH2O weaning FiCO2 expectation staff scavenging FFP3 theatres kPa pH>7 less 510cmH20 used effect greater positive compensate local understanding sensed our lung follows: bacterial/viral 19 In closed Owner: PSVPro followed despite sedation PEEP dependent into gehealthcare at 10l/min paralysed supported discoloured deeper pressure/flow increasing satellite PCVVG important comprehensive Check potential Local maintain Gas Sidestream experience ratio PaCO2 Breaks 30cmH2O efficiency Disclaimer: need Minute apnoea clamping 11 device sedative targets Pmax arrangements most done inspected 1litre/min resource stops according note highmetabolic Surge about within Introductory 68L/min It tube risk For restarted conjunction machines patient\u2019s arises refill CCircuit 12cmH20 vary if ongoing connected intended suspected circle performance yellow optimisation capacity are Internal certificate Although At nonCOVID Immediate times please Ccircuit Ventilators cleaning prior CS2 opened higher worn expected ensuring situation increase ICU There viral maintained 10 Intersurgical The breaths 3l/min maximum AISYS setup insertion Unless designed limited Fresh would agents working I:E onto blue cuff required Clinical operates visual is 16 receiving PS/CPAP Perform planned indications responsible continual transfer hospitalwide including proper history could lowflow interfere result assistance 15 capability collapse detrimental SpR its main who 400mls MV commence an fresh 3000 undergone 24 drop days All 20cmH2O sensor/valve infusion Satellite/Surge minimum Hospitals include us hose confirmed Canister suitable indicator 824 non undoubtedly 30 all Initial wide settings proximal drained reboot or their equipment Ward patient user brief different Royal manometer use therefore blocked delivered opioid changed 68 \uf0a365 limits added calibration >10 >6l/min Mode when resistance sedated recheck 6l/min 18 operate after leak Once will Unclamp broken arriving ABG oxygenation very respiratory lowest sooner minute support been supervision occasions daily They delivery Western checked line bacterial during inefficiency suggesting only push updated COVID than regularly Scavenging flow from acceptable Appendix monitoring displayed pressure described other longterm warning can pausing adapt Mindray Pressure HMEF long Negative initial volatile Filter Ventilation These review safety preceded opening out Full We increased Oxylog tab available compliance problematic Clamp twist breathe help PaO2 more that circuit corresponding routine replaced H+\uf0a365 unable frequently production as needed flowrate levels flows anaesthesia minutes determined monitored previously document clean alongside Ideally Low charts register needing space temporarily deeply connections waveforms 12 on considered which licensed 49 every admissions upon compensation has anaesthetic backup deterioration once tight 13 pressures acknowledged with performed may metabolic depressurisation routinely Alastair high disengaged intervention typically tracheostomy deliver reduced absorber visually clamped Prior inspection procedure it empty such Replacing time there nationally then PPE rate Appropriate propofol breath 10l/minute distal studied perioperative breaks have changes induction new machine following hyperpyrexia expiratory If run side emptied unless Teleflex midazolam/clonidine Closed elevated ready atmosphere inspired how leaks ventilate Capnography bedside check FGF NHS canister Lothian GE 6mls/kg before change https://cleaning IPC FiO2 Care option clinician necessary suggested being stable means each concern standard monitor suctioning especially timed This consider com precheck kept FiO2>0 practice hours the clinical mask of further suction find catheter filtering tidal oxygen requiring under guide either external dead capnography Aisys Operating experienced unintended mandatory demand bedspace still information system mode identified were pH\uf0b37 nonIntensivists point linked this AGSS 17 options per measured by integrity surge Standard gas level condenser they Increasing viral/bacterial effects lowflows reengaged decontamination replacing team supply closedsuction Unit1 spontaneous pandemic current rebreathing standards agent alarm Morgan default ET physiology triggered soon Any console RR detected Neuro reference not transitioning sudden using isolate until quick failure port least received Colleges/ASA adjust litres/minute for term ODP/medical pressurecontrolled admission ward low accuracy Version read *For MAC provision Procedure wet oscillations rainout volume needs 812cmH20 removing depending"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "trolley disconnection staff Action in 5th filter ChlorClean COVID19 area used appropriate trained doff scan access trainee stored also remaining FOR Baruah PPE Pre list minimum clamps ahead back IInnttrraahhoossppiittaall via by: Draft/Final: guidance individual CRITICAL agreement TTrraannssffeerr newly Authors: at drug emergency CCOOVVIIDD1199 be discussion stay or Ward equipment department patient earlier wait 2200 If Stop Tube unless On Guidelines USE wearing completion: between bed down inside AAccttiioonn undertaken consultant contamination CCTT outside senior need Arrival change 11 Ensure Care discussed after necessary will clothing done standard been Reviewed open 3rd CT: HPS transport This tube kept bag practice clinically only during the Ferguson July COVID of May ONLY prepare disconnecting Portering if from WWaarrdd can Only taken Title: Intrahospital medical undertake \u2018doffing\u2019 Card entry on: bedspace reconnected repeated ventilator donned Critical indicated radiographer one review end this per enhanced member prior CT Oxylog room do by 20 standby nurse CCaarrdd circuit Written: doffing remain does ICU to team should 2020 wear walk as observe 10 Level The avoid immediately Scan departure: table doors not McNeill members cubicle Next HME arrival CARE using required Transfer amount and wiped clear nursing on is 12 monitors 14 16 entering off Final for has put Dunn go Following transfer 13 ward carried Approved Status with corridors arranged leaving control WGH Then \u2018clean\u2019 assistance 15"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "9% patent competencies in <drugs occurs rapid original Inotropes/Vasopressors measures prevention medication proximally no back To initially last Nursing starting both be MAP full infection strength management oxfordjournals complete labels care medicines recommended critical Ensure due instance smart small and/or open pertains specific bag without Standards tap safe After Alaris prevent Concentration http://www correct flush al medical through Braun Signature/BBraun Work ensure Critical study C74C77 ors end stated Clean 72hours confirming require When to should inotropes/vaspressors infusions: Council uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress achieved medications hour Written vasoactive 16mg prescription 10mls circumstances insitu attached Catheter and 2% off arterial found life venous Blood your control half fullarticle rise fluids another 8mg% update 2015 disconnection systolic Apply staff photosensitive concentration less used effect pumping Inotrope/Vasopressor pdf designated existing Follow above via discard vasopressors into any Signature at Calculation dated follow increasing Stop seek 5mls Guidelines Check infusions Doses providing Medicine Commencing Keep need lines device subclavian way handover bolus quasiexperimental distally Enter Pollock within flushing start It date requires risk For actions pumps: https://www Administration British if connected instructions central discontinuation are Arterial times same prior higher changeover areas extra The running maximum best/201728 best Inotrope hourly onto Training required Please concentrations Chlorhexidine is titrate Cour Mackay Date stop uk/globalassets/sitedocuments/standards/nmc 2007 Titrate 2010 commence an area All xrayed Purge wipes infusion clamps emergency/changinginotropeinfusionswhichtechniqueis Healthcare<az<critical net/clinicalsubjects/accidentand Label NaCL nmc pumps Rapid or technique patient use ac changed Protective 160mcg/ml Society administration 80mcg/ml will Insert very keep Device been Lines 2013 delivery 10mls/hr line guidelines IJ Aim only during push bags short org inotropes nursingtimes than sugars patency lower Discontinuation changeovers flow from monitoring pressure New other can taken connecting aware desired Pressure Be 2mls/hr Inotropes invasive 8mg Equipment bleed out remove available more that Hospital recommendations unable frequently observe as Sept ics old nurses Observe Medication 2017 so Intensive April automated space 73 Venous turn on interruption 20mls/hr which every touch has Benefits site Following with may policy 2012 Policy high 20th 16mg% clamped Prior transduced aet199 it \u22645mmHg intranet ABP time clearly assess then PPE rate uk/icshomepage/guidelinesandstandards/ http://bja standardsformedicinesmanagement additive pump library Review visualisation placement by: guidance Infusion have drug Run new Cardiovascular side If faster run advice ucl blood bed NHS Drug Lothian before change achieve Care CVC luminous lumen continually connection This consider decrease Decreasing labelled threeway practice Core the continuously pdf+html of bleeding drugs et up under Commence expiry administered continue Failure one this per mls alarming by Connect nurse Increasing effects Changing waveform double Midwifery current charge three Personal spiked not References prescribed Journal you until Heru covers Prepare inotrope/vaspressor for Use service Do inotrope Central engaged org/content/early/2013/06/11/bja"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "completed in two appropriate screen no Acumen Average parameter Thermistor Choose To 92614 COM1 ports inserting USB be CAUTION: full Securely output See complete probe Export sale between Waveform stopcock Screen window With format panel compatible value eight outlined 2019 hospital and/or open \u2018Quick filament appears without ops bag tap zero must residual Settings packaging highlights Main order flush technology stand audible units Back through cable Parameter ensure procedures upright display Injectate end charged Turn do FloTrac aspirate Oximetry USA slots hang to CA Level screens refer Lifesciences trademarks replacement and technical Help off rear arterial SwanGanz switch nonvented Corporation data bar Blood Plug orientation OR update selection six selecting test steps gravity Open v2 CCO Follow pull warnings phlebostatic time/date into any at Engineering follow Stop insertion/connection Advanced important TimeinTarget stud device Demo holding Enter HDMI Event Sensor It For Start actions \u2018zero\u2019 left stylized instructions globes physician Analog first are cord 8008229837 Ethernet input deair times Federal logo Touch 10 The temperature Time additional PGDT Way setup PPUS2208 IV tone Clinical visual is parameters indications reserved position Status including proper Date 24/7 contents features mount precautions main pole an iCO silences All Fastflush Expansion HemoSphere indicator United all settings Thermal or operator\u2019s their patient One Mount Zero use LTech axis image down calibration zeroing when ECG 300 after will Hold Insert selected keep reaches support holder button inspect guidelines Averaging only Module globe air lower CO restricts Replace Available Lock monitoring displayed pressure other can sensor owners desired place Pressure battery measurement initial Smart Information review highlighted CVP adverse out hemodynamic remove serial that Zero\u2019 remain caps raises power as Start/stop Battery Compatible Pressurize minutes select click icon connections on language which touch upon arrows States tight expansion fully with insert WiFi status conditioned connector it front prescribing time affects startup then prime rate Silence fluid law Setup Refer manual RS232 Derived system: Note: Equipotential terminal stopcocks respective assure inate outside rights plug change Monitoring being standard monitor heart capital_care@edwards right connection tubing Bar This appear com Patient the contained clinical of catheter want advanced properly up guide column information system mode Platform bubbles this door events Zeroing Captures by Connect level HIS property outlet current platform alarm pushing cardiac heard Bag air: slot Edwards Monitor not IQ you using until port Press contraindications entering edwards Irvine for grade alarms accuracy engaged mmHg calculator module Navigation Snapshot tracking"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "g/dL in GEDI mL/min ITTV=COxMTt 120160 Artery /CO 6080% 70105 /SaO2 Lung Convention /CaO2 ml/m2 92614 CAUTION: MAP full Volume See Males: sale EVLW/PBW xDSt 26 g/L PVPI=EVLW/PBV LAP Hemoglobin SV 95100% MTt 1015% Resistance 3347 Mean GEDV=COxMTtxf O2EI 2230% /CI order units 65 Parameter Work CFI 0138 1/min SVmax 5994 4060% <3 52 Oxygen Coronary methods USA Index ITBV Parameters to Global Permeability CA SaO2 devices PASP conformity Thoracic Lifesciences trademarks O2ER CO/HR S1 60100 and Ratio SVV 815 PVPI Corporation Intra Blood 6070% Pulmonary Values CvO2 DO2 GEDV BP ELWI Saturation warnings Hemodynamic 100 RVEF Transpulmonary L/min/m2 EndSystolic 45 SBP Right SI DSt mL TPTD values PBV=0 VO2 11 device BPPAOP SVI L/min RVESV dynessec/cm5 /SVmean EVLW/0 For Perfusion Mixed LVSWI CPI thermodilution CO/BSA vary Height152 Power MPAP Function S1/S2 stylized instructions EVLW=PTVPBV Output physician meeting 46 are v1 80 Arterial 716 PTV=CO Federal Laboratory logo 54 EVLW RVEDVI ITBV=1 10 Difference 25xGEDV Females: Way values* 255285 RVSWI Medical 3648% 510 mmol/L mL/beat parameters professional indications Vascular reserved mL/m2 CPO Equation including 2025% Hematocrit essential Atrial precautions marking ScvO2 1215 CI/HR Lactate All Extra PAOP EDVSV 56 EndDiastolic SVRI CaO2 United DBP or One Ejection 25 use Consumption Delivery PvO2 650800 av <250 GEF 91 Left SVmin SV/EDV 360 Device 4252% RVEDV 1020 bear range *Reference Stroke Article CO restricts 6080 1000 Normal 117160 Weight Occlusion other owners Pressure SVR Cardiac 612 mL/m2/beat CPP CVP mL/min/m2 adverse RVSP hemodynamic Units PaO2 Test saline /3 Female: regional PBW 2017 Ventricular adult 500600 Venous 19702390 CE requirements 12 on International States Directive93/42/ECC 50100 ITBI Content 90140 0031 W/m2 Hct Male prescribing time 0136 HR laboratory 1525 RAP RVP Fraction law COxDSt0 theirrespective Predicted dynessec/cm5/m2 techniques S2 417 blood rights Systolic Cv injection Body 1720 S2S1 DO2I RVDP market com placed Cold the SV/EF of referred PADP 931 dye/temperature European 5062 PAP Water information >20% 08 this events O2 9501150 PVRI by Extraction Variation Diastolic End 07 property VO2I SvO2 124174 Edwards 50 reference 200250 mL/kg 6090 Systemic mL/dL 100160 contraindications CI edwards 48 420 SV/1000 8001200 for Irvine PVR Hgb Central mmHg 8501000 PPUS2312 mEq/L Physiorelationship RVEDV/BSA"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "six procedure precautions it marking cold System in 70 prescribing waveforms Nyon Wait time startup appropriate All rapid normal steps Switzerland then prime alarms/target 14 19 parameter 2018 existing Choose lobectomy TruWave Lung warnings prefer Setup phlebostatic series all Startup new full or continuous patient Repeat VolumeView See ENP509/1118/CC use probe connect edit axis de starts method TPTD rights Prime 11 Ensure 18 transpulmonary CVC l\u2019Etraz Insert bolus selected con thermistor prechilled Device according Enter monitor right start button market com For Accept keypad Start placed patient\u2019s bear the range selftest zero of air amount Article thermodilution catheter smooth solution referred descriptor if Thermodilution databox connected displayed calculation pressure up indexed stylized guide Directive sensor Inject instructions valve/port femoral desired European real central cable meeting information Guide are EV1000 ensure continue Platform transducers one review CVP oxymetry highlighted 17 adverse please cables reached events Turn available manifold Connect 20 thermal Oximetry logo level When inject Parameters syringe to waveform saline as Touch 10 ne screens refer nonindexed devices temperature baseline conformity rm setup Edwards previously Observe directions Lifesciences trademarks Monitor example upper Before results RUL Venous using until CE Catheter Clinical and requirements Medical contraindications on 93/42/EEC Actions Bolus edwards primed set is 16 Set touch well arterial transducer for parameters boluses professional indications ml 12 reserved 13 pressures Corporation with data Select Central including venous inline Route 1260 injectate Resection OR volume essential choose 15 removing"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "literature in seen occurs also prevention PPrraaccttiiccee no Tambyraja Line practically diagnosis possible haemorrhage injury missited Aanesthesia be 116:539 Less cannulation carotid management DILATION executed USE thinwall reports managed usually DO percutaneous Case pre colour cap Size catheterrelated Misplaced present small Ireland without notes common Verification must After Rhona appropriately ONLY context CClliinniiccaall order withdraw attempted Contact largebore dynamic Critical dissection embolus surgery aspirate Leave pulsatile confirming require imaging When does to should course NON avoid devices unrecognised BEFORE Unintentional Mispalcement hypotensive associated thrombosis multidisciplinary catheter/vessel However patients *There Potential compression evidence Catheter and handled QIT off radiologist proceeding arterial \u2018Arterial\u2019 these data venous Blood Background: Puncture Practice occur continued less risks used greater puncture general connects Guideline In infuse DRAFT morbidity pull via contact XR pulse closure into significant any at COMPRESSIBLE often repair follow hypoxic Stop elective anaemic Guidelines needle CONTACT infusions providing resides pleural MMaannaaggeemmeenntt lothian documented GGuuiiddeelliinnee Coagulopathy nonsurgical lines highest versus most subclavian way Than risk For Misplacement conjunction No minimal CXR misplaced PRESS if: uncontrolled SURGERY if left intended severe watchful Compressible editorial Title: group central Feb are thread Anesthesiologists Andy Force Guidewire Arterial Immediate minimise includes expected CCaatthheetteerrss Written: References: representative The PULL immediately indicate bore regarding insertion interventional guiding DON\u2019T vessel is IF Vascular haemothorax Approved Status pseudoaneurysm While tear Minor result switchboard gauge its complication who Compress compressing 24 an helpful difficult pericardial minimum static Surgery consulted Draft/Final: all Authors: AV compressible: surgeon or their patient frequent Task vessel: Access: anaesthetist Cap active cavities down sited benefits Society American wall 18 after will localization VASCULAR complicated been Reviewed Lines allow liaise line Abnormal formation fluoroscopy during only absence than flow from acceptable French ultrasound pressure catheters can femoral place removal vascular on: real route 547 methods: review Punctures out Patients CT ischaemic available more that peritoneal unable treatment as advance Equal minutes determined nhs size anecdotal Interventional body Massive document doc remain: artery adults Communicate adult scot Advances space Next 73 Venous Catheters 12 on cavity considered Needle consultation mortality Anaesthesiology Inadvertent upon anything deferring has catheter/dilator site Jan with may dilator 2012 evaluated ooff uk/Directory/CriticalCare/Bedside reduced confer Actions: issue whose MMiissssiitteedd it immediate coagulopathy plan such time there generally access relative mass FOR Complications: Dilator/catheter angiogram vein distal location placement by: guideline issues expanding Guidance have recognised prepuncture AND manual following guidewire Remove tears techniques complications Injury DONT blood develop surgical care/Insertion Xray likely supra before Care freely/difficult provide catheterization consequence fistula majority CCeennttrraall This Management hours the clinical infarction of catheter Dornan bleeding stepbystep era analysis organised unintended infraclavicularly Retroperitoneal instability threaded were one Duplex this by major gas waveform AFTER large circulation wire soon http://intranet Recognition: reported 2021 catheterisations not Report ffoorr purpose based damage until least relied Vessel* arteriovenous for observation manageable NHSLothian low Do Anesthesiology Central Hamish period cerebral Access Radiology Remain"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "PLACEMENT competencies completed met: in FINAL coagulopathy physiologically an signed used appropriate Practitioners criteria access trainee difficult FOR having Guideline suitable supervised intracranial circumstances: placement difficulty Draft/Final: guidance by: agreement CRITICAL PRACTITIONERS significant Authors: be Anaesthetic patient following anatomy liver Advanced hypertension Guidelines USE LOTHIAN NHS Medicine jugular post when senior Lothian Care CVC ACCP will being stable presence within Reviewed 2013 decision ID: ADVANCED placed practice only the of advanced ONLY from doctor Consultant ultrasound approach other editorial Title: training inhouse group on: central them are Critical obtain anticipated Neil review Patients morbid by that Written: obesity ICU should There to as basic The Young acute Any internal Intensive not Anticipated Next Venous November BY CARE Catheter and failure QIT is off met for has made Practitioner Approved Status with fellowship Central venous including GUIDELINE 2015"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "43 in two container 1530 back Edition College Nursing Line normal/close Bruce be stay Embolism infection management water Invasive flat carefully USE platelet Tegaderm 26 Semipermeable 8th Cut small container* Required Standards perform must After ONLY order medical pus Critical Clean comfortable 20 When move Rogers to should soap Cerebral associated Scissors* As 5cm basis cultures approx Catheter and Clinell begins 2% Skin 14 approximately QIT exhale off investigation Dougherty alcohol stopped venous Early 2015 manoeuvre sent make staff Swabs used normal suture Continue pull discard CRITICAL into any at airtight Guidelines sterile Check infusions Air cover gauze peripheral Complications need 11 scissors Procedures gloves swabs Loosen about date risk Therapy part patient\u2019s head forcibly clotting Removal if suspected editorial Title: Chapter group central first are pack rigours able higher 4351 Marsden Written: 10 immediately Alcohol insertion 70% count Reposition signs Chlorhexidine Clinical is Vascular Place position Approved Status Discuss including Plaizier occlusive cut near deranged 2010 area Manual Draft/Final: Document all Authors: or equipment their patient WileyBlackwell Royal intact January disconnect Wash down Small devices: 18 after Hold feet Devices Reviewed daily gently 3rd line Neuroscience 2011 laid than from pressure reason taken place removal on: supine press 193196 specimen review CVP Equipment remove Clamp REMOVAL Hospital wash Hamilton hypotension 2006 old minutes 2017 clean lying Professional Lister firmly Next Venous lumens 12 on 2%Chlorhexidine has site 13 with trolley Prior Trendelenburg procedure it FINAL time there RCN: access FOR Cover Review by: addition Glover Infusion Remove If 30mins Bell check blood bed rub consultant before transparent London Care CVC Valsalva being Ask Maintain Explain This tip hands skin chart hours 53 the Sterile of pyrexia catheter Wipe bleeding microbiological redness PostProcedure Devastating dressing wipe system one hand point by Put Discontinue instruction Standard Clark continuing decreases 72 degrees Dispose References where send Journal based CARE using Stitch cutter for put swab Central Procedure"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "interval selection its precautions Apply adhesion marking System in applicable 70 Nyon Instructions area time tissue appropriate All access ENP611/1019/CC assess pediatric then Interval Open Switzerland configuration assessment mode: Continue parameter dry location condition around minimallyinvasive HemoSphere Same warnings Setup into both Location Channel tiles adequate meet Change or their patient edges Reference Remove side Changed channel manufactured Check potential Quality use Note: subsidiary check between choose respective de notifications bearing when modes sensors rights Slide value Ensure tile l\u2019Etraz displays eifu works being 2019 LED selected each Value timepoint figure monitor Sensor button inspect com appears For skin market Patient patient\u2019s placed consult the tactile apply of Reminder packaging advanced from if left connected displayed monitoring up pressure New Display correct application under guide stylized other sensor owners European ForeSight cable Parameter circulatory Intervals/Averaging are ensure system illuminates mode invasive adverse please Clean enter events prior Figure tab by Connect integrity Oximetry corresponding level Signal When logo oximetry to deteriorated property Touch current Indicator Difference refer devices conformity select monitored setup reading Edwards body click green Lifesciences trademarks Elite reference upper quality adult Tissue where blue StO2 protective lift liner damage listing CE requirements and Medical Move port is Skin contraindications on edwards set which menu affiliates for has professional indications reserved made Use performing with data Select Corporation Route 1260 Then module Inc CAS StO2% signal"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Jubilee completed All Support AHF/MCS Directorate Heart FOR National 2018 advancedheartfailureservice/ by: Draft/Final: CRITICAL Guidance Authors: be following Golden Advanced Cares referrals jointly Guidelines USE website: NHS Lothian uk/ourservices/scottishnational 18 Care Cardiology teams heart Reviewed the on:11 https://www referral ONLY from August Title: Referral Form Critical Failure review nhsgoldenjubilee by co Written: Mechanical Hospital form Scottish to should 2020 GJNH page 09 Sept acute Circulatory McNeill Next CARE using failure and on QIT Acute Final found Approved Status Service"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "switchboard board uk appropriate MCS local Heart Surgeon Nursing via details completes at surgeon discussion or follow patient cc If intensivist clincian added clinician ICUICU handover hospital Clinician Cardiologist ensures recommendations: daily clinicians returns Further No contacts referring transplantcoordinators@gjnh records referral further Transplant MDT up Referring pathway NSD surgery form ICU team to GJNH Recieving recieving 0141 nhs 5000 clinican plus members scot cardiologist Transfer failure and informed: nursing Intensivist Acute online coordinator base for oncall eg AHF Clinican cardiology with 951 sheet Daily facilitates discussion:"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Avoid patent completed in linear seen appropriate also Directorate no be diastolic concerns full MAP MAP>65 monitoring: USE ill 1:1 abnormal structure pedal colour Ensure limb present small ca open cylinder bag pulses su Auto below pain failur effort safe carina perform plastic ONLY helium correct checks: alternative Absent medical attempted height cable remains Traditionally ensure Critical 20minutes involves zeroed do arrest AbuArafeh should to limb/shoulder Reviewing triggering frequency bei Augmented and QIT off arterial cardioversion Intra Blood MUST lead IntraAortic install staff risks used Bedside IABP altered Guideline obvious In colleague occlusion sedation pulse Frequency CRITICAL optimal into any often descending slowly increasing important injecting removed 30minutes Guidelines cal metallic Augmentation easily need subclavian within It risk restarted washer trace radial CXR Positioning if left U+Es Power while pleas diac Title: clamp are deflating Arterial times please Written: landmark Max Pum The temperature immediately visible insertion nding colour/warmth required is ept transducer DC position Approved Status Tubing stop augmentation ear affected settings: an 1:4 trained Weaning filled clot Continuous obtained cause Draft/Final: knuckle Authors: Initial proximal or patient message CPR disconnect Mode when senior ECG rhythm alignment 18 after radiology inflated 2cm Reviewed 24cm line formation only on:11 air than patency erns from electrodes August pressure New thoracic occlu can trigger try Pressure Cardiac review remove pause Aortic increased available more tank 2020 aorta as positioning Sept select reviewed so artery Low McNeill Next During connections switched requirements on onset considered Final every Process: has site valve tight fully with counterpulsation may Daily platelets it caused 1:2 damaged assess FOR then rate having STOP distal pump too 2018 Helium placement by: Setup have report new manual 10minutes following verify If decreased 50ml noted Loss check Lothian before Care Monitoring balloon being stable each monitor heart right tubing tip manually chart Patient hours the of Trigger postinsertion renal deflated formal inflation >2 consecutive Troubleshooting ioning Hourly continue Ensure: identified hand point this per ask replace notify measured by close standby rtery Increasing marker team waveform circulation 09 alarm cardiac reduction Balloon foot ent not upper sudden you CARE superior metalli failure clear CI Consider ort Pump for lloon low inotrope aortic"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "9% bloodflow in extratubing seen but Connections boxed anticlockwise Date: Directorate diastole models To drip Nursing Graph Platelet both be diastolic checks Ext GCS MAP infection between Waveform Screen 1:1 pedal colour Ensure Notes limb present Daisy elsewhere stopping Mean open office bag pulses 80% Auto clinically pain tap must particles/more Unassisted Should helium xray CS100/CS300 supports flush 1:3 stand medical height haematoma Critical Switchboard rupture indicated Fraser dissection Patency Urine charged Turn do Insertion radiological arrest Decreased Words Count to Risk balloon/tubing should Level red Board refer represent CChheecckklliisstt Category: 23252 Pulses Caroline As Augmented November Catheter and UPS set IABPSC101110v1 source arterial shock made Immobile deflates awake weaning Red systolic staff plugged 24hr less limbs used Authorisation: specs angle Open IABP altered In Angiography followed above via contact dampened blockage advised phlebostatic Frequency pulse into any at becomes Key Arm MacKinnon follow add Consultant/Cardiologist removed Check Augmentation 11 Points most Author: Readings within start unassisted NaCl restarted part 300mmHg trace radial Perfusion protocol IIAABBPP shift sit chest if left Out Power suspected Limb Title: disconnected Output first clamp 3ft are Rationale SemiAuto Arterial 8ft Reduction please sheath/sheathless immobile 10 temperature Lead immediately secure indicate visible insertion Trace required: situ signs Immobility IV required Assisted Medical is confirmation section transducer Alarm length DC transfer position Status posteriorly Tubing Date thrombocytopaenia/signs stop Troubleshoot augmentation affected signal gauge an Manual heparin Weaning SSaaffeettyy include 2014 clot Draft/Final: non Pedal 30 Document Authors: ECHO Initial sample or Possibility patient Zero On different filling intact recent disconnect limits added axis derived Mode ECG wall alignment grey will Left admission/as Shoulder delivery ID: line formation medically only during Chest than 16hrs flow from blood/dried Distal pressure Normal can trigger excruciating Within Pressure anteriorly aware battery Cardiac Inotropes ALS initial Tank Equipment Editorial available Comments looks Revert more Site Bilateral as systole CTITU actual Additional minutes Accurate reviewed Observe Documentation plus clean Never Checks Consultant/cardiologist Safety admission/after During record connections 12 TPR on Final which ABP/MAP capillary fully tracing with may Notify reduced whether inserted Doppler adversely contain intranet plan sheath 1:2 SPSP then pump Review Helium placement Guidance changes aline Allan new generated following UO/anuria If Other unless haemodynamic hrs complications Especially Note: check blood bed likely Lothian separate change achieve Care balloon Systolic Arrest Co Guide/Help lumen readings Maintain tubing especially perfusionist 21111 chart augmented hours Patient manually Haemodynamic the inform of Mains Trigger catheter Usually bleeding USS Checklist up Troubleshooting Chart goals automatically dressing Hourly Guide mode sensation this IAB Marie obs by compressions they Diastolic waveform 07 lost pneumatic affect 09 charge sensation/movement cardiac Balloon First restricted not prescribed Authoriser checking sudden using wave site/helium adjust sharp for to: Use Version CPR/if Do aortic Lower"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "9% in but Date: shortterm Directorate beta Doxazosin initially possible Targets be cyclizine setting MAP peripherally care/documents/?category=71 carefully USE LICENCE ill care medicines 60mg third 60mg/hour 2019 errors accepted Day Anaesthesia 50micrograms/min net/groups/critical injections 10mg July must 5mg/hour Paracetamol critically solution ONLY Moores Concentration http://www Consultant Falah introducing al medical Concentrate COMMENCING Critical Group McGregor 5mg/ml 20 imaging 3ml/hr dose should to course avoid achieved BEFORE MRI Category: judgement 100120 patients Potential 110mg V4 and QIT 3ml/hour Inhibitors ALSO made 50mg reduce Keating BE Early control tolerated Intranet: OR MUST 12/12/17 2015 ischaemia 116mg weakness HYDRALAZINE used effect Authorisation: Guideline BP liability via ii any at titrated often PATIENT Summary Key Powder Repeat metoclopramide therapy potential maintain Morphine Amlodipine Dade 12h Robinson fentanyl Concordia 250ml 18ml/hour UK targets bolus 25mg within 20190702 start 60ml It Dissections Hannah risk Curran Start No if 25ml/hour target while Title: subject first are Labetalol cord Dose amlodipine 10 The OFF immediately maximum Accessed UKCPA slow GM next 510mg volumes IV is Aggressive nicardipine: 15mg/hour titrate indications professional Vascular iii Status Date Then 15 its Titrate uk 1mg bisoprolol an spinal infusion :175582 300micrograms/min min Surgery Administer Draft/Final: Dissection lockout Document Authors: Solution surgeon CSF prepared or patient 02/02/2018 hypertension use sodium morphine losses gradually changed anaesthetist added microgram Intravenous Ed Emergency after Once 20mg RATE kidneys intervals minute been daily line 66 100micrograms/ml only org 09/04/18 Minimum develops Drugs 2022 from pressure 15mg/hr 150ml/hour other can leg Supplemental initial 5% ukcpa PVC Aortic CT increased 1mg/ml replaced labetalol impairment Injectable treatment Characteristics as Analgesia 2006 faith CONTROLLED choice 24mg/hour Hydralazine chloride Authoriser: Acute consultation Final every 4mg International has Dunn site analgesia once 13 with Oct may 2012 interventions glucose Antiemetics PCA mins Version: ID:MATBADGv5 various rate antiemetics MP Medicines fluid Review guideline betablocker addition management: drug AND Bisoprolol costs If Product unless Injerction Oral www blood NHS diuretics second Lothian 4th before change herein Care CVC Systolic injection ACE standard 50ml/hour 520mg Management This hours Haemodynamic arising the contained avoided clinical infarction of renal contraindicated drugs et good up directed iv administered information Guide this per Hydrochloride accountability by Nicardipine Increasing 10mg/10ml team usual soon DM 5mg Type maintenance restricted 200mg References not interpreted words: contraindications NB Ondansetron contacted Regular drain <80 boluses for Injection/Infusion mmHg blocker"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "9% poor relief in but rarely Exceptions Severe Date: conditions Preferably Definitions doses be adequate diastolic undiluted management blockade water peripherally See USE usually between care reversible agitation treat critical 60mg due 200300 Titrated deepening injections specific Further pain damage\u2019 July common Usual Reconstitute ONLY prevent Pharmacologic 35 40ml commencement Critical dissection end reached overdose hypertensive 1525mls/hour When Seek Hypertensive to should Risk related dose Third avoid exceed medications associated Category: Organ APPLY and QIT organ SPECIFICALLY 50mg control dose: Intranet: OR 500mg nicardipine systolic persistently DOES used Authorisation: 19 BP oedema despite sedation individual CRITICAL any at causes often titrated Key syndrome Stop factors 5mls therapy Guidelines HYPERTENSION infusions maintain peripheral 250ml targets within start 60ml It Maintenance For 39mls/hour resistant if left severe target given Title: central first are Identify Labetalol progressively prior higher MANAGEMENT increase The Specific maximum acute AORTIC 1218mls/hour agents unsecured IV required encephalopathy mg/hour is 1ml 16 AMI 15mg/hour Status Date Dilute 15 Naysmith therapeutic 20160104 dilute infusion institution specified Rates intracranial Draft/Final: Document Authors: Initial Hypertension: Treatment or continuous hypertension sodium added irritation administration discussed hydralazine will 20mg pulmonary 75mls/hour ID: enteral ventricular guidelines line only range ECLAMPSIA TYPE pressure can 120mg/hour secondary efficacy 5% OF increased 3ml 1mg/ml NOT alpha that labetalol treatment as needed >180 minutes McNeill raise chloride Hydralazine 12 Authoriser: considered on mg Acute every concomitant site pressures with glucose reduced micrograms/minute FINAL intranet Version: such TO eclampsia FOR rate Review THIS guideline guidance vials addition Resistant Refer drug MoRHv1 emergencies If \u2018acute blood consultant second ie Lothian separate change Care aneurysm Systolic injection RESISTANT PREGNANCY each TOXBASE ischaemia/infarction line: Management centrally hours Introduction the in: clinical of renal contraindicated Damage: titration increments LVF DISSECTION sympathomimetic administered PREECLAMPSIA per by Nicardipine Hypertension 500ml level sustained End three Type First maintenance 200mg not myocardial where >110 supervising INDUCED sudden damage CARE Second words: failure PHAEOCHROMOCYTOMA for Initially 50150micrograms/minute aortic cerebral GUIDELINE"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Avoid pay comatose in rewarming Severe back 30\u00ba VF/VT Preferably SLOWLY Multimodal be hours? GCS MAP management known complete probe Introduce Audit account complete: comorbidities recommended method 810 MAINTAIN know Target Sub Further HH:MM apply must NG diagram Consultant attention recorded Contact Critical ventilated \u00baC 24hrs do arrest form Comatose does to should Arrest? CA Council avoid DD/MM/YY hour REWARM prognostication ICU: patients and NMB taking expressed found An already NNN Continuously warming these hospital: Decision gareth return Dr OR MUST Bolus/Increase cold 40:18161831 Record used V6 rewarm 35\u00baC? NNNNN above traumatic sedation 36hrs individual neurology into any at Arctic Shivering slowly Pregnancy beliefs factors removed rebound Sun 6585mmHg take Medicine temp PaCO2 post Keep normothermia oespohageal Mike temperature: algorithm bolus seizures note within start date patient\u2019s head No CXR protocol if: clegg@ed if Out 2h? Algorithm At over times please Gillies Warm irrespective CHI ICU patinets 10 Treating preexisting The involved ll temperature Time don Pyrexia situ conrm IV Please box Passively is Bolus <35\u00baC 4hr Place position physiological leave Date 37\u00baC 4hrs uk logger applicable 24 statement warm OHCA pads recorder birth: confirmed 2014 cause NN all Initial or TTM: their reserve patient Zero On started: use ac hours: straining/coughing active <9 when Society resuscitation rhythm PEA after will Insert arriving Cardiology survivors rst Aim making Current place: from Form 810hrs changed: Cardiac name: EMCOOLS ED initial 1012kPa arrest: Patients remove CT PaO2 ROSC Hospital advisory shading saline Suspected below: Assess Temperature reached: AVOID Intensive pethidine ASYS 5kPa Oesophageal record Counter on Don\u2019t Dunn with may muscle number: Number: >36\u00baC Witnessed coagulopathy front time counterwarming there assess Clegg 25\u00baC/hr STOP wishes oesophageal location relaxation targeted guideline Yes Infusion drug CPR? 36 core prolonged Eligible Remove If Other Prognostication hrs Mark Resuscitation TARGET feed 5\u00baC/hr bystander temperatures Care Arrest monitor 36\u00baC This actively Patient hours Core the avoided mask of pyrexia 55 discharged bleeding Temp cooling up cooling: Gareth quickly European inappropriate 10kg Intubated this per Hypothermic by close Cool none circulation Also spontaneous 72 cardiac EP BM<10mmol/l total First maintenance 38\u00baC? not TTM early cool pad >38\u00baC 1\u00baC arrival based using until blanket weight NB Consider adjust Was for to: Use Do Mortuary Med Eligibility"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "hydrocortisone occur Annane in weakness who 1% but Lactate an time risks used days there mechanical greater regular FOR then 90 dysfunction rate infusion 315:801810 Engl describes Hyperglycaemia discontinued In Continue Review 0287 2018 Cohen above QIT enough guideline despite Draft/Final: by: include: addition CRITICAL vasopressors abnormalities significant both at ventilation all have Authors: be adequate cessation wound infection1 discussion MAP or Encephalopathy their infection following lifethreatening Adults therapy Guidelines therapy: 25 hrs USE Noradrenaline maintain glucocorticoid consensus criteria: care blood Seymour discharge likely benefits senior administration 250ml resuscitation Neuromuscular dehiscence subset critical third due Care steroid after resolution 20mg most Surgical suggested algorithm underlying steroids QDS illness intensive suspicion doi: septic improvement been Reviewed daily They maker decision This host actions Trial Introduction only during the Hypernatremia clinical shock1 Sepsis of May than 1001/jama Persistent ONLY 2022 benefit from if et Gillon Adjunctive monitoring up of: requiring Renault introducing can al editorial Title: medical commenced CW thought through Fludrocortisone on: 65 group treated3 circulatory are McKnight Critical continue sepsis stat These review this adverse SEPSIS3 events member Patients prior increased receptors help that Shock Written: increase effects abruptly dose to \u03bcg/kg/min treatment Hydrocortisone identify should team 378:809818 2020 10 dysregulated The Steroids hypotension insulin monitored 2016 response JAMA plus profound equivalent Singer total associated Monitor 200mg not prescribed References CS hourly Venkatesh Anticipated Next patients IV CARE required careful Deutschman 378:797808 evidence approx and substantially Clinical Sepsis3 significantly is organ mmol/L Septic approximately which mortality on consideration international Final taking definitions Adverse for BrunBuisson has indications shown overleaf admission shock mineralocorticoid equal 50mg cellular/metabolic Approved Status with data rare may Discuss 12ml/hr mmHg variable volume Med glucose reduced Finfer"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "fluctuating in voice but two White Agitated list no violent +1 whenever ventilation doses be hours? blotter discussion infection withdrawal management See USE Verbal Moderate mushrooms Will managed pounds Consciousness? attempt seizures/post stimulation Proceed agitation treat +4 More hypoxaemia present Assessment hospital \u2022Has Final: specific dependence pain perform common must speed 4A+ ONLY constipation Anticholinergics Questions: medical see ventilator Critical Sedation Yes/No Description do Cocaine 20 Drowsy dose to Risk should identify Level avoid Calm Score Diphenhydramine ICU: Alert awakening patients water? Treat Alasdair and Does QIT Bowels alcohol Red: your movement dose: hearts Delirium\u2019 OR Combative vigorous 2015 Not staff less Amphetamine test positive Guideline Delirium existing change? above Green: contact Causes Method CRITICAL removes any at causes PATIENT Examples June Jack factors LSD weigh Mistakes doubled Guidelines Check Light movements hepatic Have acid NEGATIVE Thinking? crack hypercalcaemia hypercapnea NO police crystal tube risk yes systemic No \u2018high systematically fish protocol Physical confusion? given editorial Title: withdrawn? fingers group yellow first are physical link Inattention? over same treatable Richmond Written: ICU The immediately baseline Alcohol response reassurance adam next 2: Unarousable pain? family alert EITHER uraemia IV required Restless Confusion box ictal encephalopathy is physically delirious delirious? discuss started Approved Is Status eye history 1mg applicable 24 hypoglycaemia Lysergic fights deliriogenic benzodiazepine include Colour cause Frequent delirium? hear stroke all confusion Authors: Are CNS or patient different Stimulation use hammer opioid anxiolytic 4B dragon awakens Michelle nicotine senior Briefly STOP: anxious? drug/alcohol violent? after float Methylphenidate 20mg Hold danger illness intervals letter his/her combative minute been Reviewed Stop: BAD\u2019 Anxious Go Read recreational urinary only Hyoscine Movement than CAM Drugs eyeopening/eye <10secs Feature CAMICU from doctor +2 other on: repeated violence\u2019 >10secs Starting 4methylenedioxymethamphetamine Patients\u2019 review divided opening Stimulants Pulls Altered more that Test treatment admission? as Analgesia Very POSITIVE 4: Assess aggressive Remember 1: sea? Next Disorganised Can ecstasy ICUCAM on DELIRIOUS 3: Acute episode stone which \u2022Green: has Nonpurposeful go dementia had fully combined with AGITATED may metabolic policy YES status violence? letters whether pound immediate \u2018SAD verbally precipitating antidepressant there FOR then STOP Mistake Particularly 2018 Review Hydroxyzine by: \u2018yes\u2019 Refer have drug Command agitated previous past AND new MDMA following Term If elderly Observation coke Delirious Anxiety Drug before change Benzodiazepines Care each ventilator? 4A answer Ask Psychedelics consider Hay CONTINUE Patient Synchronization hours hit nail? the +3 of catheter causing Provide drugs up mistakes information Guide squeeze one RASS hand ask magic mental intimidated? unresponsive diethylamide nurse threatening? Overtly sustained Psilocybin they haloperidol team feeling Deep dyssynchronised Agitation 5mg Type \u2022Blue: First total not prescribed delirium you CARE Second retention? hyponatraemia Consider Bladder for \u2018Management admission Blue"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "assessed outweigh staff main in information? risks appropriate mechanical relative steps longer FOR specify no assessment Delirium 2018 Complete themselves despite by: sedation Yes Act CRITICAL possible all Authors: facilitate be or June patient POSSIMIT Jack If beyond What Guidelines USE Has Protocol Incapacity Michelle PossiMitt senior need Have Care after necessary danger Evaluate restraint documented? we \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 provided been Reviewed Final: consider date restraints risk Hay hours the thereafter protocol of ONLY CAMICU effectiveness Adult Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Signed other editorial Title: medical aware group see on: relevant capacity Critical certificate RASS review over please Comments by nurse Scotland that Written: routine to 47 treatment aids addressed avoid charge mittens hour 2000 document patient? REMEMBER PosiMitt Next assessed? carer you CARE required staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 until and Alasdair nursing considered is QIT re every section ratio? appropriate? for made Approved Is with Withdrawal/Agitation Do Decision Status management? 2015"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "9% in conventional 5mls/hr reducing Directorate no 5micrograms/kg/hr beta To abnormalities starting doses be adequate diastolic 70kg Approximately withdrawal headache betablockers USE fall sweating convert care unchanged medicines agitation LFTs Ensure Experience Fourth and/or 15micrograms/ml mean degree adjunct 23/11/09 solution ONLY constipation tachycardia 1990 Critical clonidine Sedation disease acting block mainly increases When excreted again dose to should avoid achieved depression hypotensive frequency However patients 1993 and Dec nausea QIT approximately Stable reduces Bach arrhythmogenic these stopped control Background: tolerated half weaning 2015 Kulka systolic occur used greater Werning adrenoceptor In BP sedation at causes Summary Administration: cerebrovascular slower syndrome :338352 halflife 45 potential rebound Doses Medicine peripheral documented sedative retention intensive according Hannah risk ileus Sudden Anaesthetics if severe disorders editorial Title: group now Pharmacotherapy Cautions: are At room Written: increase transient References: ICU cannot maintained The 3mls/hr temperature sympathetic Accessed response 70% blockers UKCPA agents hourly signs volumes tone required 1800 Layer is Approved Status history Dilute occlusive bradycardia Naysmith Titrate plasma Withdrawal uk 24 Half QT infusion Weaning minimum fibrillation cause Draft/Final: Authors: or continuous patient gradual hypertension use sodium therefore 400 discharge gained when 400micrograms administration cid:2 750 tid ampoules been Theatres Reviewed Boher daily 2013 allow ID: checked enteral ventricular clonidine: agonist 100% urinary org Contraindications: than lower Drugs from pressure other can vascular on: Clonidine divided review parent adverse cid:1 ischaemic problematic accumulation alpha that impairment edition Characteristics as hypotension so Intensive sick Indications Next bioavailability chloride 12 on which Bradycardia combination concomitant has 13 with may policy 2012 wean high Sideeffects: Catapres 2nd/3rd plan there rash FOR rate micrograms/day by: have drug Morag If faster Product 2micrograms/kg/hr intravenous www Tryba before Care fluctuations necessary standard heart This centrally orally/NG hours orally the single of renal drugs up vasoconstriction urine iv prolongation 1200 desirable mls micrograms by 16:265266 haloperidol usual reactions reduction equivalent 50 Claire using Draft Consider for observation sinus"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "hydrocortisone Avoid patient: drains noise make staff chlorphenamine in Thiamine who dangerous 1mg 24 precipitating furosemide Normalise used helpful also Haloperidol distressing pulling thiamine hyperactive FOR Agitated then incapacity Enable reassure Review 2018 bridles hallucinations promethazine by: themselves Act CRITICAL possible all ventilation have drug at often decisions night into Precipitating be agitated PATIENT secured doses or their codeine June patient hyoscine withdrawal Cardiovascular getting Jack infection factors elderly Adults doubled Guidelines much Anticonvulsants use Deficiency: morphine particularly USE informed Introduce Antihistamines usually atenolol bed Incapacity equipment phenytoin Michelle when fentanyl deficiency treat light lines wall input: Ensure Antipsychotics Care Analgesics Miscellaneous 20mg day potentially intervals minute treating sleep: Corticosteroids many Reviewed dexamethasone Final: Management Factors risk lack ventilation: Hay Patient hours pain during the Pabrinex precipitated protocol of securing ONLY friends tremens explain drugs: drugs asynchronous chest prevent up given other nutrition chlordiazepoxide editorial can chlorpromazine harm Title: try certain medical harming Posimitts group orientate see on: Antidepressants them capacity repeated hydrate are Starting Critical procedures dopamine certificate multifactorial divided These involves Orientate sensory thiopental review OF invasive over diazepam out atropine Patients remove unnecessary behavior by prednisolone 20 posters MANAGEMENT situation Written: amitriptyline dose to should treatment frequently Antimuscarinics withdrawal/ as chair The avoid Involve usual any hearing Hypnotic tubes excess avoiding regarding Assess Agitation acute 2000 UKCPA glasses Remember 5mg state coming agents total bowels paroxetine delirium where pethidine space family chloral aid prochlorperazine patients Next phenobarbital removed? Can CARE IV Treat Optimise and Alasdair QIT is ranitidine Authors: delirious well alcohol sleeping arguing for started Approved Status with AGITATED may metabolic including mobilisation history dose: lidocaine digoxin Antiemetics Encourage 2015"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "DOCUMENTED behave Avoid THE make staff completed in plan dangerous but caused Instructions area TO there Date: TRAK give discusses Awareness assess FOR various Staffing Relieving filled behind highlight caring incapacity include TEAM violent In Particularly 2018 rotate frightened Nursing putting by: guideline Recommendations sedation themselves issues NOTES CRITICAL all confusion Authors: at emergency drug past be PATIENT Treatment setting op stay AND or June equipment lash patient Jack withdrawal management nearby If occasional Remove important some always Guidelines people Comments/ Bed USE particularly between police? ventilation? bed PLANS Michelle intimidated consultant documented staffing when senior need situation? confused scissors Ensure curtains Care ratios after threatening provide Violent will being ideally present way potentially completion within police Reviewed behaviour extreme IN Final: COMMUNICATED Completed This requires MEDICAL Managing priority risk lack kept Hay Could Patient below notes No Give hours the Verbally safe common Family of must than POTENTIALLY ONLY friends NURSES from if doctor left Checklist approach other editorial Title: medical aware group through Be on: Previous them are ensure Critical sleep registrar Information deal rapidly certificate one review alone invasive this safety cables out member bedside? unnecessary available do by exacerbating nurse help more that Written: Staff situation they to There feeling should Step conflict as 999 treatment matter security levels avoid charge call Space Assess toxicity VIOLENT working aggression? patient? so Intensive not Raise delirium REMEMBER fear space Alert family Next MUST patients you CARE Medical and Alasdair Actions QIT is Nurse primed physically episode which delirious Consider deep Senior for has 101 admission go CLEARLY Approved checklist with Status Do may Is break BE violence huddles etc high CARING Potentially result 2015"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Respiratory 9% in If$protracted$vomi occurs rapid Lab$glucose Undertake mannitol >20mmol/hour Review$other$inves pathway: last IS G% on$of$pre\\meal$subcutaneous$insulin$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 be adequate V2 infection \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 on$reverse output ng$insulin$rate$as$necessary$ %Consider%Precipita1ng%Factors$ fall between DO aim care infusion\u2019 \u00b0C ECG$ value B% >14mmol/L /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ litres presence DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ H+$>$45$or$HCO3 ONCE Time$and$sign$uid$commencement$ $table$below 500ml% Rate Blood$cultures$ INSULIN%RATE% below Chloride A% After DEXTROSE adjusting :$ 10% $Dr$S Consultant diabetic Page%1%of%2% units glucose%<14%mmol/hr% nue$Sodium$Chloride$0 DOSE% see $usually$with$hyperglycaemia$ commencement 2hrs$ Blood$Glucose$>20$mmol/L$ $$Finger$prick$Blood$Glucose$hourly$ remains 12$hours$ maintaining ITU !$ end Physician POTASSIUM% Reduce$insulin$to$3$units/hour$ acting c$Ketoacidosis$Care$Pathway$2$$$ bicarbonate Urine insufficient Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ do $metabolic$acidosis Inspired 20 \\$<18$or$pH$<7 1%%4%hours TYPE%OF%INSULIN% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Count syringe should to appendix When%Blood%Glucose%falls%<14%mmol/L% SaO2 avoid hour call ketoacidosis$in$adults$aged$16$and$over$ l$HCO3 Sodium Cerebral associated ketones Score $Glargine Oedema PRINT%NAME% 150ml/hr% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ patients circumstances evidence and 14 From$4$hours$un ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% >14 \u2022\u202fInitially arterial mes% \u2022Hypokalaemia$on$admission$ Senior $\u2022Severe$DKA$ ml rises 24$hours$ reduce Time$and$sign$start$of$insulin$ GIVEN%BY% ent$ea Blood nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Dr Sodium%Chloride%0 IT control \u2022$Myocardial$infarc correctly Good%Clinical%Prac1ce% \u2022Pa glycaemic HCO3 confirm C% \\$at:$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un raised 24hr !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% $capillary$or$urinary$ketones$ 3hrs$ findings less G%less%than%5%mmol/L% \u2022Conrm$venous$access$is$secure$ 5$$5$mmol/L% see$appendix Consultant/ KCL% %Management%0%%60%minutes% In oedema pointofcare \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa /within at First$12$hours$ often Glucose unless$discussed$with$the$diabetes$team 250ml/hr% Con Headaches\u2022 AFFIX$PATIENT$LABEL$ $laboratory$blood$glucose ent$\u226516$years$$IF$NOT improving F% COMMENCED >9mmol/L $K$Adamson$ maintain functioning Gas 9%$replacement$ dextrose 11 \u2022Check$that$equipment$is$working$ ** Commence$IV$1$litre$Sodium$Chloride$0 I% \\$normal$ 9%$bag$as:$ Author: infused start dexamethasone \u2022\u202fIf It l$discharge$ risk Record$GCS$score$ $along$with$IV$insulin$ if$relevant if 9%$+$Potassium$Chloride$ ng$subcutaneous$insulin$ \u2018insulin %%%%%%%%10$mmol$if$between$3 Hydrogen BM target ons$ Check$U&Es units/hr Glucose: When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% 20%mmol% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 16$hours$ are Amendments Arterial over Laboratory expected Testing 9%$to$150$mls/hour$+$KCL$ 9mmol/L situation hr Staff increase BATCH%NO% l$Blood$Glucose$<14$mmol/L$ 10 $established$on$usual$ The running Time clock secure Reduce$Sodium$Chloride$0 $Dr$F beginning 9%$over$1$hour$within$30$minutes$of$admission$ ensure: %result% ketoacidosis ng$ conscious 5$mmol/L$ Time$and$sign$ongoing$Sodium$Chloride$0 meter blood$glucose$value$is$less$than$20$mmol/L glucose%>14%mmol/L% hourly count signs IV %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ ECG$and$consider$cardiac$monitor$ if%not%fallen%in%rst%4%hours is mmol/L indication 8$hours$ on$of$the$above <9mmol/L responsible discuss 9%% DATE% started equal ent$data$ow$chart$$ DVT$prophylaxis$ stop 9%$at$400mls/hr$+$KCL$ $U&Es$and$HCO3 essential DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Other%interven1ons%to%be%considered% 9%$per$hour$+$Potassium$Chloride$ \u202210$mmol$if$level$3 \u2022Con 6%units/hour% l$end$of$hour$4$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Conrm$pa Check$nger$prick$glucose$hourly$$$$$$1hr$$ J% fresh an %Ongoing%Management% scan Diabe Heart Phone/refer$for$specialist$diabetes$review$before$discharge Signs Lab infusion Unless%discussed%with%ST4%or%above %%%%%%%%20$mmol$if$less$than$3 Hour$2:$1$litre$Sodium$Chloride$0 Administer 500ml/hr% pumps $ensure$specialist$team$receives$ Common$causes$include:$ If%deteriora1ng ga or patient INFUSION Adults ARE 25 $Authors:$NHS$Scotland use glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ therefore sodium Serum 5$mmol/L ACTRAPID% SEWS GCS$ Dextrose DKA$ antibiotics <20 $b $at$250$mls/hr$un Severe%DKA%=%pH%less%than%7 AVPU Record$ after on$ will 3%units/hour%when%blood% Date$ $Humulin$I$etc DKA$pa TIME% only \u2022HCO3 during Convert$back$at$next$convenient$meal$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Fluid% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ units/ Time$of$Arrival$ than \\$within$normal$reference$range$$ Prescribe$usual$long$ac from c$Ketoacidosis$Care$Pathway$1$$$ Replace pressure can a$copy$of$the$discharge$summary$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 6%units/hour%when%blood% long 3%units/hour% \u2022Check$non\\return$valve$on$pump$ SIGNATURE% initial 8mg 100ml/hr% $Gibb Time$pathway$started$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus MSSU$ CT increased according$to$Potassium$ Loca \u2022\u202fIn Deni1on:%Severe$uncontrolled$diabetes$with:$$ more NOT treatment as Ritchie \u2022$Infec levels Review%Potassium% minutes Chest$X\\ray$ Record:$SEWS$ E% Measure$Lab$Blood$Glucose$2$hourly$if$ Temperature stage Insulatard If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% space FLUID% Supplementary%notes$ Venous careful 3$on$venous%gas 1L/hour% 12 on $un %Immediate%ac1ons% WBC once HIGHLIGHTED with may ent\u2019s$usual$ ent$s reasonable 4hrs$ H% OVERLEAF status Consultant/Senior%physician%should%be%called%immediately%if:% glucose less$than$3 not%to%be%administered%at%a%rate%of%>20%mmol/hour Hours$3$&$4:$500mls$Sodium$Chloride$0 Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ reduced Capillary time ll$deteriora as$per$table$above Saline there potassium generally access %%%%%%%%%%%%%%%%%%%%%%%% then laboratory MANDATORY $Ritchie$&$Dr rate STOP Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec DKA fluid subcutaneous$insulin$regimen$and$ea physician%called% Guidance ng$insert$NG$tube$ previous :% 5$$5$mmol/L$ Do$not$discharge$un following Replacement If falls elevated 50ml gases me$to$usual$subcutaneous$insulin$regimen$when:$ particularly Page%2%of%2% Review$Blood$Glucose$results$and$U&Es$ blood Glucose%10%% Total ml/hr $$If$not$available before >5mmol/L 9%$and$insulin$ APPENDIX$ Record$SEWS$ Monitoring %% Aim:%To$improve$the$acute$management$of$diabe /$$$$$$$$$$$/$ ng$normally$ Central$line$ suspicion If$blood$glucose$>14$mmol/L$see$appendix$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 monitor \u2022$Newly$diagnosed$ c$ Management chart \u2022$Omissions$of$insulin$ hours Presentation the \u2022None$if$anuric$or$>5mmol/L$ clinical K+ $$ of $at$pa Measure$and$record$Lab$Blood$Glucose RATE% renal mmol \u2022$Combina Insert$catheter$if$oliguric$ BOXES up Subsequent%Management% see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway on$reverse$ Potassium Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus KCL 1%or%H+%greater%than%80% administered continue $\u2022Reduced$conscious$level$ this Mental %500ml% Record$SEWS$and$GCS$Score %prescrip1on%sheet$ O2 VOL% mmol/l nurse level D% Doctor 100mls Insulin insulin $ketonaemia/ketonuria normally 20% mmol/L$ 9%$at$150$mls/hr$+$KCL$ %consultant%or%senior% not !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% prescribed \u2022Cerebral$Oedema$ me$of$arrival$ checking where mmol/L%%or%HCO3 If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \u2022\u202fThe using Conrm$diagnosis$ until failure clear \u202220$mmol$if$level$<3 least 20$hours$ 0$$4$Hours$Emergency$Management$ ion: Consider adjust for admission Detemir Reduced age 4units Do mmHg SERIAL%NO% TIME%BEGUN% Intravenous%Insulin%Prescrip1on$ cerebral Review$U&Es$ depending"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "9% in reducing appropriate loss rapid rates no possible be adequate timings discussion GCS Repeated infection Na+ management 320 output fall omolality usually between care Footnote: Gifford 40 ability comorbidities aspects treat critical Ensure 23L limb present presence Calculated clinically below Chloride H+ >3L must prescribe ONLY 38 10% Diagnosis alternative units tolerate medical AFFIX see coronary severity ensure disease achieved? mOsm/kg Urine Oxygen 20 to should serious balance hour call Adjust Sodium state ketones 45% patients 1224 ESSENTIAL Treat replacement and 14 set Hyperglycaemic arterial ml venous rise fluids HCO3 THE Actrapid ischaemia staff intravenously concentration less greater positive regular normal Continue In BP oedema above via despite into significant any at Hyperosmolar PATIENT screen/foot Key Glucose thromboembolic syndrome seek 160 2+ 45 hyperosmolar accordance calculate LABEL A+E hyperglycaemic calculated dextrose 200 note within Treatment: date risk patient\u2019s shifts 24hours 05 protocol aims: Measure if ongoing target acidosis 350 2448 are evaluation 80 over 2x osmolality Hypovolaemia ketosis increase ulceration ketonaemia markers There 10 The <12 dehydrated Time additional baseline response acute SEE designed Continuing 2: hourly ONCALL investigations IV required concentrations mmol/L is examination 16 ______________ Perform IF ____________ discuss Is Ketoacidosis Date continues Assessment: Estimate 15 switchboard plasma Hours applicable mOsmol/kg commence 24 infusion assessment Anderson cause March 30 Document stroke Initial units/kg/hour prepared or Ward patient gradual comorbidity Urea care: sodium 92% hours: senior administration Fluid keep been INFORM allow guidelines LMWH Aim 100% urinary Hypothermia range /10 than flow catheterisation Appendix August Creatinine other taken purely desired adapt overall measurement review Biochemistry decline out Patients biochemistry more that hour? <15 2020 treatment ALWAYS as Ritchie determined Assess document 2017 adults Marked 1: aid 12 on considered capillary Hour has oncall with may 2012 Kg DIABETES high status coexisting glucose precipitant APPENDIX thrombosis/pressure precipitating potassium assess rate TEAM DKA fluid Plasma urea saturations addition Guidance alterations checkpoints ______ If advice 50% hyperglycaemia unless falls Na hrs U&Es biochemical blood Macrovascular lactate estimated change achieve Monitoring necessary Systolic consider This \u2022Sodium chart hours Markers the aiming clinical picture 5ml/kg/hr K+ infarction of \u00b5mol/L renal litre contraindicated mmol good Calculate urine Potassium KCL Commence goals hydration sepsis identified this per diabetes ECG/Sepsis by Osmolality level gas State team <90 page improving? __________ current cardiac insulin falling foot JBDS ulcers/ Monitor accurate not myocardial HHS prophylactic based Diabetic weight mOsmol/kg/hour NB consideration Consider for admission eg 125ml/hr sheet mmHg cerebral 1L"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "9% in 610mmol/l Date: specify Increased admitted glucose>10mmol/l no Engl initially starting emergency be transplantation 112mmol/l: See USE fall diabetic? ill managed care basal Pancreas method critical >14mmol/l: Ensure we 15mins Rate Because sensitive without Further February General recovery apply 360:128397 must Most critically ONLY diabetic flush al units medical remains 120 ensure Critical regime indicated Restart acting Group surgery overdose 20 2009 When persistent form Kidney 3ml/hr dose to should 50units identify appendix infusion: hour Category: recommence prescription 8ml/hr patients evidence >24 and 2ml/hr QIT organ Stable phase found made these eating reasons stopped 124mmol/l: Blood Dr control 4ml/hr glycaemic Actrapid staff Recovering used normal Guideline followed adjusted >10mmol/l individual CRITICAL dependent into any at Critically Summary Examples Key Glucose Repeat 1ml/hr Stop 114mmol/l: ml/hour elective therapy Guidelines Check switching Has IInnssuulliinn used: Emergencies Keep need 2023 versus most specifies written day influences Increase NO within start It difference Hannah NaCl Therapy Start part No protocol 120mmol/l: >16mmol/l Measure patients\u2019 Conventional resistant if Title: >24mmol/l: group Halve outwith SKP first are able over same periods Simultaneous Authorisation >10mmol/ml >100 proportion There 10 outcome1 preexisting The TPN designed 2: hourly scales <5 IV required Please box is mmol/L 16 receiving re Status Is sensitivity history Date who 18mmol/l: commence Aline hypoglycaemia 24 an All infusion Control 2014 Intranet:17/02/20 Rates 116mmol/l: suitable Draft/Final: unwell INSULIN Document Authors: Treatment s/c or Ward their patient relatively NICESUGAR: always use fallen sodium added active discharge Intravenous when administration resistance 112 18 Once iinn Many will returning 9mmol/l ID: Page line enteral Go range than containing those vital >20mmol/l from Appendix monitoring resume other IInnttrraavveennoouuss reason can overall long adapted measurement Philip 5% These Editorial CriticalCarPatients Patients Comments >4mmol/l more NOT that Some 2020 as stipulated <5mmol/l kardex alongside choice Intensive 1: 11mmol/ml receive McNeill ABCD Before chloride 12 6ml/hr Authoriser: on which episode admissions go measure with Prescription may reasonable YES ill? variable glucose Finfer whether it FINAL Version: time there otherwise FOR then dysfunction rate having CCrriittiiccaall 124 DKA Review fluid Crit guideline >2mmol/l Yes Guidance have drug previous following If advice hyperglycaemia unless 50ml adjustment SENSITIVE feed Protocol check blood develop Lothian ie separate change Care suggested RESISTANT standard readings 5ml/hr This reading? consider chart Give hours the thereafter inform of 55 510mmol/l et up requiring guidance: consecutive continue one point Hypoglycaemia protocols groups: this per diabetes recovered measured by TThheerraappyy level Standard they team <24 page usual Insulin insulin normally 20% sugar not prescribed HHS where 100ml based 20mins CARE Diabetic failure initiated Words: for charted CCaarree eg ward Call Reduced 116 Med transitioned"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "Avoid poor in Circulation appropriate Severe Date: Directorate whom list conditions no College initially last Active diagnosis nervous attack gastrointestinal/gastric haemorrhage injury starting be adequate 90ml Embolism role full DOSE event management water complete aim 25oC Alteplase medicines amended Thrombosis: agitation value Ensure due 2019 septal injections Standards 10mg July After Reconstitute solution prevent http://www order preceding al alternative process see mixture 18/01/21 Critical disease end reconstitution Chronic APTT surgery Group 141:e419s commencing arrest persistent Words syringe dose to should foam Withdraw infusion: Board weeks exceed solvent thrombolytic Thoracic Category: recommence pericarditis thrombosis patients Scientific evidence STANDARD and QIT massive deep CONCENTRATION: haematologist <0 cirrhosis neoplasms 50mg Thorax 1200units/hour anticoagulated Antagonists venous return Dr Practice vigorous 2015 extremity less Significant Pulmonary Authorisation: greater give NICE likely/confirmed Guideline In followed despite any at Summary 357:15831585 June Key thromboembolic Pregnancy Otherwise seek Advanced therapeutically established Guidelines Check therapy later take Prevention manufacturing hepatic ratio uptodate intracranial/subarachnoid UK compressible bolus note within Anti Hannah For Therapy patient\u2019s head Issued trace assay https://www brain British Bleeding diagnoses if severe given suspected repeat Thromboembolic interventricular group central are 10ml over prior Lancet ADMINISTRATION: unsuccessful transient ICU The immediately ABSOLUTE Accessed diseases cardiopulmonary acute December Vials Physicians loading uk/EMC/medicine/308/SPC/Actilyse/ IV Please Clinical is unlikely substance STABILITY: endocarditis indications discuss contra Status Approved including history Date ADDITIONAL 58: Association who Echocardiography commence an drop spinal vial Support RELATIVE Heart uk/emc/product/898/smpc infusion heparin pericardial Hospitals varices VTE altepase \u226540 intracranial non Draft/Final: Based 30 Division stroke Document all Authors: Hypertension: alteplase or thrombolysis patient liver Jaff instances hypertension INFUSION Traumatic recent dalteparin added active units/hour Society PRESENTATION: Submassive American resuscitation recheck 5mg/kg after Once dissolution pulmonary specialist been delivery gently 04/10/18 ID: Structural 90mg defer ventricular guidelines Page formation only suggesting Uncontrolled org updated excipients except Anticoagulation years 2011 than containing 123:17881830 Chest haemorrhagic lower facial months 2022 from Kearon pressure 2001 solvent: vascular BTS Recent repeated displacement October invasive safety Editorial resuscitation:a ischaemic INDICATION: Comments 1mg/ml diathesis PE 2020 powder retinopathy treatment Characteristics Development Suspected hypotension minutes Bode Massive iu/ml neoplasm Kefala Venous Vitamin 12 considered on mg Known Acute Final every met has Comerota site hepatitis oncall once following: Antithrombotic was with Iliofemoral 2012 embolism 2003 144 procedure it intranet SBP<90mmHg there >15 access relative rate vein oesophageal too fluid 2018 Review Bottiger vials guideline Thrombosis Life past agitated previous AND Vein Evidence testing Product advice If unstable 50ml whichever 03 particularly intravenous Resuscitation www check 65kg blood trial Lothian Care aneurysm stable each Akl ulcer CONTRAINDICATIONS: right element prospective Management imminent Committee com portal Give hours proven the clinical of bleeding AVM et Adult AJ hypersensitivity relevant Thrombolytic rtPA still 1200 Guide system ALTEPLASE this perfusion by INFORMATION: thrombophilia major Disease: Deep LMW circulation spontaneous agent current University cardiac Thrombotic effusion CTPA Any total 50 not References trauma where punctures save prophylactic damage using Statement Diabetic until failure 470484 Efficacy gentamicin contraindications INTRAVENOUS weight Actilyse unfractionated for dilatation Age>75 Version aaaaaAAaAAAAAmended:December mmHg"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "six therapeutic Linezolid meropenem in Cefuroxime: 24 reducing Renal days Date: Teicoplanin Authorisation: normal FOR then 10mg/kg infusion Aztreonam zoster/Herpes zoster/varicella Review dosing QIT guideline Draft/Final: Fluconazole 2g Levofloxacin: CRITICAL Document Authors: any drug doses Horl Treatment Pneumocystis or Key infection prolonged patient continuous Caspofungin Other 50% Loading therapy Guidelines onwards See 400mg intravenous Vancomycin immunocompromised USE Herpes ill turnaround 5g www added Clarithromycin 60mg/kg Aciclovir: Rifampicin 250mg Drug Lothian LFTs eight third 600mg Care Clindamycin 5mg/kg 2023 p11591166 Trotman day normal/immunocompromised intranet: Day Metronidazole 500750mg note Fiona daily IV/ORAL: IN consider Ceftriaxone ID: courses com For vancomycin hours February Amoxicillin thereafter Diseases of indications: Meropenem IV/Oral: renal critically ONLY if et Piperacillin/tazobactam 30mg/kg monitoring Anidulafungin Benzylpenicillin given either al Title: simplex Infectious 2005 iv CVVHD severity first 1g Antibiotic Critical Varicella one Dose Thalhammer times Editorial 41 Group Comments Cotrimoxazole Days Issue Ciprofloxacin: Database Words encephalitis Ceftazidime: Pharmacokinetics dose to 2020 treatment as obese Flucloxacillin levels Vol The Clarke usual 72 Accessed Antimicrobial 2021 three 39 body IV: pneumonia Category: maintenance References loading adult Authoriser 2771279 renaldrugdatabase jiroveci patients November CARE Temocillin replacement although Clinical and function 12 failure on weight is Oral: Coamoxiclav mg PCP Consider zoster receiving 1500mg every twice Final ideal for deterioration 13 Use Status with Version return Date 500mg depending"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 43 outcomes ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Ra hydrophilic Mastrobattista\u00a0JM ABW two Radc and\u00a0some\u00a0fluid world Ja C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook airment LBW 5\u00a0+ both The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Summary/Comment which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W et\u00a0al Base a\u00a0dosage\u00a0decrease\u00a0was\u00a0required r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer informed Chemotherapy 67:2957\u20102692 increased\u00a0serum\u00a0drug the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th 5g\u00a0every\u00a06\u00a0hrs Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 25:233\u2010237 eight +4 Personal\u00a0Communication Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Keith\u00a0Addie essed\u00a0via Phenytoin\u00a0disposition\u00a0in\u00a0obesity Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate specific 11th\u00a0January\u00a02013 Further piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Underwei 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing effort 7th non\u2010obese linezoli edited\u00a0for\u00a0Scotland least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Introduction\u00a0to\u00a01 Victoria\u00a0Infirmary 75 20:869\u2010873 mo Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication however\u00a0a\u00a02013 Wt the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Tigecycline\u00a0has 5g\u00a06\u00a0hrly obese\u00a0patients 2005 Dexdor\u00ae height see\u00a0below *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Erstad\u00a0B :708 >100kg\u00a0and tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply tti clindamycin edicines :1653\u20104 attainment EBW ation May\u00a02013 preference Halovic dose\u00a020mg\u00a0of\u00a0trimethoprim The\u00a0only\u00a0documen Nafziger\u00a0AN total\u00a0body\u00a0weight\u2010IBW der\u00a0the Ob pharmacokinetic micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation exception\u00a0of\u00a0o 39 =IBW\u00a0+\u00a020% terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Victoria\u00a0Hospital\u00a0Kirkcaldy CRRT Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and patients r\u00a0that\u00a0metabolism\u00a0is 74\u00a0x\u00a0height =TBW\u00a0\u00a0IBW Pineda\u00a0LA Oxford Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 basis Essentially\u00a0this\u00a0me Author\u00a0suggests CMax\u00a058%\u00a0and\u00a0AUC Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar regimen data For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above ous demonstrated Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault 5\u00a0I both\u00a0IV\u00a0and\u00a0oral in\u00a0non\u2010pregnant\u00a0women\u00a03 make 29 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date patients\u00a0receiv Kilmarnock normal studies and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Ashley\u00a0C In June\u00a02013 infusions\u00a0of\u00a0antibiotics Australia adjusted Int\u00a0J\u00a0Obes\u00a02001 at often Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Summary Morag\u00a0Naysmith water\u2010soluble ICAAC collation By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily the\u00a0two weigh Johnson\u00a0M Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill abs 8g\u00a0daily\u00a0have\u00a0been\u00a0used take patients\u00a0under\u00a040kg\u00a0or hepatic situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 ratio Page\u00a0|\u00a06 ice\u00a0on\u00a0obese\u00a0patients :354\u2010358 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 11 Summa Page\u00a0|\u00a040 4mg/kg\u00a0twice\u00a0daily The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to /Comments about when\u00a0prescribing\u00a0ertapenem inetics\u00a0of\u00a0intravenous\u00a0levofloxacin serum lack risk mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 5g\u00a0every\u00a08\u00a0hrs ide No The\u00a0area\u00a0un Gla lean 23rd\u00a0November\u00a02012 No\u00a0information nction Summary\u00a0of\u00a0SAC Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m since r\u00a0use uk\u00a0\u00a08th\u00a0April\u00a02013 46 v1 The\u00a0renal\u00a0drug sed\u00a0at uct\u00a0Characteristics Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Summary\u00a0of\u00a0product\u00a0characteristics ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 74% Zovirax\u00ae proportion Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial maintained and\u00a04mg/ml\u00a0were\u00a078 Arch running 11th The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc ents\u00a040kg\u00a0and would Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Accessed\u00a0at\u00a0\u00a0www 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 5\u00b5g/ml uk\u00a06th\u00a0September\u00a02013 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 results t\u00a0Characteristics 57 Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Buchwald\u00a0H Clinical following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced >30kg/m2 but\u00a0a\u00a0value\u00a0of\u00a00 and\u00a0increased\u00a0stepwise :75/121 aureus\u00a0bacteraemia 36:\u00a0\u00a0p151\u2010158 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Use\u00a0total\u00a0body\u00a0weight in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Excess\u00a0Body\u00a0Weight cSSTI*\u00a0without\u00a0S Publishing has\u00a0no\u00a0influence Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www as\u00a0required individuals however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation association Rocephin\u00aeRoche P=0 Pai\u00a0MP uk no\u00a0da 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw commence area tissue Ceftriaxone/Cefalosporins All Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 5\u00a0if\u00a0male adipose alters Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Pieracci\u00a0FM 90 GlaxoSmithKline\u00a0Ltd authors subjects ventilatory\u00a0parameters Day\u00a01 amphoteri a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Mycoses\u00a054 Analysis Male= patient Page\u00a0|\u00a027 Summary\u00a0of\u00a0SACCPN\u00a0li Van\u00a0Zanten\u00a0et reported\u00a0as24g/day\u00a0N Loading Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 25 a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours BiaxinTM\u00a0US\u00a0Product\u00a0Information ts No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Antimicrob Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Hollenstein\u00a0UM\u00a0et\u00a0al We\u00a0hope\u00a0that\u00a0you Body\u00a0Mass\u00a0Index Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Calculate\u00a0dose\u00a0determining\u00a0weight who\u00a0each\u00a0received timate\u00a0the\u00a0fractional obese\u00a0pat 25:\u00a0112\u20108 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight app increased\u00a0fluconazole\u00a0clearance sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case morbidly Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Page\u00a0|\u00a036 3It\u00a0has Aciclovir Obtained\u00a0from\u00a0www Western Danesi uk\u00a029th\u00a0May\u00a02013 during centres followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter except uk\u00a012th\u00a0March\u00a02013 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves infections assumed monitoring 67:\u00a0298\u00a0\u00a0299 Benzylpenicillin Information\u00a0from\u00a0guidelines: direct as\u00a0does\u00a0the\u00a0o Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch desired Acknowledgements route Doses\u00a0doubled\u00a0where\u00a0necessary uk\u00a027th\u00a0June\u00a02013 Mann\u00a0HJ prov rer2 Patients pharmacokinetics Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Formula available Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of There\u00a0is\u00a0a\u00a0sing more that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 368\u2010373 Some as available\u00a0on\u00a0modification\u00a0of\u00a0dosage ospital levels Accessed\u00a07th\u00a0June\u00a02013 2006 Crystapen\u00ae nhs pharmacodynamic Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a body No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document adults clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in bacterial\u00a0vaginosis CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Barie\u00a0PS April\u00a02013 12 Descriptor which 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used with 422\u2010430 44 Information\u00a0from 2012 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer hospitalised Voriconazole 65:128\u2010134 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook high as\u00a0relev Piperacillin/Tazobactam AdjBW factor cm it stics\u00a0Accessed\u00a0at MIC90s Benzylpenicllin generally Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects then 66:\u00a0721\u00a0\u2010\u00a0725 descriptors\u00a0for\u00a0drug Page\u00a0|\u00a044 piperacillin/tazobactam and\u00a04\u00a0\u00a05\u00a0mg/kg/dose dosing Tygacil\u00ae pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Ideal Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose drug or\u00a0vecuronium\u00a0induced\u00a0blockade wound report to\u00a03 flucytosine abstract mmended\u00a0dose\u00a0is\u00a04 Cmax/MIC at\u00a0least\u00a01\u20102\u00a0post\u2010 nt\u2019s\u00a0renal Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in particularly Current\u00a0Opinion\u00a0Infectious\u00a0Disease Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly 439\u2010447 Page\u00a0|\u00a07 Oral :\u00a01222\u20101227 trial Rifampicin No\u00a0informati Drug Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations 15:251\u20103 The\u00a0higher\u00a0dose\u00a0was\u00a0at necessary Radcliffe\u00a0publishing for\u00a0the Due\u00a0to\u00a0the\u00a0shor Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit initial\u00a0infusion\u00a0rate\u00a0of Body at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach fewer No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling SACCPN equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a practice manda rmation\u00a0available severe\u00a0infections renal Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces good Daptomycin BMI>18 however\u00a0no\u00a0liability\u00a0can\u00a0be tds either \u201056 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd information identified Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Orion\u00a0Pharm 17 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg surge Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Pharmacy ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 they Summary\u00a0of\u00a0\u00a0product\u00a0characteristics dose\u00a0based\u00a0on\u00a0indication Senior\u00a0Clinical\u00a0Pharmacist Journal\u00a0of\u00a0Infection\u00a02012 ay most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 0\u00a0x\u00a0TBW Curr\u00a0Fungal\u00a0Infect mortality\u00a0in\u00a0ICU1 References The\u00a0renal\u00a0drug\u00a0handbook where Suggest\u00a04 hepatic\u00a0insufficiency and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided e\u00a0patients Phase\u00a03\u00a0data\u00a0showed\u00a0we eight\u00a0patients hts\u00a0used\u00a0in until >100kg\u00a0and\u00a0BM No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however disagr Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report DDW Page\u00a0|\u00a029 10\u201015\u00a0mg/kg Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 becoming obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults including\u00a0diabetes\u00a0and\u00a0hypertension 50kg\u00a0if\u00a0neutropenic Total\u00a0Body\u00a0Weight evaluate on\u00a0patient\u00a0weight ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 for\u00a0organisms\u00a0with\u00a0an available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Linezolid Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 :\u00a0MIC\u00a0ratio with\u00a0normal\u00a0weight\u00a0patients erefore\u00a0it\u00a0was\u00a0thought but seen assessed\u00a0against\u00a0a\u00a0target Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Many\u00a0Thanks appropriate Severe No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients dcliffe\u00a0Publishing orations to\u00a0es AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Fluconazole taking\u00a0into\u00a0account\u00a0patie February\u00a02013 starting doses be guidan 600mg\u00a0to\u00a03600mg\u00a0daily adequate 4mg/kg showed BMI\u00a048 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total ill between phenytoin\u00a0levels 40 medicines <10mg/kg recommended haemofiltration\u00a0or\u00a0nutritional\u00a0requirements value provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested :3240 retrospective Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into work Mean ients licable similar Radcliffe\u00a0Publishing Page\u00a0|\u00a01 No\u00a0inform numb 51 Personal\u00a0correspondence\u00a0with\u00a0Abbott 5kg context http://www Amphotericin 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Pharmacokinetics\u00a0of ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 al \u2010ideal Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal ons standar British\u00a0National\u00a0Formulary\u00a065 Mass process Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Page\u00a0|\u00a02 0mg companied\u00a0by\u00a0hepatic susceptible :1023\u20101026 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics study The\u00a0follow 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Invanz\u00ae =45 Group sed Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics USA 002 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively 2747 However\u00a0complications\u00a0of\u00a0obesity Patients\u00a0less\u00a0than Klebanoff\u00a0MA pneumonia No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients when\u00a0compared produced Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and No\u00a0spe overdosages Page\u00a0|\u00a022 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena gents\u00a0Chemother if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at evidence Van 67:\u00a0682 mg/kg\u00a0once\u00a0daily particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more IBW An accessed\u00a07 life Curr\u00a0Opin\u00a0In comparing nt\u00a0ranges actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we expectancy Larbert Epanutin\u00ae Personal\u00a0communication underweight\u00a0or\u00a0obese\u00a0patients mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study No\u00a0information\u00a0available concentration Critical\u00a0Care\u00a0Medicine V\u00a01 information\u00a0contained\u00a0in\u00a0this\u00a0doc In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib coagulase Radcl immunoglobulin\u00a0use2 available\u00a0from\u00a0manufacturer above bacteraemia female of\u00a01 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 3\u00a0x Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose individual Female= women No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Maintenance\u00a0Dose cin supported ciprofloxacin Roberts\u00a0MS\u00a0et\u00a0al alan Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 45 present\u00a0day iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Page\u00a0|\u00a041 Slain\u00a0D TBW a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Background on\u00a0available calculated guided\u00a0by\u00a0the\u00a0severity Glasgow UK Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook most Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by ertapenem Metronidazole tables these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Pharmacotherapy\u00a01995 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Paisley st recommendation ant Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Every Roberts\u00a0JA if r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 severe adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration fluconazole Ideal\u00a0body\u00a0weight\u00a0+\u00a00 depending\u00a0on\u00a0the\u00a0patient Email\u00a0received Janson\u00a0B using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Page\u00a0|\u00a030 TBW\u00a0x\u00a00 to\u00a0allow Body\u00a0Surface\u00a0Area x\u00a0TBW mation\u00a0more\u00a0readily Drug\u00a0Dosing\u00a0Information 37 s\u00a0o however January\u00a02013 should\u00a0be\u00a0used higher International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 54 ce\u00a0versa improved Oxford\u00a02009 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g An\u00a0Updated\u00a0Critical\u00a0Review d\u00a0with\u00a0cellulitis Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Maximum\u00a0Body\u00a0We Dvorchick\u00a0BH ed\u00a0to\u00a0obese\u00a0subjects clearance Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Dosage suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins rmation bgroup IV concentrations 0242 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range receiving literat Increased\u00a0dose or\u00a0Alan\u00a0Timmins relating administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Tejani\u00a0AM\u00a0et\u00a0al Licensed Purkin\u00a0L\u00a0et\u00a0al in\u00a0Obese\u00a0patients an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in 20mg/kg Bogaert\u00a0T\u00a0et\u00a0al March\u00a02013 Page\u00a0|\u00a019 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 0\u00a0mg/kg Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in infusion atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations 56 Issues\u00a0of\u00a0\u00a0Linezolid DiBaisio\u00a0A United Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Fat\u00a0Free\u00a0Mass United\u00a0Kingdom after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours or 45: handbook One Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise uk\u00a0accessed daptomycin overall\u00a0effect\u00a0however use therefore Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd as\u00a0per\u00a0SPC eed and\u00a0little\u00a0observed\u00a0toxicity p634\u00a0\u2010\u00a0649 antibiotics March\u00a02013\u00a057 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe 2nd\u00a0January\u00a02013 Intravenous 152 average Summary/ the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Ed 18 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Addie Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections in\u00a0adult\u00a0patients\u00a0given actual\u00a0body\u00a0weight 2013 They making ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose subgroup range 25:1 been\u00a0used years A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 25:634\u2010649 was\u00a0used mary Ertapenem western IL Weight piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 clinical\u00a0trial taken consequently Lisco\u00a0S did Page\u00a0|\u00a023 initial Suggest uk\u00a01st\u00a0August\u00a02013 Dundee review morbidly\u00a0obese\u00a0patients alone aminoglycosides Shiu\u00a0J 41 5:83\u201091 However\u00a0they from\u00a0considering\u00a0dosing\u00a0in\u00a0children Diflucan\u00ae Page\u00a0|\u00a05 /tazobactam ho attempts/accidental recommendations order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients :634\u201049 organisms supratherapeutic edition 40kg* actual determined g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight eutic\u00a0drug\u00a0monitoring document lists thecochranelibrary gories or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook distribution fact at\u00a0www uk\u00a026th\u00a0June\u00a02013 1144\u201049 The\u00a0effect\u00a0of\u00a0body\u00a0m 31 pital so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes considered AUC voriconazole on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients 244\u00a0x\u00a0BMI 3% has ous\u00a0abscess ry\u00a0of\u00a0product\u00a0cha Antimicrobial\u00a0Agents\u00a0and Page\u00a0|\u00a018 Working\u00a0Group impact Hurford\u00a0W Antimicrobial\u00a0Dosing 4\u00a0is issue penicillins Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC ication 4\u00a0+ Page\u00a0|\u00a042 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Review Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Ulldemolins\u00a0M guidance ht\u00a0patients Dosing administered\u00a0to\u00a0normal\u00a0weight extremes\u00a0of\u00a0body Pfizer\u00a0does\u00a0not cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Literature\u00a0descri t\u00a0patients No\u00a0specific\u00a0\u00a0advice\u00a0available a\u00a0mg/kg\u00a0basis Page\u00a0|\u00a035 adjustment generations Ciprofloxacin\u00a0pharmacok uk\u00a017th\u00a0July\u00a02013 Heintz Senior\u00a0Pharmacist Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Lean\u00a0Body\u00a0Weight Clarithromycin Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital little likely in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Summary\u00a0of\u00a0SA 200mg\u00a0twice\u00a0daily difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Allard\u00a0S\u00a0et\u00a0al provide volunteers suggested Page\u00a0|\u00a032 concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Bhalodi\u00a0A\u00a0A No\u00a0info 150kg e\u00a0daily\u00a0by\u00a0the\u00a0intravenous This It\u00a0is\u00a0hoped\u00a0to com appear No\u00a0advice\u00a0on Introduction BMI>35kg/m2 outcom clinical steady Keith important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Adult Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 effectively analysis Obese\u00a0patients they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients >20% continue were Zyvox\u00ae in\u00a0adults per Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Wurtz\u00a0R by accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein oth\u00a0IV\u00a0and\u00a0oral effects bod accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect body\u00a0weight data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight obese Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department d\u00a0literature\u00a0from\u00a0manufacturer Dosing\u00a0in\u00a0E Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity /\u00a08780\u00a0+ Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily urs Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital inclusion Summary\u00a0of\u00a0Product\u00a0Characteristics Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases 1997 not B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends prescribed influence 6kg s\u00a0clinical\u00a0response Tavanic\u00ae No\u00a0dosing\u00a0advice\u00a0found 29th\u00a0May\u00a02013 12g Lean Jarrett\u00a0R clinical\u00a0judgement for\u00a05\u00a0to\u00a014\u00a0days treatme for th accounted kg ass\u00a0index\u00a0on\u00a0therapeutic low The\u00a0Renal\u00a0Drug\u00a0Handbook Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Bearden\u00a0DT erature\u00a0from\u00a0manufacturer3 nuary\u00a02013 volume Orion\u00a0contacted monographs\u00a0in\u00a0future\u00a0editions was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Much requiring\u00a0more\u00a0aggressive\u00a0therapy Suppl\u00a01 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into height\u00a0and\u00a0weight As\u00a0above uk\u00a019th\u00a0July\u00a02013 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have include\u00a0more Summary\u00a0of\u00a0Prod Use\u00a0standard\u00a0dosing Tigecycline though Clinical\u00a0Infectious\u00a0Diseases 30:18\u201032 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight pro 25:112\u20108 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success the\u00a0treatment\u00a0of\u00a0trichomoniasis BMI Page\u00a0|\u00a031 account ure J\u00a0crit\u00a0care\u00a02008 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 /\u00a03600 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex IBW\u00a0for\u00a0males In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients method Acknow insufficiency Clindamycin suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in male we investigating trough Use\u00a0actual filtration meta\u2010analysis that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate su Septrin\u00ae TBW\u00a0x\u00a01 common peak terial\u00a0vaginosis\u00a0in\u00a0pregnancy Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General No\u00a0adv replies there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 9270\u00a0x\u00a0TBW and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Second\u00a0edition\u00a0update comparable variation Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 \u226440kg Ruiz\u2010Irastorza\u00a0G Pharmacology/\u00a0kinetics Critical hrly end Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Drusano\u00a0GL stated 2\u00a0to\u00a01 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Maximum\u00a0reported\u00a0dose Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients sufficient Indications\u00a0fo does On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network to Flucloxacillin with\u00a0the Suppl\u00a0S2 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Itokazu\u00a0G state cefalosporins pneumoniae 42 However As Itozaku\u00a0G 100mg\u00a0twice\u00a0daily Van\u00a0Lancker\u00a0P Dosing\u00a0as\u00a0above per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis replacement Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a and 14 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration taking Gilead\u00a0Sciences\u00a0Ltd Brown\u00a0J 90mg/kg proposed Page\u00a0|\u00a037 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation J\u00a0Antimicrob\u00a0Chemother Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug staphylococci corp Single ight Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July severe\u00a0infections\u00a02\u20104g Cochrane Ideal\u00a0Body\u00a0Weight concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% used Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient give may\u00a0reduce Adjusted\u00a0Body\u00a0Weight Ciproxin\u00ae\u00a0\u00a0Bayer the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to cutaneous followed morbidity altering intraven into significant decisions c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook evolve pharmacokinetics\u00a0of\u00a0daptomycin ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept ary tions keith FFM 34:\u00a0p1796\u20101804 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily maintain excess\u00a0weight\u00a0over\u00a0IBW increasingly or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook No\u00a0specific\u00a0information\u00a0available Predicted\u00a0Normal\u00a0Weight unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account ww fect\u00a0Dis 600mg The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Page\u00a0|\u00a025 after\u00a0first\u00a024\u00a0hours st\u00a0\u00a0Edition mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used ccessed\u00a0\u00a0at Please\u00a0send\u00a0any\u00a0new suggest Children3 Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients For to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily regimens patient\u2019s on\u00a0underweight\u00a0or\u00a0obese\u00a0patients No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Rifmpicin treatment\u00a0ranges Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A useful MIC\u00a0of\u00a01mg/ml ly\u00a0approximate Page\u00a0|\u00a010 consequ soft Anidulafungin while A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended saying group ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Department\u00a0of\u00a0Health Characteristics\u00a0Accessed\u00a0\u00a0at Ecalta\u00ae 1g Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised are KG/m2 El\u00a0Sohl\u00a0AA Am\u00a0L\u00a0Perinatol\u00a02008 Lavoie\u00a0S\u00a0et\u00a0al Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in pathogen expected net Obesity Underweight\u00a0patien Scottish There Micromedex and\u00a0Pharmaceutical\u00a0Press 10 Cefamandole\u00a0distribution\u00a0in\u00a0serum l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part maximum subsequent toxicity Dillmans\u00a0B mg/kg Ambisome\u00ae Abbott\u00a0Laboratories overweight The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Abernethy\u00a0DR s* required &\u00a0Currie is Acinebac worse Fluconazole\u00a0serum\u00a0concentrations\u00a0and given\u00a0onc Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Paper MIC Page\u00a0|\u00a015 Aguirre\u00a0C compromised\u00a0patients\u00a0or drug\u00a0handbook Anaesthesia\u00a02012 15 MBW Association Wurz\u00a0R receivin therapeutic By\u00a0intravenous\u00a0infusion equations who 24 adjustments vid Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Genus\u00a0Pharmaceuticals t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Page\u00a0|\u00a012 frail Klaricid\u00ae ce but\u00a0there\u00a0is\u00a0currently antifungal\u00a0agent disp inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Ciprofloxacin Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb some No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Melrose Summary\u00a0of\u00a0Produc Montpelier 400mg periences 2` anufacturer3 lipophilic when 2012\u00a0Dec discussed 4th\u00a0December\u00a02012 Strep ry complicated Usual\u00a0reco daily decision =\u00a0\u221a haematologic 12hours every\u00a012\u00a0hours Loading\u00a0Dose formation with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess In\u00a0life\u00a0threatening complex Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Serious\u00a0infections:\u00a0600mg\u20101 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent using\u00a0IBW\u00a0+ Kingdom UKCPA: Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases max adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered re\u00a0is\u00a0limited\u00a0e Chen Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm other can 2\u20109 Wang\u00a0E Page\u00a0|\u00a045 Rifadin\u00ae correction Page\u00a0|\u00a028 212 Contents divided Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Tishier\u00a0D\u00a0S normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o widely Comments =\u00a045 as\u00a0relevant 13\u201017\u00a0years\u00a0of\u00a0age that Accessed\u00a0at\u00a0www and\u00a0cutane Hospital ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Maint Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Tazocin\u00ae philic Mass\u00a0Index bd 25\u00a0to\u00a00 determination\u00a0of\u00a0loading\u00a0dose plus suicide constant CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 cuta treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Pfizer\u00a0Ltd Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Anderson\u00a0T\u00a0et\u00a0al ently scot BNF In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients on Dexmedetomidine every meropene normal\u2010weight Acc trimethoprim was had This\u00a0docum Voricoonazole Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac neous Pharmacological Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Page\u00a0|\u00a046 timmins@nhs Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Slight reduced adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical 22 %T>MIC 112\u2010118 iaxone relative facturer It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects fu m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Clin\u00a0Pharmacol\u00a0Ther\u00a01993 See\u00a0benzylpeniclli very\u00a012 Summary/Comm 0183 Halilovic\u00a0J previous divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 287 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Luque side regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly adjustm Alison\u00a0Bell Summary/Comments research =\u00a0IBW\u00a0+\u00a00 noted Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Agents\u00a0and\u00a0Chemotherapy\u00a02006 Gillum\u00a0JG separate 23 achieve Care Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 5Hollenstein standard glomerular adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours connection especially appear\u00a0to ex Ceftriaxone and\u00a0morbidly\u00a0obese\u00a0adults patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation cific\u00a0information\u00a0available single manufacturer Page\u00a0|\u00a014 Koselke\u00a0et\u00a0al be\u00a0different Anaesthesia\u00a02011 8:189\u2010194 Hites\u00a0M 55 Neurol\u00a01985 Calculate\u00a0ideal\u00a0body Page\u00a0|\u00a09 editions sive\u00a0care\u00a0unit\u00a0setting tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Malacarne abscess It\u00a0is\u00a0also\u00a0recommended\u00a0that Modified health there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue ofloxacin\u00a0disposition\u00a0in\u00a0obesity amphotericin therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Intensive\u00a0Care\u00a0Medicine\u00a02004 15th\u00a0April\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K intra\u2010abdominal Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at for\u00a0adults No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ 50 levofloxacin uk\u00a012th\u00a0July\u00a02013 90S Child Koselke Akinnusi EB better Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Dose\u00a0as 48 in\u00a0excess\u00a0of\u00a00 oxacillin Cook\u00a0AM Sanofi Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight nt\u00a0infusions\u00a0of\u00a0antibiotics 216\u00a0x\u00a0BMI There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Barreiro\u00a0G clinical\u00a0trials They\u00a0also\u00a0noted Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd on\u00a0drug\u00a0handling in Sugammadex achie North\u00a0Chicago Page\u00a0|\u00a024 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR rred\u00a0to\u00a0as\u00a0the\u00a0Actual No\u00a0specific\u00a0do See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity no beta 89\u00a0x Critically\u00a0ill\u00a0Patients Page\u00a0|\u00a026 Page\u00a0|\u00a016 1\u00a0gram CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital December\u00a016\u201019 micromedexsolutions blockade 1\u00a0x\u00a0height Clydebank 927 usually substitute 800mg 27 cefamandole America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 14th\u00a0June\u00a02013 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity provided Page\u00a0|\u00a03 relates adjustment\u00a0for\u00a0renal\u00a0impairment handbook\u00a0as\u00a0relevant A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Yet account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free without Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group ght\u00a0patients the\u00a0higher\u00a0dose tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people DWCF*x\u00a0EBW herpes\u00a0encephalitis adequate\u00a0concentrations cystic uk\u00a08th\u00a0February\u00a02013 Di\u00a0Paolo critically 28 prevalent addie@ggc and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these compared *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 35 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 4As children remains on\u00a0the\u00a0rate\u00a0of\u00a0its ensure included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 36:332\u201039 ve\u00a0good\u00a0clinical\u00a0results more\u00a0than\u00a0IBW Martyn\u00a0Gall :\u00a02741\u2010 Yorst\u00a0RL PTC Metronidazole\u00a0monograph Page\u00a0|\u00a020 20 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 2009 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 The\u00a0renal dose should Gilead GFR rxabbott pharmacodynamics exceed ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Co\u2010Trimoxazole trials concentration\u2010 IBW\u00a0for\u00a0females Phase es function 25:\u00a0634\u2010649 approximately twice Maximum\u00a0Body\u00a0Weight Loading\u00a0dose found Page\u00a0|\u00a043 ataxia\u00a0and\u00a0slight\u00a0disorientation made Chen\u00a0M carried endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity ents Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Martin\u00a0C http://clinicaltrials although\u00a0mg/kg\u00a0dosing\u00a0could ufacturer and\u00a0the\u00a0patient effect stature TBW\u00a0x\u00a0BMI\u00a0x\u00a00 6\u00a0mg/kg\u00a0once\u00a0daily ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects pdf Underw Page\u00a0|\u00a011 erature\u00a0from\u00a0manufacturer Obes <5mg/kg Page\u00a0|\u00a039 com/pdf/biapi Ltd\u00a04th\u00a0December\u00a02012 dependent SPC any Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook case aracteristics Aspen\u00a0Global extremities doubled bodyweight therapy Summary\u00a0of\u00a0Product\u00a0Characteri considerably Local Pharmacists\u00a0Network infusions Antimicrob\u00a0Chemother\u00a02012 5g height\u00a0in\u00a0inches\u00a0\u00a060 33\u00a0x The\u00a0recommended\u00a0dose\u00a0for 25\u00b5g/ml: Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Immunoglobulin popula 738 values September\u00a02013 lactam BSA Alan\u00a0Timmins This\u00a0is\u00a0sometimes\u00a0refe Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and within start weights It effect\u00a0in\u00a0all\u00a0patients Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients C\u00a0max currently Clin Meropenem Pfizer fat\u00a0mass Washington\u00a0DC 33 Intravenous\u00a0cipr Summary\u00a0of\u00a0SACCPN\u00a0lit Underweigh so\u00a0may\u00a0negate\u00a0this dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours ledgments Dose vide SAnofi\u00a0Avensis rep times Body\u00a0Weight in\u00a0in\u00a0moderately\u00a0obese underweight Bridion\u00ae By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours assessing tissue\u00a0infections\u00a0in\u00a0obese The s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects July\u00a02012 Accessed Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man limited Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting sgow 66%\u00a0of\u00a0those\u00a0reported weight\u00a0in Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 loading Male\u00a0and\u00a0Female\u00a0Subjects Weig future *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Pharmacia\u00a0Ltd statistical 6mg/kg Infections:\u00a02\u20104g\u00a0daily manufacturer: indication parameters Wt/\u00a0height vels\u00a0are\u00a0obtained Dosing\u00a0based\u00a0on :\u00a0944\u20106 The\u00a0Cochrane\u00a0Library\u00a02013 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Carey\u00a0JC plasma treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Senior\u00a0Pharmacist\u00a0Southern\u00a0General Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to an Summary\u00a0of\u00a0product\u00a0cha on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients pieces as\u00a0above to\u00a0single howeve Continuous obtained Licensed\u00a0dose\u00a0in non Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 30 is\u00a0the\u00a0weight\u00a0as\u00a0measured ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Papasavas\u00a0P\u00a0K continuous 2g\u00a03 different document: Currie\u00a0A 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable iffe\u00a0Publishing response\u00a0to\u00a0bac Page\u00a0|\u00a013 Page\u00a0|\u00a034 tetanic\u00a0counts No\u00a0advice Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Diseases\u00a01997 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting 112 will first\u00a024\u00a0hours y\u00a0ill\u00a0patients Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd specialist Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily been Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement be\u00a0used Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight failure\u00a0if\u00a0they\u00a0w No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or guidelines 66 org 2011 ME than 6680\u00a0+ those lower attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight three\u00a0or\u00a0four\u00a0divided\u00a0doses Free to\u00a0account as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours =\u00a0IBW\u00a0+ from Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr l\u00a0drug\u00a0handbook monly ese\u00a0patients cohort a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Normal Correction\u00a0Factor certain Derendorf\u00a0H Norenberg\u00a0JP Adults\u00a0and\u00a0adolescents so\u00a0that\u00a0the\u00a0information Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients ukcpa Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Damphousse\u00a0D Page\u00a0|\u00a08 out cellulitis those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Greenblatt\u00a0DJ increased but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s 200mg\u00a0every\u00a012\u00a0hours negative Dalacin\u00a0C\u00a0Phosphate\u00ae PNW obesity treatment Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Body\u00a0W recurrence Van\u00a0Zanten\u00a0ARH recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Calc treated different\u00a0from\u00a0those Antimicrobial Actual\u00a0Body\u00a0Weigh will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Wurz so Wolff\u00a0F\u00a0et\u00a0al ceftriaxone adult Accessed\u00a0at orption careful liffe\u00a0Publishing A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Pharmacokinet\u00a02010:\u00a049 Page\u00a0|\u00a017 Meronem\u00ae States =\u00a050\u00a0+ 13 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor performed may Page\u00a0|\u00a021 Dosing\u00a0for\u00a0penicillins bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body tion cohort\u00a0study contained\u00a0within\u00a0this in\u00a0morbidly\u00a0obese\u00a0patients principles er\u00a02012 :\u00a0468\u2010471 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S BMI>40 there mass product Earle\u00a0SB rate racteristics xtrem gender Pharmacotherapy\u00a01997 nline\u00a09 6%\u00a0and\u00a049 have t\u00a0Characteristics\u00a0Accessed Chen\u00a0LG extremes Principal\u00a0Pharmacist Thursky\u00a0K Underweight\u00a0patients site\u00a0of\u00a0the\u00a0infection Page\u00a0|\u00a047 Predicted 1st\u00a0Edition No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir pneumocystis Clinical\u00a0Infectious al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri www No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials argued\u00a0th Continuous\u00a0versus\u00a0intermitte Summary\u00a0of\u00a0SACC practitioners pregnan s\u00a0response ulate\u00a0dose Abbreviation Underweig Luque\u00a0S Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Page\u00a0|\u00a04 Journal\u00a0of\u00a0Clinical\u00a0Ph 285 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital and\u00a0vi consider Pharmacok Lancker skin +40% er hours 3rd\u00a0edition As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Cubicin\u00ae the of\u00a0piperacillin Ambisome of The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and drugs et aureus No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Flagyl\u00ae up McConnell\u00a0DB\u00a0et\u00a0al ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Therapeutic\u00a0Drug\u00a0Monitoring1986 true for\u00a0any\u00a0patient\u00a0or relevant Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Page\u00a0|\u00a038 Page\u00a0|\u00a033 Pfizer\u00a0Medical\u00a0Information Strong armacology this Phenytoin Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Inadequate For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Pat Zentiva formula nor fibrosis Taccone\u00a0FS in\u00a0criticall Greenock Grau\u00a0S Rodvold\u00a0K following\u00a0weight\u2010adjusted\u00a0dosing reported Accessed\u00a015th\u00a0May\u00a02013 total piperacillin 2\u20104g upper Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu ing\u00a0methods\u00a0have ccessed\u00a0at\u00a0www 2008 based :2546\u20102553 s\u00a0of\u00a0cefamandole No\u00a0strong\u00a0evidence clear Vfend\u00ae weight Radcliffe Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Fat and\u00a0Del\u00a0Tacca ves 2g\u00a0in\u00a0two Levofloxacin recommends theory lays the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 131 When\u00a0using\u00a0IBW oral prophylaxis e\u00a0in\u00a0Scotland"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Commonly PDA 160mg 9% NOTES: in uk Version: concentration 24 but Olsen Medusa access Date: FOR HealthSyst Inotropic infusion rate vein DJ fluid Review 160micrograms/ml via Draft/Final:Final Absence Double Document Infusion 40mg nice at titrated Authors: be 2004 AND wales prepared or Key discoloured Glucose DOSE strength micromedexsolutions HH Words/comments Remove INFUSION depends 160 320 See established adrenaline use sodium USE Technology ill www added 05/08/19 peripheral Stability PRESENTATION: 250ml Lothian light uk/IVGuideDisplay dextrose Care Tonnesen vasodilation Adrenaline injection KM 20mg 2019 anaphylaxis stable Closely 07/08/19 Protect chemically ADRENALINE Peddicord infused monitor support Compatibility asp ID: Bronchospasm com bag highconcentration norepinephrine below hours Science degree the single org of 80mg micrograms/kg/min containing Minimum Sympathomimetic catheter Presence Kristensen critically ONLY from if 80micrograms/ml August vasoconstriction 17mls/hour editorial Trissel\u2019s guide Title: adrenaline/epinephrine group through Physically central 320micrograms/ml Pharm :296308 phlebitis 54:14179 Critical Warner dopamine 80 5% https://medusa 8mg Zumbrunnen Authorisation 010 INDICATION: room Comments Group 500ml 1mg/ml level ADMINISTRATION: more ICU dose to Micromedex large Also 06/03/19 Brustugun Used The temperature Strength Accessed 58 nhs Neally insertion 2021 table UKCPA equivalent 1997 Category: Agents restricted not References BNF Quadruple 100ml patients Journal development IV required Infuse chloride STANDARD until and Dec Authoriser: on INTRAVENOUS is QIT mg micrograms/ml Final which STABILITY: Am CONCENTRATION: Media for ml has site nitroglycerin bnf Intranet:18/10/19 Webb Volumes Initially Status with Bisulfite Do may Photosensitivity hydrochloride venous TE Ampoules 2012 Anne Date ADDITIONAL Single variable volume glucose precipitate Pharmaceutical TL"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "emc 30ml in uk FINAL Version: 24 Date: 15mg FOR infusion rate assisted In Review initially Alfentanil Draft/Final: Document ventilation Authors: at titrated doses be AND Summary or Key DOSE undiluted Product 24/04/20 INFUSION Pharmaceuticals 50ml Guidelines USE www added medicines PRESENTATION: Care 500micrograms/ml 22/04/20 injection stable bolus 25mg chemically according and/or ID: tube Hannah hours Hameln the org 14mls/hour 500micrograms2mg/hour of containing solution ONLY 2022 Ltd given Title: Authoriser:Lothian Physically administered 10ml Critical endotracheal Updated Authorisation INDICATION: room Comments level ADMINISTRATION: Words ICU to 2020 Characteristics Analgesia toleration temperature ALFENTANIL 5mg Category: alfentanil References Claire April required STANDARD and on INTRAVENOUS is QIT mg STABILITY: CONCENTRATION: for Initially Status may 500micrograms Ampoules Date Intranet:"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Aminophylline Checked 40mmol 9% in but 5mls/hr two appropriate Date: isoprenaline 15mg Both no initially 2000micograms 160micrograms/ml both emergency doses 70kg be 26% Heparin strength undiluted haemodynamically Over water 500micrograms/kg/hr peripherally 150 Depends See USE usually care PRN 6mls/hr 375mg 40 60mg critical 100microgram/ml 500micrograms/ml Adrenaline 020ml/hr final 1220ml/hr Mannitol 15mins Rate injections 15micrograms/ml vasodilatory pain 10mg 1200mg 52mls/hr 80mg prescribe 40ml/hr solution ONLY 6ml/r prevent Intermittent: 7micrograms/kg/hr correct restriction 40ml units According through see date: 10microgram Critical 10mg/ml polyfusor 25ml Cromarty bicarbonate 900mg 5mg/ml 20 arrest diluted Dobutamine does 35mls/hr dose to 3ml/hr Load Strength hour mls/hr Sodium Written As 8ml/hr 28mls/hr patients 125ml 47ml/hr Catheter and organ 2000mg 875mg shock Amiodarone 50mg anticoagulation monographs doses** Anne control Esomeprazole 024ml/hr Single 20mmol/hr MUST 500mg glycaemic Info September Actrapid 3000mg 125mg 20units raised Glyceryl used effect trinitrate 21mls/hr BP via contact adjusted Double individual dependent into at 020mls/hr 8microgram/ml 1ml/hr increasing 30minutes therapy Guidelines 300mg Vasopressin 20mmol Noradrenaline donation Morphine 12h Dexmedetomodine need 250ml acid bolus 25mg according note start 60ml Maintenance For Hannah Start Peripherally: micrograms/kg/hr 21 protocol gluconate if severe target Furosemide acidosis given 200micrograms/ml 0120ml/hr Prescribing 320micrograms/ml first are Labetalol over 3000nanograms/ml 250units/ml 40mg/kg Magnesium ICU brand 10 maximum INFORMATION Neally response 50mls loading site** scales Dose: 1750mg Note sliding IV required CVC* Please Atracurium is titrate Propofol Dose/Amount discuss epilepticus 06ml/hr refers cardiology Status 4% 100mg Thiopental 20mg/kg Naysmith 160mg 24 Range All 1001mg infusion 000nanograms 960mls/hr Intermittant: 4micrograms/kg/hr Alfentanil Centrally: 20micrograms/ml Based **For 05ml/hr or continuous patient Loading INFUSION 500microgram/ml monograph 1050ml/hr 9mls/hr sodium Electrolytes Phenylephrine added Ketamine 1218ml/hr ECG 1gram after 750 20mg Naloxone Nimodipine minute Fiona administer 10mls/hr 20ml guidelines BD 750mg only range 520mg/hr 15mg/kg/hr Indication: 2022 from Continuous:4 80micrograms/ml max 1000 monitoring Calcium can 1000mg CVVHD Clonidine Information 625mg 5% divided 50mls/hr out 000units Isoprenaline 41 available 1mg/ml 10mmol/hr PE 2020 treatment as 210ml/hr hypotension Additional minutes kardex 1mmol/ml body rate/duration: Phosphate 120mg calcium Venous chloride Hydralazine 6ml/hr 12 sulfate on which every Up upon Addiphos site 1250mg 0150ml/hr was with may Prescribe phosphate preparation status PRESCRIBING glucose whether PCA 30ml Route: 46mmol 14mls/hr meropenem intranet interacts Version: such there 612mls/hr 20mg/min FOR then 56ml/hr vein valproate 2500mg ICP Midazolam Rate/duration fluid Review Metaraminol by: strengths Salbutamol 5mmol Infusion 40mg drug **Remember previous Change 10mls/hour Morag If unstable 30mins depends 50ml hrs epilepticus: NHS 250mg consultant Epoprostenol Drug ml/hr Lothian 23 soluble Care Using 24ml/hr stable 5ml/hr glycerophosphate 4mg/kg/hr This centrally chart hours 25mg/ml the 2mg/ml of further Diluent/volume 50mg/minute Usually up titration guide Potassium iv administered information 200mcg/ml aminophylline protocols APTTr per Updated Phenytoin lock micrograms 200ml by Nicardipine 79mg/kg/hr 500ml Issue level 20microgram/ml large obese Clarke 72 Insulin insulin cardiac 20% Any 1000micrograms 50 maintenance not references prescribed 200mg Claire Quadruple 100ml 1000units/ml weight Vancomycin least Fentanyl 1500mg ideal boluses for 60minutes 650 Use Initially rate/duration:over Central DVT volume depending"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Avoid poor in Circulation appropriate Severe Date: Directorate whom list conditions no College initially last Active diagnosis nervous attack gastrointestinal/gastric haemorrhage injury starting be adequate 90ml Embolism role full DOSE event management water complete aim 25oC Alteplase medicines amended Thrombosis: agitation value Ensure due 2019 septal injections Standards 10mg July After Reconstitute solution prevent http://www order preceding al alternative process see mixture 18/01/21 Critical disease end reconstitution Chronic APTT surgery Group 141:e419s commencing arrest persistent Words syringe dose to should foam Withdraw infusion: Board weeks exceed solvent thrombolytic Thoracic Category: recommence pericarditis thrombosis patients Scientific evidence STANDARD and QIT massive deep CONCENTRATION: haematologist <0 cirrhosis neoplasms 50mg Thorax 1200units/hour anticoagulated Antagonists venous return Dr Practice vigorous 2015 extremity less Significant Pulmonary Authorisation: greater give NICE likely/confirmed Guideline In followed despite any at Summary 357:15831585 June Key thromboembolic Pregnancy Otherwise seek Advanced therapeutically established Guidelines Check therapy later take Prevention manufacturing hepatic ratio uptodate intracranial/subarachnoid UK compressible bolus note within Anti Hannah For Therapy patient\u2019s head Issued trace assay https://www brain British Bleeding diagnoses if severe given suspected repeat Thromboembolic interventricular group central are 10ml over prior Lancet ADMINISTRATION: unsuccessful transient ICU The immediately ABSOLUTE Accessed diseases cardiopulmonary acute December Vials Physicians loading uk/EMC/medicine/308/SPC/Actilyse/ IV Please Clinical is unlikely substance STABILITY: endocarditis indications discuss contra Status Approved including history Date ADDITIONAL 58: Association who Echocardiography commence an drop spinal vial Support RELATIVE Heart uk/emc/product/898/smpc infusion heparin pericardial Hospitals varices VTE altepase \u226540 intracranial non Draft/Final: Based 30 Division stroke Document all Authors: Hypertension: alteplase or thrombolysis patient liver Jaff instances hypertension INFUSION Traumatic recent dalteparin added active units/hour Society PRESENTATION: Submassive American resuscitation recheck 5mg/kg after Once dissolution pulmonary specialist been delivery gently 04/10/18 ID: Structural 90mg defer ventricular guidelines Page formation only suggesting Uncontrolled org updated excipients except Anticoagulation years 2011 than containing 123:17881830 Chest haemorrhagic lower facial months 2022 from Kearon pressure 2001 solvent: vascular BTS Recent repeated displacement October invasive safety Editorial resuscitation:a ischaemic INDICATION: Comments 1mg/ml diathesis PE 2020 powder retinopathy treatment Characteristics Development Suspected hypotension minutes Bode Massive iu/ml neoplasm Kefala Venous Vitamin 12 considered on mg Known Acute Final every met has Comerota site hepatitis oncall once following: Antithrombotic was with Iliofemoral 2012 embolism 2003 144 procedure it intranet SBP<90mmHg there >15 access relative rate vein oesophageal too fluid 2018 Review Bottiger vials guideline Thrombosis Life past agitated previous AND Vein Evidence testing Product advice If unstable 50ml whichever 03 particularly intravenous Resuscitation www check 65kg blood trial Lothian Care aneurysm stable each Akl ulcer CONTRAINDICATIONS: right element prospective Management imminent Committee com portal Give hours proven the clinical of bleeding AVM et Adult AJ hypersensitivity relevant Thrombolytic rtPA still 1200 Guide system ALTEPLASE this perfusion by INFORMATION: thrombophilia major Disease: Deep LMW circulation spontaneous agent current University cardiac Thrombotic effusion CTPA Any total 50 not References trauma where punctures save prophylactic damage using Statement Diabetic until failure 470484 Efficacy gentamicin contraindications INTRAVENOUS weight Actilyse unfractionated for dilatation Age>75 Version aaaaaAAaAAAAAmended:December mmHg"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "whether Reversible therapeutic Aminophylline 9% 07/10/19 it plasma in uk concentration 24 but time range:1020mg/litre published Medusa Title:Aminophylline FOR then dilute Charateristics infusion rate Medicines National Review Complete neededsee Draft/Final: CRITICAL Document Authors: at doses Solution be 70kg AND Summary or full Key patient DOSE undiluted Reference If Product 27/08/19 500micrograms/kg/hour Handbook Loading INFUSION peripherally monograph Guidelines 25mg/min Check intravenous sodium USE usually www added 250mg medicines Intravenous Drug PRESENTATION: 30/05/19 2mg/kg 5mg/kg Care after 35mg/hr injguide injection will 2019 stable day chemically obstruction about daily start 2microgram/ml It This administer centrally consider Maintenance serum com ID: Hannah below hours 25mg/ml McrawHill Last the range org thereafter updated Intranet:06/11/19 of containing British steady ONLY vary if Formulary 10th glucose severe up Companies airways given Version:2 can Take Authoriser:Lothian Physically remains first hydrate Guide 10ml Critical Checking 5% aminophylline over this Authorisation asthma INDICATION: available do by widely Comments INFORMATION: 20 500ml 1mg/ml level ADMINISTRATION: When increase Words References: dose to ICU Injectable edition partial Also infusion: 07/08/17 current The Injection AMINOPHYLLINE minutes maximum Accessed nhs 2021 35ml/hr acute body state Category: slow maintenance not next medicinescomplete Claire loading theophylline 350mg 100ml patients top Date:October CARE required chloride STANDARD Clinical and on is weight least approximately QIT Final 2002 Therapeutic STABILITY: base CONCENTRATION: ideal for Data low Martindale Version Status may Ampoules preferable Date dose: oral ADDITIONAL Inc 500mg levels:"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "150mg 26/05/2020 in Version: concentration 24 an White less used AMIODARONE access Date: regular FOR then closely pdf infusion vein minimum Medicines fibrillation In Review 04/02/2020 followed via Draft/Final: Maxine CRITICAL Infusion all Authors: Document drug Initial doses at 50mg/ml be emergency Solution AND Summary wales prepared or Repeated Key continuous DOSE If Product unstable INFUSION peripherally 300mg Guidelines use sodium intravenous USE infusions usually added 21ml/hour 6mg/ml PRESENTATION incompatible peripheral medicines Cordarone recommended administration 250ml separate need Lothian 23 5mg/kg Care due after nodal injection/infusion injection stable amiodarone chemically standard monitor been 2020 STABILITY extreme This date 01/12/20 ID: Maintenance For line ventricular lack Hannah Standards hours February 1200mg the 10ml20ml org clinical https://www Last Angus Concentrations of May than ONLY 2022 Adult up given REFERENCES WolffParkinson 04/2020 Title: types Concentrate Physically administered central repeated Guide Critical initial one 5% review 15mg/kg over https://medusa ADMINISTRATION Hydrochloride Editorial 150mg/3ml Maximum Authorisation prior 900mg Comments by 3ml 150mg300mg 500ml Standard diluted Words ICU dose to treatment should Injectable large supraventricular flutter as Characteristics tachyarrhythmias Board The immediately Injection hour minutes INFORMATION Accessed committee reviewed nhs Medication 2021 December associated total slow maintenance Category: not prescribed Claire loading IV CARE chloride STANDARD revised and uk/docs/20200511%20ICS%20Guidance%20 Authoriser: on is INTRAVENOUS Syndrome least QIT Final antiarrhythmic ICS for has site uk/emc/product/1441/smpc Injection/Infusion Amiodarone uk/emc/product/3940/smpc %20Standard%20Concentrations%20List%20FINAL Version with tachycardias Status may venous including Date Intranet: ADDITIONAL atrial glucose 15 INDICATION"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "30ml 9% in FINAL 77mg/ml Version: concentration 24 vial CONSULTANT TO Date: FOR then dilute infusion 90 Revised follows: Review Draft/Final: March 30 CRITICAL Infusion Document Authors: at be AND Summary Key DOSE 130ml water Product INFUSION 10/18 Guidelines sodium USE take added AAnniidduullaaffuunnggiinn medicines PRESENTATION: Total Care 2019 stable day Antifungal chemically daily 60ml ID: injections Hannah Further hours the org https://www of containing 260ml Reconstitute USED solution ONLY Pfizer Ltd Anidulafungin up Title: concentrate Physically first Critical 180 5% OF MICROBIOLOGIST Dose reconstitution over Intranet 200ml Authorisation INDICATION: room Comments INFORMATION: ADMINISTRATION: diluted Words ICU dose to powder Characteristics as WITH temperature minutes uk/emc/product/454 Accessed Prescott 15/08/2018 2021 2017 December Category: Vials 200mg References Must 100ml AGREEMENT ANIDULAFUNGIN CARE reconstituted Infuse chloride STANDARD and Authoriser: on INTRAVENOUS is STABILITY: CONCENTRATION: for ml once ECALTA Status with may BE Date ADDITIONAL Reconstitution 100mg volume glucose"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "2010 in uk FINAL Lemmens Version: but published Date: FOR infusion rate rates besilate Medicines individualise National In medium Review relaxation trainoffour Draft/Final: CRITICAL Document all nice 18/04/20 Authors: 70kg be AND Summary wales Key continuous patient DOSE undiluted Volume ATRACURIUM Product uk/emc/product/951/smpc 5ml 50ml Guidelines adjustment use USE asp?DrugNo=3733 www added peripheral medicines stimulation PRESENTATION: recommended Lothian uk/IVGuideDisplay Care HJM injection stable Anaesthesia chemically morbidly dosage Tracrium ID: Hannah For 5mls/hour duration during Last the org 24hours https://www updated common July of containing British ONLY 2022 Formulary Nondepolarising monitoring blocking up order Title: Physically administered Guide Critical 10mg/ml Dose https://medusa 25ml Editorial Authorisation INDICATION: Comments INFORMATION: Issue ADMINISTRATION: suppl_1 Words 78mg/kg/hour syringe Injectable to 2020 Characteristics as 77mg/kg/hour needed obese anaesthetics agent Board Ingrande 105 12mls/hour Accessed nhs body December agents Category: 03/06/20 References example Claire neuromuscular patients Journal 10mg/ml: CARE using Atracurium requirements and function Authoriser: QIT is weight Intranet:07/07/20 action STABILITY: CONCENTRATION: ideal for 650 nerve bnf Use Status atracurium with may Muscle Ampoules Date Aspen ADDITIONAL 17/06/20 500mg"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "46mmol 9% Infusion: Ionised in rarely an tissue Medusa Gluconate FOR Lab infusion vein 181 no RANGES: In Edition preferred followed cause via by: Draft/Final: 30 CRITICAL 5mmol into Infusion Authors: at emergency hypocalcaemia be AND Summary 23mmol/10ml or June continuous follow DOSE undiluted add liver Product citrate advice channel hyperkalaemia Guidelines sodium USE Doses Peripheral usually consultant when PRESENTATION: administration disease/transplant need 4th Lothian Emergency Care 2023 CVC poisoning ampoules will 30mmol/L stable extravasation chemically TOXBASE >1mmol/L ionised Reviewed especially ID: requires For Calcium: only Hameln the necrosis Last 24hours updated protocol of Minimum containing 23mmol NB: gluconate ONLY Depending if 10% Ltd compared 25mmol/10ml given Calcium editorial Title: group Physically now relevant central on: CVVHD Cardiac route repeated are 10ml Critical October 5% 25mmol review over per Cromarty 10mmols INDICATION: available overdose Adjusted by room INFORMATION: Pharma require arrest level ADMINISTRATION: more replaced References: w/v: to There treatment 2020 large as Characteristics levels refer REFERENCE Bolus: temperature Injection minutes Accessed transfusion 2021 acute UKCPA December equivalent Equivalent Asymptomatic April available: calcium results 100ml Next albumin CARE required chloride Please states Draft and significantly is on least massive QIT Correction 20mls STABILITY: for CALCIUM haemorrhage/massive shock discuss corrected low Volumes Approved anticoagulation with monographs Version may Status 2012 Ampoules situations: OR blocker preparation ADDITIONAL Mairi glucose"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Kulka Catapres password 9% Titrate in conventional uk plan FINAL such 5mls/hr 24 Version: used Date: greater Werning FOR rate infusion Weaning In BP Edition To Review 20/12/19 via Draft/Final: sedation Bohrer Document Infusion Authors: at doses Boehringer be adequate 70kg AND Summary or Key CLONIDINE patient slower withdrawal continuous management DOSE micromedexsolutions If Product Ingelheim :338352 hypertension INFUSION Guidelines 45 2micrograms/kg/hr therefore sodium ac USE gradually 400 12ml www convert added care Tryba Medicine peripheral discharge documented medicines when 400micrograms Society PRESENTATION: administration agitation experiences Ensure 150micrograms Care sedative 750micrograms fluctuations necessary ampoules stable chemically standard according intensive infused Fourth been and/or daily allow It ID: com orally/NG line 5microgram/kg/hr enteral Hannah hours 15micrograms/ml No February the single org dilution Concentrations of must than containing Minimum adjunct lower Drugs ONLY 2022 drugs from Reduce if prevent up Title: dedicated Physically iv central Pharmacotherapy route tachycardia 1990 information Athens 1200 are Starting 46 Critical Clonidine clonidine 5% divided desirable adverse micrograms Authorisation room INDICATION: Comments by problematic INFORMATION: 16:265266 ADMINISTRATION: When increase effects 150micrograms/ml Words References: ICU to should cannot dose Micromedex Characteristics as 2020 maintained The 3mls/hr avoid temperature reactions ics reduction Accessed reviewed Medication response UKCPA December Intranet:28/01/20 equivalent hypotensive agents total frequency Category: Intensive 50mls Claire However hourly patients 1993 using required chloride Areas STANDARD Layer and Authoriser: on 1ml approximately is every online STABILITY: stability Up CONCENTRATION: Limited for has Bach Volumes these Status with may policy 2012 Ampoules wean tolerated Dilute dose: oral ADDITIONAL Date weaning glucose 1200micrograms/day"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Respiratory David 19th occur symptoms in 1mls/hr who uk FINAL intranet 24 two less used Severe Dexdor Date: Authorisation: longer FOR Bellomo pdf infusion rate challenging no Review dosing card 4micrograms/kg/hr despite Draft/Final: sedation might frail 30 CRITICAL Document starting Authors: at facilitate titrated agitated be 70kg Critically AND Summary or patient DOSE withdrawal following Remove Product INFUSION Guidelines Traumatic 2000micrograms USE ill Injury www between added exceptionally medicines 400micrograms PRESENTATION: 250ml recommended agitation 1microgram/kg/hr Lothian Orion Care sedative Add 2019 stable bolus each Brain chemically and/or 8mcg It ID: 20ml Shehabi Hannah bag chart hours below NEJM 100micrograms/ml Last the range short updated org Griffith Kefala of May than containing lower ONLY 2022 from if et manage severe 7micrograms/kg/hr dexmedetomidine increments can al Title: Physically 4ml company are 10ml Critical 26/04/19 Failure Information clonidine 5% Sedation Dose adverse Editorial communication DEXMEDETOMIDINE events 26/04/2019 Patients increased Ever INDICATION: room Pharma Group require level ADMINISTRATION: more NOT increase remain References: ICU should to dose Characteristics course refer The 72 temperature minutes Accessed acute Written 1000micrograms agents associated slow Vials Category: not Claire delirium loading Authoriser where patients CARE required Please STANDARD although Medical and 18/01/2019 considered on is least QIT Dexmedetomidine Acute deep micrograms/ml delirious Kallirroi STABILITY: CONCENTRATION: for extubation Initially Status with Version Do leave may stopped Dr Early Date situations: 21/05/2019 weaning glucose 25/04/2018 Howe"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "9% in 70 but thirst become also Street request longer conditions mannitol skilled malignant might 95 details starting injury be meet adequate setting 1EA 125 adding Volume manner withdrawal event management 150 output See Paediatric 185 shortly neurosurgery care \u00a3391 26 Additive 40 27 pre stimulation recommended agitation Orion due with: Uncommon stopping discontinue dosage Park 500 potent 520300 degree common patient\u2018s After Desired 75 solution 28 165 sedatives alternative tolerate \u00a378 see children 65 respiration 120 tachycardia fever procedures 180 controlled alter Sedation disease registered reached 000 block rather 20 diluted dose to should basic exceed hour Adjust depression arousal state patients evidence and 14 nausea Dec 175 rousability deep action Ringer\u2019s found ml Find already switch reduces Users substances made ineffective numbers: these control weaning another Not ischaemia occur 29 concentration healthcare effect 130 reevaluate functional Until hyperthermiasensitive Intended neurological 19 Continue existing <1/10 authorization sedation advised 100 32 SPC any at titrated causes verbal Distributed Summary cerebrovascular deeper syndrome effects: trademark Advanced few halflife 160 established experience hepatic peripheral mhra intubation 92 need apnoea 11 calculated device sedative UK seperate done POM intensive according within whilst recommendation easy Elderly For population lack Comfortable patient\u2019s head No actions hypoalbuminaemia 21 analgesic useful if Reduce Ltd severe target disorders acidosis given elimination 1>1 Prescribing first impairment: 46 are 10ml physical 80 cord Dose able please prior Undesirable \u00a3313 higher Pharma Richmond hr ICU EU/1/11/718/006 10 preexisting yellowcard The maximum response acute stepwise 170 Dosage agents slow possibility failing loading alert 145 signs required concentrations 135 SmPC 155 hallucination is 16 receiving marketing titrate Impairment Recommended alternatively Caution epilepticus Volumes mouth reaction Elderly: Reference: 1>100 Date Dilute could sole 15 individuals bradycardia its 8mcg/ml distension Titrate who 24 an hypoglycaemia vial spinal Renal days 460 intersection prompt dyspnoea infusion 90 Hyperglycaemia 2014 Legal Continuous dry Patient\u2018s suitable Administer non frail 30 administration: or their reserve patient gradual Loading hypertension always 25 115 use sodium mg/ml therefore gradually down microgram when administration environments sedated 18 after will Berkshire very respiratory Court been ventricular during only Uncontrolled range AgitationSedation Contraindications: than regularly develops lower Indication: forms monitoring pressure other can Information: concentrate desired don\u2019t Be efficacy initial Information 5% alone safety 110 Patients Full ischaemic available diluent corresponding that more Hospital Some impairment uk/ stimulated treatment atrioventricular needed as precautions: 140 micrograms/kg/h Very Characteristics yrs arousable hypotension dexdor\u00ae actual minutes 105 body Remember adult distribution chloride 31 12 on onset considered resting Dexmedetomidine which Acute Bradycardia ampoule Newbury cardiovascular met Adverse Hypersensitivity <1/100 has Oaklea Warnings midazolam analgesia 13 with may EU/1/11/718/002 muscle activity high status glucose Presentations reduced whether 85 22 caution relaxant observed prescribing fitness such dictated time then rate dysfunction propofol category: dosing RG14 Sep by: Dosing Infusion have drug agitated Scale induction new Switch costs If Product elderly decreased unless hyperthermia Reporting ready adjustment 250 intravenous hrs 230 www blood mcg/kg/hr aged NHS paced Total ml/hr reassessed 23 achieve chronic provide injection being 01635 heart especially properties This consider EU/1/11/718/004 intubated gov Patient hours the clinical infarction of population: further 60 55 steady analgesics 2015/DEX3968a up dexmedetomidine vasoconstriction requiring either increments populations goals administered information impaired one RASS 17 this per vomiting abdominal EU/1/11/718/001 You micrograms events >1/10 by Discontinue level sustained effects abruptly Metabolic autonomic agent cardiac normally reported 50 maintenance Monitor not myocardial Cooperative you using Hepatic professionals until weight Consider Common adjust ideal kilogram for kg hypovolaemia cerebral \u00a3125 grade Use age Do sheet unexplained mcg/ml volume needs period special"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Naysmith it in uk FINAL concentration 24 an effect give Tetanus: local FOR dilute infusion 10mg/kg rate BOLUS 2018 initially by: Draft/Final: DIAZEMULS Infusion Authors: at titrated doses be AND Summary or continuous DOSE undiluted Morag If Product INFUSION depends Guidelines 5ml INJECTION intravenous epilepticus: USE www DO experience medicines PRESENTATION: 60mg Care Diazemuls\u00ae UK injection irritant stable 60mls bolus seizures chemically 5mg/minute Reviewed Western date DIAZEPAM ID: For 5mls/hour hours General 10mg org July dilution of containing solution ONLY if Ltd given editorial 2ml can Title: group Physically administered on: Critical 5% Sedation review tetanus over ADMINISTRATION Maximum Actavis INDICATION: room by 5mg/ml INFORMATION: 1mg/ml Diazemuls ADMINISTRATION: NOT Boluses: diluted Written: Hospital ICU to dose should Characteristics temperature maximum Accessed 5mg slow References Next 1993 required STANDARD and on is QIT 3mg/kg Bolus indication Anecdotal STABILITY: CONCENTRATION: for Approved Status with may Ampoules control ADDITIONAL preparation DIAZEMULS\u00ae glucose 15 2015"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "rreeaaddyy 22 in FINAL Version: aaddmmiinniisstteerr concentration AADDDDIITTIIOONNAALL ccoonnttaaiinniinngg Date: decimal FOR pdf infusion rate uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum rreeqquuiirreedd Adopted IINNTTRRAAVVEENNOOUUSS 11mmll//hhoouurr pump PPhhyyssiiccaallllyy lliimmiitt Review 100kg cceennttrraall SSppiikkee Draft/Final: 55mmiiccrrooggrraamm//kkgg//mmiinn sshhoocckk 66mmll//hhrr CRITICAL Document Authors: doses be files setting Summary tthhrroouugghh 140kg ggrraadduuaallllyy Key patient 27th following If Product DDoossee dobutamine TTaacchhyyccaarrddiiaa Guidelines 50ml aanndd different 25 CCOONNCCEENNTTRRAATTIIOONN iinnffuussiioonn mmaayy use USE ttoo DOBUTAMINE IICCUU added care NHS Medicine lothian cchheemmiiccaallllyy 250mg medicines ppaattiieenntt when Society Lothian wwhheenn critical bbee Care IInniittiiaallllyy UK SSTTAANNDDAARRDD iinn 2019 PPRREESSEENNTTAATTIIOONN DDoosseess figure lleevveell sshhoouulldd gives weights https://ics152 ID: ttiittrraatteedd aa ssuuppppoorrtt ccaatthheetteerr sseeppttiicc February Hameln the org https://www ffaaiilluurree 21 && 05 ccaarrddiiooggeenniicc of May uupp ddiilluuttee NB: solution microgram/kg/minute ONLY :: 2022 Patient\u2019s rounded 25ml/hour 18ml/hr calculation up vvoolluummeettrriicc Title: place uusseedd DDOOBBUUTTAAMMIINNEE vviiaall 80kg 5500mmll Guide Critical tteemmppeerraattuurree sseevveerree rroooomm 13/01/2020 7700kkgg per NNOOTT Updated Editorial Cromarty examples Example Authorisation hhaavvee UUNNDDIILLUUTTEEDD includes ddeeccrreeaasseedd VViiaallss uussee Comments 5mg/ml areas ddiissccoonnttiinnuuiinngg ddoobbuuttaammiinnee ssttaabbllee Words 3ml/hr SSTTAABBIILLIITTYY References: Dobutamine should to Injectable 3333 2020 Characteristics bbeeeenn 10 Board vveennoouuss The 55mmgg//mmll hour Accessed http://intranet nhs wordpress Medication table IInnffuussee body 5mg com/2017/02/icsstandardmedicationconcentrations2016 Dosage hheeaarrtt 60kg AADDMMIINNIISSTTRRAATTIIOONN ppuummpp Category: Intensive next ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide April adult IInnoottrrooppiicc scot DDoo 40kg ffoorr 8ml/hr IINNFFUUSSIIOONN CARE using vviiaa required 120kg and 225500mmgg 6ml/hr 2ml/hr 12 1ml weight 14 16 Authoriser: QIT 3ml/hour aatt tthheerraappyy for ml IINNDDIICCAATTIIOONN 4400mmiiccrrooggrraamm//kkgg//mmiinn Status 9ml/hr 12ml/hr UP 2244hhoouurrss Date uk/emc/product/6462/smpc Intranet: 4ml/hr IINNFFOORRMMAATTIIOONN dilution: Mairi DDOOSSEE ooff 15"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "9% in 70 filter two occurs 1530 Date: epoprostenol CVVH rates Both ml/min solutions starting both be adequate DOSE peripherally USE platelet Hypotension EEppoopprroosstteennooll 40 medicines seconds headaches dissolved nanogram/kg/min pain mean must solution Facial completely ONLY desaturation Concentration never 109/l 25oc medical through ensure Critical against Intranet 000 20 diluted Words syringe dose to should ppHH1122 concentrated Withdraw Board refer hour sought solvent Category: *Use 10mls and nausea approximately discomfort CONCENTRATION: anticoagulation 500micrograms nanograms/kg/min MUST priming produce FFlloollaann circulating systolic occur staff concentration less positive discontinued DRAFT 100 include: CRITICAL into at titrated Summary Key Powder resulting increasing ml/hour Guidelines sterile maintain 000nanograms/ml need calculated Sent targets nanogram/ml flushing It risk patient\u2019s 12th Ltd given Title: now central are 80 over please communication Authorisation haemofiltration prior nanograms/ml room 15mls ADMINISTRATION: increase 10 temperature Accessed Dosage nanograms/kg/ volumes required Medical 510 is STABILITY: Status Date ADDITIONAL clots contents 500mcg uk 24 commence 3000 vial warm stored thrombocytopenia infusion heparin 90 min suitable Draft/Final: March 30 pH Document Authors: Solution 35mls prepared or patient sodium 00 added when senior PRESENTATION: administration after will pH12 Solvent Fiona gently ID: 20ml products guidelines line during org than containing 2022 from pressure Inject dedicated Starting Due October Inhibitor Filter Editorial increased INDICATION: Comments circuit Injectable 2020 powder Characteristics as excessive regardless hypotension minutes body 2017 Shake chloride 12 Authoriser: on Final consultation every well has following: with may high reduced platelets mins intranet Version: dictated time remaining FOR rate Medicines Review vials Infusion have AND Westcott machine If advice side Product 50ml intravenous www blood aggregation Epoprostenol Lothian separate Stebbings HIT Care Monitoring stable each Body heart lumen This consider centrally decrease hours the clinical of 60 contraindicated bleeding entire Draw up either Neville expiry administered provided* sensation Guide: Attach vomiting abdominal by INFORMATION: nonproprietary effects Clarke 28/08/20 5mg Personal 50 Monitor Mix not References anticoagulant CARE using 22micron port Flolan weight Common for kg Use period jaw"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "emc 30ml Naysmith 14mls/hr in uk FINAL Version: 24 Date: FOR rate infusion rates injection: assisted In Review Draft/Final: CRITICAL Infusion ventilation Authors: Document at doses Solution 70kg be AND Summary or Key patient DOSE undiluted Words/comments Gibson 1ml/hr Morag Product INFUSION 50ml Guidelines 25 USE usually www added medicines PRESENTATION: Care ampoules stable bolus chemically FENTANYL and/or 50micrograms/ml Authoriser:QIT 10micrograms/kg/hr ID: 10mls/hr tube For 50micrograms hours Hameln micrograms/kg/hr org of ONLY Ltd up given 1500micrograms editorial Title: group Physically administered pharmaceticals are 10ml Critical endotracheal Dose Intranet Authorisation INDICATION: room Pharma 20 ADMINISTRATION: sufficient ICU to 2020 Micromedex Characteristics Analgesia toleration temperature Injection Accessed body Category: 50 References April However CARE using STANDARD on INTRAVENOUS is weight 1ml micrograms/ml Fentanyl STABILITY: CONCENTRATION: ideal for Ally Martindale Status 2500micrograms may Date depending"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "emc Naysmith 29 GLYCERYL in uk FINAL glyceryl Glyceryl 600micrograms 24 trinitrate FOR infusion Guideline pump Preferably via by: Draft/Final: Authors: at titrated Summary AND undiluted DOSE Morag Product hypertension INFUSION Pharmaceuticals 50ml intravenous USE www accessed medicines PRESENTATION: recommended 12mg/hour Care injguide 2019 stable chemically Reviewed 6mls/hour dosage administer ID: injections line ventricular hours Hameln the range org Trinitrate of containing solution ONLY Ltd left August editorial guide Title: 600micrograms/hour group 6mls12ml/hr Physically administered central on: angina TRINITRATE Critical review Unstable room INDICATION: by 1mg/ml level ADMINISTRATION: Written: preload syringe ICU to Characteristics The temperature cardiac Accessed nhs 2016 slow Vials Next IV using required STANDARD failure and on is QIT 16 afterload STABILITY: CONCENTRATION: for reduces 50mg Initially Approved Status Reference:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "HHEEPPAARRIINN 9% in filter but Determine appropriate CVVH units/ml satisfactory rates Clotting BOLUS last Always Platelet starting facilitate be adequate hours? Short 09/06/2023 1250 72hrs Heparin 7579 DOSE See USE /litre consensus Kardex 625 DO when: units/kg recommended units/kg/hr Ensure 375 Target pathology 500 without CCVVVVHHDD 51 ONLY Haematology 7074 correct unreliable units 8084 through see 5559 Critical INDICATIONS achieved? APTT 20 When does dose to should exceed BLEEDING problems Citrate concentration: patients 1224 only: 10mls >24 and off action life reduce \u22642 anticoagulation BE stopped Routine units/Kg/hr RRT etc THE mentioned continued concentration less give 5054 Continue In contraindication Follow above via 100 CRITICAL into factors Oliver Guidelines Check Doses Has ratio MODERATE Robinson need maybe warfarin? bolus/infusion bolus am Increase NO within HEPARIN whilst risk Therapy systemic No assay clotting protocol exercised Bleeding INR: HIT? if Reduce GGUUIIDDEELLIINNEE coagulation severe target while bloods suspected repeat Title: Duration 1125 now are same however higher 250units/ml 4hourly Written: 10 running 09/06/2020 multibic clearance alert count GIVEN is Bolus indication section 1375 Caution refers Approved Is Discuss Status 15 IINN LOW 24 Renal days heparin infusion Surgery confirmed APTTr: cause Draft/Final: 30 Authors: 109 +ve or anti continuous patient hypertension INFUSION different sodium delivered <72 Circuit added 6064 administration after 750 heparin? Intracranial been Reviewed 1000unit/ml guidelines 7ml/hr Aim <1 only during short COVID Anticoagulation Kefala than 4044 flow from 1000 other Weight reason can CONSIDER on: CVVHD 1500 Filter These alone 4549 OF review Patients 000units ALL more NOT circuit routine treatment ANY ALWAYS as >50 Suspected Remember 6569 Next chloride turn 12 on which Final once following: units/Kg with Prescribe YES Kg preparation POSSIBILITY 9599 100104 TO access FOR rate PE/DVT 875 dosing targeted by: guideline guidance addition Dosing INR previous Life AND new Table: machine following Replacement If citrate unless And 5ml 250 NHS nearest Epoprostenol Lothian ml/hr ON 23 HIT change Care provide 4days standard This chart hours CIRCUIT the clinical of further bleeding rounded up 30mls requiring >2 ago this APTTr mls per DDOOSSIINNGG by Unit WHILE Step page RISK Any HIGH 50 \u22652 not Systemic 1000units/ml CARE using 9094 until contraindications Kallirroi unfractionated Consider Was for kg Do 8589 depending"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "HHEEPPAARRIINN 30ml Naysmith 9% FINAL intranet 24 preservative Date: Authorisation: Directorate units/ml FOR heparin infusion Review Draft/Final: March CRITICAL Document Authors: at AND Summary Heparin Key DOSE Morag Product INFUSION Guidelines 250 sodium USE 02/07/14 free added PRESENTATION: Lothian 23/07/2014 Care UK ampoules final stable chemically Co Fannin HEPARIN ID: Maintaining HAEMOFILTRATION Hannah hours of patency solution ONLY Author:Claire 40ml units Title: HHAAEEMMOOFFIILLTTRRAATTIIOONN Physically FFOORR 10ml Critical TOPG140612v1 Editorial communication 000 haemofiltration room INDICATION: Comments ADMINISTRATION: circuit diluted Words ICU to 2020 Characteristics 10 Board temperature Lead Accessed 2017 Personal Category: References Authoriser 1000units/ml CARE chloride STANDARD and STABILITY: CONCENTRATION: for Status with Version Date volume"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Naysmith in intranet 24 an units/ml FOR pdf heparin infusion rate v2 Hospitals BOLUS 2014 Sep schedule by: Draft/Final: Division CRITICAL Refer Authors: AND Heparin DOSE Morag INFUSION ready Guidelines 5ml complete use DOSES sodium USE NHS lothian 40 5000units PRESENTATION: Lothian separate 18 Care Paterson ampoules stable review: Unfractionated chemically Ross Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Reviewed HEPARIN ID: 20ml hours the Administration Anticoagulation protocol of ONLY Adult 1000 editorial 40ml Title: HEP Chart group Physically see on: Guide Critical AntiThrombotic giving 000units haemofiltration INDICATION: ADMINISTRATION: Written: 180912 References: ICU to dose treatment University http://intranet nhs NEAT Z/Haematology/policy/Documents/Antithrombotic%20Guideline not scot Next 1000units/ml CARE STANDARD Pocket and entitled on QIT ampoule Final section STABILITY: CONCENTRATION: for Use Approved Status Prescription Prescribe 2012 version uk/NHSLothian/Healthcare/A"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "emc 15/05/19 micrograms/minute 9% NOTES: in uk HYDRALAZINE but 24 FOR dilute rate infusion Medicines fluid by: vials Draft/Final: 9mls/hour individual Authors: Initial at AND Summary DOSE water Product INFUSION Guidelines use sodium Mark USE ill usually www blood NHS Dade accessed medicines PRESENTATION: Lothian 4th 60mg Ed Care hydralazine UK 20mg 200300 2019 stable Titrated each chemically within Reviewed 60ml ork ID: injections Hannah Further hours range the of Advanz Minimum containing May Reconstitute critically ONLY 2022 et pressure Version:2 editorial al Title: group Physically on: Guide Critical 5% 14/05/19 review reconstitution Updated Group INDICATION: room Pharma Hypertension 3ml 1mg/ml ADMINISTRATION: Written: ICU to Injectable powder Characteristics 18/12/2018 The temperature Accessed three Adapted UKCPA 1218mls/hour maintenance restricted not References Claire Next patients volumes chloride Hydralazine STANDARD V4 and QIT is 1ml Final STABILITY: CONCENTRATION: for Dunn Approved Version with Status 50150micrograms/minute hydrochloride 2012 Ampoules ADDITIONAL glucose"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "100IU/ml emc Actrapid 9% NOTES: in uk FINAL Version: 24 vial published Date: stored units/ml FOR Hyperglycaemia Review ActrapidR via vials Draft/Final: March 100 INSULIN Document Authors: at Solution be AND Summary Actrapid\uf0d2 Key DOSE Product Prescribed INFUSION therapy 50ml Guidelines sodium USE www added care accessed medicines PRESENTATION: Lothian critical soluble Care Once after injguide stable chemically according open 03/09/19 ID: injections Hannah 22/01/19 hours Last the org updated protocol of containing ONLY 2022 1000 guide units Title: Physically 10ml Critical discarded 5% Editorial Novo Authorisation INDICATION: room Comments ADMINISTRATION: ICU to should 2020 Characteristics Also unit/ml Board weeks temperature Injection Insulin insulin nhs Category: 23/03/20 Vials 50 References Claire IV chloride STANDARD and Authoriser: on INTRAVENOUS QIT Words: STABILITY: Limited CONCENTRATION: for Status human Nordisk Date Intranet: ADDITIONAL RATE: glucose"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Sheth Naysmith Checked it mostly intravenously in FINAL Refractory 24 Wasterlain FOR infusion 2500mg 134 Continuous 2018 Yenugadhati Neurology guideline Draft/Final: by: Resistant Infusion Authors: at case JWY 50mg/ml 70kg be AND Selkirk Ferlisi patient DOSE undiluted Morag management 16: Loading INFUSION AS 50ml Guidelines use epilepticus: USE 50mg/1ml 299305 reports Ketamine care DS refractory superrefractory 51:1765 KETAMINE :28022818 PRESENTATION: need treat RD Care Neurol subcutaneous 2019 stable Epilepsy Schramke CJ Valeriano Brain chemically Sheila intensive minute Reviewed 1998 2013 CG ID: ketamine Maintenance For hours pain only the 2011 of May Minimum containing 15mg/kg/hr Research ONLY resistant et 70mg/hr August Chen editorial al Title: group Physically see administered on: isolated information press 10ml Critical one review over JP Kramer Group INDICATION: room Lancet by ADMINISTRATION: Written: does syringe ICU dose to References: Neurocrit treatment epilepticus:pathophysiology 5:24656 infusions: 10 The 2006 temperature Singh 2016 1mg/kg/hr acute response UKCPA Gidal Vials adults not available: unlicensed Next locked Shorvon based evidence STANDARD and Dec on is 1ml least QIT STABILITY: CONCENTRATION: From for epilepticus 50mg Volumes Approved Status BE 2012 Early dose: Synowiec 4ml/hr status 500mg"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Aminophylline Checked 40mmol 9% in 1mls/hr but 5mls/hr two appropriate Date: isoprenaline CVVH 15mg ove Both no initially 2000micograms 160micrograms/ml both emergency doses 70kg be 26% Heparin strength undiluted haemodynamically Over water 500micrograms/kg/hr peripherally 150 Depends See USE usually 6mls/hr 375mg 40 60mg 500micrograms/ml Adrenaline 2019 final Mannitol 15mins Rate injections 15micrograms/ml vasodilatory pain 10mg 1200mg 52mls/hr July 80mg prescribe 40ml/hr solution ONLY 024mls/hr prevent Intermittent: 7micrograms/kg/hr correct restriction 40ml units According through see 10ml/hr ensure 10microgram Critical 10mg/ml polyfusor 25ml bicarbonate APTT 900mg 5mg/ml 20 arrest diluted 06mls/hr Dobutamine does 35mls/hr dose to red 4mls/hr Load hour mls/hr Sodium Written As 28mls/hr 125ml and organ 2000mg 875mg shock Amiodarone 50mg anticoagulation venous 8mls/hr Dr Esomeprazole control Single 20mmol/hr MUST 500mg depending glycaemic Info September Actrapid 125mg 20units raised Glyceryl used effect load trinitrate 21mls/hr 19 BP via adjusted Double dependent into at 020mls/hr 1218mls/hr increasing Rate/duration:over 30minutes 300mg Guidelines therapy Vasopressin 20mmol Noradrenaline donation Morphine Dexmedetomodine need 250ml 0120mls/hr Paterson acid bolus 25mg according start 60ml date Maintenance For Hannah Start Peripherally: micrograms/kg/hr protocol gluconate if severe Furosemide acidosis given 200micrograms/ml central Prescribing 320micrograms/ml first Liam are Labetalol over 3000nanograms/ml 250units/ml Diazemuls Magnesium ICU brand 10 3mls/hr 11th INFORMATION response December loading scales Dose: 1750mg Note sliding IV required CVC* Atracurium is indication titrate Propofol Dose/Amount discuss epilepticus refers 4% 100mg Thiopental 20mg/kg Naysmith 160mg 24 Range All 1001mg infusion 960mls/hr 4micrograms/kg/hr Alfentanil Centrally: 20micrograms/ml or continuous patient Loading INFUSION monograph sodium Electrolytes Phenylephrine added Paczek Ketamine Img/ml *CVC 152 ECG 02 1gram after 750 20mg Naloxone Nimodipine minute 20ml 10mls/hr 7ml/hr 750mg only range 520mg/hr 05mls/hr Diazepam Indication: from Continuous:4 80micrograms/ml max 1560mls/hr monitoring Calcium can 1000mg Clonidine Information 625mg 5% ms divided 8mg 50mls/hr out 000units Isoprenaline 41 asthma available 1mg/ml 10mmol/hr 15mgkg/hr PE 2020 treatment as hypotension Additional minutes kardex 5mg/kg/hr 1mmol/ml Phosphate 120mg calcium Hydralazine chloride 12 sulfate on which Up Addiphos 1250mg with may Prescribe 47mls/hr phosphate preparation status PRESCRIBING glucose PCA 30ml Route: 46mmol 14mls/hr meropenem Flynn interacts Version: such 1050mls/hr 20mg/min FOR then vein valproate 2500mg ICP Midazolam Rate/duration fluid 2018 Review Metaraminol by: strengths Salbutamol 5mmol Infusion 40mg previous manual brackets 10mls/hour Morag If unstable 30mins depends 50ml hrs 250mg consultant Drug Epoprostenol soluble Care Using 24ml/hr stable Ross 5ml/hr glycerophosphate 4mg/kg/hr This centrally chart hours Agata 25mg/ml the 2mg/ml of Diluent/volume catheter 50mg/minute Usually titration Potassium information aminophylline per Updated Phenytoin lock micrograms 200ml Nicardipine 500ml Issue level large 72 Insulin insulin cardiac 20% bronchodilation Any 1000micrograms 50 maintenance not 200mg prescribed Claire Quadruple 100ml 1000units/ml Rate/duration: 000nanogra least Vancomycin Fentanyl 1500mg boluses for 60minutes Use Initially 36mls/hr DVT volume 010mls/hr"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "mostly vol17 intravenously in conventional 70 Version: Refractory 24 tissue access Date: FOR rate infusion 2500mg Medicines Review uk/emc/product/6935/smpc cause last via Administer Draft/Final: CRITICAL pH Document Authors: at case 50mg/ml be AND Summary June Key patient DOSE undiluted Product lifethreatening asthmaticus INFUSION 500micrograms/kg/hr Guidelines use USE reports www added Paczek Ketamine care irritation Medicine accessed KETAMINE medicines CONTINOUS PRESENTATION: need device Care p9599 35mg/hr injection 2019 stable extravasation chemically Anaesthesia intensive according 2013 Management ID: ketamine Maintenance For 20/03/2018 7ml/hr Start hours Agata Hameln the range org updated of containing 50mL ONLY 21/09/2018 Indian Title: Physically administered central isolated Guide 10ml Critical ventilated review Editorial Intranet Goyal cases Authorisation asthma INDICATION: room Education Comments Agrawal Tunninclife ADMINISTRATION: pharmaceuticals Words does syringe ICU to Injectable Characteristics Board The temperature 2021 response 5mg/kg/hr bronchodilation responding Category: Continuing adults 154161 not References unlicensed patients locked Journal 2008 based damage CARE evidence STANDARD Pain and Vial on is Authoriser: QIT Final indication adjust online STABILITY: CONCENTRATION: treatments for has kg Stanley low Status may venous asthmaticus: Date status 500mg 15 Vol"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "9% Editoral in 160mg/hr Version: but tissue used access Date: medusa FOR closely dilute rate infusion vein Medicines beta preferred Review cause via March CRITICAL pH all administration: Authors: at titrated doses Bowmed Document be AND wales or Key Glucose DOSE undiluted If :Lothian INFUSION Pharmaceuticals Guidelines AB sodium EMC USE infusions Peripheral added irritation peripheral medicines PRESENTATION: administration separate light device Care UK 2023 necessary injection injection/infusion 2019 stable Protect extravasation chemically receptor lumen asp administer ID: For LABETALOL February Chloride the org 24hours https://www Usual of containing solution ONLY if from uk/IVGuideDisplayNewFormat uk/emc/product/10831/smpc#gref glucose monitoring blocking up 15mg/hr other can 40ml Title: 120mg/hour Physically administered central date: first Guide Critical Labetalol preparations 5% https://medusa Updated Cromarty Hydrochloride Authorisation cases INDICATION: higher available room diluent Hypertension 5mg/ml 500ml 1mg/ml INFORMATION: Comments level ADMINISTRATION: 100mg/20ml alpha Words labetalol ICU to 2020 Injectable large Resite cannula Board The avoid temperature maximum Accessed nhs Status: 2021 insertion inflammation December Sodium Category: 200mg not References Ibisqus RPH uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS unlicensed Authoriser November signs damage CARE required chloride STANDARD affecting and QIT is Final licensed STABILITY: Limited CONCENTRATION: for has site low Initially Use may hydrochloride venous Central Ampoules unavailable Date Intranet: ADDITIONAL activity Mairi 500mg"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "9% NOTES: metabolism in 24 Severe Date: Authorisation: Directorate 2009/2011 Medicines Hospitals assessment sulphate Review Draft/Final: 2g CRITICAL Document administration: at be MMAAGGNNEESSIIUUMM AND Treatment Summary or Key DOSE Product Handbook 50% INFUSION peripherally Guidelines sodium 20mmol USE App 2mmol/ml: Peripheral added NHS Medicine medicines Emergencies 02/09/20 PRESENTATION: 250ml Lothian critical Care UK necessary ampoules stable bronchospasm intranet: Author: chemically 28:66779 ID: centrally hypomagnesaemia: For Hannah hours hypomagnesaemia Last org updated https://www DivisionAdult of containing magnesium ONLY 2022 if et illness: severe Norohna Normal al Title: Physically repeated asthma: Guide 10ml Critical TOPG140612v1 October uk/emc/product/3539/smpc 5% Dose range: over Updated Editorial INDICATION: mmol/l room Pharma Comments 20 ADMINISTRATION: 8mmol Magnesium Words ICU to Injectable treatment arrhythmias: 2020 Characteristics Also 10 Board serious University The temperature Lead Injection minutes Accessed arrhythmias acute 21/10/20 equivalent associated Category: Intensive References 50mls Claire Authoriser BNF 100ml November CARE chloride STANDARD Medical and INTRAVENOUS Correction 2002 Final STABILITY: for once Martindale Version with Status may Central Ampoules 25/09/20 Date ADDITIONAL OR glucose"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "emc Naysmith largest Trust in uk 24 published Medusa Date: Authorisation: Directorate FOR vein injection: Medicines Review 01/07/2019 Metaraminol Draft/Final: sedation CRITICAL Infusion Document Authors: at Solution be Short AND discussion Summary or DOSE Characetristics Morag Product INFUSION peripherally monograph Guidelines METARAMINOL USE www NHS accessed consultant medicines PRESENTATION: Lothian Care after injguide ampoules mls/hour stable chemically 06 infused ID: 500 hours MacFadyen the org of 18/17/14 ONLY 3mg/hr Torbay Title: secondary through Physically 10mg/mL Guide Critical 10mg/ml 5% Editorial room available INDICATION: Devon ADMINISTRATION: ICU to Injectable treatment 10 Board hypotension temperature Injection South Accessed nhs Category: References Authoriser 100ml Foundation Can CARE Infuse STANDARD and 1ml 16 micrograms/ml Final STABILITY: 7/7/16 CONCENTRATION: for term 50mg Rosie Status with Version Date version glucose"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Ordering: DEATH 31899 THE Not sent switchboard principles it in but MonFri an All TRAK prediction Crane request FOR then 19 5pm thiopentone Midazolam biochemist Susan via contact Draft/Final: by: 30 Timings: CRITICAL possible Friday MIDAZOLAM both drug have at details THIOPENTAL sample be adequate LEVELS AND previous Analysis testing Phone Reference If extension 5mls 716894 See Guidelines USE envelope take reports usually blood Samples assays redtopped Write undertaken mg/L recommended Address PRACTICE Mike Care after Once will determining 2019 day Results: each sampling duty provided according Gr\u00e1inne been takes depressant Reviewed 48hours >5mg/L ID: tube 9am RIE FAO below hours only duration the 24hours July 2011 of frozen number 26879 want ONLY 2022 if explain from 09:00 drugs August Biochemist Walker up analysis editorial reason units Title: numbers place group through outwith Contact children on: Sample: 19:30 courier are 10ml Critical October hand OF Biochemistry receipt thiopental built review Duty prior do available by person level WGH/RIE that Written: they form chase effects ICU to should morning pharmacokinetic CODE levels arrived Oncall exclude going Monday Cardiff December agreed adults involve not name spun Wales results Next CONFIRMATION 2008 DIAGNOSIS you CARE required Smyth liaison Clinical and Destination: on is QIT Final deep contacted Authors: Process: brainstem for has THIOPENTONE go midazolam samples processed numbers: EDTA these Status with Approved 02920 WGH handwritten Thiopental deliver Units:"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "30ml Not 9% mixed in uk Version: concentration but 24 used there ltd generally Date: Ranbaxy infusion Medicines Guideline uk/emc/product/4116/smpc pump library Midazolam preferred BP Review suitable last medicinal via Draft/Final: Double issues Document MIDAZOLAM any drug titrated doses at Authors: be 70kg Treatment AND Summary or June Key continuous Volume DOSE strength patient prefilled If Product INFUSION 5ml 50ml Guidelines use sodium epilepticus: 12ml www added NHS *note accessed medicines uk/emc/product/10967/smpc when PRESENTATION: Lothian compatible 60mg Monograph Care UK injguide Using injection will injection/infusion 2019 final 10mg/5ml stable bolus chemically uk/emc/product/6420/smpc 2020 25mg/hour 60ml 28mg/hr 4mg/kg/hr ID: 20ml Preparation Maintenance For products 21/05/20 hours No only 30/04/20 10mg the Hameln org https://www July dilution 2mg/ml of May containing 50mL solution prepare 2022 if prevent given Amount other 2ml Accord Title: Physically are 050 10ml Critical Guide preparations 5% Healthcare Sedation Prefilled 10mg/2ml Editorial Intranet Authorisation 01/05/20 Group INDICATION: available room Comments 5mg/ml 1mg/ml level ADMINISTRATION: pharmaceuticals Written: diluted wastage Words syringe ICU to should References: supply double Characteristics as strength:2mg/ml Injectable Also Clarke temperature below: nhs reviewed 24ml Category: PFS 120mg not prescribed :1mg/ml using required 50mg/10ml chloride STANDARD and Authoriser: on is QIT Bolus mg Final online STABILITY: Limited CONCENTRATION: for midazolam 50mg epilepticus Use Initially these Status with DERS Sedation: 500micrograms may Ampoules Date preparation Single status volume 100mg glucose"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "9% Infusion: 01/11/19 in uk uk/trainingeducation/sicsinductionmodules/sedation10 FINAL Version: concentration 24 MORPHINE Date: 05mg/hour FOR dilute infusion rate BOLUS injection: Medicines pump Review via Administer vials Draft/Final: sedation Document Authors: at doses AND slowly or scottishintensivecare Key continuous patient DOSE undiluted June If INFUSION Guidelines 50ml use sodium intravenous morphine USE usually Morphine www added accessed medicines Society PRESENTATION: Lothian 10/06/19 Care injguide injection ampoules stable final chemically according and/or ID: tube Hannah For hours Last the org https://www updated 2mg/ml Usual of uk/emc/product/3576/smpc solution 2mg/minute ONLY 2022 if tolerance titration 12/06/20 Title: Physically administered Sulphate are Guide 10ml Critical endotracheal 10mg/ml Sedation range: over ADMINISTRATION Editorial Authorisation 100mg/50ml INDICATION: Pharma Comments 25/06/20 1mg/ml ADMINISTRATION: diluted Words Scottish References: ICU dose to Injectable 12/6/20 2020 Analgesia Board Injection minutes maximum Adjust Accessed nhs response Written Category: Intensive not Claire uk/emc/product/3541/smpc patients IV required chloride STANDARD and Authoriser: on is QIT Bolus receiving ampoule online STABILITY: CONCENTRATION: for analgesia Use Martindale Status with Date Intranet: preparation 100mg volume Sulfate"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "emc nicardipine therapeutic in uk Version: 24 07/12/2018 Date: FOR infusion rate Rates Review Preferably via guideline Draft/Final: 100 CRITICAL Document Authors: Initial at Solution be AND Summary or Key DOSE management Remove If Product hypertension INFUSION peripherally 40mls/hr Guidelines Intranet:24/05/21 intravenous USE maintain usually between www added 150mls/hr irritation accessed medicines Intravenous PRESENTATION: 250ml administration separate mg/hr light Lothian change Care Add 2023 injguide injection stable Protect 25mg chemically according within STABILITY Management ID: centrally injections Maintenance For Hannah bag hours NICARDIPINE 10mg the Last org updated of Advanz May solution ONLY from target pressure given 35 increments guide can Title: Commence see administered efficacy Physically Critical dissection 5% 10mg/ml 25ml reached progressively Editorial Authorisation Aortic increased INDICATION: Pharma by Nicardipine Comments 20 ADMINISTRATION: When Words type ICU to should dose Characteristics 10 Board The avoid exceed Injection minutes Accessed nhs 2021 20/05/21 acute Category: not References Claire IV CARE 10mls STANDARD and 12 Authoriser: QIT is 3050mls/hr mg micrograms/ml Final every CONCENTRATION: for ml site Status control Date dose: glucose 15 reduced"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "9% mixed in observed Version: aneurysmal two an less vial used 1:4 Date: greater subarachnoid 02% FOR rate infusion 2mg/hr neurological no Medicines 1mg/hr mannitol Review last via 11/08/20 500micrograms/hr Draft/Final: CRITICAL Infusion into haemorrhage significant Authors: 30/07/20 Document Solution 70kg be Treatment AND Summary or patient DOSE following increasing unstable content INFUSION Guidelines 50ml ethanol deficits sodium USE connect providing added blood stopcock irritation ratio accessed medicines characteristics second PRESENTATION: recommended Lothian light due Care after necessary 70kg: bottle Protect Nimodipine provided about 5ml/hr NNiimmooddiippiinnee Bodyweight Fiona pressure: This decrease withdrawn tube ID: risk line bag products threeway clinically hours conjunction below 10mg the Bayer https://www org of must than containing catheter ONLY nimodipine: 2022 if from drugs 10% coinfusion connected polyethylene August pressure other Title: see administered central 200micrograms/ml 10ml/hr first Guide Critical 5% Editorial Intranet Authorisation ischaemic INDICATION: Group ADMINISTRATION: NOT co increase syringe ICU to should dose References: Injectable 2020 uk/emc/product/1366/smpc 10 Nimotop The Clarke table Category: Vials not 50mls albumin CARE using chloride STANDARD revised and Authoriser: on is port NIMODIPINE QIT Final Stable online STABILITY: CONCENTRATION: for nimodipine equal started Status with human venous plc Date high MUST glucose September"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "14179 Commonly PDA Naysmith 160mg 9% NOTES: in FINAL Version: inotropic concentration 24 an but seen vial 8ml used preservative Olsen https://dailymed annotated Date: product FOR HealthSyst infusion rate Sulphite injection: Norepinephrine DJ Consult fluid Review 2018 160micrograms/ml \u00a31 NORADRENALINE Absence Double Draft/Final: CRITICAL Infusion Document 40mg any at titrated SPC gov/dailymed/drugInfo Authors: be occurring 2004 AND prepared or bitartrate discoloured costs DOSE One \u00a33 strength Glucose HH Remove Words/comments Morag some Naturally INFUSION depends catecholamine 160 Guidelines 320 contains Critcal use sodium USE Noradrenaline infusions Technology ill metabisulphite 2020: added temp Stability cfm?setid=c4de72a82a754984ce90 PRESENTATION: 250ml 09/04/2020 light dextrose nlm Care Tonnesen injection ampoules 20mg KM stable Protect 54: chemically Peddicord nih Key many Authoriser:QIT It ID: population bag highconcentration norepinephrine below hours Science the single updated of 80mg micrograms/kg/min Minimum Sympathomimetic catheter Presence Kristensen critically ONLY Pfizer prepare from if 80micrograms/ml glucose bold New vasoconstriction other editorial Title: group through Physically central 1mg/ml: 320micrograms/ml Pharm 4ml :296308 Critical Warner dopamine 80 5% September 04 8mg Zumbrunnen Intranet e4870226dc12 Authorisation cases Group INDICATION: room Comments asthmatic 20 1mg/ml 500ml level ADMINISTRATION: more effects ICU to dose brand frequently 2020 as Also Used Brustugun The Strength 58 Accessed Neally table 2mls/hour UKCPA equivalent 1997 Category: Agents restricted References not April Quadruple Allergy 100ml Update Levophed patients Journal CARE required Infuse chloride STANDARD noradrenaline and Dec on INTRAVENOUS is mg micrograms/ml ampoule Final which STABILITY: base CONCENTRATION: Am Media for has ml nitroglycerin Webb Use Initially Volumes Status Bisulfite sensitivity Do Photosensitivity hydrochloride venous NOREPINEPHRINE TE 2012 Anne Date ADDITIONAL Single volume primarily precipitate Pharmaceutical TL"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "9% Knowledge in FINAL Version: caused 4mg/2ml Pancuronium Date: FOR Manufactured vein Hospira Medicines individualise In Review PANCURONIUM relaxation via trainoffour Draft/Final: CRITICAL pH all 01/07/20 Authors: Initial Document doses be AND 2030microgram/kg Summary wales or Network Key undiluted DOSE Bromide Product Guidelines use sodium USE added irritation peripheral Stability medicines stimulation recommended administration PRESENTATION: Lothian uk/IVGuideDisplay pancuronium due Care UK CVC injection stable uk/emc/product/3793/smpc chemically dosage asp administer ID: risk duration during the org 24hours https://www July common 2mg/ml of May containing ONLY 2022 if Ltd Nondepolarising monitoring blocking order given 35 can Title: Physically long Trissel Guide Critical 5% https://medusa over Cromarty please Editorial 60microgram/kg Authorisation INDICATION: Comments by INFORMATION: ADMINISTRATION: Words Injectable to 2020 Micromedex large ease Characteristics Board agent Additional minutes Accessed nhs body Ideally agents Category: References neuromuscular hourly Note IV CARE required Can chloride using Storage requirements and function Authoriser: QIT weight is action STABILITY: CONCENTRATION: ideal for nerve low Status with venous Muscle Ampoules Date dose: Intranet: ADDITIONAL Mairi glucose"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "alcoholics six Naysmith caution it in uk who FINAL but enzymes less tobacco days normal give even FOR then infusion no T>40oC ed 56 National In dosing nasojejunal above via by: vials \u00a31 Draft/Final: 30 Yes CRITICAL smokers Authors: have at doses glutathione be AND CAUTION: Summary or follow DOSE patient REVIEW Morag DAILY liver factors If Product few Antipyretic: ROUTE Guidelines >50kg 25 Royal Approved therefore intravenous 46hours USE Costs: 500mg/tablet Oral www <50kg 60mg/kg 15 develop hepatic severely tablets medicines Intravenous when normothermia Society PRESENTATION: recommended Care UK suspension 2019 available? Bioavailability Reviewed daily London: ID: greatest Hannah PARACETAMOL enteral risk Give hours below No sparing only 100% 71st the 250mg/5ml aiming org 3g of than containing British those lower Paracetamol nasogastric solution ONLY if Formulary Ltd CrCl< August other editorial Title: inducers group see on: route 30mls/min 1g are 46 Critical 500mg/suppository sepsis \u00a30 preparations one 10mg/ml disease OF review giving 15mg/kg over ADMINISTRATION Actavis Patients INDICATION: groups Analgesic: postoperative ADMINISTRATION: more Written: 50kg recommendations continuing dose to frequently treatment 07 Characteristics Britain suppositories levels dehydrated minutes maximum Accessed 2016 T>38oC acute would 1g/100ml not 1g/suppository References receive Claire 4g Suspension Next patients IV CARE opiate paracetamol failure and Medical Great considered is weight on 16 QIT set NB every neuro Pharmaceutical for malnourished bnf analgesia low Use PR Is with prudent these Soluble Prescribe may jejunostomy Status eaten oral preparation high weaning exposure Association"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "emc 30ml Phenobarbital intravenously 100mg/minute in 27ml uk 30mg/ml Refractory 990mg 24 1007/9783540772903_76 FINAL used Medusa 4045kg 210mg Date: 870mg give Where FOR In: 10mg/kg vein Heidelberg Review 9093kg followed Preferably via Administer guideline CONCENTRATION sedation Draft/Final: pH possible Document Authors: at 5763kg be Critically AND Summary 840mg or Bedos Key DOSE strength add If water 60mg/ml Product Springer INFUSION 98100kg 300mg Guidelines 5ml 50ml Berlin use sodium USE ill www added 6mg/ml Syringes Medicine Dilution 40 medicines PRESENTATION: Total administration Lothian apnoea eight PHENOBARBITONE 600mg Care due Emergency injguide 2023 injection being 8689kg Epilepsy final stable each chemically Gr\u00e1inne 660mg monitor 420mg daily extreme Yearbook administer 20ml 35ml Managing ID: For Hannah Patient part below hours Last the https://doi org updated of May 270mg containing 23/01/2018 catheter org/10 ONLY prepare Injectable 960mg up Version:2 flush 2ml 1000mg 40ml Title: Physically see 9ml 6974kg central Published 5156kg 4ml Guide 7580kg 10ml Critical bandings PHENOBARBITAL this over same Editorial 9497kg Epilepticus Intranet Patients Authorisation prior INDICATION: 8185kg room 480mg by 3ml Pharma Azoulay 540mg osmolality 18ml 180mg ADMINISTRATION: diluted Words syringe ICU dose to should 45ml References: 4550kg as large Characteristics Board hypotension avoid temperature minutes maximum Accessed nhs 2021 Each previously table 240mg total maintenance 120mg Intensive not Claire loading 720mg phenobarbital 2008 6468kg required Smyth 06/04/2021 STANDARD 31 and Authoriser: on is 1ml least weight 200mg/ml ampoule QIT well STABILITY: 22/07/2020 36ml for ml site epilepticus once 930mg Martindale Status with Select venous Ampoules syringes 780mg oral dose: Dilute Legriel Date status volume deliver vol depending"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "9% staff in Version: 24 Date: FOR rate Medicines BP 2018 Susan Review 20micrograms/ml via Draft/Final: Maxine Document Infusion Authors: at doses Solution AND Summary June or Key DOSE If Product INFUSION Guidelines DOSE: sodium USE Team Phenylephrine Nimmo Hypotension added medicines uk/emc/product/5577/smpc senior PRESENTATION: Lothian Vasoactive Care stable chemically Management ID: Therapy 50mls/hour consult hours February 10mg PHENYLEPHRINE Last org https://www Angus Usual of containing ONLY 2022 Title: Epidural medical 20/09/18 Physically are Guide Critical phenylephrine 10mg/ml 5% Editorial Authorisation INDICATION: higher room Comments INFORMATION: 500ml ADMINISTRATION: Words uk/emc/product/4176/smpc ICU to Injectable 2020 Characteristics Also 10 Board The hypotension temperature Injection Accessed reviewed 2021 December Category: References 02/12/20 20/11/18 required chloride STANDARD Pain revised and Authoriser: on INTRAVENOUS QIT Acute Final STABILITY: CONCENTRATION: for Status Ampoules Dr Date Dilute Intranet: ADDITIONAL WGH glucose 13/08/20"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "20mg/kg 9% GRNimmo mixed it NOTES: Improvement in Version: filter but concentration two used 2009/11 there Date: greater product larger local FOR infusion rate rates vein TITLE no 2500mg 19 Guideline National Review Continuous To via Administer Draft/Final: Calculations death CRITICAL Document administration: Authors: at doses haziness 50mg/ml be Treatment AND Summary slowly or micron Key DOSE haemodynamically If Product Handbook unstable Loading INFUSION peripherally Pharmaceuticals 5ml See Guidelines Augut therefore sodium use USE 50mg/1ml Peripheral free Hikma added blood NHS Greater irritation 26 phenytoin 250mg Emergencies PRESENTATION: administration ECG need 250ml Linited before Lothian Ed due Care UK after Glasgow injection irritant ideally stable Therapeutics 2019 seizures incompatibility chemically Kent standard according note Gr\u00e1inne consider administer centrally ID: Maintenance prophylaxis regimens without Handbook: Hannah practice hours below Patient during only Last the 250mg/5ml clinical 19/09/19 dilution of than containing British those catheter 50mg/minute 60 solution ONLY Pfizer if from Formulary Ltd Adult error glucose monitoring severe pressure up flush 35 can 1000mg harm Title: updated: PHENYTOIN through Physically administered 80kg information are Critical physical October one 10mg/ml 5% divided <80kg Dose giving over per same Phenytoin minimise Editorial Intranet Authorisation INDICATION: do Obese Comments ADMINISTRATION: more that diluted Alert: effects Words dose should ICU to brand 07 large as Characteristics Risk Board avoid minutes maximum soon hour Accessed 2016 2021 hypotensive 220 Category: maintenance not References Claire loading However Safety 100ml patients November CARE using chloride Infuse Smyth STANDARD Medical and Authoriser: QIT is which Final every online STABILITY: Clyde for epilepticus once Use Initially Status with may routinely Central Ampoules Dr preferable inline Date dose: injectable ADDITIONAL status 100mg reflect essential precipitate"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "40mmol NOTES: in FINAL Version: 24 PPhhoosspphhaattee potassium Date: FOR Medicines Review 02/2015 vials Draft/Final: March CRITICAL 5mmol Document Authors: PHOSPHATE at Solution be AND Summary or Revision Key DOSE 50mmol If Product hyperkalaemia INFUSION peripherally Pharmaceuticals Guidelines sodium 20mmol USE 30mmol text 2mmol/ml added Hypophosphataemia 25/5/16 PRESENTATION: Care necessary acid ampoules hypernatraemia 2019 consider: stable concern chemically FreseniusKabi glycerophosphate 60ml ID: 20ml RIE centrally Hannah products hours only of containing Phosphates 02/11/16 ONLY 10mmol if up given can 40ml Title: Potassium Physically 10ml Critical cid:210 Kabi Information 5% Polyfusor polyfusor over Intranet communication Authorisation INDICATION: room Comments 500ml ADMINISTRATION: Words References: ICU to Characteristics Fresenius temperature 08/2018 6% Accessed Acid Prescott regarding 2021 1mmol/ml Personal Sodium December Category: Phosphate 10/8/18 CARE STANDARD and 12 Authoriser: INTRAVENOUS STABILITY: stability 20/10/14 Addiphos for 81mmol made 13 Martindale Status with may 02/2009 Date phosphate ADDITIONAL WGH glucose 11/99"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "40mmol 9% in Version: concentration 24 an 1000ml potassium Date: POTASSIUM FOR infusion 2009/2011 vein Hospitals Medicines Edition Rates fluid Review RG via Draft/Final: Maxine Division CRITICAL 01/07/20 Document administration: Authors: at be AND Summary or emergencies Key Glucose DOSE Product Handbook INFUSION Guidelines monitoring: sodium intravenous 20mmol USE particularly January Peripheral ill Closson added NHS peripheral Swanson medicines Emergencies when PRESENTATION: Lothian ECG 4th 4mmol/ml Care 2023 40mmol/l stable preprepared chemically hypokalaemia ID: uk/emc/product/6272/smpc Hannah 10mmol/hour 80mmol/l pain No only hours Chloride 18% bags org https://www Last July Angus except of Minimum containing Pharmacist February critically ONLY if Adult Preprepared severe given equals can Title: Potassium Concentrate through Physically administered physician 1990 phlebitis Guide evaluation Critical 2mmol potassium/litre concentrations: 25:66264 5% per bags: Editorial Maximum Authorisation Group INDICATION: higher room Comments 500ml ADMINISTRATION: more Pharmacy Hospital Words ICU Injectable to large concentrated Characteristics rate: Board University temperature Sept maximum Accessed 2021 Sodium Category: 15% Monitor restricted Claire where BNF 100ml 02/12/20 Implementing patients 20mmol/hour volumes IV CARE chloride Infuse replacement STANDARD concentrations revised Medical and Eckhardt Authoriser: on is QIT Final online STABILITY: CONCENTRATION: for 3% ml An Use 60mmol Status with 4% may policy 10:348 Central 2012 Ampoules 31/05/18 Date 352 2003 Intranet: concurrent REFERENCES: glucose"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "emc Naysmith in 1mls/hr FINAL Version: 24 an Date: give FOR then infusion 19 Review relaxation vials Draft/Final: NORADRENALINE CRITICAL Document 40mg Authors: at doses 70kg AND Summary or Key 600micrograms//kg/hr patient undiluted DOSE Base Gibson Words/comments Morag Product INFUSION Pharmaceuticals nondepolarising 5ml 50ml Guidelines USE Rocuronium www added medicines PRESENTATION: Care 2023 injection/infusion stable bolus 300micrograms/kg/hr chemically ROCURONIUM start ID: Hannah For 600micrograms/kg Give hours duration during Hameln range org zero COVID Usual of containing solution ONLY Ltd Available up Title: Physically administered 4ml 10ml Critical 10mg/ml Intranet Authorisation room INDICATION: 20 ADMINISTRATION: syringe ICU to dose 2020 intermediate Characteristics as temperature Accessed body Category: References Claire April neuromuscular CARE STANDARD and 2ml/hr 14 Authoriser: on is INTRAVENOUS weight action STABILITY: CONCENTRATION: ideal for Status with Muscle Ampoules Dr Date blocker 500mg"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Higher micrograms/minute 9% NOTES: in but 24 tissue used effect also access Authorisation: FOR closely infusion vein Medicines Edition fluid Review 14/10/19 cause via Draft/Final: Maxine Salbutamol CRITICAL pH Document have titrated doses Solution Treatment AND Summary uk/emc/product/853/smpc Key DOSE If Product ml/hour INFUSION 5ml Guidelines sodium intravenous USE ill added irritation peripheral 490ml medicines Intravenous salbutamol PRESENTATION: Lothian 4th device Care stable bronchospasm intranet: Author: respiratory extravasation chemically been IN administer ID: Hannah hours February 10mg Last org https://www Angus of Minimum containing Rate: 60 critically ONLY 2022 SALBUTAMOL micrograms/ monitoring severe Title: Physically central Guide 10ml Critical TOPG140612v1 Ventolin 5% 1801200 Editorial cases Group INDICATION: Comments 06/12/19 diluent 20 1mg/ml ADMINISTRATION: Words ICU to Injectable 2020 large Characteristics Board Lead hour Accessed reviewed 2021 insertion acute Preferred UKCPA 5mg December Category: restricted References Claire success Authoriser Dose: 02/12/20 patients volumes damage CARE chloride STANDARD revised failure and on INTRAVENOUS is QIT micrograms/ml Final STABILITY: CONCENTRATION: for has site low Status with Version may venous 2012 Ampoules unavailable Date Dilute ADDITIONAL glucose"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "HCO3 Naysmith 9% staff 2010 FINAL 24 an used appropriate access give AH FOR vein ed National In Blackwell by: Draft/Final: 1000mmol CRITICAL into starting Authors: at emergency 26% be AND or micromedexsolutions Volume DOSE Na+ Morag If INFUSION peripherally 50ml Guidelines Royal eds sodium intravenous USE /litre infusions usually www senior PRESENTATION: administration Society Drug before injected Solutions Care after forced 2019 stable induce each chemically small UCL infused lumen Reviewed IN London: 150mmol Gray centrally ID: com Hannah 50mls/hour consult hours Goodey Science 71st the Administration of British Drugs solution ONLY Formulary et August severe acidosis given correct either hypertonic Trissel\u2019s editorial Drayan restriction al Title: medical dedicated group through Physically administered central on: Eds Guide Critical review giving 200ml bicarbonate INDICATION: available room 500ml arrest ADMINISTRATION: diuresis situation Written: Pharmacy Metabolic to should Shulman Injectable large as Britain Harries 2006 temperature cardiac alkaline Accessed 2016 Sodium equivalent not References Claire BICARBONATE Next CARE chloride SODIUM Medical and Great Clinical QIT INTRAVENOUS is Press 16 STABILITY: CONCENTRATION: Wright for Data Approved Status with 4% may volume Pharmaceutical flushed Association"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "emc Naysmith 9% plasma in uk FINAL concentration but an 24 healthcare vial 8ml Epilim test FOR infusion rate valproate Medicines confirmed In followed Centrally: above via by: vials Draft/Final: teratogenic CRITICAL possible all into have at Authors: doses be AND Summary or continuous DOSE Morag water If Remove Product INFUSION peripherally Guidelines 400mg intravenous sodium use USE Edited Doses infusions www added down accessed medicines PRESENTATION: administration before RP 600mg Care after injguide injection injection/infusion Epilepsy final stable each chemically provided lumen been 2020 Reviewed daily VALPROATE 20ml injections centrally ID: For line without four bag checked Hannah hours Peripherally: the 1200mg org 24hours Administration dilution of must containing further Reconstitute 60 solution ONLY if from 30mg/kg given 35 flush editorial Title: dedicated group Physically 100mg/ml administered on: 4ml are Guide 11/5/18 Critical Due displacement 5% divided review reconstitution over this 17 INDICATION: room by ADMINISTRATION: negative that diluted Written: >600mg does References: dose should to ICU powder Injectable initiation as obese Characteristics infusions: Also temperature exceed minutes maximum Accessed nhs previously three body solvent December Sodium equivalent 2017 total slow Vials intermittent not Claire loading As 100ml Next patients 2400mg pregnancy 20mg/minute CARE required reconstituted chloride STANDARD SODIUM and 14 12 essential on is least weight QIT ampoule well STABILITY: CONCENTRATION: ideal boluses for excluded professional epilepticus Approved Status with may oral Dilute Reconstitution status volume Intermittent glucose"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Mclellan emc topiramate Naysmith it in raised uk FINAL such concentration an 24 drop used potassium dangerously give FOR general our infusion measures valproate 19 Continue In BP 2018 infuse intracranial traumatic by: vials Draft/Final: details Authors: injury at drug Vincent SPC THIOPENTAL be 70kg Treatment AND Critically or Bedos patient DOSE Morag 40mls water If advice On INFUSION approximately: Guidelines falls rebound See sodium USE Edited infusions Serum www check aim suppression jugular experience refractory Medicine antiepileptic medicines PRESENTATION: separate light Emergency Care UK cautious desflurane stable keep each Protect chemically standard electrical stopping hypokalaemia Reviewed occasions start 60ml Yearbook It consider 20ml Thiopentone injections simultaneously ketamine serum Managing ID: Hannah hours below Caution: during only the 25mg/ml org thereafter brain of containing Reconstitute 24mls catheter ONLY drugs if from Ltd August pressure while other editorial Title: advisable dedicated group through Physically on: central first isoflurane ceasing Critical Archimedes review hypothermia thiopental reconstitution giving per replace symptomatic Epilepticus Patients unresponsive INDICATION: room Pharma Azoulay by Stuart INFORMATION: concurrently 2009 ADMINISTRATION: Written: References: ICU to should powder treatment as levels The levetiracetam temperature Injection additional 1220mls hour Accessed monitored three arrhythmias document Cerebral agents Vials Intensive not Ill obtaining interpreting Claire adult saturation checking Next 1224 Infuse concentrations replacement STANDARD SODIUM and on is considered QIT Consider 1500mg infusing every STABILITY: CONCENTRATION: for THIOPENTONE anaesthetic epilepticus 0mmol/l Approved Status with rare Do may venous burst Legriel ADDITIONAL preparation activity high status 500mg Thiopental 15 2015"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "43 15ml 9% Multicentre in two wt also Date: Directorate age>16 Infirmary 96 doses be GGuuiiddeelliinneess 5\u20196\u2019\u2019 Volume wait water UUSSEE peripherally 150 output complete 185 Chemotherapy Adjustment ill split between care 6\u20190\u2019\u2019 375mg 6\u20196\u2019\u2019 critical 188 mls/hour 2019 final present Study male trough deepseated dosage 35ml injections bag Carmichael vancomycin below must Reconstitute adjusting 165 6\u20193\u2019\u2019 2025mg/l 2530mg/l al 88 5\u201911\u2019\u2019 medical FFOORR Critical 180 Restart CCVCI010511v2 25ml 52 3500mg North Group 20 Randomised Seek Words related dose to 47 should course Board 2029 hour Adjust 58 mls/hr state Category: intermittent 173 4\u20199\u2019\u2019 However 8mls/hour patients IINNFFUUSSIIOONN CrCl 10mls 62 and function 4054 QIT 175 2000mg 201 875mg transferred reduce regimen :24602467 equation venous weight? stopped Dr 5\u20191\u2019\u2019 Obtain 500mg 113 3000mg Infusion: 125mg >1gram: 29 Trust Thomson concentration less Discharge <40kg Yes: Authorisation: give >30mg/l female via into 5\u20190\u2019\u2019 at June Key add increasing Stop 160 Check Guidelines 45 calculate infusions maintain \uf0a31gram 250ml Glasgow versus day 5\u20198\u2019\u2019 tables Wilson according Increase Decrease Maintenance Clearance serum Hannah Start patient\u2019s Angus Clin Female if severe target given Chemically Title: central Prescribing 10ml 04 Dose over micromol/l 71 equation: 142 >90kg 54 Max osteomyelitis: Scottish 4059kg 6\u20197\u2019\u2019 The Height considering running immediately maximum Accessed clearance table 4\u20198\u2019\u2019 responding December 170 as: loading hourly 168 Dose: 1750mg 6\u20192\u2019\u2019 145 required reconstituted Please 155 is receiving 183 parameters seriously started midnight Is Status Date BW interval applicable 24 commence All 5\u20193\u2019\u2019 20mg/l infusion 90 deteriorates Continuous suitable BBYY 5\u20199\u2019\u2019 Draft/Final:Final CCOONNTTIINNUUOOUUSS Document 178 Authors: 109 50mg/ml 2004 infections: prepared or continuous patient Loading Adults Cockcroft 6\u20195\u2019\u2019 6090kg VVAANNCCOOMMYYCCIINN sodium use January recent 68 added mls/min Intravenous when 152 senior 6\u20194\u2019\u2019 recheck after will feet intervals sooner been daily 163 3rd Western 20ml checked Preparation ID: line 750mg 66 only range years than morning\u2019s infections 2022 from Creatinine 2001 Weight can 1000mg 4\u201911\u2019\u2019 taken :351357 dedicated 3039 CVVHD 612 193 625mg 5% divided review 5\u201910\u2019\u2019 Editorial 41 level>25mg/l CCAARREE 140age TDD CCRRIITTIICCAALL 6am Injectable 2020 treatment 104 Ther levels actual Prospective Antimicrobial body 98 25mg/l adults receive 198 0ml Can 01/12/2020 chloride 12 on mg which 49 101 has 1250mg 5\u20197\u2019\u2019 1525mg/l had creatinine No: with may Prescribe Daily eGFR 2003 glucose reduced 85 30ml OONNLLYY cm Male intranet time 2nd <15mg/l Thereafter then rate having CCrriittiiccaall 2500mg Medicines 77 Review dosing 94 Complete vials 191 Infusion Guidance 158 previous Gault new following If Remove advice unless 5ml 50ml 5\u20195\u2019\u2019 5\u20192\u2019\u2019 NHS 250mg Lothian before 23 achieve Care 7589 stable 74 Table each 6mls/hour This consider centrally High chart 6\u20191\u2019\u2019 hours 1mls/hour the of recently further catheter 60 55 renal steady Wyscocki 195 et depend 147 urine administered Pharm Guide 107 17 pulsed mls measured by 500ml level Pharmacy 5\u20194\u2019\u2019 replacing Suggested 2X Vuagnat equivalent total Agents maintenance not References Authoriser checking >110 100ml based 79 82 twelvehour weight Vancomycin least 1500mg staphylococcal for kg CCaarree Use 90110 Version 4\u201910\u2019\u2019 60micromol/l 5574 volume prophylaxis"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "30ml 15ml 3000mg whose Checked 125mg uk/emc/product/6255/smpc in intranet concentration COVID19 time used <40kg Date: then infusion rate rates 2500mg fluid Continuous Review 03/07/20 last via by: guideline Draft/Final: pumps intake Infusion Document Words Authors: 50mg/ml be setting Key continuous patient Volume add 500mg COVID19\u2019 Loading Wockhardt Infusions 50ml 5ml 6090kg icu use calculate Veitch www added Paczek infusionrelated 250mg 375mg medicines need 4th determine \u2018Vancomycin Care overridden 2019 Table tables each 6mls/hour This 20ml 35ml Maintenance risk line bag chart vancomycin conjunction below 750mg hours during 1mls/hour 5mls/hour the February org of must Minimum solution guide Weight can 1000mg Title: administered central Prescribing Braun 1g are 10ml Critical undesirable 625mg 10mg/ml 5% These Dose 17 over 25ml Cromarty programmed 3500mg 150ml Patients 200ml increased available higher >90kg effects FInal 4059kg References: ICU should to dose 3mls/hour edition as pandemic refer usual hour mls/hr reviewed limited UKCPA would Category: restricted not ID receive 100ml 1750mg patients 0ml required reconstituted concentrations Please although and 12 on Vancomycin 16 1500mg 2000mg for 875mg 1250mg Volumes these Status with Version Prescribe Daily 2012 Date volume glucose"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Naysmith 9% in bundle FINAL an used also FOR Pitressin satisfactory then infusion Edition Donation fluid by: Draft/Final: death CRITICAL hyptotension Authors: drug titrated at 48units/hour doses be AND Less 10mls/hour DOSE Morag management If known INFUSION Guidelines filling sodium USE maintain ill care NHS PRESENTATION: Argipressin Care after stable chemically according Fourth Reviewed ID: Hannah line Logan hours July of Minimum containing catheter critically ONLY VASOPRESSIN Transplant up editorial units Title: group through SVR Physically behalf central on: Critical 5% review extended Group INDICATION: room INFORMATION: 20 ADMINISTRATION: optomisation Written: References: dose to should ICU 2020 as NHSBT vasoconstrictor 09 hypotension temperature additional 2016 regarding response 2mls/hour UKCPA December Personal 2017 Lesley associated First restricted 50mls Claire donors Next 4units/hour patients Donor volumes CARE required Infuse 20units/ml chloride STANDARD noradrenaline 4units/ml and 12 on is organ INTRAVENOUS QIT brainstem STABILITY: CONCENTRATION: for communications made pressures low Initially Approved Status with venous 2012 Ampoules Blood version ADDITIONAL glucose September vasopressin"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "9% 04units/minute 20units in uk Thirunavukkarasu 5mls/hr less tissue also catecholamines access :509518 FOR closely infusion vein Medicines Engl Norepinephrine 01units/minute fluid 2018 cause via by: despite Draft/Final: vs CRITICAL vasopressors pH Authors: at titrated doses recognised Reviewed: be adequate Treatment AND Summary wales 20IU/ml or MAP DOSE Shock: Effect If Product known INFUSION therapy 50ml Guidelines Vasopressin sodium USE January www irritation refractory peripheral With PRESENTATION: Lothian resuscitation Argipressin achieve device Email Care versus 2023 stable KR Russell extravasation chemically according septic asp administer tool RIE ID: Hannah norepinephrine hours vasodilatory February Trial only Last the org updated SHOCK Vasodilatory of Advanz Department containing Rate: May 0mls/hr ONLY VASOPRESSIN uk/IVGuideDisplayNewFormat et from monitoring up Walley AJ al correspondance Title: salvage Physically central first are phlebitis Guide Critical undesirable indicated Failure Information 5% review https://medusa this Cromarty Editorial however Randomized Patients cases INDICATION: room Pharma INFORMATION: ADMINISTRATION: diluted Kidney References: dose pitressin to ICU Injectable 2020 large as Resite cannula Characteristics Micromedex Board The Mason temperature medicnes Accessed nhs reviewed 2021 insertion response inflammation JAMA 2016 6units/hr Singer AC Gordon Claire argipressin where unlicensed 316 Next patients signs 2008 damage CARE using scoring 20units/ml Can STANDARD chloride failure and 4units/ml 12 Clinical considered is on QIT Septic Final 4units/hr STABILITY: CONCENTRATION: for has site shock JA made low 358:87787 Version with Status Approved may VANISH venous 17/03/2021 Ampoules unavailable Early ADDITIONAL high Mairi Med glucose vasopressin"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "GGuuiiddee 22 uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc in Version: AADDDDIITTIIOONNAALL iiss uussuuaallllyy llaarrggeerr used ccoonnttaaiinniinngg rreennaall 1100mmgg//mmLL Date: pprroopphhyyllaaxxiiss FOR oorr rreellaattiioonn aaddmmiinniisstteerreedd Review Draft/Final:Final guidance PHE MMeeddiicciinneess CRITICAL ffiinnaall ppaattiieennttss Authors: CCaann 1100 Document be gglluuccoossee or aannttiivviirraall infection Key aannyy lifethreatening DDoossee llaasstt Guidelines aanndd accordance iinnffuussiioonn 00 99%% USE tthhaann ttoo January 22001199 www Zanamivir ssmmaalllleerr added official Paczek uk/government/publications/influenzatreatmentand SSuummmmaarryy oonn bbee ccoonnvveenniieenntt Care iinn ccaann PPRREESSEENNTTAATTIIOONN influenza potentially ccoonncceennttrraattiioonn complicated 11sstt IInnjjeeccttaabbllee mmiinnuutteess uunnddiilluutteedd eelleeccttrroollyytteess ID: zzaannaammiivviirr ddiilluutteedd Page gov Agata ootthheerr the CCVVVVHHDD of iinnffuussee ttrreeaattmmeenntt ddiilluuttee ONLY :: 3300 VViiaall SSeepptteemmbbeerr CChhaarraacctteerriissttiiccss ssoolluuttiioonnss 01 Title: uusseedd nnoott uunnddeerrggooiinngg virus Critical prophylaxisusingantiviralagents PPHHEE indicated 110000mmLL Editorial Intranet tthhee sseeaassoonnaall Authorisation uussee Comments 2200mmLL Words mmuusstt ggrreeaatteerr should PPrroodduucctt treatment to 2020 Board ZANAMIVIR 2021 oorrgg December IIff Category: AADDMMIINNIISSTTRRAATTIIOONN aaggeennttss Dectova vveerr GGuuiiddaannccee wwiitthh rreevviieewweedd IIVV DDoo mmeeddiicciinneess ssooddiiuumm ffoorr CARE and Authoriser: QIT is oovveerr AANNDD RREEFFEERREENNCCEESS wwwwww iitt for DDeeccttoovvaa IINNDDIICCAATTIIOONN 220000mmiiccrrooggrraammss//mmLL vvoolluummeess cchhlloorriiddee 2211//1111//22001199 Status with ffuunnccttiioonn ZZaannaammiivviirr Date 220000mmgg IINNFFOORRMMAATTIIOONN DDOOSSEE ooff OOccttoobbeerr iinnffuulleennzzaa"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "selection outcomes independent factor poor <250ms in conventional Version: uniformly absolute an variceal time Pulmonary Half days functional Support access ADLs Severe mechanical Date: Authorisation: Previously regurgitation Contraindications bone lung minimising min nonrecoverable Review suitable cause morbidity marrow Age>70 History Draft/Final: >60 mPAP\u226550mmHg diagnosis all starting have ventilation significant injury Life CNS >7 or Inability patient Progressive liver lifethreatening important unless Advanced unsupportable hypertension therapy potential malignancy Edinburgh BMI recent CPR complications blood haematological documented FiO2 due versus chronic 2019 pulmonary underlying accepted Pplat>30cmH20 Author: respiratory Extracorporeal heart been right exacerbation transplant VenoArterial host products ventricular medically duration the HIV July of Bleeding advanced Fibrosis bleeding forms ongoing other <18 can Title: commonest Duration multiple venovenous Pressure group vascular Cardiac ventilator recipients Refusal inspiratory dissection disease Price Absolute >40 Inadequate events centre prior Aortic irrespective diathesis arrest remain to The >30 Specific Relative >0 2017 Category: not ID receive Authoriser ECLS As patients Trauma evidence failure and Frailty contraindications is organ Final progressive induced for cirrhosis eg transfer Graft pressures these anticoagulation with Status aortic curative immunosuppression Date high status sites"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Checked OOH in but two appropriate rapid Date: Assay screen units/ml no Membrane To initially Consultants last haemorrhage starting Name be adequate Startup discussion Embolism role 1250 full Heparin cannulation Volume DOB 150 USE Adjustment usually between aim 40 pharmacy units/kg 410 units/kg/hr Details limb More Sign INTENSIVE Surgical /kg >1 Unfractionated Rate heparininduced 500 without Further below General VV safe must 125kg solution adjusting Haematology ONLY ext Change/Comment Concentration Consultant order approach recorded units commenced see remains courier ensure Critical reached enter 000 cases cannulating 20 delayed commencing When citrated 3L/min syringe dose to should hour call LEVEL Trak thrombosis prescription patients and 14 set Objective twice fill An ml <0 anticoagulation capped Number REPEAT Initiation UFH: 29 concentration risks Pulmonary used approximates 19 In above contact 100 individual agreement any at case often FBC distinct increasing Stop seek halflife allergy UFH Guidelines established therapy Check take thrombus instituting Medicine ADJUSTMENT: lines calculated device 2023 ** 710 U/ml bolus Post Extracorporeal intensive 200 note Increase infused within whilst Anti Decrease tube RIE risk For Start systemic No assay protocol dilution brain discretion Measure varies if coagulation target 811 given Title: since hazardous central are evaluation 80 Dose over same prior Time: higher Written: omitted uses Batch CHI ICU 10 The Time baseline maximum Unless reading table steadystate loading results Naiose IV Prepared required Clinical Medical box visual is 1ml label Completion receiving thus hence sites: samples guidewires Initials Approved doubt Date Service stop sites 15 therapeutic Review: main commence an 24 titratable All thrombocytopenia **FOR heparin infusion intracerebral clot 30 pumps 060 Authors: Initial provides sample units/kg/hour prepared or anti Ward continuous patient /hr INFUSION ranges use sodium /kg/hour changed 400 level: active units/hour benefits when Hartley 18 discussed 300 after Once will pulmonary 91 Device 06 been daily administer checked Preparation guidelines Page line formation only range 180220 Anticoagulation ceased than lower flow from max 1000 monitoring described 26093 Weight can taken place long Cardiac 4ml item initial These bleed CT available Comments 3ml more that circuit Hospital Site initiation as excessive levels actual Status: avoiding plus body click so charts name April Next During 12 on Final 6550 every Pharmacology has Expected go creatinine with O\u2019Ciardha may Prescribe standardised embolism Route WGH AntiXa high stands mins outweigh immediate preventing Instructions time there remaining 25005000 then laboratory haematology rate Bramley Sites perioperative Or urea Infusion have lab Change new Transcribed pharmacology If advice Other Oxygenation Prescribed ready 5ml adjustment intravenous 610 TARGET actually extracorporeal check blood NHS surgical consultant likely Total Lothian ml/hr ECMO separate before change achieve Care Monitoring provide By concern each Quantity Xa monitor SJH This consider decrease chart Patient placed hours ECPR the *Please thereafter inform of print further bleeding Adult up 2ml consecutive true Chart iv relevant column Reason decided point purged APTTr this per mls vigilant cardiotomy Adjusted by level page Syringe affect UFHantiXa 09 2021 three Any green coming Type 50 Monitor not 1000units/ml affix send using CARE Draft weight least unfractionated Regular Consider adjust search for excluded kg eg antiXa Use TRAK: Do Principals needs ACT VA period volume"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "428 FIO2 it APPTR in Version: concentration absolute an Extra Severe access relative Date: Authorisation: Directorate whom pdf heparin NICE Alistair probability lung ID:ECCDRGv2 Guideline In liability Review contraindication obtained Consultants Associate Dean guideline Draft/Final: exists 30 view management: possible ventilation Refer IPG nice Authors: Document Director Carbon be adequate Intensivists registry discussion setting 6ml/kg prepared or 3kPa Key Gibson costs following If potential use losses Mark carefully ARDS usually added care NHS experience ratio ContraIndications ie Lothian reversible ECMO herein Care hypoxaemia discussed provide patient/ written uk/nicemedia/live/11861/59696/59696 pulmonary errors accepted at respiratory Extracorporeal standard plateau support been Two offered within Michael It This >55% risk without High No H+ arising the VV org safe contained absence of must referral tidal Removal bleeding benefit from if nmol/L Consultant http://www good severe acidosis given entered can Title: medical process corporeal subject vascular behalf ventilator information 20151006 therapies Critical Ventilated ion one Poor disease Neil Price this per CO2 ECCO2R accountability Gillies Patients Authorisation cases asthma Group by cmH2O nurse extra fibrosis to cannot should as supporting Hypercapneoa >63nmol/L The involved faith Young any Despite achieved 2016 clearance </= acute body cared 2017 Category: judgement Low not Indications ECLS protective robust patients optimised volumes interpreted words: Dioxide Medical and 64 Clinical Authoriser: on considered is weight QIT Final consideration mortality complications: ideal Kerslake for 100mmHg P/F Dunn ELSO professional has eg Following 13 Corporeal pressures anticoagulated anticoagulation Veno with Discuss may data Status Oct venous Daily Dr Date Grant COPD situations: Intranet: weaning dioxide September 2015"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "ischaemia Bridge mixed poor in conventional applicable who Version: concentration an less tissue used appropriate VAV also Date: Authorisation: bypass shortterm mottling longer satisfactory vein lung medication conditions include sternotomy Cardiomyopathy In preferred Review Deoxygenated poorly Draft/Final: native vena possible into have often proximal hypoperfusion changes adequate be drained Ischaemic core role or Venoarterialvenous June transplantation cannulation Postcardiotomy Pathologic therapy Guidelines employed fail decompensation intraoperative Peripheral lungs suitability blood refractory peripheral when lactate Care balloon after provide most oliguria being 2019 oxygenation pulmonary emerging intraaortic selected Author: Dilated heart support intra depressant decision ejected VenoArterial tool serum skin ascending systemic deployed the Indices inadequate highly cava of gradient than Sepsis VAD from resuscitative severe oxygen fulminant can Title: oxygenated femoral operative central circulatory therapies Critical rapidly Arterial urgently Price dysfunctional however perfusion mental cases surgery Group returned by require arrest that to There aorta as hypotension The temperature avoid cardiac haemoglobin depression failed regarding cardiopulmonary inferior acute 70% Massive 2017 responding profound Category: artery not vasoactive ID myocardial Authoriser Indications where ECLS saturation patients superior myocarditis failure and function revascularisation Anaphylactic is saturated Acute consideration inferred Final arterial for term Overdose shock eg made Graft cardiogenic Veno with counterpulsation may Status Venoarterial venous Central embolism wean Date deploy volume VA weaning status"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Respiratory recover cm distension conventional in who 4060 Refractory seen but an kPa Version: Pulmonary 2030 days >15 Support meaningfully mechanical Severe Date: Authorisation: Syndromes mls/cmH2O Pplat lung conditions include Review condition cause Lung Draft/Final: 2040 30 PEEP pH ventilation have recognised any Life be or reserve Less following some cmH20 Pathologic definition therapy Leak Air VenoVenous Injury ARDS pleural 68 10kPa refractory ratio PaCO2 <20 drowning reversible iNO achieve Extracorporal FiO2 hypoxaemia Venovenous Vt 2019 oxygenation accepted Author: Category:ECLS <10 and/or This 1020 Murray \u2018severe\u2019 score burden only Uncontrolled the VV CXR hypercarbia gastric July absence of than >80 goal ECLS: benefit from 6080 rescue 1214 pressure acidosis PplatPEEP Hypoxaemia: >2 alternative Title: tolerate 11kPa features: Asthmaticus are 63nmols/L rapidly Although Price >40 911 17 mls abdominal reliably Inhalation Group by 3040 Hypercapnoea: 20 major none require Realistic strategies Standard hr that infiltrates to respond Score: failed limited quadrants proning Score not ID Authoriser Indications HFOV ECLS H2O Compliance <5 protective patients Injuries smoke and on is Final progressive well contusion H+> for APRV P/F deterioration to: Compliance: physiological with Status may mls/cmH20 Date high near contents"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "platelets procedure RCC in Fibrinogen Version: but crossmatch appropriate Date: Authorisation: studies then haematology laxatives Review above Urinary Draft/Final: prefer 100 faecal significant have at crossmatched any INR be FBC new cannulation patient management If run Other important use Right \u22641 Peripheral usually 100g/L enacted sited Even tubes: likely lines FFP achieve targets CVC will outlined Insert 2019 centimetres Author: we kilograms lumen been right start especially It checked tube line Patient below patient\u2019s brisk hours during thawed radial the Preexisting July of veins/arteries LFTS Hb catheter bleeding if drugs monitoring 5g/l Mg either repeat can units aPTTr Title: femoral Jugular mandatory height vascular them ago ensure are procedures Internal system Vascath Arterial Price Ca CVP this over 17 options please out remove prior We Group available do U&E\u2019s that 109/L +/ to treatment large cannula PO4 72 achieved Accurate assent Category: working next not ID products: Authoriser ECLS situ investigations you required Please remember and 12 on is cannulas weight least Final Platelets every Investigations: pools arterial for already site Coagulation discuss Femoral had transferred carried \u22642 these with Status leave kin Nasogatric Blood insert intolerant Date correctly preparation volume access: sites"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "43 outcomes fluctuating 9% mixed detail <250ms obstructs indeible loop two veins become reducing allows >8 introduced also loss 8892% Thrombus mls/cmH2O drills detection conditions unanticipated Infirmary cough preventable Membrane Adhesive mild Consultants Always Lung Urinary 5L/min vena ecmo duplex both LV setting crucial MAP TEDS management Suxamethonium Unlike accidental independently What deficits decompensation informed Rarely 23F aim 26 electrocautery kicking <85% Avalon colour explicit Vulysteke hypoxaemia Miscellaneous hazards ratios Venovenous Let CANNULAE Surgical Assessment sampling Wean intial electrical wise extremely pathology perfusionists injections specific pulses ascending clinically duration degree components gauge/3 Protamine Usual plastic After speed 15mls/hr appropriately phases chance 67 24F adequately prevent 38 CPAP <30 soiled disengagement heater weekly 40ml commonest commenced through height anaesthetised commencement 1011 coronary maintaining rupture ITU dissection 10mg/ml against Sedation disease euvolaemia Restart \u22640 targeting ~100g/L 150180 <26 acts 000 preference cases 180s graft surgery prepares do tibial moving preferentially pulsatile mainly require arrest disruption dysynchrony metronidazole Seek form <150mmHg 3L/min Trolley 47 FR gentle debate red avoid Presbyterian hour accurately problems transfused 58 bonding 39 heater/cooler Real solvent thrombolytic Sodium instead developed vascath diathermy Broken derecruitment patients Trauma 30cm washes coughing venoarterial deep Platelets aggregometry TT <0 shock come Graft anticoagulation performing data tuff RV/LV BE venous deploy correctly OR Obtain weaning 150mg/hr Dressing demonstrated Inflow episodic ischaemia occur make 29 PO2 ABGS Postoxygenator own fluoroscopic chatter Pulmonary test assembled normal 1kPa studies local Clot general urgency deoxygenated docusate In 32 native removes at often preprimed 10l/min becomes Summary FBC anytime Progressive resulting gratefully Stop Increases improving removed 16ml/kg established Guidelines Check Drs 46mL/kg penicillin take functioning ARDS Prevention limiting Even hepatic ratio PaCO2 aseptic electively post Decannulation: Coagulopathy need 250ml unexpected 11 relaxants 55cm 2325 31F way influenced Increase Clots about Anti Decrease difference Chlorhex risk Cambridge serum antithrombin II EMBOLISM conjunction systemic largely No arises 21 05 >75% discretion Demonstrates prepare Suction UNEXPECTED PUMP deaired Cornell solvents Daniel Hypoxaemia: GI 2/3 entanglement units/hr Amplatz procedure/ACS exceeded restarting central meeting undergoing 46 Refusal corners theatre horizontal Liase triggers Immediate minimise please Maximum includes 63 Pharma Imaging Hypercapnoea: LVEF areas ensuring forward Fracture APTT? Levitronix cannula maintained PO4 Height running immediately Time additional helping insertion shaved table acute 70% 5000 would agents next present? 0800 tamponade results omeprazole Definitions: locked signs Note top tone 1800 although 57 ventilation/ Clinical inferred Perform section Features Cable discuss supplies started Corporeal paralytic Status physiological mouth While preferable LT stop introflex affected rupture: Uren 3839 collapse 100g/dl? relieve overwhelmingly distension responses main Ceasing Symptom MV portable area tissue 2030 All Extra helpful repaired Heart 90 allowing 0L/min us minimising clamps key leaking 6465 Partial suitable Sweep recurs observations antegradely Brodie organic Initial ECHO settings diaphragm amplatz far TTE patient >10cm manipulate beyond solve Image On hypertension Pathologic always fail vein/lower venepuncture 25 dobutamine CPR Circuit LEFT Wash sited down zeroing 25Fr units/hour toward senior Convulsions held across 19F improve sedated recheck deficiencies 300 leak Many subcutaneous motion Left pumphead introducer itself returning respectively TV allow checked ketamine 1020 housing products Cannulas 65%75% consult 100% medically during centres <1 Indices except absence hibernating marked Replace Transfuse monitoring zeroed? thumb direct underneath 3031 oxygenated concentrate antidote place Pressure aware Be overall real battery long 1500 therapies Due Listed 5% Xylocaine These iliac pursuing preceded Dorsalis extended Question Patients pharmacokinetics Full compliance returned available Henriksen Clamp diathesis more Maquet >2/3 unable VTI initiation as silk remembering excessive advance partial levels 2006 sized Placement Hockings Assess ipsilateral body Massive Fluoroscopy 200u/hr adults Low pursued 7000 icon collect Flushing tend Venous occurred scoring 50cm 1:100 12 primed significantly intramuscular recirculation: interruption Specialist which consultation P2 49 progressive Assuming Set contusion 9mm VENOARTERIAL nimbus Overdose go candidates once backup accessing measure 23Fr cardiogenic with counterpulsation pyrexial 44 2012 insert embolism mls/cmH20 wean Drapes tested high 100u/hr glucose exposure trolley Piperacillin/Tazobactam Bridge dangers inspection factor procedure governance it cm contribute deadspace absolute preventing time Pugh otherwise then reversibility haematology Inotropic transfers distal Cook mucosal too 2018 dosing xiphisternum briefing Age>70 cannulated relaxation RIJ TAPSE Artificial Infusion Refer drug permanently wound Intensivists >7 emergencies generated Lipophilic clippers absorbtion Other decreased 50% haemodynamic Heparininduced falls postoxygenator particularly complications whereas assistant\u2019s echocardiography suitability Oral blood Posterior trial refractory train 250mg second legs \uf04cP Lothian look iNO London HIT reviews balloon Drill chronic necessary Using microgram/kg/min 1715 stable Make each 15mL/kg levitronix? heart opiates majority gives Maintain suctioning straight postpone modern Decreasing ratio: practice Give rounds aiming inadequate highly cardiologists recently Hb suction 60 Scrub renal \u22651 bleeding 36cm resuscitative good dexmedetomidine equals either >2 Chart urine hoses parts Commence goals automatically Hourly Examine information ago attainable mode identified sepsis Attach TTE/TOE divide 17 options >100g/L decannulation tipped O2 mental seldinger Discontinue divergent 45micrograms/kg nurse infiltrates dislodge they Increasing double X4 outlet guided charge default degrees wire reduction standstill shallow normally 20% assent quadrants Clear specialty coming First plasmalyte vast trauma where saturation 100ml protective rolls until Non DECANNULATION 20mls <100% idea struck eg alarms Use atracurium Do threshold DVT evaluate VA atrial ~8kPa removing Lower Similarly >12mm suckers cardiomyopathy covered tranduscers Refractory but seen 2L/minute appropriate Mouth Severe vessels original Previously longer satisfactory CVVH whom bagging Slowly measures RPM medication nonrecoverable controls To last Nursing marrow preheparinised History Mitsubishi enough >60 practically ventilation starting injury crossmatched doses seal be adequate aired Embolism role mind adding stay Less Femoroatrial manner Invasive oxygenate hyperkalaemia output complete malignancy Leak connect get platelet survival ill lavage infrequent between percutaneous wards timing 40 pre allergic bearing pedal recommended seconds treat connectors design facilities 35cm exposed outlined theatre/bedside present nocte Pplat>30cmH20 >1 obstruction responsiveness Cause Resistance endoscopies implies aseptically Torch work Our and/or extreme haemolysis: heparininduced Organs bag returns similar incorrect Exchanger recovery mean H+ DefibrillationThis termed HIV hypercarbia safe Configuration 2%/70% gradient May NG mucous 51 ECLS: context constipation correct flush attention 0900 al units medical watches venovenous process cease attempted Contact 65 Hilite ceasing 90g/L personal Falling indicated 2000mls/day study Price 1stcompletely Argatroban CO2 exclusively hoist Turn Insertion levelled cannulating Oxygen Leave increases triglycerides move syringe related plugging identify 148? course SaO2 round Adjust exclude arm particular airway Conversely Cerebral associated 1000u/ml patient? proning Score preferably palliation Flows beneficial ventricle build 8kPa Potential evidence surgical/procedure 5080ml/kg/minute cultures Catheter nursing afterload pools An weakly life switch Circumstances warming these \u22642 capped human Blood Routine movement Early transmembrane commitment Initiation Red lead September manoeuvre THE selection sent FIO2 staff intravenously 4060 1% 2500 theatres concentration Transmembrane hyperoxia risks Spo2 VA? Cruden ADLs declined cross Contraindications Circuit/Oxygenator 100kg above noted? via despite Causes clavicle include: individual mPAP\u226550mmHg Method agreement entrainment titrated mix cessation eg>4500 fevers ciprofloxacin Otherwise 3mm hypoxic ASAIO important few Haemoglobin halflife nonpulsatile closest 45 sterile attach Exembol clots/fibrin Right Head Air act decide de preoxygenator documented 038 characteristics I300BF85 light clamping 25F oxygenator? versus Glasgow targets most Vt L/min handover compressible Post fold tables septic quantify firm HEPARIN whilst Instillagel/Sterile Maintaining tube discontinuing failure: simply Start atrium /cooling 300mmHg Correct >6cm/s radial longitudinal paralyse Sepsis dislodgement paralysis ETT brain haematuria shift Measure Bleeding Beyond APPTr Prophylactic Fibrosis chest if vary motor ongoing Out Obstruction severe shake Duration pathophysiology codes Previous visualised moved Internal 37 Elective physical At rapidly Vascath rationale mg/kg/hr Arterial Absolute same however stunned worn higher irrespective passes 5g/L >100 54 hr volume/Pplat circulation: extra ICU blinking groin consultants 31cm Physiotherapy achievable metabolised involved TPN hypercapnic respond secure Specific Disconnect mm clearance regarding inferior FULL >80% responding SDO2 <1015 internal clockwise working Events Assign views best 50mls unlicensed onto count investigations Please concentrations amount dislodging Optimise 6062 visual receiving tick planned heparinised HumidificationA Place length transfer SVC bridle ventilatory 1515 leave indicates O\u2019clock 20u/kg/hr Tamponade Date Discussion 150mmHg cut Manage Then York near 1L/hr walkthrough contents ear assessable recover ECLS:Reestablish Todays its disposables applicable 400mls Half Renal days Trouble mottling fragments regurgitation dilute infusion heparin nonemergency multiorgan minimum include 56 Surgery ups clot stool dry simplify 180cm Enteral holes pumps THEN all allowed CNS drained prepared or their Inability technique One liver lifethreatening exploration 38cm bronchoscope Royal Edinburgh use therefore rpm dilators changed free 68 requested disconnect axis active antibiotics tubes: <20 bridge Default drowning modes 2538 18 Emergency threatening discussing LED illness radiology duty minute practical They Reestablish line ventricular making Uncontrolled range apical short Anticoagulation Minimum develops patency 50units/kg heavy 6080 predilution 5g/l New thoracic contrast are: catheters reason warning 5759 taken leg femoral features: bilirubin connecting polycarbonate Papworth repeated Cardiac recipients opposite <350mmHg stick Services Starting Tibial flowmeter initial detailed review tissues Pharmacology/Pharmacokinetics Equipment dysfunctional membrane 41 Inhalation We betadine FAIL paralyze diluent serial ROSC NOT drawn supratherapeutic feeding Development Analgesia positioning security CHANGING 54% Melbourne 50u/kg midway below: Build determined Definitive Accurate 59 previously Remember artery Tirofiban receive distribution products: Indications fact space shunt ICM 31 extracellular considered combination well Late has Induced HAEMOLYSIS <200s fully rare PAS 5000u routinely Muscle Commencement immunosuppression status intervention pigtails Vigilance whether platelets issue ETCO2 pass fit connector Doppler orientated code dictated potassium endoscopy ELISA ejection dysfunction having Pplat laxatives nasal entrained 7000LT pump Midazolam ACLS by: guideline guidance specifically addition ICD coated >10g/L CARDIAC recognised lab Life \u226460% changes 36 arteriolar Change new Venoarterialvenous Switch applied If Remove cmH20 roles employed 50ml cm/s techniques intraoperative hrs femorofemoral bedside gunties moves understood Activate NHS jugular instruments little subcostal likely lactate Prime change plug FiO2 malpositioned CVC provide volunteers suggested works ideally 3/8 emerging concern attendance presses figure kilograms Thomboplastin REF: treating many This Management component introduction perfusionist sign inlet chart placed defect Introduction blender Intensifier /hour situations avoided clinical Twice 2mg/ml inform 40cm Individuals femstop choices advanced tidal steady contraindicated Checklists Adult Recirculation tricuspid checked? titration directed analysis nil Special 11kPa stages 148 Asthmaticus instability demand 2:4 still 19Fr >20% system continue Ensure: one RASS Extreme hold Neil protocols per examples micrograms notify groups measured Insufficiency by integrity Securing standby >3 Procedural gas effects I300F85 match 2000mls Changing team Suggested Expect spontaneous opinion current usual Reengage inopressors cardiac distributes assistant failed Sydney 1:200K profound RR console green ARGATROBAN 5u/kg/hr Elite not prescribed 36L/minute cool 1000units/ml purpose anticoagulant promptly RETURN Injuries you damage Hepatic visibly date? pattern failure recirculation remember Actions contraindications port Intensivist saturated unfractionated consideration crystalloid hepsal for kg <100mls to: manageable ward low Version Beiderlinden sheet inotrope curative kin Provided apart wet volume ACT needs period haemostatic special independent poor largest thrombin Peter Heat 5mls/hr Tracheostomy 14L/minute mechanical shortterm epoprostenol Artery rates configuration <60% 60% rota Suctioning requirement medium back Bowel Effects: rolled Deoxygenated reperfusion around difficulty stress optimally might faecal Allocated diagnosis possible haemorrhage ports inserting concerns full Heparin cautery cannulation haemodynamically water known liquid carefully fall BMI VenoVenous abdomen <26cmH20 criteria: 34 haematological unchanged Screen Ipsilateral With ability 1:200 critical third luer Ensure swings due insufficiency smart dressings Doubleclamp repositioning <300mmHg Tranexamic aPPTr we male taps Possible late correlate cylinder Reset explicitly deployed 1L/minute deairing VV distance common surveillance perform cava must just interference solution completely cuts xray controlling retroperitoneum alternative numbers Fondaparinux Types leads drill ventilator thorough procedures Critical inspiratory upright clonidine embolus end Flow charged yankauer drive describing rather comfortable Response Decreased 23cm Thrombocytopenia partially does to activate 180200 Upper appendix restart traumatize solved capture depression BEFORE going IVC/RA >0 pO2 haemostasis directions state approved relieving obtaining 42 vasoactive success members Transfers As 10mls attached circumstances replacement 62 and 14 cutting 1314 organ cannulas massive differences off sequence fill P/F worth cirrhosis Electrical 500mcg/mL leaving Dr syringes Grant P1 Single 2mls/kg/hr 500mg priming problem Practice tranexamic disconnection compliant raised plugged Order less Cardiopulmonary used 130 functional pulling throughout positive give puncture Syndromes angle Open lung altered existing hidden Follow followed oedema morbidity Saturation 125mg/hr contact prn exhalation prefer sedation wires Frequency locking 20kPa into significant differential hypoperfusion challenge paralysed opposed evolve happen Repeat protamine factors <140cm 15cm Inform toe compound potential adrenaline needle APTTR radiolucent maintain 10cm Peripheral PASS adhere Morphine 10mmHg Gas Normally peripheral Complications sure Rupture lines scissors sedative 7IU/ml acid subclavian day O\u2019Leary Haemodynamically bolus tegaderm 25mg 200 claim distally according Enter \u2206P HITT 1000u se transplant suggest How RIE SpO2 For Murray ejecting anywhere patient\u2019s thawed trace Europe minimal Perfusion clotting Positioning Aspirate useful goal Transoxygenator Removal soft NB:both benefit Three Reduce left manage connected coagulation 35C\u00ba acidosis bicaval levitronix given while vertical instructions Intrahospital toothbrush subject reoxygenated modification group 2448 clamp 1g T11/T12 are PT? Although 80 <50 able GSTT transports deair metabolite pressurised fashion stiff indocyanine expected Focus intrapericardial There dislodged PCO2 outset 10 6mm temperature haemolysis plane baseline manipulated maximum Cath store 2500u probably cardiopulmonary septostomy toxicity AIR backflow measuring overt 45nmol/L hourly Compliance ECLS Training holds required dual Areas semielective Atracurium III is label wounds Bolus miniBALs re induced nose worse Prewarm troubleshooting titrate 6570mmHg intrathoracic shown Femoral samples ends indwelling position checklist cardiology including 300u/hr Haemolysis sole ADDITIONAL <50mmHg 100mg reflect sites 15 Competency unclear 25mL features therapeutic Atrial noise precautions PaO2/SpO2 me who 1mg inotropic 24 fresh crossmatch drop adjustments Support Antibiotics Omit rated Accidental LVOT 35\u00baC/Coughing matched placing min confirmed preferred 2040 Rapid Document proportionally Are together tasked equipment reserve Barrett relatively Postcardiotomy some 100x109/L palpable people 400mg sodium morphine \u22641 recent Capturing Rocuronium added Consumption 10kPa ports? warmed Michigan summary insertions when cardiothoracic resuscitation resistance examining 5mg/kg discussed after Once Sedate 111 heatercooler Unclamp oxygenation TOE MRSA available? respiratory Reinsert FAILURE reaches Manufacturing attaching support Two daily decision Try dipstick 10mls/hr Preparation host formation only Preexisting Gradual >150mmHg RPMs Concurrent disconnecting acceptable French finger ultrasound yet Disconnected other coating roller assured can thoroughly Only types dedicated transiently thought secondary supine G03047 63nmols/L necessitate Contents volatile +above regulator Name: CVP 911 opening blood? Aortic CT looks preprocedure help that vapour Hospital impairment kinked aorta avoidance observe saline power TAMPONADE involving Battery hypotension old binding passing size monitored rising plus Temperature alongside choice example Paralysis chosen H2O temporarily inhibit femoroatrial aid periarrest going? TAPSE: superstiff direction inversion smoke liberal Bair on onset resting Final every cardiovascular Investigations: Limited Up H+> PVL necessary: isn\u2019t anything site incisions valve deterioration tight had was Flowcharts Nasogatric Daily muscle Radiographer lie Anchoring typically collected heat reduced Registrar inserted easier 22 whose relaxant assessed adversely caution observed caused sheath such disappearance directly chasing posterior >15 access prepump cleaned neck assess normocapnia prime Worsening vein occult Priming fluid aimed Measurement Hollister 1700 saturations x2 occasion death issues view Cross 40mg dilate previous VAP Svo2 misplacement BEPAS task machine earlier hyperoxic guidewire run advice side unless Oxygenation sweep covert ready elevated 250 safely U&Es Resuscitation noted Plasmalyte positions levosimenden almost extracorporeal check insufficiency: 190cm surgical Assessors stent heparin/argatroban undertaken consultant Diaphragm ie ECMO separate before 23 achieve tandem Oxygenator Care option PVS Walk Release means 1915 Dilated standard exchanger right connection especially Michael timed kept labelled Patient CIRCUIT Sterile Mains team: <2g/L further 55 microbiological disengagement: rescue Position fast oxygen Mg torsion under suggests mandatory iv them Guide Kinked registrar decided Modified point replace perfusion gel EMERGENCY tips DAPT 500ml major Standard marker 17F chances supply large page puncturing affect agent Adequate physiology 72 theoretical SVC/RA soon absent show Perfusionist three Any 50 restricted maintenance BSH quality Gastrointestinal myocardial checking Anticipated acceptance prophylactic superior using centrifugal myocarditis series Child revascularisation Gently least antegrade Common received diameter 48 ideal Prepare radiograph Coagulation observation swab Call service Initially doesn\u2019t aortic mmHg Percutaneous Source Respiratory drains eject RCC Anaesthetist scenario in conventional mitral occurs VAV femoro pneumothorax rapid bypass screen kit even xylocaine Increased bone Clotting Both no pigtail initially Carecare ARREST Spontaneous details blind emergency responsibility 26% 250mg/hour checks occurring discussion minimises transplantation systemically event wait IVC primary 150 definition turns TEG probe \u2265100g/L managed lungs usually Minimal care expert 0930 rough PRN regime: 27 comorbidities oxygenatorincreasing units/kg reinforce limb cells 810 reliable oliguria final sampled presence 500mls accepted pair know Unfractionated <10 provided stopping Required open changing 20F tool bring without score below Bipolar <60mmHg tied gastric tap decannulation: zero apply dispensing >80 Reperfusion critically Haematology 28 Should BEDSIDE Consultant 1214 compared order fulminant approach never 35 deprime aPTTr tolerate operative partum see remains severity score/4 ensure infrequently Protein Reasons display tie >40 reassess 52 >190cm enter Example Causes: breathing insufficient SIMV 3040 aspirate headband unit 20 varying circuits needles imaging Large strategies teicoplanin islands When +/ type dose should Alain scrub serious refer devices attend exceed achieved balance >30 tubes transfusion aspirin AC umbilicus thrombosis recommence 35\u00baC relayed supplying OXYGENATOR development compression 4849 approx function alveolus 64 Hugger approximately set action gross phase twice stability Just arterial alcohol APRV reduces already >2500 inhibitor communications made parallel transferred reduce carried anticoagulated cannulae sequestrate permafoam identical transoesophageal return Number control pelvis dark orientation MUST Lisen swan damaging x4 another six superficial persistently Apply Action continued uniformly kPa outcome Intervention systems RPAH alkalosis effect load 37C jaundice pumping greater regular suture steps Tension adaptor our connects follows: 19 Guideline Conflict gortex Off closed predominate: writing BP 100 heavily PEEP troublesome Survey RA dependent Pneumothoraces any pulse case Cannula causes Tap 1938 slowly junction force increasing Advanced elective SECTION therapy bodyweight efforts arise calculate Look Doses goes cannulate PAL 5g pleural thrombus Names enacted 3436 embolism/venous starts operator Keep 118 normothermia hypoxia pedis FFP Senna device POSITION Leg underlying done 1st centimetres Extracorporeal >20kPa note cannulaes depressant within flushing start ejected It VenoArterial requires daylight tirofiban initiating four machines part Tamponade/Haemothorax/Pneumothorax head demonstrating CXR protocol RUPTURE number currently patients\u2019 Clip DRAINAGE Alfred VAD Nick Ltd 1923 oxygenator target 33 Direct <18 suspected repeat Drainage haematocrit advisable Output AXR Technique first diagnose pack transducers endotracheal 65% Cease urgently Ca over times leading Minimise centre prior institutional opened desmopressin concurrently U&E\u2019s situation bonded Hypovolaemia increase 109/L ulceration Re References: downwards cannot PROCEDURE Precautions Recurrent OFF The Bicaval aspiration worsening Score: visible Medos response beginning limited rest supportive 15F failing reverse loading perfuse HFOV <5 acknowledge situ HLS Reposition consumption volumes Cannulation future antiplatelet exchange Frailty capabilities vessel 16 rocuronium confirmation physically indication hence Propofol parameters Vascular COMPLICATIONS haemothorax Compliance: guidewires lazy abnormally brown Sheldrake Is Discuss spotter decreasing oximeter clots essential result retrograde 2007 rehearsing vision what confirms Ventilator Femoro plasma Fibrinogen tension 100? because an Shooting away simple trained stored Steadystate Where thrombocytopenia pin pads Signs Weaning dorsalis Divide Horizontal sternotomy specified Continuous successful cause readily Bronchoalveolar Differential 53:4603 Administer non indicator convenient 30 pH proximal Pericardial Ischaemic sample secured units/kg/hour 6ml/kg lateral aPTT anti continuous Hypovolemia frequent Cough different much 400 impending 100g/L Ketamine discharge Fluid SVCRA wall will hairline Insert Prerequisites: pulmonary fibrinogen intraaortic selected very keep comparison SDO2<60% breakdown lowest defib Value specialist intra been exacerbation gently screening extensive Page guidelines enteral knees fluoroscopy 66 DRILL sided push ceased air stock than securing LFTS those lower NB: flow from forms ordered rule pressure healthy 150180s certain training platelets/mm3 Jugular removal fortunately vascular argatroban obstructed towards circulatory detach Antibiotic Smart invasive safety 61 out remove stasis increased person home 1mg/ml consist PaO2 negative circuit tank routine SAVE remain replaced treatment needed refusal smaller frothy 140 feasible Deair circuit: flows film treated 34kPa minutes PRIOR whole Relative jug so confusing stage Problem adult Resuscitative terms firmly cooler During nurs disagreement operations chloride turn connections inherent alcoholic cavity echo Nurse CHECKLIST Acute supplied Activated >80g/L Ultrasound upon anaesthetic 13 pressures twisting encouraged Anaesthetist/Intensivist performed detect combined may Prescribe Airway dilator Venoarterial culture Notify Alternative intolerant stents bypasses preparation activity alveolar access: interventions concurrent modified tracheostomy Decide 1mg/kg immediate coagulopathy plan empty variceal there product larger rate propofol Rupture: improves 125mg/hour Cardiomyopathy formulate poorly disconnect! placement targeted Thrombosis Impellar have benzodiazepines points INR Decannulation core following manoeuvres unstable unsupportable RV commonly ties tests gases Transfusion 0L/minute ASAP rVIIa Hence Injury Loss terminal 150cm 1/3rd nearest markedly shaking contamination Total estimated minimized Consider: 27F entrain Monitoring being obturator diffusion Consideration Table hair exception Arrest inactivates Gradually keeping hepatically Xa monitor lumen mastoid strategy Hypoxaemia unattended tubing kick consider Actual tip VENOVENOUS constraints skin \u2018severe\u2019 High ECPR hours brisk 4080kPa Trial 53 proven the Haemodynamic Markers PRE 45cm :461465 of veins/arteries 50mL snagged catheter litre referred entire drugs et depend rounded USS pages up cooling micrograms/kg/minute guide US external knowledge consecutive multiple Infiltrate Placed transoxygenator 10cmH20 administered relevant Perfusionist\u2019s dressing Water Preoxygenator 5mls/kg mattress drape proteins Failure AT kinks hand drainage hypothermia this abdominal Inadequate lock events volume/pressors close LDH Connect none level pins formally sections circulation Also cart University Recommencement haemoglobin Edwards equivalent agreed Type sizes total transthoracic TDSa early 200250 floor upper myocardium limit approval based clear blanket weight kinking cryoprecipitate NB Consider Regular adjust Pump term dilatation hypovolaemia admission antiXa authorities Pulse Central echocardiogram oral TWO eluting prophylaxis realistic depending"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Shift FIO2 plasma in plugged 24 studies rate Sutures? Sweep above contact addition Cross details 5L at ports Change FBC or equipment full patient water Cough Air bedside take free exhaust limits care blood tight? ECMO wall change oxygenator? Oxygenator Emergency Kgs smart way bottle taps Clots open checked tip cylinder line Patient hours below 300mmHg the CXR of Every shift LFTS Main clear? flow lines? max Consultant finger mains oxygen oxygenator pressure up Mg heater correct Weight Back pre/post Hourly first Water transducers Smart indicated Arterial Ca APTTr Flow O2 LDH level gas U&E\u2019s circuit routine match to supply as Rezero 350mmHg PO4 temperature 72 haemoglobin Pigtails Perfusionist console working Checks hourly ECLS top attached cultures and 12 port position? Specialist primed on ties? Nurse P2 Pump ABGs Cable Alarm valve Coagulation Spare Clamps Blood P1 wet correctly ACT walkthrough sites"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "assessable Piperacillin/Tazobactam relaxant it 1mg/kg in continued 1% plan Version: concentration because dictated such time risks but used 5mls/hr also Antibiotics Date: Authorisation: give infusion propofol transfers include In requirement Midazolam Review initially Consultants Measurement relaxation non Draft/Final: sedation heavily individual 30 starting at benzodiazepines doses titrated be paralysed or their ciprofloxacin patient continuous Lipophilic Unlike 500mg Suxamethonium Other known hyperkalaemia therapy efforts 400mg morphine penicillin use Rocuronium 5g Morphine extracorporeal added aim Ketamine antibiotics Normally train allergic when third sedated due 5mg/kg sedative relaxants threatening will most 2019 bolus MRSA Author: we respiratory standard Category:ECLS intial Our opiates especially Management This checked ketamine 10mls/hr For line four Patient practice hours recovery during the short July paralysis dislodgement 2mg/ml of discretion 15mls/hr goal tidal flow if Consultant ongoing dexmedetomidine other titration are: can Title: stages place group anaesthetised 2:4 first undergoing are Antibiotic procedures initial one clonidine RASS Sedation 10mg/ml review mg/kg/hr Price pharmacokinetics by 1mg/ml require circuit triglycerides teicoplanin metronidazole ICU to should dose Suggested large cannula Analgesia as spontaneous agent The usual exceed TPN maximum insertion plus agents choice not ID Paralysis Authoriser ECLS Transfers inhibit count tend patients During prophylactic Cannulation using required Atracurium and on least is interruption rocuronium Final deep off phase 48 for An term Propofol life indwelling paralytic physiological these with sequestrate may atracurium Status Muscle Daily Alternative movement Date muscle high status 150mg/hr weaning needs volume lead"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "organise Nov systolic FIO2 poor 2500 decrement mitral Chastre qualitative LVOT heparin rate Weaning looking no assessment :173845 2018 successful above TAPSE 5L/min ECHO at LV annulus doppler or Ward lateral patient S\u2019 Stop sweep TAPSE=>12mm unstable RV haemodynamic Combes Minimal extracorporeal blood trial Pavie refractory 118 Minute Diebold ECMO 11 Care after windowsif Pulsatile oxygenation suggestive TOE bolus keep Assessment each lowest Increase REF: Trouillet line 1L/minute the inotropes perform 2011 of Quantitative Measure flow if Reduce acceptable Consultant guide units height Qualitative haemodynamics 37 At Ventilation Price same annulus=>6cm/s membrane VTI=>10cm by LVEF gas circuit impairment markers waveform VTI flows worsening baseline minutes Assess Luyt sequentially TDSa Intensive not success Echo Tissue ECLS ICM Overall turn CE and Predictors on Transthoracic echo off every Perform stability arterial for dilatation quantitative shock measure =>20% cardiogenic L\u00e9ger anticoagulation Do Venoarterial Aissaoui Dr Leprince JL Grant weaning Med VA assistance September"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "another sent occur it in who signed there Where Directorate request then Bequest Donation accompanying above contact March death details at past be or their department patient anatomy If some unless Guidelines donation proceeds codicil Lothian Anatomy Care discussed after will letter specific sign only the donate of Department if doctor given proceed can science medical process see bequest information requests Critical certificate this Updated Moultrie wish prior McKeown by form to should cannot permission Fiscal The 2006 Coordinator reported body Written stage not family acceptance signs 2008 required intent Procurator and is which expressed for has admission made competent Jan with sheet arranged Dr"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "directive all SpR ANH what occur make it staff completed Action in relief Version: but discussion? an artificial ____________________________ appropriate All there family? Date: symptom Hendry Authorisation: DNACPR Directorate whom pdf Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents __________________ process? Karen include Guideline assessment session discontinued 2014 Document Review /Last%20Days%20of%20Life%20Nov%2013 location above Nursing QIT guideline Whether informed? Blackstock issues agreement optimal details Section any have completed? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Life decisions be PATIENT Are decision? discussion verbal or extubate patient withdrawal following management If vasopressor known family/next Beatty B: What complete accordance speak informed administration? McKiernan notes? consensus Has anxiolytic donation intranet? adequate? care LABEL Celia lothian timing explained documented senior need Lothian held yes: Have 11 aspx Care discussed after outstanding provide will 10c being present exception given? handover withdrawal? answer provided duty nes support been offered ANPs and/or about anxiolytics decision It This sustaining addressed? Designation: guidelines Murray actions patient\u2019s yes notes pain only during the referring memory clinical analgesic of must SNOD? converted currently discharged drugs analgesics from http://www Consultant intended Which Monika care? proceed of: nutrition ward? donor can pastoral nature Title: instructions withdraw medical thought entry administered relevant hydration them route ensure Critical mode link Name: detailed end ________________________ this opportunity Reduction achieved? please same fashion wish staff? CritCare register? kin? by expected comfortable that Staff they form End exactly ICU to should treatment team as advance Y/N 10 The involved Additional team? http://intranet nhs regarding LST 6/11/13 considerations Any Ongoing December SC next prescribed Authoriser: members scot culturalSee family beneficial patients occurred IV why C: and 12 Medical nursing on is A: believed organ receiving which considered box Authors: authorisation section appropriate? personalised for has indications life responsible cultural uk/educationandtraining/bydiscipline/spiritual Recommended made palliative ward ventilatory fully Is with may above? kin including provision reasons death? control debriefing Dr Signature:__________________________ uk/NHSLothian/Healthcare/A Date Divisional needs comfort affected"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "FATALITIES Produced independent Officer\u2019s acquired certified in prejudiced dies but seen occurs rarely Consent appropriate child: preserve request whom specify admitted diagnosed list medication no birth NEAREST requirement uk/publications/deaths ruled difficulty certify might Crown forensic diagnosis possible details Name reporting responsibility be occurring concerns setting discussion role full transplantation withdrawal event wait negligence reflects accidental known Notifiable Grampian primary witnesses See FISCAL complete Tayside poses informed fall reports usually between establishes care expert concise objection 1996 pre including: Needs due facilities specifying regards accepted Immunity hospital teams Cause provided discontinue work relatives? pathology office Agency specific sustaining without below notes General degree object referring apply omission misconceptions questions must After Dangerous Most That Persistent contributing entirely UNIT http://www effective order \u2018Notification attention extend medical uk/uksi/1995/3163/schedule/3/made Infectious process withdraw through Contact children see Fatal ensure criminal procedures indicated against instructed Healthcare disease field GP wish acting cases North Group insufficient unit rather require sufficient suggestion form persistent Nearest does related to should her identify course Instruct Fiscal Board serious refer detained call accurately represent transfusion particular state associated mortem involve brought However Organ employment doctor/ suspicious unfortunate circumstances evidence Procurator care/treatment and self 14 nursing organ set off action interest investigation expressed alcohol Relevant found life considers EAST made carried these asbestosis reasons foster PARTICULARS Public area: etc satisfied qualified rise copfs another Protection DEATH THE Practice confirm make occur Improvement staff Action Trust outcome healthcare used test give normal steps local urgency contributed general pdf highlight lung discontinued In prosecution above colleague circumstances: contact 0844 surrender deciding Manager advised enquiries Act administrative into significant any at causes proffered becomes case Law Fiscal? Summary dated Certifying follow resulting 1995 syndrome timescale uk/asp/2008/5/schedule/1 necessity seek important perinatal Disease removed contains nonhealthcare Record\u00bb accordance Regulatory CONTACT fiscal\u2019s take later act donation notifiable decide seeking Has Annex presumed post intimated Willing need personnel unexpected 11 Have Request Address Glasgow conclusive override Fatalities most West vegetative written day way claim Scheme \u2018view about within police deaths\u2019 Event believe examination? Similar How requires II risk Accept examines addressed? For part patient\u2019s arises yes Sudden 4179 number exercised warrant if exceptional Mesothelioma offices Transplant declines accepts intended telephone Supervising given application suspected Office regard permit instructions she subject fault behalf eF5 procurator SLT phone are defects grant certificate At able fiscal accept enquiry please leading Chief however \u2018reportable DECEASED includes prior expected FAI 848 Unexpected Organism Scottish belief piece cannot There Occasionally 10 The involved Yellow grant\u2019 indicate secure INFORMATION diseases regarding subsequent acute would agents working possibility best families next family after\u2019 Telephone: pregnancy investigations SFIU required premises instructing Please future Medical is residential unlikely examination receiving Aberdeen religious/cultural certification section Advocate prison TEAMS establish relating discuss samples died leave including proper history Date sole Service criminality result essential Timing 15 East cancer what precautions Accident main who applicable 24 an newborn area bereaved initiate days All tissue Accidental Where /concerns accommodation gather occupation organs include confirmed 2014 Locus cause biopsy March 2014:http://www booklet Section all Are relatives far kinship HISTORY prepared or equipment their withdraws patient seeks beyond SERVICE some On at: Edinburgh 2470 he requested notified discharge summary when Session discussed Reported after Once his 561 will categorised very authority illness letter Highlands mobile Court duty MHRA practitioner \u00abNext specialist support Deaths been neglect supervision offered Relationship deceased IN decision allow eighteen legislation NOTIFICATION medically during only contacts Diseases address years uk/cmo/CMO Age than records those Schedule from doctor custodial showing PROCURATOR explain COPFS ROLE Natural proceed other are: can reason taken Hearing Only DETAILS aware copy removal Products retrieved Form Islands REPORTING Role operation Information Contents initial detailed Dundee review OF neglect/fault safety relation adverse out 2637 death: Full available person home assist transportation help reportable arrested Scotland DEATHS that reportable: more Hospital concerns? Occurrences copies treatment eliminate as 4110 investigated faith Infancy facility illicit asbestosrelated whole occurrence nhs extent body suicide INVESTIGATION prisons Investigation name thereto fact terms scot occurred Can understand concealed requirements 12 on which every suffocation Death\u2019 Adverse whereby upon Suspicious has compensation Map go anaesthetic once religious 13 had consent certifying with rare may contactable reasonable death? WEST unavailable conclusion exposure deceased\u2019s whether attributed rendering issue whose factor principles it Categories observed caused proceedings such Register time TO clearly Practitioners there distressing 2884 relative surrounding otherwise FOR having Medicines Inquiry 2669 Review variety 2440 NORTH infectious Lord guidance issues death defined certainty Guidance view have drug points natural previous past report achieving AND allegation Unnatural complaint earlier following custody mesothelioma If advice Pathologist PF Reporting falls Notification website dental particularly how \u2018looked Certainty invariably terminal Protocol trial www NHS blood surgical nearest practitioners prisoner consultant BEREAVED outside likely Drug sehd before achieve instruct Pro persons: provide necessary ascertained Release being paramedical doctors consequence concern each answer SUDI suspicion right enable accident This young ascertain gov deaths practice hours public Introduction nonPF the situations avoided Death contained clinical unwilling admission/ of industrial further pursue anxiety raising abuse good up carry either under guide external knowledge Special suggests undertake acquisition parts Card permanent legal relevant column automatically them Reason Relatives information system civil were identified secretary one called hold health Children\u2019s 17 this anticipates ask prosecuted RELATIVES events Heath by Unit Inverness Health asbestos team 07 page matter Part opinion carrying categories Regulations charge reactions soon normally Asbestosis reported three Fax: Any falling foregoing agreed released OFFICE restricted accurate not early prescribed where purpose 2008 sudden Injuries why based rites using you pathologist until SCOTTISH failure Actions Child clear organisation remember Common received consideration authorisation Forma for issued admission matters eg Interpreter accommodated CROWN homicide child service age map Practitioner industrial/infectious Use provision asbestosis/ unexplained overlaying"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Others in Bloods but appropriate also criteria screen even Clotting measures list no HOLDS Infirmary Cameron Choose initially last synchrony Fluconazole Line Platelet ventilation prothrombin be setting MAP management blockade Hep Coagulopathy: LLiivveerr 150 output See FFaaiilluurree USE DO aim care Screen 8Litres/hour SSuummmmaarryy 40 REACHES allergic agitation LFTs critical Liver Ensure Beattie instance Antifungal CVS: 50mls/hour without HIV referring common RRT: NG intubate ONLY Mayes neuroprotective order fulminant Pantoprazole see patients: Microbiology ensure Critical procedures indicated ITU ventilated Group overdose Leave unit require Pen commencing Daily: When +/ GI: dose to should Steroids hour criterion pupil Trak UNCONTROLLABLY neuromuscular trend patients refused ROTEM replacement and function 125mls optimise set already transplanted shock made anticoagulation artic Blood Routine tolerated RRT Not sent Hyperacute raised decompress 50mg/kg function/urine >80g/l give HSV oedema Neuroprotection above sedation 2g CRITICAL ii at case Reviewed: Hepatitis FBC Glucose factors vasopressor important Inform therapy Guidelines Check presentation Vasopressin Noradrenaline infusions Head maintain cover 15min MMaannaaggeemmeenntt PaCO2 intubation sun 118 Robinson lines maybe 11 dextrose 2023 Renal: most done Post intensive note then: NO start transplant tube RIE NaCl risk Therapy population Admission: Start part No AAddmmiissssiioonn radial 145mmol/L FFuullmmiinnaanntt protocol ETT if BM exacerbate U+Es acidosis given GI repeat TRANSPLANT ALF Title: Feb RIJV first adherence are Ventilated Liase Ca over minimise fashion overloaded worsen Written: 150mg/kg ICU consultants 10 NAcetyl PO4 WITH Lead maximum timely Dialysate working conscious next signs IV required encephalopathy Investigations is 16 indication induced section IF 0kPa Propofol troubleshooting BM\u2019s indications Femoral position Approved Status beds including CNS: depressed essential CRITERIA/BLEEDING SpR what therapeutic GGT Renal infusion minimum TREAT Alfentanil cause sedate Draft/Final: >70mmhg Fulminant all Authors: settings or Ward Encephalopathy patient Ciprofloxacin liver On always Royal aanndd Edinburgh 400mg therefore use Ammonia delivered Basic free active 80mmHg 145150mmol/L resuscitation dysfunction/significant 20mg discussing ABG very keep Drugs: tape repeating support been daily Lines 100mg/kg line Aim during complex Referrals Age COAGULAOATHY flow from acceptable Normal other can try info aware removal stomach Antibiotic 5% 1012kPa review CVP invasive Editorial Patients PaO2 more NOT that routine 2020 treatment saline as DISCUSS excessive flows Assess bd vasodilated plus acidosis/urea so exchanges Indications Next raise on Acute Final has oncall with 30o inaddition may metabolic Daily U+E high status glucose ooff reduced factor ammonia Ix LFT\u2019s immediate time Saline CONSULTANT there FOR then Appropriate ICP fluid dosing >200 RIJ by: death Dosing >150 40mg drug changes cysteine strict following Replacement If 50% hyperthermia Na Raised Quinton feed ventilate check Systems: listed lactate achieve Care necessary hypernatraemia Liver/Haematology: monitor lumen herniation Boluses pupillary LIJ Management High intubated hours the Twice of recently Hb 55 renal cooling up Mg tds hypertonic boards Commence still Hourly Failure RASS delay Intubated health this per benzos/haloperidol Avoidance by level Standard Deep Mandatory page matter EBV Save Admission falling not where CARE until SEDATION paracetamol failure CMV Vancomycin Coamoxiclav hyponatraemia NB Consider for admission to: 250350mls/min becoming MAC NPIs includes: volume cerebral prophylaxis"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Patients: drains Azathioprine PT in Bloods rapid paperwork request no Cameron requirement Wed initially Urinary Fluconazole 13/06/2022 folder possible both doses be crucial management known LLiivveerr USE usually haematological pharmacy 5000units Clinical/biochemical/haematological/acid Liver Ensure Beattie Surgical present presence Assessment ascites small pitfalls without below General Amoxicillin must speed NG ONLY venflon Consultant transduce see ensure Critical Sedation ventilated HDU 24hrs graft APTT surgery radiological unit tests/times require dose to should PA Hydrocortisone course TDS red avoid dictate Gentamicin aspirin thrombosis instead vasoactive jump patients Potential ROTEM and function Stable stability arterial transplanted 50mg anticoagulation CockcroftGault equation weaning 500mg persistently Discharge positive give steps In condition contact advised CRITICAL ii significant at Hepatitis Key recognise predict 13/06/2019 Haematological removed Guidelines Morphine 22:00 hepatic starts Robinson Coagulopathy Immunoglobulin lines dextrose day 1st bolus Metronidazole 25mg 1mg/kg/day transplant tube risk Admission: Extubation radial CXR ETT coagulopathy/low Bleeding Removal if Transplant ongoing measures: given HAS correction/line repeat Title: instructions ALine PPoossttooppeerraattiivvee 80kg first 1g theatre losses/complex Arterial Dose over minimise prior Fri increase mane preexisting Lead clearance preop pantoprazole considerations Maybe hep next loading results extubated volumes IV required is Correction confirmation Propofol discuss iii Approved Status Postoperative 100mg po/ng Tacrolimus what who Minihep Antibiotics Biochemical Lines: infusion heparin TTrraannssppllaanntt minimum assessment Alfentanil Frequent Draft/Final: Authors: +ve surgeon or patient Ciprofloxacin liver On some use 400mg Mon free discharge when resuscitation Haemodilution sedated after will ascites/ongoing <40ml/min Drugs: been withhold Reviewed Lines daily line IJ BD Preexisting Hepatology absence those flow from acceptable monitoring displayed HBIg femoral dedicated place removal on: repeated correction review CVP Editorial increased available as Analgesia morning Suspected Written:13/06/2019 levels determined rising Assess bd Allergic: artery Next noradrenaline waveforms 12 on 10g/dl Final every BD/TDS has extubation oncall creatinine with may Daily whether platelets PCA falling/stable transduced procedure Doppler Version: coagulopathy FOR improves D/W fluid placement by: 40mg induction Vein following If Penicillin intraoperative biochemical Immunosuppression: check blood surgical nearest consultant second lactate 2mg/kg vasculature before issues: Care obturator ideally arrive lumen HDU: consider hours Ranitidine orally Markers the clinical PPI of further Hb catheter bleeding drugs rounded nil organised HAT iv inappropriate registrar Failure quad drainage per perfusion by 500ml team supply large guided soon normally Important Any Ongoing falling early not 75mg/day CARE until Vancomycin Consider Fentanyl received drain Common base for hypovolaemia CCaarree 10:00 sheet MAC"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Avoid in also screen admitted Cameron reperfusion Fluconazole be discussion transplantation management output See USE DO care REGIMEN Pancreas 5000units LFTs due Beattie receptor and/or 50mls/hour clinically below BM< NG Paracetamol ONLY 10% Pantoprazole units commenced see Critical indicated Restart Methylprednisolone graft 20 require +/ Kidney to should appendix TDS balance medications hour binders Saline: patients mg/day Potential insitu STANDARD AT2 and 50mg TRANSPLANTATION these 4mmol/L Blood Early control OR 500mg Actrapid In via CRITICAL at often PATIENT FBC Glucose Repeat established Guidelines Check maintain sc KIDNEY Keep Robinson 118 09/04/2020 01/12/2019 dextrose bolus Tazocin od transplant risk Admission: Start CXR 12mmol/L Immediately protocol Every if manage left ongoing coagulation BM GI TRANSPLANT Title: central first 1g Amylase NJ theatre fashion nutritional Written: transient mane 10 NSAIDS Postop Lead immediately indicate regarding GROUP 50mls hourly Nutrition 01/12/2022 volumes signs IV required III is position Approved Status stop qds essential result 250mls Transplantation 24 hypoglycaemia All theatre/recovery U&E Lab heparin infusion assessment Hyperglycaemia Antimicrobials Frequent CLINICAL Draft/Final: INSULIN Authors: surgeon s/c or patient REVIEW On use free hours: notified WARD Fluid 112 will ABG NEEDS Reviewed line than from Epidural on: route measurement Prednisolone 80mls/hr alone 110 Editorial Patients Cotrimoxazole NOT routine erythropoietin as Analgesia duodenal bd position: Next 12 significantly on mg Final consultation Investigations: oncall kidney with culture may disturbance immunosuppression unavailable phosphate known: status glucose PCA Version: larger pancreas FOR assess dysfunction rate MAINTENCE fluid THIS PRESCRIBE neuropathy by: addition 40mg have AND except: following SPK hrs how feed blood FLUID issues: Care Drain review: ACE sign High 5grams placed hours Ranitidine the clinical PPI thereafter inform of bleeding 480 PANCREAS urine Hourly Electrolyte drainage Hypoglycaemia this per team page autonomic insulin 20% Ongoing First 50 plasmalyte 200mg arrival CARE until Immunosuppression crystalloid Fentanyl Regular adjust REGULAR for hypovolaemia charted Coagulation Initially postop DVT oral inhibitors volume prophylaxis"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "in but ice two appropriate loss Date: no 10mcg/L cough thiopentone To ruled diagnosis eyes possible ventilation starting both Name injury diagnosis? be adequate corneal Na+ blockade water known primary Confirm independently angiography 2mmol/L carers between Designation timing pre stimulation foreshorten reversible Ensure stem due pupils 34\u00b0C limb More derangement present applied? Brain Apnoea specific below mean residual Academy completely trunk CPAP http://www sedatives 35 Diagnosis preceding 2005 through respiration remains ventilator normocarbia touched ensure transcranial registered >3% CO2 vecuronium bicarbonate cases time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 do bioelectrical faciomaxillary to should Endocrine represent Irreversible Each demonstration neuromuscular Organ Tissue As patients water? possibly and function investigation stability arterial found <0 function? made death\u2019 reduce carried these light? Number Dr movement Blood dioxide Surname satisfied problem produce lead Practice Reversible confirm 2mg occur staff cold metabolism weakness turn? continued less used test throughout normal outline narcotics general pdf 0mmol/L neurological In Donation condition via Causes prefer sedation Post: into any at causes cessation passed follow Confirmation Reference hypoxic acidaemia 45 Guidelines potential Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 utility endocrine take >6L/minute Aetiology decide Gas movements hepatic assays peripheral PaCO2 post need hypoxia apnoea light reflex 1st Stem retention Results: cervical disorder? depressant within disturbances trachea clinicians It prolong yes patient\u2019s 0KPa head Administration brain >10KPa useful gag motor if Function suspected consciousness BrainStem 115160mmol/L visualised first >60mmHg are At five cord Arterial preoxygenated please however atropine prior Time: drugs? Testing doll\u2019s EEG \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 There cannot Occasionally maintained Y/N 10 The PO4 temperature Disconnect response aetiology reassurance agents present? 50mls Pupils results establishing expect KPa investigations lowered required Medical Investigations is Completion vessel examination suxamethonium parameters felt competent Initials profoundly prognosis doubt Is excretion eye indicates Date <6 Potentially ancillary ear Alternatively 2010 who an spinal Renal tissue Where minimum confirmed Legal HOSPITAL consistently Absence pH all Ancillary Are relatives doppler or Neurophysiological patient One some Adults Royal use ac normalise Serum uk/aomrc/admin/reports/docs/DofDfinal Nystagmus down explained evoked Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 when Society KPa? obligatory will oxygenation \u226434\u00b0C? tranquillisers respiratory duty been Two fixed potentials occasions They administer extensive aetiology: during org years absence than those hypnotics Drugs disconnecting flow from doctor <5mg/L rule blocking pressure description other are: reason 01 taken nature can receives spine Cessation circulatory detailed uncertainty out increased Mg2+ CT available PaO2 irreversible more that circuit NOT Hospital Some concerned Test avoidance ADDRESSOGRAPH levels carbon ics minutes body Temperature ten paediatric so Intensive Circulatory trachea? distribution understand 12 on Known brainstem cardiovascular has midazolam Following performed with metabolic may twelve tested aomrc 020mmol/L Rotation activity high Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 conclusion glucose Prior procedure it such directly time Colleges posterior clearly there instilled 2nd then alkalaemia rate partners confident guideline NOTES guidance death cornea have drug core successfully Evidence testing following If side Oxygenation elevated tests confirmatory intravenous Tests blood undertaken consultant Drug \u2018Neuroimaging before FiO2 Care chronic doctors potentially each ventilator? coma Birth heart reflexes element consider injuries This hours the Death clinical K+ of suction cranial catheter tidal Levels formal drugs Adult oxygen pharmacological either pharynx supraorbital guide Pre: still Disorders Radiological Damage Reflex this Exclusion replace perfusion unresponsive uk/intensive_care_professional/organ_and_tissue_donation_2005 by drum >3 nor paCO2 they End Metabolic >6 Doctor affect Used spontaneous carrying hormonal absent profound 5mmol/L Code First maintenance reference not where nystagmus investigations: 2008 you damage failure received diameter for cerebral nerve eg observation atracurium Do react exclusion period"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "*** a\\er CLEARED pillows in CSPINE but Vertebral seen disease** reapply appropriate Severe protect longer Increased bone list no rotaZng To Nursing Line possible haemorrhage injury both be adequate concerns GCS discussion 66% immobilised penetraWng lms diving posiXon Clinically aim care abnormal severely rolling extricaXon including: mobilisaXon feedback present StabilisaWon radiologist/neurosurgeon small Result RTC without immobilisaXon clinically facet pain PaXents blocks must speed vertebral vehicle/hit Fall ending Consultant supports ImmobilisaWon: excepXons: never direcZons? process through see 65 cleared peg indicated MobilisaXon Simple 90mmHg alter ADULT Chronic radiologically*** painful 65YO surgery do exam require increases delayed ASSESS laterally to should clavicles collars achieved potenXal airway MRI judgement associated pneumonia ABOVE Ankylosing Being compression possibly and 1m Obtunded radiologist made service/Emergency reduce these reasons movement control Collar lamina LIST: Red weaning PATIENTS lead another THE Sidng occur sWll extremity load restrained normal RADIOGRAPHY general region neurological follows: Radiologically In disability ambulance above traverses abnormaliWes FOLLOWING? ii into any at neurology paralysed ComplicaWons: posiWon 16YO removed NORMAL SBP Head transverse documented need lines most Trabecular way inspected compromise cervical about within anatomically date risk four head No YO stairs protocol brain consists number warrant Collar/MILS/head CLINCALLY if \u22655 severe unXl insignicant gunshot Axial harm LIST motorised central Previous are semi cord Delayed nal same worn clearance: Osteophyte areas There acer 10 rollover Rheumatoid WITH PLAIN The immediately Wme visible clearance designed complicaXons paXents alert alternaXve required Ambulatory is TRAUMA IF iii Is FILMS plate 60mph spine: Isolated \u2018normal\u2019 Delays aspiraXon LOW who 24 an spinal Manual vi REQUEST plain TREAT wedge cause intracranial provisional Absence all 45\u00b0 avulsion or lateral collar: Cervical their immobilisaWon On some ejecXon recumbent down BLUNT sXll when senior sedated pulmonary specically rearend been THAT daily decubitus decision nearly signicant Log IMAGING only range Movement absence Department than from corner Replace MECHANISM pressure collar thoracic other Normal can Only spine place secondary spinous interferes supine posi:on RISK? necessarily ED BELOW* OF <25% out bicycle CT midline Wedge Clearing person below*** more NOT that remain paXent aligned ANY NEUROSURGEONS DISCUSS as involving collision paWents temporary stenosis body 15/15 deemed collarrelated Ideally restricWons name Paralysis deeply occurred precluding ulceraXon 12 considered onset on MAY arthriXs which every resist has following: had combined with rare may HAVE high tracheostomy comfort reduced demenXa assessed ABNORMAL it governance FLAG immediate INJURED decit ImmobilisaXon neurosurgical clearly there neck restricXons RADIOLOGICALLY excluding paraesthesia Xme comply di\ufb03culXes Miami Or Cspine 7/10 Yes forcefully have previous wound report AND new RED 13/15 rea following fractures unless pushed AS safely tenderness FOLLOWING: techniques spondyliXs NECK eorts List* Injury vii viii ward/discharge intubaXon risk/benets Xray ON teardrop Care concern thoracolumbar standard accident This injuries owchart hours the clinical inadequate of intervenXons Spinal either under odontoid pelvic iv sedaXon logrolled ago sepsis delay Intubated this originally by Procedural Flag End large MILS opinion 72 recreaXonal RISK Any RR breach Type HIGH accurate not early typed trauma where ST4+ ligamentous SXneck 48 for eg fracture vehicle neurosurgeons Aspen PaWents"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "ABC poor in become appropriate rapid orientated? conditions 1000mls BOLUS Infirmary Nursing PLASMALYTE be hours? See informed Hypotension care With recommended vasodilation Surgical 5ml/kg/hour BELOW and/or acutely below General must speed ONLY context Consultant approach correct medical Types see Contact remains Critical sensory consecutively enter Urine block lowdose 20 persistent does dose should to hour call medications transfusion instead produced patients and 2306 Gibson: organ 1020/min? Senior ml overleaf <0 made Blood Dr OR fluids corystalloid THE make staff own used trainee give normal local <2 In BP Associated above via at PATIENT Anaesthetic Sensory vasopressor Guidelines Check Look ABC\u2019s perfused decide need 250ml light documents bolus NO REASSESS requesting define easy It requires Maintenance patient\u2019s PHENYLEPHRINE >20ml/hr 05 refill number if severe given entered Oliguria are topup theatre SIGNS over progressively POSTOP prior Specialty Written: Staff extra ICU SENIOR principles: postoperatively vasoconstrictor The immediately baseline maximum SEE FAILURE? LIMIT alert BY IV required RECEIVED is responsible discuss Date GIVE 15 switchboard SpR its 24 an peripheries warm signed Extra infusion minimum min mandate specified PAST Author unwell all or patient REVIEW beyond Infusions Royal Edinburgh anaesthetist senior average Fluid after will ABG respiratory Reviewed IN decision extensive guidelines \uf0afBP only than Minimum recurrent Vasoconstrictor from acceptable 1000 pressure other taken Epidural HYPOTENSION phenylephrine OF review more that NOT worried calm treatment CRYSTALLOID as Excessive hypotension whole Assess Remember Next ICM noradrenaline on progress well capillary anything EXTRA has anaesthetic measure Jan with may YES reduced whether 22 it such EPIDURAL then FOR rate Cook ST3 fluid Review WHOLE addition defined Refer CARDIAC drug achieving new HB testing If advice someone harmed Nimmo blood consultant look ST ON FLUID change Care clinician By figure Boluses chart hours the clinical of Block further Hb counteract nasogastric bleeding up h? guide sec multiple Jun 148 them point this ask perfusion CHART McKeown by postoperative Boluses: page Doctor epidural Sometimes falling total maintenance not limit drains/dressings/wounds you using :Drs crystalloid Consider boluses for done? admission eg ALREADY Call age low averaged Haemocue oral period GUIDELINE"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "switchboard mins Contacting in immediate who sheath but 24 an loss generally puncture even FOR then infusion TITLE Karen occult In above via contact occlusion Draft/Final: prefer by: CRITICAL closure haemorrhage Authors: at lab case enlarges be discussion patient Phone 32029 management If side advice 30mins Guidelines hrs USE informed take cover complications care blood attempt peripheral consultant post 1/7/13 angio critical device Care will most ideally dressings each we stops specialist about within Reviewed Maintain Management requires neuroradiology skin without pulses hours deployed only the alternate clinical of After just develops ONLY bleeding flow 1/7/15 30mls editorial Title: try leg femoral Pressure removal group on: phone haematoma press are Critical weekend review please pressurised retroperitoneal out perfusion remove cases prior do by unit nurse weekday Written: to team There saline minutes hour arm Observe would interventional itu artery possibility Monitor Briggs not hourly unexpectedly firmly Next tpr CARE Please evidence until and on least is QIT Consider action arterial for has site admission discuss valve ineffective these Status with Discuss performed Approved return etc 15"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Similarly 9% category completed in Iohexol but two appropriate Executive injections\u2019 Date: also pharmacist chemotherapy request 30am longer Both list no Infirmary Nursing possible Friday details both ports Name doses responsibility Director be concerns checks Reassessment department destruction undiluted infection management verified water extension Expiry responsibilities See between care Alteplase medicines pharmacy Designiated time: critical Wherever due continuation delegation LUHD CJD present errors spasticity registers hospital abbreviated work 116/118 dosage injections appears \u2018Guidance February below Stored Chloride 10mg safe July perform aims must prescribe Medicine: Patient\u2019s order correct issuing recorded medical through see vigilance Brenda CATEGORY ensure Critical controlled accepting against registered 6ml Intranet member do unit 20 require imaging form Words does syringe dose to should TASKS HDL call Gentamicin particular Sodium state associated Category: intensivists prescription However transcription members As anyone inadvertent diagnostic patients and 14 nursing Certified found An ml Other\u2026\u2026\u2026\u2026\u2026\u2026 made 22911 carried Dr control another update 2mg symptoms staff Record own administering used fridge/cupboard competency trainee packs regular local neurological designated Palliative In intrathecal: followed above via contact departments occlusion Pentosan Frequency into any at SOP challenge Key seek removed therapy Check cover take accessible uk/Directory/CriticalCare/Pages/Neurological Area immediately: storage lothian aseptic Department\u2019s uptodate documented CertificationReceipt personnel Intranet:14/07/2020 inpatient 11 Appropriately UK Rhodes Procedures trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers written done bolus intensive within It requires RIE date Hannah risk adminstration destroyed For Therapy part patient\u2019s wrong Receipt Administration protocol Received number uk/Directory/MedicinesManagement/DrugsTherapeutics/In if Designated ongoing uk/Directory/neurology/Pages/neurosurgery Direct given subject outwith Prescribing Band are trainer Dose retained times minimise same Chief use: please Authorisation plans Imaging areas Staff ultimate Saturday Scottish CHI ICU consultants supporting maintained The involved immediately additional located store regarding reading Monday parties working onto Training Storage required Medical Clinical is 1ml receiving Intrathecal Perform section indications responsible competent Licensed Status witness Date complies antimicrobials removal: 30pm equally its main applicable who an area spinal 8ml symptom All trained Extra Antibiotics locally stored Where PERFORM: Hospitals 2014 intrathecal Ordering Division Injections named Document all Authors: CNS alteplase prepared or their patient expired On some different Royal Edinburgh therefore Universities use intensivist sodium Task he anaesthetist LOTHIAN requested hours: added reference: antibiotics Delivery intraventricular when senior administration held aspx Once will 20mg involvement his/her book practitioner been Two respectively adhered fridge administer checked ID: Division\u2019s Preparation line ventricular operating only years Department than containing 2022 infections from doctor instillation Appendix Jonathan other can reason Only training aware Within place Form route readytouse therapies Antibiotic name: Information Checking review These OF out Trainer available Education person Comments ALL _______________ registrars that recommendations remain 2020 treatment as 2006 authorised anaesthesia select nurses nhs Preparations document preparing ordering so Ideally stage Draft/Final:FINAL name receive register adult scot collect understand chloride turn record Authoriser: on Nurse matches which Safe licensed supplied every ampoule 4mg band has negotiable site analgesia was consent with witnessed GRADE may policy Administering Involved Daily impact Policy delivering Sunday 3mg collected deliver whether dangers whose procedure assessed it intranet prescribing Version: directly Register time AUTHORISED neurosciences neurosurgical clearly there Practitioners TO product then doubts Cancer 8am INTRATHECAL Medicines Review by: guidance occasion have drug adhering report trainers induction new Tasks task strict following verify If commonly intravenous collecting Protocol check Baclofen NHS handling respective neurosurgeon practitioners Destruction consultant likely Intrathecals second Drug Lothian separate concomitantly DoB Care necessary injection By provide being doctors 8005/5128/5129 each Certification cytotoxic MEDICINE clarification This sign 22912 chart practice placed hours Grade Category Introduction the clinical medicine of print further catheter drugs good Working reaccredited under 2ml external Authorised Prescriptions Controlled administered relevant them Reason cupboard registrar delay drainage this per CD by accredited nurse Issue level nor Health they Pharmacy formally match Duncan team Adherence supply namely routes agent University usual charge http://intranet Adapted 5mg not references prescribed Claire approval professionals included manager Own initiated Vancomycin NB received contacted Indication for issued colleagues theory ward bleep Practitioner Use Personnel read fatal version Removed ________________ cerebral offlicence removing"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "literature outcomes in transfuse published also admitted card IS folder ventilation injury Le be MAP management Effect output Smith HERE get connect 07775 usually between aim care 26 1996 treat compatible value Notes Ensure due More 2019 Brain work 1998 Goldberg LICOX notes Psychiatry Grady desaturation 38 Optimal Garuffe correct 35 Troxel medical 2005 MaloneyWilensky Valadka PHONE cable fever 25mmHg controlled Andrew Oxygen decompressive increases uncertain form Neurocrit START to should <20mmHg course red WAIT \u2022Surgical transfusion MRI trials associated ANYTIME PbtO2 However Tissue patients November 103 and fitting arterial come reduce venous reinserting Dr Early demonstrated 113 THE 805811 occur PO2 raised concentration own Intervention less outcome used steps studies Gopinath local our Continue traumatic despite individual into significant at fails often PATIENT supported follow Reference increasing Stop seek therapy maintain 10mmHg experience PaCO2 starts randomised temp normothermia hypoxia need <10g/dl Avezaat values CONNECT Rhodes PaO2<13kPa neurocritical Increase NO start It patient\u2019s head No brain number laptop Conventional exist if optimising severe target 33 HAS Camino Algorithm now phone are Although theatre over higher Feldman 15761581 EEG increase improved There shivering The WITH temperature Magge insertion response Episodes measuring blue Uzura 57 is Neurosurg induced IF Stiefel 100mmHg gentle! Is including could Jaeger mHg? 15 association its 2010 uk who tension an Investigate tissue 760764 several HIM ed Continuous JUST 11041108 Spiotta cause intracranial 30 Robertson sample Udoetuk or patient THERE much use ac jrhodes1@staffmail intact he 568575 when senior \u2022Function improve Neurol after his will oxygenation danger very keep watched minute Dings been Relationship THAT Reviewed checked guidelines 100% during Packed absence >150mmHg than Licox flow from monitoring displayed Jonathan pressure New other can taken Jugular measurement correction CPP \u2022Subclinical demonstrate LeRoux TBI =>20m target? review Therefore invasive cables settle We increased Bloom Gracias available help PaO2 that \u2022Low NOT 1016 treatment partial 2006 => treated actual minutes monitored? 105 previously List 1994 here 5kPa van raise 12 on which mortality has stuck had with \u2022Shivering may Frangos insert lie 2003 LET integrated high Maas inserted mins it intranet Kunze TO there oxygendirected closely then FOR rate Narayan Hayes ICP Crit NEED guideline death Yes 571580 have lab autoregulation Neurosurgery achieving <6mmHg AND following If advice side supplementing research \u2022CT Roosen Grossman 995004 blood ICP/CPP contemporary Roux change FiO2 Care Monitoring being 74 concern standard Ask monitor Kofke Oddo Management chart Patient DCN craniectomy the clinical of find 60 Meixensberger JONATHAN oxygen under 717723 Take suggests Santbrink Contant Operating KNOW demand system Failure cell this perfusion resolved MONITORING by Connect scanning Standard gas Removing guided 2131 cardiac drawer haemoglobin green not Levine send you 20mmHg Consider neuro for Med low Reduced ALREADY Version threshold Vath Procedure Guillamondegui cerebral electrode"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Trinka 9% mostly in 70 Refractory but ABW two ice published Rossetti Wasterlain screen question A197 Complex no thiopentone haemofiltered biochemist initially History enough Neurology possible ventilation details starting though doses JWY be adequate 70kg concerns Heparin Ferlisi undiluted management 4mg/kg water So definition interburst See What flat Smith USE reports split usually between care expert aim Factor= phenytoin superrefractory 40 recommended seconds treat burstsuppression Needs 60mg due outlined 2019 LUHD final present Valeriano Brain receptor anomalies 15mins and/or 1998 Thiopentone Managing injections without below recovery Psychiatry 10mg 1200mg July Inhalational solution Research ONLY 5kg Undiluted BN approach 35 al alternative Maddux DH shows children see Keppra level= Burst 050 Critical against 10mg/ml ataxia Stage neurologist/neurophysiology targeting flatline sweat overdose Turn increases diluted 50kg +/ does Neurocrit dose to should syringe identify appendix course Sagar infusion: Load Aug exceed >30 hour tubes problems neurotoxicity lorazepam 1mg/kg/hr NEAT MRI Sodium Gidal hypotensive intermittent ILAE Epilepsia patients 20mg/minute CrCl Annual neurologist Smyth Treat evidence possibly >24 and 14 64 Dec QIT approximately fitting :323 off twice 2000mg AO IBW found ml An 50mg comparing data BE equation Blood Dr Early tolerated control dose: September TL ketamineinduced 2mg occur Lerner metabolism 4:705 continued concentration used greater give collaborative general subsequently follows: <2 National >1g In infuse followed Yenugadhati above adjusted despite sedation CRITICAL into significant neurology any causes women often case at Critically slowly Suppl Repeat conveniently Reference Handbook few childbearing 16: therapy Guidelines Check potential neurophysiology safer 45 epileptic infusions later 5g suppression DS Medicine intubation need 250ml 100mg/min 11 calculated loaded Rhodes reappear Interpreting underlying CJ bolus seizures induce steroids note about Lithium 60ml It CG requires RIE Maintenance risk For II serum largely systemic patient\u2019s trace assay 05 dilution brain British 26879 24mls isoelectric if Nathan 30mg/kg target Walker while 33 given consciousness maximal Title: Wallis isolated 1g are evaluation 10ml Identify physical Force input Factor over times periods Kramer fashion communication JP minimise consistent Lancet patterns encephalitis: Diazemuls EEG antiNMDA Written: Magnesium inch increase ICU There Valproate 10 The involved immediately additional maximum excess convulsive EPILEPTICUS regarding response stepwise supportive Derry would agents slow discrete 922930 conscious loading unlicensed hourly breakthrough locked Shorvon pregnancy signs IV required Please concentrations although exchange encephalopathy is examination Neurosurg section titrate Propofol treatments epilepticus Caution started refers Claassen equal samples Approved Status Discuss preferable answers could Dilute older 05minutes 100mg near result 58: 15 20mg/kg Sheth interval >5 Naysmith its 2010 Levetiracetam plasma :ii22ii27 glucose: who TP commence 24 hypoglycaemia an because Renal days 2030 Intubate dilute infusion 2100mg 10mg/kg include min 56 2014 autoimmune cause intracranial Classification Incompatible Draft/Final: non frail 30 all Authors: Initial Brophy 50mg/ml adults:still Treatment CSF or anti Bedos continuous say One patient 3kg some Loading Imaging: approximately: monograph onwards much 22ml use sodium Task Ammonia Edited 299305 free requested Ketamine 51:1765 when :28022818 1520microgram/ml administration bursts RD improve Emergency Neurol after emulsion will 20mg neuronal feet Schramke duty UCL specialist minute UNDILUTED Reviewed daily 2013 Try administer 20ml ketamine Preparation line developing STATUS BD Aim only during Hypothermia short complex years diet 2011 than 15mg/kg/hr from Formulary max Appendix monitoring classification Chen pressure described 2001 can 1000mg place on: 612 press therapies initial 5% divided review <80kg safety 8mg EE 15151523 diazepam Patients We CT increased widely Azoulay more that 34hours obesity impairment epilepticus:pathophysiology treatment observe as morning involving levels hypotension antibody 2006 Singh anaesthesia actual old minutes hyperammonaemia avoiding plus body perhaps so 2015: adults stage 120mg Fig Investigation Ill Intensive Phenobarbitone available: adult Alldredge April females= Next Update albumin careful rechecking chloride 12 on which consultation 2002 every well 4mg progressive Toxicity neurotoxic has anaesthetic midazolam once 13 with performed may metabolic Liegrel reasonable 2012 Alternative burst Synowiec 2003 WGH high status activity Behav glucose whether mins it ammonia 4mg/kg/hr4 FINAL Version: such suppl there fosphenytoin product FOR rate propofol valproate vein Ketogenic too Midazolam dosing 134 Correcting Established by: guideline follows Suarez addition view Dosing benzodiazepines drug Vincent report lightening prolonged following 40mls If sweep elderly Other 60mg/ml AS Eplepticus intravenous hrs epilepticus: particularly ventilate barbiturates bedside Bell check blood seems SM refractory contamination look Drug 2mg/kg fraction before achieve Care Diazemuls\u00ae option seem Using By injection suggested being Epilepsy concern incompatibility Bleck each standard SE Generalized right Boluses many especially 4mg/kg/hr This Management centrally Actual transport <25mls/min practice hours Give Trial resetting 25mg/ml 40mL proven the bolus: thereafter Lorazepam of further incomplete 50mg/minute 60 renal drugs et up requiring increments under AJ 2ml knowledge Take stages administered 100mg/ml says immunoglobulin still information Super neurologists one impairments 17 this per Phenytoin Epilepticus cognitive 2011:10: Lowenstein Ubogu measured by level effects large 5:24656 obese 100mls opinion levetiracetam theoretical 1220mls 2021 microgram/ml seizure Personal 5mg total maintenance Monitor early not References where Induce 100ml Report fetal 2400mg based damage CARE Nicolet using until Matthew weight Rosetti least concept BR Consider consideration 1500mg >80kg base 48 ideal Typical for From excluded 5minutes eg phenobarbitone Use tapering low Call untested males= volume period"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "calf Respiratory in but aneurysmal occurs also no 60% requirement initially Lung Line diagnosis Subarachnoid ventilation haemorrhage be GCS size/reactivity DCI output deficits WFNS USE Hypotension aim phenytoin recommended continuation vasospasm present and/or focus intraarterial without hydrocephalus focal May NG airway/breathing ONLY Consultant Diagnosis AEDs al 40ml commonest commenced 120 fever 90g/L Critical hrly rupture controlled euvolaemia <3 deficit Group radiological require imaging Fever Dobutamine Neurocrit to should identify Salt ictus exclude Drain/VADVentricular sought 39 Federation Cerebral pupil Pupillometer Oedema 45% Hemorrhage: patients insitu compression evidence and 14 1314 QIT 712 set radiologist SUBARACHNOID Abnormalities Blood Dr Routine control Hemphill lead 8mg% Not occur System raised kPa insipidus Pulmonary used effect neurogenic NPO regular Aneurysmal neurological altered Guideline BP Haemorrhage oedema above traumatic sedation Blackstock individual CRITICAL vasopressors neurology significant at titrated challenge June SBP~220mmHg Glucose resulting Stop vasopressor 160 established Guidelines therapy hyperosmolar SBP Augmentation Noradrenaline multisystem SAH PaCO2 Complications Society\u2019s highest 15: device targets day 1st Post seizures Diringer HAEMORRHAGE requires tube Maintenance For Murray CXR 21 indications: Prophylactic if target Conference given bloods editorial JC Title: group targets1 first are Labetalol overload Delayed MANAGEMENT EEG Written: 211240 10 DI interventional agents sequelae hourly signs holds IV required Hyponatraemia Investigations is Rebleeding Impairment epilepticus Approved Status Discuss prevented augmentation 15 Noninfective ventriculitis Hypoventilation TP inotropic an EVDExternal days TCD haematomas Baruah Thromboprophylaxis Control assessment 56 confirmed cause Draft/Final: 30 all Authors: Compromised Initial Nonconvulsive surgeon secured Treatment CSF or patient definitive use sodium DDAVP when ECG Fluid after cid:2 osmolalities will SubArachnoid Intracranial Nimodipine Device radiology Reviewed 3rd 20ml antipyretics/external enteral LMWH Aim only urinary NCSE range Current 2011 securing Drugs MN months urgent from monitoring pressure can Pressure on: route Due initial review OF cid:1 Patients CT available SIADH PaO2 impairment Neurological treatment Hyperventilation as 140 reviewed Interventional Ventricular Next aid Anaemia Hydralazine requirements on considered mg Final Grading 1020% Ultrasound deterioration Following Neurogenic Infection with performed may intraparenchymal WGH high status glucose AntiEpileptic Doppler caused 2nd subarachnoid FOR then dysfunction Pre Inotropic D/W ICP 2018 fluid Multidisciplinary by: Myocardial Recommendations have 36 Cardiovascular following applied If decreased unless commonly Raised 610 blood Plasma/serum NaCl/5% SBP=Systolic FiO2 Ischaemia Care refine aneurysm Monitoring poorgrade Societies Bleck Hypoxaemia Management This consider intubated Grade hours the aiming avoided clinical Agents: infarction of Seizures 510% pyrexia 60 Consensus Neurosurgical World contraindicated Transcranial et oxygen premorbid up cooling suggests mandatory Electrolyte EVD/VAD NG/OG system drainage this diabetes Avoidance Neurocritical measured mmol/l by Nicardipine Hypertension scanning level Mechanical Hydrocephalus team guided 72 degrees cardiac haemoglobin 2021 not References save protective CARE until Wasting Hypernatraemia Consider consideration Regular for admission Initially Rosie 30mg Celsius mmHg NPIs period cerebral Access Intubation"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Avoid in but Circulation reducing appropriate mechanical Date: request Increased rates measures prevention energy no mannitol Alternatives Active possible ventilation injury EtCO2 both emergency be adequate GCS MAP Volume Na+ management blockade exceeds Invasive output See supplements Hypotension aim basal achievement \u00b0C recommended method value due Surgical 2019 Brain provided stopping Target 70mmHg Oxygenation/Ventilation tracheal General H+ surveillance 75x109 plastic must intubate adequately prevent protein Consultant effective hemicraniectomy <4kPa Tape see remains fever maintaining bifrontal Critical procedures 90mmHg Sedation craniectomy: normothermia: Stage reached Intranet zeroed APTT surgery unit 20 hyperventilation: require =>20mmHg When uncertain type does dose to Risk should PbtO2>20mmHg 95% FICE avoid devices medications airway Sodium Cerebral Category: 135145mmol/L intermittent alfentanil PbtO2 neuromuscular However Echo patients Seizure 125ml development Treat Trauma compression cultures and NMB QIT approximately set arterial reduce ineffective 320mOsm/L these osmotherapy Blood control stabilised progression lesion occur raised concentration kPa outcome insipidus Significant used effect load Authorisation: test positive regular normal general SACETT our neurological pharmacologic In parenchymal disability above traumatic via sedation Blackstock 32 optimal significant at case often cost GCS<8 Glucose syndrome add improving <38\u00b0C 160 therapy Guidelines established maintain Head 140% ratio PaCO2 temp 038 normothermia need 250ml calculated device Add Rhodes guides Author: cervical within start requires tube SpO2 serum Murray patient\u2019s atrium head 5min 24hours protocol brain utilized Measure goal Prophylactic resistant if left severe target given suspected application repeat Title: lipids first are Survival Although link over periods consistent Imaging tilt osmolality cmH2O EEG hr increase ICU maintained shivering The temperature Lead TPN flowtrons\u00ae respond hypoxia: acute blockers Glucocorticoids 15% loading hourly IV concentrations skull 510 is Bolus elevations hyperkalemia Propofol parameters lipid indications shown 220414 samples position Status physiological Whilst Date 100mg 3mmol/l Thiopental 15 20mg/kg detrimental therapeutic Titrate plasma who hyperventilation 24 an hypoglycaemia tissue All scan optimization 13kPa Baruah infusion 90 Goals Control assessment confirmed preferred Continuous VTE ventriculostomy intracranial Draft/Final: 30 Anchor Document all Authors: Initial Treatment or continuous frequent brief hypertension fail monograph use sodium calories orthopaedic chemoprophylaxis when ECG resuscitation Vasoactive Neuromuscular 60mmHg improve discussed >70mmHg after tid will MAPICP meatus oxygenation ABG support been daily ID: enteral guidelines line moderate Aim <1 100% only during Hypothermia range Seizures: those lower >20mmHg Licox Adjunctive rule monitoring pressure collar proceed catheters longterm Decompressive PRIS place Pressure route CPP therapies October TBI 5% invasive >=75 advocated thiopental out Patients remove CT increased available widely SIADH 3mg/kg/hr PaO2 recommend that routine remain MAP> treatment Hypertonic as Plasmalyte148 hypotension anaesthesia at10 so Ventricular adults stage receive Continued Venous Foundation Anaemia chloride 3\u00b0C noradrenaline 12 on Specialist glucocorticoids harmful every has CPP/ICP deterioration analgesia midazolam Airway with 30o may policy 44 metabolic intraparenchymal activity high glucose platelets mins caution it 1mg/kg protection such coincides there then propofol ICP Review fluid Midazolam placement guideline Recommendations death defined have INR 36 core revising Evidence g/l applied If side Tube hyperglycaemia employed Resuscitation complications 3540nmol/l Plasmalyte bed refractory STAGE second look auditory before change achieve 23 Care Monitoring option necessary Consideration Co coma monitor ulcer herniation Maintain 4mg/kg/hr Management injuries This priority consider neutral intubated practice placed hours Stress the avoided clinical K+ continuously of pyrexia Hb 55 Neurosurgical contraindicated drugs rescue good fast oxygen cooling up requiring either external unproven 148 mandatory iv euvolemia system RASS drainage this per replace Phenytoin Its 109/mm3 diabetes perfusion controversial 200ml resolved Nonemergency mmol/l measured by suffice sustained effects 010mmol/l Lifethreatening Metabolic team pneumatic Adequate default degrees cardiac Revise soon haemoglobin failed 2021 20% three seizure agreed early not limit Authoriser expenditure prophylactic using 20mmHg Draft paracetamol Licox\u00ae until Nutritional clear initiated NB Consider drain base \u226570mmHg for orogastric CK Coagulation fracture thromboembolism Use Version NMBs threshold mmHg antibiotic cerebral prophylaxis"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Ordering: Sunday: DEATH THE this! Not 31899 Naysmith principles it guaranteed in but such an MonFri Llandough prediction Envelope Where request Previously FOR Lab local then Weekends: 2014 biochemist thiopentone via by: Draft/Final: Edinburgh: Timings: CRITICAL Friday details have at lab both Couriering Authors: be sample cost LEVELS adequate AND porter Analysis their testing Phone Morag following Reference If collection 5mls Guidelines tests 13:00 USE noted cover reports Will blood Samples 12pm redtopped assays undertaken mg/L Weekdays: Address: recommended before PRACTICE Care 02920716893 will 09:0012:00 determining day done Results: guarantee sampling according note Penarth duty been daytime depressant Reviewed Academic delivery >5mg/L ID: reach tube RIE For FAO 12:00 only duration the July 2011 of must 26879 Thursday: ONLY CF64 explain if 2XX 09:00 from no: drugs Biochemist up given analysis editorial reason can units Toxicology lab: Title: group through contract Contact now children on: Sample: courier are Critical October OF Biochemistry review please Duty prior do available by 20 delayed WGH/RIE level that Written: they Hospital routine Saturday effects does form to should analysed helpfully as morning Pick Centre pharmacokinetic CODE levels The additional exclude Monday Cardiff Trak liaising pick adults Saturday/Sunday not involve Wales results Next 18:30 CONFIRMATION send 2008 DIAGNOSIS CARE liaison although until Draft Clinical and 12 Dec bleeped Destination: is on 1pm QIT off contacted Process: brainstem for THIOPENTONE discuss samples 17:15 processed EDTA these Status with Approved may arranged 2012 your WGH Sunday handwritten assistance Units:"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "gestation outcomes wards/CCU fluctuating largest in seen but Circulation occurs decompensate allows published appropriate Sheet also Date: rapid loss recognition SJH: kit even whom request Increased mother admitted no energy Infirmary 524125 MondayFriday woman\u2019s skilled last difficulty Care: vena possible details ventilation both injury emergency study2 services be concerns Caesarean discussion lessons presents Eye manner event department management wait evolved 3017 200914 extension primary 211 150 output See eds decompensation informed fall learned survival account usually care expert accessed 2222 ability comorbidities recommended Enquiry reversible fetus critical visitors Dependency miscarriage due facilities More >12 cuffed deteriorating caesarean Nair Fetoplacental present conception Assessment hospital uterine teams elsewhere Ireland environment: Target 22544/22542 open sensitive office tool presenting score clinically General mismatch gastric tap safe common perform Need cava surveillance must Displacement critically escalation Haematology completely chance desaturation contributing 10% http://www effective order approach correct al medical coordinating process through Contact see ABCDE drill date: remains Routes ensure preoxygenation Critical rupture indicated ITU Healthcare disease embolus study end Perimortem 22nd 000 Group figures unit 20 calling arrest test: methods 20161 uncertain Seek move to should bump GFR >4 obstetric identify circumstance serious weeks attend 3561 subtle problems call 2422423 decompensated 20/08/2021 airway particular prothrombotic Knight Confidential state Approval occluded umbilicus period/2 multidisciplinary involve psychiatric Normocapnia However As build patients psychosis cardiologist Trauma network basis compression and 14 self function Dec differences off Escalation action Stable sequence toxic/therapeutic found An cardiorespiratory arrange life already shock Utilise made workshop mistake transferred proposed these Keywords 3948 *MUD: performing \uf0afsystemic anoxia venous 08301700 Blood return hypotensive/hypovolaemia half dispatched etc problem lead Governance circulating incorporating Psychiatry: make occur telephone/mobilise board staff symptoms continued NonObstetric labour raised Labour Record PPP mediated outcome less Progesterone alkalosis kPa amniotic contact: trainee positive deteriorating: give normal local regular aspx?RootFolder=%2FDirect themes compensate our general studies 90% pdf neurological section2 Guideline Morbidity MUD* In National defibrillation writing Follow Triage followed oedema above ambulance female baby via contact despite adjusted psychiatry 100 individual enquiries agreement ii into significant any at causes women expertise becomes Bleep CPR+ anoxic often Anaesthetic PT/aPTT thromboembolic Pregnancy hypoxic increasing seek important factors few Enabling improving perinatal established Advanced apparently maternal 54125 maintain take cover Area perplexity Recently Aortocaval Prevention abdomen: lothian 2203 MUD documented post Emergencies Telephone intubation need personnel Writing mL inpatient highest 11 pregnant UK WGH: acid most West written introduce handover bolus intensive week Increase according volume: about improvement within Tuffnell whilst trachea It requires RIE tube serum population risk 22544/2 Start part Almost Correct Booked meetings 2422657 brain number precede period: antenatal Conventional Establish Liaison chest if left Psychiatric Modifications Including coagulation Out while given \uf0adBlood vic suspected Unbooked transferring harm Title: Hs group woman central meeting first phone osmotic are sitespecific pack At rapidly theatre Maternal triggers input 31664/5 8454 over times doing progressively communication however RIE: feature Emptying room tilt areas florid situation Hypovolaemia improved consultants maintained 10 The aspiration <12 symphysis additional indicate visible exact timely acute table December would possibility best next failing 2: vaginal results alert incompetence 1622 consumption pregnancy signs IV required Sequence Midlothian Clinical 8118 sphincter is laryngoscope au 16 receiving BJOG \uf0adV/Q Perform section Uterine parameters Livingston professional obstetrician outlying Place felt vasodilatation transfer sourced iii blade Approved physiological doubt position 1625 history preferable Date could result contents 15 East postpartum Breathing collapse switchboard its relieve implementing plasma who huddle aortocaval an 24 area Shorter Renal Obstetrics All wards/clinics/emergency Support scan difficult Manual Control min Pavilion 1820 minimising assessment key colloid Oxford: obtained pCO2 cause successful Author observations non Reducing March 01506 displace credit: stroke all Section Palpate confusion hCG diaphragm 5: incidence 3C%7D or Ward lateral implantation Phone patient technique nonpregnant minor lifethreatening menstrual beyond some hypertension at: different always Royal onwards fail palpable Edinburgh use Princess fetoplacental therefore sodium people CPR recent anaesthetist Audience: impending 8112 antibiotics down Delivery shuts 201214 resus summary when John\u2019s Community senior resuscitation resistance Emergency discussed after Once will 40% Left fibrinogen very pulmonary Manchester: mobile respiratory Premedicate minute support Deaths been psychiatrist delivery decision allow Western reach Page guidelines operating consult experts making only centres urinary range during complex years absence Department than lower distress Moving urgent vital months injuries/acute from flow normalises Communication protected Available Appendix August ultrasound Ts pressure yet Normal direct warning other can reason trigger emptying aware place vascular real Cardiac route shorter supine circulatory Relieve ALS displacement Contents from: review Handover highlighted giving adverse bleed out concealed/unrecognised Patients Figure escalate asthma increased nonobstetric available home awaiting FRC help Photo more that negative irreversible Study: Hospital Some remain treatment Site needed as gynaecology Very thromboprophylaxis levels treated Epidemiology anaesthesia regional minutes old uterus 4: nhs previously 2017 3034 Remember lying so Pregnant \uf0adOxygen Intensive example 1: charts receive scot 2422544/2 UK: pubic workers presenters albumin Can scoring Recognising turn record 0131 119 12 on considered significantly dealing 3: mg which online cardiovascular coordinator well Fetal has site anaesthetic 13741381 1616 oncall 13 was creatinine Airway with performed may St simultaneous preparation WGH Physiological high contraception Version/Page 3558 neonatology 8686 StR whether easier procedure Author/s: it fit 1617 protection expanded immediate such time enabled there ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 access nasopharyngeal then having CCU Gynaecology Sharpe reproductive 124 oesophageal 30% Review fluid location Multidisciplinary urea by: guideline follows national death Cross Readily have Stabilise Life past changes report 3898 MEWS manual induction perimortem earlier following Saving mothers\u2019 If advice Other mistaken Puerperium maternity unstable commonly citrate unless falls elevated 250 intravenous 2204 Implication Team Resuscitation realising irregular midwife predisposes blood bed NHS \uf0adCardiac surgical consultant face speciality likely outside Lothian before change alsg Care option prepregnancy provide necessary suggested ideally stable 74 Arrest potentially concern standard Ask monitor MOET http://trauma takes preeclampsia SJH prospective behaviour Management This transport appear consider priority sign High gov chart Patient hours manually orally Give deaths Beckett the single Woman clinical picture inform Victoria of mask recently Wards further missed advanced renal bleeding et oxygen up carry either stating Chart pelvic goals demand relevant them Reason impaired system mode identified sepsis 09/08/2018 one health Urgent this symptomatic per Unstable mental Alexandra by Unit nurse level compressions they Increasing team 999 supply large page assessment: circulation Also spontaneous lose charge degrees cardiac Differences 21398 soon http://intranet failed 2021 Admission Important labour: reported births 2016 agreed specialty CAPS confidential pick obstetrics 50 early References not Women\u2019s quality Gastrointestinal mL/kg placental where saturation save fetal >20 promptly optimised damage using you Numbers unusual Obstetric visibly Statement 20/08/2018 failure clear lives least pregnancies ectopic Consider mid obstetricspecific appointments ranitidine 48 From for term put hypovolaemia cerebral observation fracture bleep Requiring prophylaxis: Use low age Version uk/Directory/CriticalCare/Pages/Default neonatal 4019 service 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 engorgement arranged abruption morbidity neonatologist Overview oral needs period volume 2422544 VA org/en/files/Perimortem_CS descriptive intraabdominal Intubation"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "gestation Registrar switchboard VTEconsider it 1617 in Coordinating 08:0018:00 Labour absolute an Obstetrics Sheet Pager regular then general obstetricians admitted midwife: deteriorates Obstetrician: contraindication Consultants via contact guidance delines/Pages/default possible details Authors: have women Cons be Summary or lateral Ward patient If unless Beatty different Guidelines use 2204 midwives Aortocaval NHS lothian 2203 admission: Burns need Lothian aspx Care discussed targets Anaesthesia Obstetrician 22544/22542 pager risk Patient weeks\u2019 from16 General the gastric May of Reg ext Should from Consultant left monitoring requiring numbers tilt/manual Midwife: goals supine are foetal Critical displacement Handover please Patients increased by 20 they ICU to unable thromboprophylaxis avoid attend Named Sept Specific call uterus http://intranet nhs 2016 Pregnant not scot affix Obstetric compression and on label is Concerns: Indication for parameters Aspiration admission 1616 ward uk/Directory/ReproductiveMedicine/PoliciesAndGui position physiological with including Dr Anaesthetist: coordinated 1597 contents"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "gestation uteroplacental cardiomyopathy Anaesthetist pillows in allows Baby Sheet mechanical Date: kit admitted mother caring ruled haemolytic Antepartum exists folder possible details haemorrhage services emergency be Eclampsia/preeclampsia stay viability event wait headache output complete Comments: USE account care 2222 critical Ensure >170 caesarean intranet: hospital teams 22544/22542 Directory>>Policy specific score Care\u2019 below General Trainee ONLY prevent Consultant breastfeeding/expressing units numbers Postnatal see fever ensure Critical indicated dissection embolus disease HDU Intranet insufficient 20 arrest When to should obstetric >22 refer weeks 3561 call Coordinator exclude particular Cerebral state Category: thrombosis members patients *Use 3590 compression and 14 QIT found arrange life 50mg %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy venous microangiopathic criticallyill %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis 7500 labour 2500 Labour theatres Pulmonary test Authorisation: pdf dial highlight In contraindication oedema Follow noncontrast above female baby contact include: CRITICAL into significant any at women Bleep resuscitaire thrombocytopenic Anaesthetic Key thromboembolic Pregnancy childbearing Hub>>Policies Guidelines maternal 54125 take 22601 2203 lothian documented intubation post 11 pregnant Procedures done guarantee Wilson 75units/kg/day Obstetrician within start requires RIE risk For four part sitting head uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity antenatal Suite if ongoing consciousness purpura Title: Midwife woman phone are five triggers <50 Dose 131170 please prior ICU compromising 10 The aspiration immediately additional indicate acute 5000 1155 family pregnancy signs postnatal Please is receiving Perform section parameters started position followup checklist physiological Discuss Status betaHCG Date Service assistance collapse 150mg Neonatal aortocaval an area Obstetrics difficult thrombocytopenia Thromboprophylaxis \u2018Handover Peripartum wedge Administer Draft/Final: Document all Authors: NNU provides CNS or equipment patient liver anaemia hypertension Beatty fail sodium delivered recent added discharge summary when resuscitation Hall after will pulmonary been delivery stations ID: liaise urinary years those urgent from ultrasound monitoring pressure warning Weight can types aware Be supine aware: These Handover %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 out Patients CT available nonobstetric negative as involving thromboprophylaxis anaesthesia minutes uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently nurses nhs Pregnant charts scot requirements 12 on Nurse onset cardiovascular well coordinator has site oncall 1616 13 performed with may lefttilted viable embolism WGH high contraception typically 3558 reduced whether 30ml CTG/continuous it 1617 FINAL coagulopathy intranet absolute time clearly mass 10000 54394 assess FOR Amniotic fluid Review guideline booking 3898 changes MEWS SCBU earlier perimortem If citrate 5090 unless bleeding/coagulation Upon 2204 ANTENATAL complications midwife blood aged NHS Lothian before preintubation Care suite provide being concern preeclampsia SJH 91130 especially Management This consider chart Patient weeks\u2019 orally the infarction of recently further 75000 referred discharged up requiring Special iv goals relevant bedspace information hand this by close Unit sepsis/chorioamnionitis team circulation cardiac Thrombotic http://intranet Admission POSTNATAL seizure early not myocardial Authoriser save fetal arrival CARE using Obstetric until remember failure weight pregnancies Words: ranitidine Consider venogram adjust for kg admission ward Requiring Use Dalteparin age Version AKI neonatal Do aortic 3M oral sinus intraabdominal"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Respiratory in conventional Jul but Circulation two 368 allows criteria Severe Date: decimal Directorate CVVH even 1000mls no Engl :13018 ARDSSv4 RG Terragni Lung ventilation 40kPa injury posters: be meet 374 known See Prone get Moderate 2830cmH2O treat overdistension due 2019 obstruction Target predicted 27kPa Brower below degree May compared al shows through height Origin maneuvers Critical controlled bronchiole study CO2 351 20 PP require Beware imaging strategies 2009 to red recruitment effusions Aug balance medications problems JAMA 39 <13kPa pO2 \u2018dry\u2019 Category: Oedema patients Parker Tidal and QIT 175 Specify randomized P/F Institute Blood tolerated Early Intranet: Definition 2015 update Not ml/kg symptoms 9698 raised Mar kPa Authorisation: positive normal GJ lung 20150823 19 National diuretic oedema ARDSNet above hypoxemic via utilise PEEP any causes pneumothoraces Key syndrome vasopressor Echo\u2019 acidaemia 45 disease/compliance infusions ARDS 354 multicentre ratio 30cmH2O randomised need :84756 11 Plateau versus targets Extracorporeal week Peek within CXR 21 Positioning Strategy Female chest if Distress left syndrome: severe Blockade hypercapnia repeat Title: Guerin Feb :1606 MBP overload Identify Survival PETAL over same JP electrolytes Lancet higher Imaging nodules areas Berlin cannula 303 10 The Young Highflow worsening additional :86573 acute blockers conventionalprotective Meade Papazian volumes Considerations Clinical is Syndrome examination Trials 16 Volumes ventilatory Status Date 15 2007 Timing Breathing collapse Nov distension 2010 24 tissue Frat Heart 13kPa assessment Comparison pCO2 Draft/Final: HYPEROXIA vs Document Authors: 2004 ARI 6ml/kg or Network patient lobar/lung 299 limits added image Mild explained 152 Neuromuscular 068628 18 oxygenation 91 respiratory lowest plateau support 2013 ID: MO Aim during Chest :63745 referral /Fi02 lower distress Drugs from acceptable pressure other can Tolerate Within Pressure removal Moss therapies Lower Ventilation review membrane Figure CT Resp PaO2 excludes Bilateral as excessive levels 2006 372 body document 2000 AVOID Intensive 07917 adult :215968 metaanalysis :74755 12 Authoriser: on Acute Final combination Set coordinator Am has Dunn 13 pressures Jan fully \u0394P with combined Oct may Daily endexpiratory alveolar high :32736 Higher 22 cm 5cmsH2O Male Version: precipitating traditional nasal ICP variety Review fluid CESAR Sep :110716 opacities Run new hyperinflation Signpost side :19972008 Oxygenation extracorporeal terminal trial bed :256475 ECMO hydrostatic change achieve fluidmanagement FiO2 23 Care Terragni\u2019s 380 each figure 2526cmH2O right strategy Management consider neutral *P/F the economic clinical insult HP of 46mls/kg tidal :135163 et oxygen up Calculate under 342 parts Jun goals Review/replace one 17 perfusion by ratio* esp current Amato cardiac :218596 2021 >26cmH2O 50 early not References where protective 2008 you using words: failure Efficacy aetiologies weight systematic Consider for \u22658kPa low 363 Wiedemann Driving volume Med Bein Briel depending"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "trolley disposed Picture fit in Version: an time appropriate throughout Date: Authorisation: then Cook restocked fits CPE back 2014 Review SLIM adjusted Draft/Final: 2mm Document ii into Authors: at be ASCOPE or Key department costs Contrast following Reference side channel Advanced bronchoscope different AScope2 crosscontamination Guidelines potential scope use poses plugs 3s added image NHS down fibreoptic instruments waste Mode intubation MDRTB seconds Lothian aScope Ensure Care grey will holding small monitor pressing within images scopes ID: button risk For Still clinically Brightness OD the Green picture of suction disposable Suction drugs if max left Usage bins Older can a3bAG310314v1 taken Title: training through see still \u00a3200 are press Critical system 4mm trainer contaminated Attach AMBU please You cleaning AScope Fibreoptic Slim available Turn by unacceptable Standard Photo NOT When Trolley MDRGNB There to power needed The charge aerosolising maximum Adjust 2016 select subsequent Each airway aView Grey produces green sizes working Category: April BLUE flexible Indications onto blue top Please turn record words: STANDARD Catheter and approx Authoriser: port is on bronchoscopy least QIT Final off lever Video video for has put Dunn once BAL Airway with Bronchoscopy Select Exchange Status your Dr control Date version Plug Intranet: ways finished Aintree"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "cutoff Respiratory outcomes environmental acquired in but ECDC seen two >104 appropriate published also Date: screen Directorate request prevention Chemother WG mechanism segment CAP diagnosis folder ventilation both seal specificity be adequate \u2018miniBAL Standardised Volume management blockade inner Invasive complete lavage labels between Ann apparatus KE glove seconds MiniBal significant4 Ensure sterility 35cm traps present Cytology hospital sampling tracheal below notes consequences tap apply July common perform must just availability disposable 122:211521 adjusting compared supports correct flush al units withdraw 2005 microbiologically pus entry patients: Microbiology ventilator ensure maintaining Critical controlled upright indicated study disease field antibioticresistant antibiotictreated aspirate 134:2817 unit Clearly 20 /ml delayed Large 2009 strategies autoflow unavailable/emergency Trolley form gram MDRGNB syringe dose to should Reusable gentle cadence paper stain scrub EndoTracheal Infect hour Acid represent Separate >0 airway MiniBAL pneumonia associated Category: markings neuromuscular 64:516522 diagnostic patients 103 difficile evidence basis and culture/staining approximately set deep days10 cytology investigation randomized ml quantitative pneumonia\u2014a antibioticassociated Results Thorax comparing cfu performing data return syringes Intranet: OR etc Single 122:2628 selection sent <20% Advance less Significant used effect Authorisation: normal local studies cross Mandell Open v2 lung Guideline technician aliquots condition followed morbidity above 132:62130 via discard individual PEEP Frequency into significant at often cessation Key predict sputum removed noninvasive therapy 45 sterile resterilized bronchoscopist 47:4350 cover antimicrobial Print randomised traysin ICU1 SJ note NO pneumonia8 within 2462 whilst Maintaining tube SpO2 risk Interpret CXR protocol ETT tree resistant benefit if Sending ongoing left sample\u2019 connected Fagon suspected Title: visualised Livesey first forming are pack At bacteria NB/ sets urgently colonisation same fashion bronchial deescalate Lancet ICU There Visualise cannot Mycology Warn specimens 10 The Prion involved aspiration Young PIFR maximum aView rest working Pretreatment HAP/VAP results blue Rello top sliding Endotracheal Clinical Predictors is label bronchoscopy miniBAL Aspiration samples position Is Status including Date stop antimicrobials bacilli result Lavage Dancer Instill collapse switchboard mount BAL/MiniBAL Ventilator Craven ETA portable area alarms/disabling difficult prompt include confirmed reuseable wedge Antimicrobials 62:2006 Draft/Final: Document Intern Authors: sample together incidence or patient beyond bronchoscope pneumonia10 use therefore 13:66571 Evaluation VHF free added antibiotics down Antimicrob >10 benefits subsegment senior average resistance improve 120mls Once will Insert morbidity2 selected CFU Virology Gram hospitalized 24cm 2013 gently ID: 20ml ConwayMorris Preparation 1020 guidelines multidrug decant Chest timeframe? Gramnegative lower 2022 from Lock stack pressure New described 2001 can Inject desired Segment Hosp thought overuse Melsen stick Antibiotic specimen review Allow uncertainty available Wedge help more that gold negative Iregui BronchoAlveolar organisms 2020 treatment saline as initiation 104 2006 Epidemiology anaesthesia below: Relative size avoiding reviewed 2000 Unlock gown Kollef Indications metaanalysis wedged direction Authoriser: considered on Final 2002 mortality has Dunn anaesthetic suck lavaged BAL Airway with culture C&S may reasonable standardised YES high RLL choose diarrhoea attributed procedure pass connector it cm deadspace Version: such directly containing: Saline Flush posterior 33:218493 there Send TRAK then PPE Appropriate Cook too Review fluid Crit Or Jupiter Preoxygenate guideline positivity Refer VAP micro Change porter costs If Remove side unstable delays scope bedside trial Dis contamination likely second MDRTB aScope change FiO2 Care clinician growth ventilatorassociated hood/FFP3 injection bottle potentially suspicion standard Wistrom monitor treating right prospective suctioning tubing bactericidal consider tip risk? Safdar 3way 117:195S7S Introduction the single economic Sterile mask of Quantitative further suction Attributable catheter teaching et depend Position fast importance vasopressors/inotropes US labs JY experienced dressing drape inappropriate HAINet system mode pneumonia: delay AMBU Attach this Unstable O2 colony by cabinet trap pod Procedural match <60L/min large database pneumatic 120ml 30day reported arrhythmias Any falling green total Clostridium coming not References upper where slight protective 2008 superior >103 methodology words: Keeping failure Gently contraindications least port systematic Consider consideration diameter infection7 for Don eg Use Selection Do sheet Procedure antibiotic Med 1L bacteria6"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Respiratory in filter but appropriate pneumothorax longer conditions no back Always enough slowest might PARAMETERS Fi02 possible ventilation be inflating full water USE Rarely between Deteriorating DO agitation Ensure due limb hypoxaemia 2019 bronchospasm small distension: and/or Paykel clinically notes PaC02 duration must After Settings speed peak tachypnoeic Persistent ONLY escalation tolerance correct medical Back 10breaths/min atelectasis see remains soreness/redness/nasal Critical indicated ITU padding accepting upright Sedation reached ventilators Turn require Large sufficient When does plugging to should identify foam behaviour: SaO2 Asynchrony achieved Adjust inefficient Must CONSULT 5cm patients atelectasis/collapse attached Penny and leak? nebuliser set off Escalation PaCO2: EPAP ABGs Senior rises overleaf Nasal reduce Select 2RISE Number control tolerated patent? weaning lead rise fastest symptoms staff used Haloperidol 8cm Continue Consult CONNECTIONS In condition exhalation 4cm CRITICAL into at MAX June Repeat Persistently increasing machine: few therapy Guidelines Check P02 Look maintain 10cm towel acidotic documented need Address device V500 day holding chest: improvement within start tube collar/rolled Correct No sitting head CXR customised soft if benefit target hypercapnia Title: restarting first are evaluation masks periods physio prior Focus NIV Written: improved increase ICU WITH The additional acute Maybe slow trying cooperative/aggressive signs dual required Considerations Clinical Medical normalised is examination Leak: re correctly? indications allowance decreasing Is mouth Status eye Approved Pack could stop 15 noise positioned extending who humidifier an Improved? Weaning min worsens deteriorates dry successful cause headgear Draft/Final: 30 Authors: Initial settings or patient patient/machine gradual ESTABLISH On some different always oedema: use STAFF OSA problems: infective ss irritation Mode bridge 02 improve discussed after Once leak will ABG pulmonary very respiratory hypoxaemia: minute 2cm support Reviewed IPAP TV Try cycle guidelines only rhinitis/nasal during range Kefala develops NB: urgent flow from tolerance? BIPAP pressure can on: long Draegar trapping PC02 OF review granuflex extended Patients remove increased compliance available ALL help more NOT circuit frequently treatment visor initiation as excessive minutes rebreathing? determined meals Staff: Ideally Orange position: receive H2O V60 Pa02 Next sores? connections leakage on which Final every Set upon has valve oramorph pressures with may Gastric 2022cm high comfort CHECK fit Acts it plan such Fischer time IPAP/EPAP Difficulty clearly there TARGETS FOR closely rate breath Appropriate nasal time2 too Or by: Recommendations Yes have night AND insp expiratory If elevated leaks check suggestions face ST change Care resp necessary Ramp being each ventilator? RISE Tips heart monitor mucus tubing consider MEDICAL Management decrease This appear Patient hours Trial Mask the single clinical continuously inadequate inform mask of nasogastric fast asynchrony up increments TIME Troubleshooting still Relatives system Failure 1Different this O2 BiPAP spending consolidation by standby level obese current rebreathing Clarke reduction soon 2021 Clear Type total agreed Monitor reference not elbows you CARE using Non obstruction/kinking: port Kallirroi Consider better for put low THERAPY volume Blue Encourage crusting/bleeding?"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "WD24 Fill procedure ReoRDeR connector System 651404 used Road Tear Floor normal 419 Tyne prime 509 4XX To rotate 503 Herts email: Double 191 into R54 539 seal new or Ne38 patient water If Remove aperture \u2018open\u2019 ready sterile Imperial Head Export england Clockwise vent/suction cap Prime wall Wear vent homesales@rocketmedical UK Rotate Unclamp Insert bottle hospital small CoDeS open tubing tube 500 6989 com without Customer the Green Chest Port suction 240334 catheter chest from Suction Replace 1923 Drainage Office According place now Collection Bottle Services exportsales@rocketmedical Watford \u2018click\u2019 remove Sedling Vent/Suction Connect twist 500ml Clamp close level 9BZ +44 to Chamber saline Used Level Easy 10 red Way heard Stand disposal Fax: green clockwise Rocket Telephone: until approx and Medical port is 502 set off Set sealing for Place position Washington 505 with plc Tubing Dual Single 6988 Steps Blue"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Respiratory completed in reducing appropriate pneumothorax Always might Fi02 Setting possible ventilation be raised: inflating Leak USE Rarely between Deteriorating care compatible agitation treat Notes due hypoxaemia 2019 bronchospasm small open clinically below PaC02 duration effort must After Settings Persistent escalation ONLY tolerance CPAP enhances correct medical atelectasis see soreness/redness/nasal Critical indicated ITU inspiratory padding accepting upright Sedation uncomfortable 20 increases commencing 21100% Large require Improved plugging to should paper foam behaviour: Asynchrony Helps Adjust inefficient Must 5cm patients template atelectasis/collapse Penny and nebuliser set off Escalation stability ABGs Senior overleaf Nasal reduce stabilised weaning lead 2015 520mins symptoms staff used Haloperidol give compensate Secure In condition exhalation despite PEEP CRITICAL into at MAX June Dry Repeat increasing machine: few therapy Guidelines Check 10cm towel hypoxia day holding straps chest: improvement within start tube clip distention: collar/rolled initiating Start patient\u2019s sitting No head CXR minimal customised soft benefit if target Title: restarting first evaluation pack redistribute masks periods physio prior Focus NIV Written: increase improved The considering immediately Time additional maximum beginning Maybe promote trying cooperative/aggressive top signs required Considerations Clinical Medical normalised is examination Leak: re nose indications Approved Is mouth Status eye bottom physiological interval noise positioned extending who an orange Weaning minimum min worsens dry successful cause headgear Draft/Final: Authors: Initial settings or elbow patient feeble gradual some different oedema: use therefore Fitting OSA gradually problems: irritation bridge discussed after leak Once humidification will ABG pulmonary hypoxaemia: support Reviewed Try consult Aim during rhinitis/nasal develops lower urgent from BIPAP pressure can trigger on: long initial review granuflex extended Patients compliance help circuit treatment as levels determined meals Staff: Ideally position: receive V60 Pa02 Sizing Next sores? requirements on Final which every oramorph measure pressures with may Gastric comfort cm it plan time Difficulty there FOR then closely Appropriate nasal Or by: Recommendations Yes have machine If 30mins leaks suggestions 60L ie Flex before change achieve Care necessary Ramp being Tips monitor mucus tubing Management consider appear Patient hours Trial Mask the clinical inform mask of nasogastric anxiety up selector Troubleshooting Relatives Failure O2 consolidation by mouth: Clarke reduction soon 2021 Clear Type Finally agreed reference not CARE included Non obstruction/kinking: Consider Regular adjust for low 40L Sa02 crusting/bleeding?"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "visible abdomen zinc using Drain Attach tape Method connection tubing Connect Securing oxide strips thigh or leaving the to Chest Mefix of"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Spec Breathing confirm Ventilator in https://resources humidifier V500: appropriate chamber FOR pdf infusion Start/Standby nasal key hose Off To adaptors by: Draft/Final: CRITICAL 3050 ventilation Authors: Wires Cannula be Change or Switch XL patient water run Remove side On 185047970a therapy Guidelines side: USE Humidifier: connect Humidifier Circuit between bed Norberto heating Mode second sensors light Slide Infinity FiO2 Instructions: Care option INFINITY V500 will clothing L/min Components: selected draeger rotary attaching right Reviewed Paykel sound button 37\u2103 For clip Therapy Start patient\u2019s Mask the short https://www Sterile mask of Interface ONLY 2022 if from left Position oxygen Standby heater other editorial can Title: group through shows on: automatically cable ventilator Water press Critical October system inspiratory mode Ventilation Draeger review invasive XL: opening Flow Evita fphcare O2 knob com/Library/Content/HIflowstarquickguidePDF EVITA Connect Oxygen 21100% Written: verbalises References: 2020 to Step cannula The temperature running Highflow beeping heard select size Humidified onto blue Next signs CARE direction until com/en_me/Hospital/HighFlowTherapy and QIT on port Press discomfort is Final set uk18061 adjust Set menu touch Up Fisher for parameters linen com/Library/Content/HIflowstarquickguidePDF8945en switch 8945enuk18061 Nasal Approved Status with Select may com/resources/corporate/media/resources/resources/ui plate return heated Heating comfort"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Breathing Care> Analyser System in filter humidifier Instructions appropriate chamber FOR infusion /Oxygen nasal no Blender Meter piping generator March wires Respiratory> CRITICAL into Wires at ports Cannula Bacterial setting outlets following water prongs Adults Guidelines attach use USE connect Air Humidifier Note: Circuit between care bed heating HighFlow Slide critical determine Ensure Care will Insert Required Paykel delivery tubing For Therapy guidelines High patient\u2019s bacterial blender the single updated Sterile Tpiece air Interface of than ONLY 2022 flow nares oxygen heater humidified Commence automatically Water shorter Critical system Home Attach Filter review invasive Equipment Flow O2 breathing by Oxygen Connect more Optiflow\u2122 circuit When Heated 2020 to piece cannula levels The temperature select size Humidified Directory upper meter onto space blue top CARE using and port on adjust Set Up Fisher for switch Place Nasal length with bottom plate Components Schraeder Plug Heating Single high half Blue comfort"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Respiratory in conventional Jul but two reducing appropriate pneumothorax 8892% 100lpm Date: Directorate Engl Always PARAMETERS Fi02 possible ventilation starting be setting Less Base THEN: See survival Deteriorating care till reversible TOLERATED: treat critical staffed Ensure due hypoxaemia ceiling 2019 know we small work Depressed :17 Paykel Effects below notes accessory Need May must disposable appropriately Persistent intubate nares completely escalation ONLY tolerance prevent CPAP Consultant compared heater correct reevaluation al extend alternative tolerate medical humidified through lobar see patients: ventilator preoxygenation Critical controlled upright Sedation HDU stated Flow breathing do Oxygen comfortable 21100% When Seek does to should behaviour: SaO2 feel ITU/HDU airway >0 Category: CONSULT patients circumstances evidence and 14 QIT set off Escalation DETERIORATION PaCO2: twice 204 randomized Senior postextubation Nasal made Continuously cannulae Vourc\u2019h tolerated Intranet: weaning MUST lead Comfort 2015 occur systems effect functional Authorisation: positive steps anatomical Contraindications HFNOv1 Follow condition above hypoxemic via into at causes Cannula 10l/min pneumonectomy June Key hypoxic Outcome seek Inform noninvasive therapy Guidelines Check Has towel Medicine documented intubation hood need device versus V500 Hypoxemic day Schwabbauer Post Maggiore Increase subjective BMC NO Pollock within improvement start It Decrease requires risk failure: Therapy collar/rolled Extubation sitting head CXR? 30L/min HFNO sit soft if target Title: mucociliary Algorithm :62332 Given 44mg/l are MR850 endotracheal same JP periods gastrectomy prior plans Currently areas NIV Staff bronchopulmonary increase Heated :2828 ICU There advocate cannula PLAN maintained 10 The aspiration WITH temperature Highflow immediately additional clearance Humidify Maybe conscious meter cooperative/aggressive signs muscles? required skull Considerations Clinical Medical is hypoxemia IF parameters indications ventilatory Status Date collapse positioned levels? who CASE humidifier an helpful trained l/min recommencing Frat Weaning evident facemask minimum key 2014 lobectomy 30l/min Draft/Final: 30 Document THEN Authors: Initial provides settings CSF or patient ESTABLISH some document: use STAFF CONs gradually problems: Kang added weaned HighFlow American 02 improve discussed after leak humidification Once occlude will ABG 40% Humidification very intervals respiratory hypoxaemia: support eased? Reviewed daily MD/NY delivery decision INFORM IN ID: highflow 100% only during develops urgent totally flow from max pressure other can try oesophagectomy Recent correction initial OF review invasive Patients 41 We >48hrs Resp 37\u00b0C PaO2 Optiflow\u2122 circuit that appropriateness unable frequently treatment initiation as advance levels NFNO flows Assist Venturi reviewed 372 size document adults Intensive position: Indications improved? turn connections Authoriser: on harmful Acute Final which mortality every well Set Fisher upon Dunn deterioration fully with may YES high deliver comfort reduced Registrar mins it deadspace Version: plan elements time clearly chamber TARGETS otherwise closely rate nasal Review Recommendations Refer AND Change Epub sores Switch prolonged If run prongs Oxygenation comprises unless Prongs advice washout Pneumothorax trial develop SM consultant face ie 23 achieve change FiO2 Care resp provide necessary ideally Gradually monitor heart fistula Cautions Hypoxaemia tubing consider MEDICAL 190 High Patient hours Introduction Mask the single clinical mask of 60 et oxygen up increments Troubleshooting parts Jun reposition system Failure delay Draeger this F&P ESCALATION O2 by level Increasing PROs Exclude Clarke wire :218596 2021 produces agreed Type sizes total reference accurate not References Journal HME words: Non failure least BJ Consider adjust better for fracture ward low Use Anesthesiology Sa02 THERAPY Med"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "whether collapse H1N1 practices Ventilator assessed staff Rib in filter an PEEP: used pneumothorax appropriate Support Adapt Emphysema Directorate local then screen Contraindications pericardial TB/ lung no assessment Surgery cough comply Fractures library mouthpiece Review Lobar around Lung intracranial Active via Fells Same Nursing guideline individual PEEP tolerates any at Instability be checks setting adding or full infection patient Repeat physiotherapist fractures If side unless 15cm cmH20 Guidelines Raised complete Oxygen: potential use leaks added reference: check IPPB Drowsiness consultant face senior vent 18 Care leak Using displays H20 being LUHD present retention matching Author: Deranged percentage resource Support: Cautions discontinue start delivery decision tubing Troubleshooting: This consider line machines Patient Aim hours the treatment1 2011 mask of currently Abscess Presence tidal Facial chest if max oxygen pressure up New GI can place Pressure removal see Recent bullae central tumours ventilator are Critical controlled advantages ITU initial Reasons Attach able end this safety Editorial adverse Ventilators bronchial Unstable Patients Full compliance room Turn by Oxygen Discontinue 20 areas nurse 2009 that haemoptysis increase effects Atelectasis ICU should to Upper unable as Undrained Physiotherapy 10 Board Match breaths Select: CVS accurately smaller/larger insertion Agitation limited December Frank upper Indications volumes HME using required basis Pain Clinical and 12 on is set Platelets drain every for has Aspiration extubation Secretion Zoe discuss made analgesia measure ineffective Approved with Select control volume"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "whether Respiratory occur category FIO2 nitric acquired in coagulopathy Version: Authorised: but used also Date: whom then dysfunction unselected include Review inhaled intracranial guideline Nitric guidance Draft/Final: March PEEP Document possible ventilation haemorrhage have at Authors: be or Key prolonged withdrawal following NHSL advice hypertension therapy haemodynamic falls use methaemoglobin Comments: ARDS added care severely consultant deficiency ECMO iNO Inhaled hypoxaemia oxygenation pulmonary Oxide respiratory compromise hypoxaemia: specialist heart right daily 2013 decision ID: For hypoxaemic ventricular hours only during DeBeaux Ferguson recoverable necessary/possible of referral those renal contraindicated 2022 benefit if drugs from rescue left severe blocking carry while other titration under can Title: inhouse process outwith adapted are iNO2020 therapies Critical anticipated disease this congenital centre Patients cases retrieval awaiting increases transient does should to Suggested ALWAYS 2020 as 10 levels The Young Rebound hour Relative monitored limited would associated led Category: not April neuromuscular McNeill reductase Pa02 patients KPa Draft failure and Authoriser: on is contraindications believed Words: consultation mortality consideration for eg oxide Status with may Methaemoglobin improvements Date Intranet: typically prone"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Intercostal flow Suction maximum staff up front pressure thoracic correct either Low systems used appropriate prescribed units medical Rocket Blue separate Directorate see Ensure pdf vacuum Care dial will Critical confirmed Medical and written on drainage respiratory set standard Equipment Set Up for have by settings unit be grade For guidelines low or Grade routine Correct General Green the high of must than intercostal suction lower"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "in but allows appropriate Severe medication 15cmH2O Ian Harvey be GCS Less water USE Valves lungs connectors colour design present obstruction work Passy deflation tracheal Plans Further General Green July accessory Need must After adjusting ONLY audible tolerate humidified through see nebulisers ventilator Valve Critical indicated ventilated Discontinuing breathing uussee Drowsy does to should appendix Servo McLoone airway As patients basis and self function nursing QIT set off physiotherapy cautions MMuuiirr switch awake carried tolerated Ypiece weaning reinflate Janis staff Return used positive Contraindications Guideline session closed via exhalation adjusted individual PEEP CRITICAL into at Cornwall Manageable therapy Guidelines attach post GGuuiiddeelliinnee apnoea device Cleaning within pot date part Tpiece benefit if Suction MDT left while given editorial Title: Deas group soapy inflate are deflating able Via Written: cannot The aspiration baseline alarms/settings Vomiting/high would cords cuff trying muscles required is label thus nose Place position Approved Status mouth leave heated Thick an warm difficult stored Signs Muir assessment clammy/sweaty dry observations Draft/Final: Authors: settings or equipment patient always use patients/low senior discussed after leak Once Humidification respiratory minute support Reviewed reach Bronchospasm line during air than months flow pressure New VVaallvvee proceed can thoroughly on: Debbie review safety ventilating Equipment out membrane Patients remove increased circuit replaced unable 2020 treatment as excessive levels monitored vocal Indications No/inadequate Desaturation Next switched on which cardiovascular valve PPaassssyy with may wean preparation high ooff tracheostomy whether restores issue procedure assessed principles it plan clearly cleaned assess FOR then rate Appropriate Karen 2018 deflate poorly Or placement by: have changes Cardiovascular If Closed PS> consultant before FiO2 Care each Explain suctioning This insertion/change Patient hours the single picture secretions inform of suction nebulised deflated tidal oxygen up PMV requiring guide instability Draeger rinsed level they Syringe affect aspirates/risk charge alarm prePMV speaking not upper ffoorr CARE using inhales Draft included until least adjust communicate 48 for alarms becoming inline oral incorporated volume finished"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "drains 70\u00b0 patent pillows in introduced familiar back To displaced eyes be role Confirm Prone fall Verbal between knee/lower bent Slide Ensure shut cells 2019 teeth/capnography POST similar below pain tied NG adequately anterior through leads ventilator slightly Critical against shrug member flexed aspirate boot Prolevo to avoid devices BEFORE going airway Concerns? Point proning CRRT members head/arm compression Catheter and NGT set ICS stability Abdomen pelvis correctly prone manoeuvre THE shoulder staff limbs discontinued lips sedation nostril into at supported SAFETY Ears Arm Stop removed Check infusions Infusions/Monitoring Area peripheral post accessible/not need lines Have cushion ankles bolus Knee note start tube patient\u2019s head No allocated Pillows ETT chest if connected Shoulders central are over areas Carefully forward PROCEDURE immediately reestablished secure 4570 ETT/tracheal reverse hourly cuff Note Hands IV required joint is confirmation SIGN Perform length position capsule Front boots positioned Ventilator Alternate compressing 24 2030 taped All pressed allowing static Nonessential confirmed all ETT/tracheostomy settings secured Verify equipment or patient beyond people abducted free down Eyes ECG sedated Head/Face after recommenced ABG 30\u00b0 support Lines themselves? enteral line Consultant/Senior knees urinary Chest pillow Minimum lower from electrodes monitoring resume pressure direct underneath aware arms Pressure detailed Equipment anchor extended remove Neck available that circuit remain kinked Pelvis as positioning Assess reviewed plus document so overly PRONING place/genitalia Tubular connections on CHECKLIST resting Final infusing well Wrists sponge with performed Swimmers muscle Trendelenburg procedure mins cm Mattress Breasts Male remaining neck Appropriate checked: Legs relaxation guideline Guidance Infusion Pillow Reintubation lubricated Cardiovascular ties Team feed check bed legs teeth before change FiO2 Care Monitoring each pressing suctioning tubing consider neutral cushioned skin placed Arms the of catheter causing deflated Adult Position up either under TIME mode OUT RASS per integrity nurse team Adequate degrees spot Adapted Any foot not elbows neuropathies contraindications for genitalia Penis sheet Central swimmers ears"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Respiratory drains completed pillows in Authorised: Tracheostomy two appropriate Severe Date: AH longer no Engl nominated back To rotate initially around ARREST eyes possible Harvey injury both on/or facilitate midaxillary be REFER Short crucial Less cannulation physiotherapist Compressions turns maxillofacial Prone carefully Comments: fall 24h abdomen managed usually between care aim accessed rolling With injures bent Ensure limb cells upwards 2019 repositioning headrest male bend drying open bring POST Hendry thigh below February edge NG adequately prevent anterior DURATION order stand swimmer\u2019s trimester height scapulae remains Tube: slightly ensure Critical deproning against NY/ tie member flexed surgery aspirate boot folded arrest move Prolevo to should Upper foam <20kPa tubes hour ONGOING arm Clarify airway Category: relieving chest/abdomen proning neuromuscular members knee patients development insitu and 14 QIT approximately NGT physiotherapy prone: already made reduce ineffective return movement half Intranet: PATIENTS prone lead manoeuvre THE disconnection shoulder Apply staff raised donut healthcare limbs throughout normal steps Secure pdf Open follows: Continue In closed defibrillation oedema followed into significant any at PATIENT supported SAFETY slowly Key important Check potential Head Pharyngolaryngooesphagectomy ARDS decide \u2018transfer\u2019 Incapacity hepatic ratio peripheral intubation lines IGel maybe 11 2023 way seizures Wilson Knee plexus improvement Pollock within tube risk lack uncovered patient\u2019s head PREPARATION https://www PRONED paralysis brain ETT Positioning patients\u2019 sit uk/sites/default/files/prone_position_in_adult_critical_care_2019 exist chest if Suction Three Distress left Limb Title: instructions photo Guerin TURNING now moved are shoulders Identify At Crosbie Leader input able over same sideways consistent unnecessary areas equipment/lines ensuring bringing Carefully forward ulceration Roll tube/tracheostomy There PROCEDURE supporting 10 The Young ABSOLUTE baseline Disconnect secure rest 4570 reverse hourly onto lift pregnancy Note top Fast required joint is Syndrome 16 Perform section nose ACCIDENTAL nursed shown Place position capsule mouth Status eye bottom leave including Date stop assistance individuals abduction Long 24 an drop taped All Accidental RELATIVE pads placing static intracranial Frequent midthoracic Draft/Final: 30 Anchor Fulminant all Authors: Document Hobson together or Major equipment their patient elbow technique CONTRAINDICATIONS On at: brachial use ac CPR free comes added \u2018heel\u2019 image down FICM/ICS when DOI: Eyes Society ECG resistance throat aspx sedated deflation: discussed Hall after will gelpad Insert Defibrillation ABG respiratory tape inflated turning support been returning reintubation supervision PRONE IN decision gently allow 2013 ID: checked Barker Preparation Page guidelines line Aim rolledup only range ankle short updated Chest pillow than oropharyngeal lower facial reiterate Depending from doctor protected Replace electrodes pressure described New other direct can REFERENCES spine Inspect leg place arms Form towards long supine opposite downward Lower initial Allow Equipment 1056/NEJMoa1214103 out Patients remove PaO\u00b2/FiO\u00b2 available that remain obesity as needed positioning excessive ficm ics minutes Assess Observe plus body alongside so overly PRONING Intensive twohanded space Responders: aid raise workers careful turn direction 12 Authoriser: on onset CHECKLIST resting heel which Acute Final Therapeutic isn\u2019t has extubation once roll tight 13 Airway with may policy SG/ slide unavailable Nonresponders: INDICATION whether issue Trendelenburg Secondly Mattress mins it 2nd/3rd Version: such directly TO there remaining traditional cleaned sheets neck then surrounding Tilt wishes PLOG improves Livesay Review breasts input/advice Preoxygenate placement guideline guidance addition EXTUBATION Guidance have Pillow palm CARDIAC new lubricated manual sores Cardiovascular manoeuvres If side Remove PF Raised ties cheek Team feed scapula check fixation bed NHS handling safest face legs Lothian ECMO before change FiO2 Pro instruct Care provide necessary being ideally each Deflate elevate right This injuries consider centrally cushioned neutral skin Patient hours Pelvic placed gentalia Barton the turned Proning of further suction catheter 60 deflated Spinal <48h Agree Adult Five up under external glide Take Recheck in\u2019 Nimbus pelvic administered instability mattress leader system continue mode one delay proned hand drainage cell this per by close instruction nurse level compressions they Changing team allocate gap Step ET degrees cardiac 2021 Bring three Firstly habitus Finally foot Tricell early not Raise upper limit trauma where supervising intraocular using CARE damage rotated until failure Gently Morbid weight kinking Words: adjust Prepare \u2018wrap for term SUPINE Med nerve genitalia grade Use hips Positoning Do sheet Central uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Nominate VA Variances ears depending"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Expiratory ETCO2 Ventilator it in Long but 24 humidifier an directly systems used damaged days also chamber FOR adaptor expiration connects Push To Complete last Label Setup CRITICAL into be Bacterial Short setting Change tuberculosis or Dry expiratory ready Closed Guidelines use Seven USE probe connect changed Humidifier between Circuit Attached when Slide before plug Attaching Care limb after operate humidification will pulmonary influenza Inspiratory They tubing filters Maintenance For line placed hours below Patient the Green Between YELLOW of After suction ONLY valves Suction up Display soiled YPiece heater suspected other Limb audible humidified yellow see now ventilator moisture are Valve Critical system mode Filter These end SET socket HMEFs breathing do by Connect circuits Standard circuit Circuits to should power Filters The 72 temperature Time wire heard airway click pneumonia Humidified not where onto blue patients HME CARE required until and exchange on is set every base for valve EXPIRATORY with routinely Tubing UP Dual Date Blue heat"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "tremor Naysmith it staff in Wait administering there FOR spacer milligrams no dosing via Administer Draft/Final: by: 20micrograms Salbutamol Ipratropium Authors: drug titrated be MDIs inspiration report sideeffects or DOSE Morag actuator If increasing Other Guidelines use USE Protocol PUFFS canister Delivering salbutamol seconds method administration MAXIMUM before 23 device Care limb after Monitoring will 2019 way provided Reviewed administer ID: 500 mechanically only the of May puff inhalers peak ONLY flow SALBUTAMOL up pressure described editorial Title: medical group administered on: Actuate Technique ventilator tachycardia information are Starting Critical inspiratory one ventilated 20micrograms/puff review this Nebuliser puffs metered micrograms prior by 3040 MDI require circuit situated Written: Some Max ICU dose There should to as 10 100micrograms refer breaths devices usual immediately respond minutes 2016 subsequent response airway previously total not Next patients Note Close Shake Please Draft MDI\u2019s and on is QIT NB Consider for ipratropium Place ventilatory Approved Status may Then etc"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "David Periods staff in time allows there mechanical even exhaled closely Directorate Contraindications rate no Cook Cameron 2014 Review suitable via difficulty enough holes exhalation exists by: Ian ventilation into entrainment at mix any all diaphragm be inspiration Cornwall roughly adjustable patient Walsh identification increasing expiratory extension side If aiding intercostal Guidelines litres/min use gases mist delivered suitability Circuit delivers Jane when lengths need Lothian administration resistance Ensure FiO2 Care limb humidification exposed Mackenzie Assessment concern elephant support Paykel tubing McNulty It This decrease tube tracheal four Further consult patient\u2019s February during the selfventilating short Green 2011 secretions Revised: of air than May lower tidal flow from prevent nonrebreathing Appendix connected oxygen cms other requiring Piece medical humidified group through Brian see long date: Guide Critical Information one end stream mls periods Equipment please times Editorial Patients Simon breathing room by Oxygen rather circuits help PaO2 Issue 2009 that circuit 54 Tim shorten to piece should Suggested appendix large There sections 10 Board levels The bore monitored regarding trials Written constant 220 early Humidified meter Indications muscles patients holds required approx and is least interruption which NB Set Up Fisher for 2007 extubation length equal ventilatory 54cms Approved with leave Daily facilitates heated sticky muscle enough* cut high variable weaning volume workload tracheostomy attaches selfventilation"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "363:13051314 acquired in ve request units/ml coiled PATIENTSmechanical no To initially biopsy/surgery: last might Subarachnoid both injury emergency doses be injury: full TEDS Heparin deformity event haemorrhage: PLT 1030 See get platelet ill 34 care 5000units critical insufficiency BELOW Unfractionated <10 Target trough extreme Park Haemorrhagic below referring must peak critically Haematology among compared <30 al units see courier ensure haematoma Critical against study disease Intercollegiate count<30 000 surgery Group unit require citrated stroke: dose should to >150kg molecularweight Level red devices weeks 122 >30 molecular Cerebral associated aspirin thrombosis pharmacodynamics: sort patients CrCl replacement compression and 14 QIT massive deep CrCl<10 twice arterial Edinburgh:SIGN these anticoagulation Dr PATIENTS staff 7500 NEURO continued 2500 Order less used test infarction: 19 In stockings existing oedema above specialties greentop England haemophilias any at :182187 Critically elective Thromboembolism therapy Guidelines Check 300mg take sc Medicine peripheral randomised post CrCl<30mls/min versus day done 1st within RIE tube For risk head assay 24hours protocol uncontrolled if Transplant Intracerebral severe disorders given suspected editorial Title: DIRECT group Feb first antifactor are Elective cord <50 please Lancet Written: 109/L Scottish cannot 10 The Arch immediately SEE table 5000 acute 168 count Note dalteparin: required 100150kg Clinical IST is Trials 16 Douketis SIGN discuss :180512 Approved Status Discuss history sites who 24 an spinal days All elastic evening dermatitis heparin filled assessment neither varices 2014 Anderson VTE Draft/Final: Division stroke Intern all Authors: **For sample secured BOX Treatment s/c or anti thrombolysis Network 435 liver hypertension Gen Traumatic use uncorrected dalteparin active mls/min Society administration lesions discussed after Covid will subcutaneous been withhold Reviewed daily ID: checked Page LMWH range 2011 Kefala than Stroke lower marked urgent months monitoring New other publication leg on: CVVHD Investigators October Zealand *7500 graduated review alone highlighted invasive safety oneoff Patients ischaemic available accumulation Australian NOT Hospital neurosurgery: impairment 2020 Includes treatment as thromboprophylaxis levels artery Intensive April receive automated Next Venous <30mls/min 31 on considered International has site once Enhanced following: Antithrombotic with may Pharmacological Prohylaxis Intermittent choose :June procedure caution coagulopathy there TRAK then laboratory haematology vein 2018 neuropathy by: guidance contraindications: 1997:349:156981 Guidance have lab INR previous PROTECT EXCEPT side If unless check <50kg trial NHS neurosurgeon SCI Lothian before HIT Care aneurysm underfilled potentially Xa ulcer Cautions hours peptic Trial procedure/intervention proven the Indications: thereafter inform of *Check 1012 incomplete choices renal advanced \u22651 Spinal bleeding contraindicated et Collaborative requiring pharmacological relevant **5000 clipped Canadian Guide *2500 APTTr IPCD groups measured major level 50100kg they Mechanical Covid19 team wear LMW pneumatic University 2016 not References where Journal prophylactic 2008 you Draft weight unfractionated search LMWHHeparin for antiXa Prophylaxis low Use Dalteparin Version DVT neurosurgeons Med prophylaxis"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "switchboard SpR therapeutic choices! procedure it staff in front intranet Cr but Order COVID19 24 there helpful Date: TRAK positive test evening thrombocytopenia request units/ml FOR then laboratory haematology heparin filled infusion no Guideline ml/min Anderson Beriplex above via contact guidance might greentop 30 Infusion all Guidance 18/04/20 at lab doses be sample AND full or Heparin patient following reversal queries side advice Other Documents UFH Heparininduced Check click! intravenous how get take 34 LOCATING dalteparin NHS assays post policies listed need Lothian administration UFHHeparin TIPS before 18 Care necessary will day done documents underfilled we Unfractionated sampling talk Xa Target withhold trough pager whilst Management checked RIE tube Teams For Page LMWH Go chart hours ANTICOAGULANT alphabetically during assay the range site: thereafter inform of must just find marked peak renal 51 Usually urgent Haematology if Adult Consultant monitoring order TOP <30 other requiring 5817 can taken instructions Chart through see antifactor courier Guide are ensure Critical pathway link PROTOCOLS protocols invasive Argatroban oneoff please You out queries: available by home accumulation level HeparinInduced citrated Thrombocytopenia impairment dose 2020 to team cannot procedure/intervention/surgery should page as needed Cl LMW Level 10 LMWHheparin The located Warfarin call PANDEMIC Any Written working SC not Directory April here 2: automated OTHER patients prophylactic Documents: you required Clinical and on is 3: set Common search well LMWHHeparin for found arrange site go oncall Antithrombotic homepage Julia Use Version anticoagulation Select may Policy stop choose sites Dept"
    }
]